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Identification of structural and antigenic components of Bacillus 
anthracis spores and their application to rapid detection using biosensors 
Tracey Elizabeth Love 
Abstract 
The work presented in this thesis describes a rational design approach to the rapid 
detection of Bacillus anthracis spores. A range of assay formats are available for detection 
of B. anthracis, however none fulfil the criteria of speed, sensitivity or specificity. Optical 
biosensors have shown promise for the near real time detection of low molecular weight 
analytes, although exploitation of these systems for bacterial detection has been restricted 
due to a comparative lack of sensitivity. Electroporation was unsuitable as a disruption 
method for immunoassay based techniques, whereas preliminary experiments suggested 
sonication could be utilised. A novel tubular sonicator designed to operate in a continuous 
flow format, and to minimise antigen denaturation was shown to remove the exosporium 
and some of the underlying spore coat of B. aflthracis spores, resulting in a significant 
increase in assay sensitivity (up to 500 fold). A range of methods were employed to 
characterise the structural and antigenic components of the spore, focusing on those 
released by sonication. Many of these were not suitable for detection purposes due to the 
high levels of identity with homologous proteins within closely related species. However, 
BxpA and EAI and two novel B. aflthracis spore proteins, a homologues of B. cereus 
ExsA and MntA, were identified as potential targets. Computer modelling techniques 
mapped the unique regions of these proteins to potential binding pockets, indicating that 
they could be utilised for the production of specific recognition elements. Due to the 
inherent problems with the use of traditional antibodies, single chain antibodies (scFv) 
were developed. EAI was used as a target as it was consistently identified using a range of 
methods. Results indicated that it was predominantly associated with the spore and was not 
completely removed by Urografin purification and subsequent wash steps, in variance to 
previous work. Elimination of previously observed cross reactivity of scFv produced using 
a standard biopanning procedure was possible through the development of a one step 
competitive panning strategy. Finally, through the use of the scFv produced, combined 
with flow through sonication prior to the assay, near real time specific detection of B. 
anthracis spores was demonstrated through the use of a known protein target. 
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Chapter 1 Introduction 
1.1 Detection of pathogenic micro organisms 
Biological agents with potential use in biological warfare (BW) and bioterrorism, can 
broadly be divided into three categories, toxins (that have a range of sources such as 
animals, bacteria and plants), viruses and bacteria. The number of agents that could be 
utilised is extensive; however, of these a significantly smaller proportion could be 
effectively disseminated and infect through the aerosol route, considered the most likely 
route for a large scale attack (Christopher et al., 1997; Eitzen, 1997; Pile et al., 1998; 
Franz, 1997; Kortepeter and Parker, 1999). Microbial pathogens that could be used 
include: Bacillus anthracis, Yersinia pestis, Venezuelan equine encephalitis (VEE), 
Francisella tularensis, Variola virus and the haemorrhagic fever viruses (Arenaviridae, 
Filoviridae, Flaviviridae and Bunyaviridae) (Christopher et al., 1997; Hawley and Eitzen, 
2001). Toxins also represent a threat from potential use as BW agents; examples include 
those that could be isolated from Clostridium botulinum, Ricinus communis, trichothecane 
mycotoxins or staphylococcal enterotoxins (Hawley and Eitzen, 2001). Some of these 
agents, such as VEE, are considered incapacitating agents and others such as Bacillus 
anthracis as lethal agents (Hawley and Eitzen, 2001). Of all the lethal agents the most 
serious to the human host are haemorrhagic fever viruses such as Ebola, Lassa fever or 
Marburg as no prophylaxis or vaccines are currently available (Bray, 2003). However, 
these viruses are much more difficult to produce than toxins or bacteria. Virus propagation 
requires more sophisticated equipment and a higher degree of expertise, for example tissue 
culture. Bacteria by comparison are much easier to grow once a source of the pathogen 
has been found. 
The rapid, sensitive and specific detection of pathogenic microorganisms is essential if 
effective countermeasures are to be provided to a susceptible population. In the case of 
bacteriological testing, traditional microbiology has proved a time consuming procedure. 
Organisms have to be isolated, grown and usually a series of biochemical tests must be 
completed for identification (Helrich, 1990; Poxton, 2005). Techniques such as the 
polymerase chain reaction (PCR) used for the amplification of pathogen-specific DNA 
sequences have proved to be sensitive. However, when using environmental samples a 
degree of sample preparation is required as impurities contained within the sample may 
inhibit the PCR. Furthermore the use of small sample volumes (sometimes I 110 means 
that the sample often has to be concentrated to obtain the desired sensitivity (Radstrom et 
al., 2004). 
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Biosensors are particularly attractive as a means to detect and identify potential pathogenic 
microorganisms due to their potential specificity and sensitivity (although this is also 
governed by the choice of recognition element), together with the provision of information 
in near real time. Biosensors also allow the analysis of complex sample matrices (Hobson 
et al., 1996; Ivnitski et al., 1999). To provide protection, i.e. timely warning of the 
presence of a pathogen, environmental samples are often analysed using biosensors. This 
presents an additional problem in that other microorganisms will also be present within the 
sample. The detector needs to be able to discriminate the pathogen of interest from the 
background and this can be achieved in a number of ways. These include (a) detection of 
an increase in the number of particles; (b) detection of an increase in biological particles; 
(c) detection of pathogenic biological agents; and (d) the specific identification of a 
biological agent. Specific detection is dependent on the interaction of the target analyte 
(for example, a protein) with a recognition element (for example, an antibody). The use of 
biosensors for sensitive specific detection of a pathogenic microorganism still remains a 
significant challenge and success is often dictated by the nature of the detection element 
(the specific ligand) and the choice of target analyte (Labadie and Desnier, 1992). 
One bacterial agent that has attracted a significant amount of interest is Bacillus anthracis, 
the aetiological agent of anthrax. The nature of the spore and the fact that it is very closely 
related to other species within the B. cereus group makes sensitive and specific detection 
of this pathogenic micro-organism a particular challenge (Quinlan and Foegeding, 1997; 
Helgason et al., 2000; Zhou et al., 2002; Ivanova et al., 2003; Read et al., 2003; Rasko et 
al., 2004; Todd et al., 2003; Redmond et al., 2004; Williams et al., 2003). 
1.2 Aims 
The aims of the work presented here are to improve our understanding of the structure and 
antigenic composition of the B. anthracis spore and associated products, and to utilise the 
knowledge gained for the improvement of biosensor sensitivity. 
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1.3 Objectives 
1) To investigate the efficacy of different methods for the disruption of B. anthracis 
spores to release putative target antigens. 
2) To characterise surface and antigenic components of the B. anthracis spore. 
3) To identify protein targets from the spore surface and assess their suitability as 
detection targets. 
4) To utilise specific spore surface proteins in the production of suitable recognition 
elements for use within biosensors for the detection of B. anthracis spores. 
1.4 Overview 
The work in this thesis describes a rational design approach to the rapid specific detection 
of B. anthracis spores. Chapter 2 is a literature review providing a background to B. 
anthracis, biosensors and recognition elements. Chapter 3 details the materials and 
methods used in this study. Chapter 4 evaluates and characterises disruption of the spore. 
Chapter 5 examines the antigenic and other surface components of the B. anthracis spore 
released by disruption and methods developed for identification of such components. 
Chapter 6 describes the development of a procedure for the development of specific 
ligands against a protein target that is also present within other Bacillus species. A general 
discussion and concluding remarks are give in Chapter 7. 
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Chapter 2 Literature review 
2.1 Bacillus anthracis - a bacterial pathogen with potential use in biological 
warfare 
One bacterium of particular interest from a BW perspective is Bacillus anthracis, the 
aetiological agent of anthrax. B. anthracis is a Gram positive, rod shaped, non-motile, 
spore forming and facultatively anaerobic bacterium (Mock and Fouet, 2001). The 
vegetative cells have characteristic square ends when viewed under the microscope. Under 
aerobic conditions at the end of the exponential growth phase a centrally, or sometimes 
subterminally located ellipsoidal spore can be observed that does not swell the sporangium. 
B. anthracis is susceptible to a number of antibiotics such as penicillin, and other P-lactam 
agents, which is often used as a method of positive identification as other closely related 
species are often resistant to these antibiotics (Turn bull, 1996). Very few cases of natural 
antibiotic resistance to penicillin G and P-lactam agents have been reported (Odendaal et 
al., 1991; Cavallo et al., 2002; Mohammed et al., 2002). However, a number of in vitro 
studies have demonstrated that resistance can be acquired to a range of antibiotics such as 
ciprofloxacin, doxycycline, fluoroquinones and 13-lactam antibiotics (Brook et al., 2001; 
Price et al., 2003; Athamna et al., 2004). 
Anthrax is recognised as being one of the earliest documented infectious diseases. In 1887 
Robert Koch demonstrated that anthrax infection was due to B. anthracis by inoculating 
animals using pure culture, a model used to develop Koch's postulates. In 1881, a heat 
killed preparation of the organism was used as the first anthrax vaccine for livestock by 
Louis Pasteur (Koehler, 1999). After introduction of the vaccine and the advent of 
penicillin, research into this pathogenic microorganism declined as its significance as a 
human pathogen decreased due to the eradication of this disease in a number of countries. 
However, anthrax still remains enzootic in certain parts of the world (Hugh-Jones, 1999; 
Schmid and Kaufi-nann, 2002). From a military perspective, B. anthracis is still considered 
to be one of the classic BW agents. Many of the properties of B. anthracis, including the 
highly resistant nature of its endospore, ease of mass production, potential for infection via 
the respiratory route and proven weaponisation make, it an ideal candidate as a biological 
warfare agent (Wyatt, 1980; Manchee et al., 1981). Concerns over potential usage have 
been highlighted by incidents such as the release of B. anthracis spores at Svedlovsk, 
Russia, in 1979, the unsuccessful release by the Aum Shinrikyo cult in Japan, concerns of 
production and weaponisation in Iraq, and its potential usage in the Gulf wars (Zilinskas, 
1997; Kortepeter and Parker, 1999). The only known deployment of B. anthracis as a 
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biological warfare agent was in the 1940s by the Japanese army in Manchuria (Harris et 
al., 1994). More recently, the intentional release of anthrax spores from bioterrorist attacks 
in the USA in 2001 associated with the presentation of 22 individuals with anthrax was of 
particular significance. In total, 11 cases were confirmed as inhalational anthrax and 11 
cutaneous (7 confirmed and 4 possible). In total there were 5 fatalities, all from the 
inhalational form of the disease (CDC update, 200 I; Jemigan et al., 2002). These 
incidents have confirmed the relative ease with which B. anthracis spores can be 
effectively prepared and disseminated and have led to a significant increase in interest and 
research into this organism (Jemigan et al., 2002; lnglesby et al., 1999, 2002; Traeger et 
al., 2002; Griffiths et al., 2003). The requirement for specific and sensitive detection is 
due to the presentation of individuals at the early stages of infection with non-specific 
symptoms and the need for prompt administration of antibiotics before a lethal infection is 
established, particularly when infection has been acquired via the respiratory route. 
2.2 Genetic discrimination of B. a11thracis 
B. anthracis is a member of the B. cereus group. Several other closely related species are 
found within this group; B. cereus, B. thuringiensis, B. mycoides, B. pseudomycoides, B. 
weihenstephanensis and B. medusa (Bavykin et al., 2004). Of these, the closest related 
species are B. cereus and B. thuringiensis which, along with B. anthracis, are medically 
and economically significant. B. cereus is often considered a soil dwelling opportunistic 
pathogen and has been implicated in rare non-lethal infections most commonly associated 
with food poisoning. In this instance, two manifestations of the disease can be observed, an 
emetic form believed to be caused by a short (~5 kDa) polypeptide, and a diarrhoea) form 
caused by at least five enterotoxins (Kotiranta et al., 2000; Jensen et al., 2003). In some 
cases a lethal infection similar to anthrax has been observed (Miller et al., 1997; 
Hoffrnaster et al., 2004). B. thuringiensis also produces a series of plasmid encoded 
endotoxins which are toxic to certain groups of the insect population (Aronson and Shai, 
2001). Genetic analysis has revealed that B. anthracis is very closely related to B. cereus 
and B. thuringiensis. Helgason et al. (2000) suggested that all three were in fact the same 
species and that B. anthracis and B. thuringiensis evolved from a common ancestral 
species (B. cereus) through the acquisition of plasmids encoding toxin genes, such as 
pX01 in the case of B. anthracis. However, there is considerable phenotypic variation 
between all three; for example B. anthracis is non-motile. However, phenotypic variation 
between B. cereus and B. anthracis is thought to be due to differences in expression and 
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regulation rather then the loss or addition of particular genes (lvanova et al., 2003). 
Furthermore, B. anthracis is exceptionally monomorphic at the molecular level (Keim et 
al., 1997). In contrast, B. thuringiensis and B. cereus are both highly polymorphic 
(Helgason et al., 2000). Sequencing ofthe B. cereus 10987 genome and comparison to the 
B. anthracis genome revealed that chromosomally encoded genes were more highly 
conserved than those observed in B. cereus 14579 (Rasko et al., 2004). This strain was 
also found to contain a number of known virulence factors such as the genes encoding the 
NHE complex, the two major phospholipases and cytotoxin K. Furthermore, an -209 kb 
plasmid (pBc10987) was also identified similar in organisation, and encoded genes, to B. 
anthracis pX01, excluding the presence of a pathogenicity island and in particular the 
genes encoding toxin subunits, lethal Factor (LF), oedema factor (LF) and protective 
antigen (PA). A strain of B. cereus has also been identified that is capable of causing an 
illness with clinical manifestations identical to those observed with inhalational anthrax 
infection. This strain (G9241) was found to carry a plasmid with 99.6% identity to pXOl, 
including the toxin genes and a plasmid encoding a capsule that was not identical to pX02. 
The presence of the pX01-like plasmid in this strain of B. cereus suggests that horizontal 
transfer of genetically mobile elements is possible in nature (Hoffmaster et al., 2004). 
2.3 Anthrax infection 
B. anthracis can infect mammals, birds and possibly reptiles, although it is mainly 
observed in domestic livestock and other herbivores (Tumbull, 1996). The organism can 
be transmitted through carriage of spores from infected carcasses (e.g. by vultures or blow 
flies) to water or shrubs and trees. Bacilli can also be shed in the faeces of infected 
animals, and these sporulate on contact with air. Spores can also form in the tissues and 
exudates of animal carcasses. Once formed, spores may remain viable within the 
environment for decades (Turnbull, 1996). The most common reason for human infection 
is contact with dead or infected animals or contaminated products, or ingestion of infected 
meat. Infection occurs when spores enter the host and the mode of entry defines the type 
of infection. In the case of humans, there are three main forms of the disease: (a) 
cutaneous; (b) inhalational; and (c) gastrointestinal anthrax. Any of the types of infection 
can result in systemic anthrax, which is nearly always fatal (Mock and Fouet, 2001). 
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2.3.1 Cutaneous anthrax 
Cutaneous anthrax is the most common form of the disease in humans, accounting for 
more than 95% of reported cases. This occurs when the organism gains entry via a cut or 
abrasion in the skin (and the occasional report of transmission via an insect bite) followed 
by migration to the subepidermal tissue (Turell et al., 1987; Bradaric et al., 1992; Mallon 
and McKee 1997). The incubation period can vary from 9 hours to 2 weeks, but is 
typically 2-7 days. The infection initially presents as a papule which forms a ring of fluid 
filled vesicles around it and over a few days develops into a characteristic black necrotic 
lesion or 'eschar' accompanied by significant oedema. The skin lesions appear not to be 
suppurative as there is no abscess formation or tissue liquification. Histological 
examination of the lesions has, however, revealed lymphocytic infiltrates. Localised 
haemorrhaging, sometimes accompanied by thrombosis, may also be observed (Mallon and 
McKee 1997). Cutaneous anthrax is often self-limiting but can take up to six weeks to 
resolve, with or without appropriate treatment. Cutaneous anthrax usually remains 
localised to the site of infection and can be successfully treated with the use of suitable 
antibiotics (such as penicillin, deoxycillin or fluoroquinolones). Approximately 20% of 
untreated cases will result in systemic anthrax, in which clinical manifestations of disease 
progress to septicaemia, renal failure and death of the host (Hambleton and Tumbull, 
1990). 
2.3.2 Gastrointestinal anthrax 
Gastrointestinal anthrax occurs after ingestion of material contaminated with B. anthracis. 
There are two manifestations of the disease, intestinal or oropharyngeal. In the case of 
gastrointestinal anthrax it has been hypothesised that the bacterium infects the host at an 
opening in the mucosal lining (Dixon, 1999a, b). Histological examination shows the 
presence of vegetative bacilli in the submucosal and mucosal tissue although the exact 
location at which the spores germinate is unknown (Dutz, 1971). Significant mesenteric 
lymphadenitis is observed and ulceration of the stomach lining occurs, although whether 
this is localised at the point of infection or as a result of the action of the anthrax toxins is 
unclear (Dutz et al., 1971, 1981). As in cutaneous anthrax, significant oedema and necrosis 
can be observed within infected tissue (Dutz et al., 1981 ). Symptoms of intestinal anthrax 
include: fever; vomiting; abdominal pain, haematenesis; and bloody diarrhoea due to loss 
of blood, fluid and electrolyte inbalances (Ndyabahinduka et al., 1984; Kanafani et al., 
2003). Blood may also be observed in vomit due to the extensive ulceration of the gut. 
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The rapid administration of effective treatment is essential to prevent systemic anthrax 
infection (Nalin et al., 1977; Jena et al., 1980; Ndyabahinduka et al., 1984). However, in 
mild cases there is evidence to suggest that an individual can recover without treatment. 
Oropharyngeal anthrax has a mortality rate of approximately 50%, even with treatment. 
Clinical manifestations of this form of the disease include; a sore throat, local 
lymphadenopathy resulting in dysphagia, respiratory distress, and fever (Doganay et al., 
1986). In this instance, lesions are observed in the oropharynx as pseudomembraneous 
ulcerations (Alizard et al., 1995). 
2.3.3 Inhalational anthrax 
Inhalational anthrax occurs when spores enter via the respiratory route, commonly from 
spores aerosolised from contaminated hides or other animal products. In a military context, 
inhalational anthrax is the most likely form of infection and one point of particular concern 
is that a biological hazard can exist at a significant distance from the point of dissemination 
(Manchee et al., 1981; 1982; Steme, 1982; Abranova et al., 1993; Jackson et al., 1998). 
Bacillus spores enter the host via the nasal passages and are subsequently deposited in the 
lungs; however, in most cases infection at this site has not been observed. Bacterial spores 
are phagocytosed by host macrophages at the primary site of infection and are transported 
to the mediastinal and peribronchallymph nodes. Germination of the spores occurs as the 
macrophages migrate to these lymph nodes, within which outgrowth occurs causing 
mediastinitis and subsequent spread through the lymphatic system and bloodstream. Early 
diagnosis of inhalational anthrax can be particularly problematic as an infected individual 
will often present with mild non-specific symptoms such as malaise or fever. However, 
this is followed by the rapid onset of severe symptoms characteristic of the systemic form 
of the disease such as dyspnoea, cyanosis and disorientation. The severity of infection is 
usually greatest in the case ofinhalational anthrax (Webb, 2003). Death results within 2-3 
days due to shock, sepsis and respiratory failure (Tumbull, 1991 ). Systemic inhalational 
anthrax has a mortality rate of close to l 00% and the LD50, based on studies using primates 
could be in the region of 2.5 x 103 to 5.5 x 104 inhaled spores for humans (Inglesby et al., 
2002). The timing of the administration of effective treatment is critical to survival. Oral 
antibiotics, if taken during the presymptomatic incubation period, can be very effective. In 
the presymptomatic stage, combination antibiotics and intensive hospital care can 
sometimes be effective (Lincoln et al., 1965; Inglesby et al., 2002). However, once the 
disease has reached the fulminant stage and a critical threshold has been reached with 
regard to the production of the anthrax toxins, antibiotic therapies become ineffective 
(Brachman, 1980). Natural isolates of B. anthracis are susceptible to a range of antibiotics 
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such as penicillin, doxycycline or ciprofloxacin (Jones et al., 2003a). However, in a BW 
scenario, these treatments may be ineffective if a strain has been engineered to allow for 
resistance to a range of commonly used antibiotic therapies. Work conducted by Stepanov 
et al. (1996) detailed the genetic modification of a vaccine strain of B. anthracis to confer 
resistance to penicillins and tetracyclines. 
2.3.4 Anthrax meningitis 
Anthrax meningitis develops as a complication of other forms of the disease, with a 
mortality rate approaching 100% (Dixon et al., l999b). Only a few cases have been 
described of recovery following rapid diagnosis and treatment (Khanne et a/, 1989: Lalitha 
et al., 1996). Patients may present with symptoms often observed with a meningeal 
infection and also fever, myalgia, vomiting, seizures and delirium. Clinical symptoms 
include marked inflammation of the meninges, elevated cerebrospinal fluid pressure and 
appearance of blood in this fluid due to haemorrhaging, followed rapidly by death. An 
autopsy will also reveal the presence of the characteristic 'cardinal's cap', due to 
haemorrhaging of the leptomeninges (Koshi et al., 1981; Levy et al., 1981; Abranova et 
al., 1993; George et al., 1994; Lalitha et al., 1996). 
2.4 Virulence factors 
The major virulence factors are encoded on two p1asmids, pX01 and pX02; namely two 
toxins involved in cell death and evasion of the host's immune response and the poly-y-D-
glutamic acid capsule, which inhibits the phagocytosis of vegetative bacilli and 
dissemination of the organism from the lungs (Leppla, 1991; Drysdale et al., 2005). It has 
been hypothesised that the toxins are predominantly responsible for the morbidity and 
mortality of anthrax infection and the capsule for evasion of the host's immune system and 
thus survival in vivo (Hanna, et al., 1998; Mock and Fouet, 2001; Ascenzi et al., 2002.). 
Expression of the major virulence factors is affected by host-specific factors including 
carbon dioxide (C02) concentration (2~5%), elevated host temperature (;::>:37%) and the 
presence of serum components (Makino et al., 1988; Dai et al., 1995). The expression of 
both toxin and capsule genes is controlled by the transcriptional activator atxX. Loss of 
either or both plasmids results in reduction in virulence. Attenuated strains have been used 
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as vaccines, such as the Steme stain (pX01+pX02-) which produces the toxins but is 
unable to synthesise the capsule. 
2.4.1 pXOl 
The pXOI plasmid is a 184.5 kilobase pair (kbp) element, that encodes three toxin genes 
along with other regulatory genes, a resolvase, a transposase and a germination operon, 
termed gerX (Okinaka et al., 1999a; Mock and Fouet, 2001). On the plasmid is a 
pathogenicity island within which the major virulence genes are located within a 44.8-kbp 
region which is flanked by inverted IS1627 elements. Genes also encoded within pXOl 
include DNA topoisomerase (Fouet et al., 1994) and 15 Open Reading Frames (ORFs) 
which have been implicated in horizontal transfer (Mock and Fouet, 2001). 
The atxA gene is also located on the pXOl plasmid within the pathogenicity island and is 
flanked by pagA and cyaA. The atxA gene encodes a 476 amino acid (aa) protein that 
exerts positive and negative control over genes located on pX01, pX02 and chromosomal 
elements (Vodkin, and Lepp1a, 1983; Mock et al., 1988; Robertson, et al., 1988; Tippetts 
and Robertson, 1988; Welkos et al., 1988; Uchida, et al., 1993a; Koehler et al., 1994; Dai 
et al., 1995; Guignot et al., 1997; Hoffinaster and Koehler, 1997; Bragg et al., 1999; 
Bourgogne et al., 2003; Mignot et al., 2003). Evidence suggests that atxA is affected by a 
number of host factors such as temperature and C02 (Dai and Koehlar, 1997; Uchida et al., 
1997, Mock and Mignot, 2003). A tricistronic operon named gerXis also located on pXOI. 
Deletion of this operon has found to have an effect on the virulence in vivo using a murine 
model (Guidi-Rontani et al., 1999a). The gerX operon is thought to encode proteins that 
have a role to play in the germination of B. anthracis within the aveolar macrophage. 
However, conflicting results demonstrated the presence of this operon within an attenuated 
vaccine strain 'Carbosap' (Adone et al., 2002). Investigation of this strain also revealed 
the presence of other common virulence determinants such as the toxin encoding genes and 
the two trans-acting regulators acpA and aLtA. This suggests a more complex mechanism 
for the regulation and expression of virulence factors than has been elucidated to date and 
also highlights the care that is required for identification of pathogenic B. anthracis strains 
based on genetic methods (discussed in more detail in section 2.8.1 ). 
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2.4.2 Anthrax toxins 
The structure and function of each component of the two B. anthracis toxins have been 
characterised and reviewed extensively (Escuyer et al., 1988; Robertson et al., 1988; 
Welkos et al., 1988; Bragg and Robertson, 1989; Ascenzi et al., 2002;; Brossier and Mock, 
2001; Mourez et al., 2002; Collier and Young, 2003). Anthrax toxins consist of three 
subunits; oedema factor (EF), lethal factor (LF) and protective antigen (P A) encoded by 
the genes, cya, lef and pag respectively which are all located on the pXO 1 plasmid (Dai et 
al., 1995: Hoffinaster et al., 1997; Okinaka et al., 1999; Mock and Fouet, 2001). The 
individual subunits are non-toxic, but combine to form two binary toxins LF-PA (Lethal 
toxin or LeTx) and EF-PA (oedema toxin or EdTx). The binary toxin is of the A-B toxin 
family, the A moiety (LF or EF) acting on targets within the cytosol, and the B moiety 
binding to a specific host cell receptor and allowing translocation of A into the cytosol 
(Ascenzi et al., 2002). Each of the toxins has a specific role in the pathogenicity of B. 
anthracis. Guidi-Rontani (2002) hypothesised that the toxins disrupted cells to allow the 
bacteria to enter the bloodstream. 
An overview of toxin entry and action is shown in Figure 2.1. Protective antigen (PA) 
binds to a surface located host receptor. To date, two anthrax receptors have been 
identified; these are tumour endothelial marker (TEM8 or ANTXl) (Bradley et al., 2001) 
and capillary morphogenesis protein 2 (CMG2 or ANTX2) (Scobie et al., 2003). Cleavage 
of P A occurs by a furin-like cell-surface membrane protease, releasing a PA20 subunit. The 
C-terminal 63 kDa protein subunit (P~3) remains bound to the host cell and oligomerizes 
to form [P ~3]7, a heptameric ring, capable of binding a maximum of three molecules of 
LF or EF. Recent work conducted by Christensen et al. (2005) suggests that there is a rapid 
phase of dissociation of PA20 from PA63 followed by a slow isomerisation phase which 
has been hypothesised to allow for oligomerisation of PA63 in the presence of LF and EF. 
The resulting toxin complex is internalised through clathrin mediated endocytosis (Ascenzi 
et al., 2002) and transported to an acidic endosome. Evidence suggests that membrane 
insertion and translocation of LF and EF across the membrane and into the cytosol is 
promoted through a conformational change in the P A oligomer, triggered by the acidic pH 
in the endosomal compartment (Larantz et al., 2004). Simultaneous initiation of these 
events, triggered by low pH, would appear to be essential, as, if a pore were formed before 
translocation could occur, there may be a change in membrane potential and permeability, 
leading to death of the host cell (van der Groot, 2001). If cell death was triggered, then 
this in turn could initiate an inflammatory response. Evasion of this response is thought to 
be critical to anthrax pathogenesis (Park et al., 2002; Agrawa1 et al., 2003; Moayeri and 
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Leppla, 2004; Fukao et al., 2004). P A also appears to insert preferentially into intraluminal 
vesicles rather than into endosomal carrier vesicles (ECV) or multi vesicular bodies (MVB) 
and these are finally translocated along microtubules and into late endosomes. This 
mechanism ensures that after translocation, LF and/or EF are present within the lumen and 
not the cytoplasm ofthe endosome; thus they can refold, and are protected from lysosomal 
protease degradation (Abrami et al., 2004). Release of EF and LF has been hypothesised 
to be due to a back fusion event whereby intraluminal vesicles fuse with the limiting 
membrane during the late stages of the endocytotic pathway (Abrami et al. , 2004). Once 
released into the cytoplasm, EF and LF are then able to bind to their target molecules. 
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Figure 2.1 Mode of action of B. anthracis toxins (Adapted from Sanchez and 
Bradley, 2004). 
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2.4.2.1 Protective atrtigetr (PA) 
P A is an 83 kDa protein that is essential for host cell recognition, binding and subsequent 
translocation of LF or EF from the extracellular space to the cytoplasm. P A has four 
domains; one domain is responsible for binding to the anthrax toxin receptor (ATR), a type 
I membrane protein (Bradley et al., 2001). The second domain of PA contains two 
calcium ions and a site allowing for cleavage by a furin type protease The third domain of 
P A is involved in oligomerisation to form a heptameric ring structure which can bind to LF 
and/or EF at a 252 aa region of theN-terminus ofPA (Singh et al., 1994; Mogridge et al., 
2001; Cunningham et al., 2002; Lacy et al., 2002). The fourth domain is a large flexible 
loop that has been hypothesised to interact with the host receptor and has a role in pore 
formation (Santelli et al., 2004; Rainey et al., 2005). 
2.4.2.2 Oedema toxitr (EdT.t:) 
EdTx forms as a result of binding of EF to P A. EF is an 89 kDa calmodulin or calcium 
dependent adenylate cyclase that causes a dramatic increase in cyclic AMP (cAMP) levels 
within the host cell, resulting in an imbalance of water homeostasis, thought to cause the 
significant oedema observed with cutaneous anthrax (Leppla, 1982). Initial investigations 
of the effects of EdTx using a skin test on animal models resulted in only localised 
oedematious necrotic lesions (Thome et al., 1960; Stanley et al., 1961). In vitro testing 
also demonstrated the ability ofEdTx to inhibit neutrophil function, an effect that has also 
been observed in human cases of cutaneous anthrax (O'Brien et al., 1985; Alexeyev et al., 
1994). However, more recent investigation using highly purified EdTx suggest that it 
causes a series of rapid pathological effects, finally resulting in death of the host, in a 
murine model (Firoved et al., 2005). 
2.4.2.3 Letlral toxitr (Lfl'x) 
Lethal toxin is formed through binding of LF to PA. LF is a Zn2+ metalloprotease which 
affects the mitogen activated protein kinase signalling pathway through cleavage of host 
mitogen activated protein kinase kinases (MAPKKs or MEKs) with the exception of 
MEK5 (Duesbery et al., 1998; Vitale et al., 1998; Vitale et al., 2000). Evidence suggests 
that LITx can exert a multitude of effects on a wide range of cells involved in the immune 
response (Park et al., 2002; Fukao et al., 2004; Moayeri and Leppla, 2004). For example, 
it has been demonstrated that anthrax LITx can inhibit cytokine production and induce the 
release of immunomodulatory molecules such as tumour necrosis factor (TNF-a) and nitric 
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oxide (NO) by lipopolysaccharide (LPS) or y-interferon (Pelizzari et al., 1999; EIWin et al., 
2001). It has also been shown that LITx lyses macrophages in certain murine models and 
can trigger death of human macrophages when sensitised by LPS or TNF (Chaudry et al., 
2002; Mourez et al., 2002; Moayeri et al., 2003, 2004). Agrawal et al. (2003) 
demonstrated that anthrax LITx also has an effect on adaptive immunity using mouse and 
human dendritic cells. After exposure to LITx and subsequent exposure to LPS, a 
significant reduction of secreted proinflammatory cytokines (e.g. TNF-a, IL-1a, IL-6 and 
IL-12) was observed, coupled with no detectable up-regulation of eo-stimulatory 
molecules. 
2.4.3 pX02 
The smaller pX02 plasmid (95.3 kbp) contains 85 predicted ORFs and encodes the genes 
required for the capsule biosynthetic operon (capBCADE) (Uchida, et al., 1993b, Makino 
et al., 1988, 1989, 2002), degradation and regulatory elements. Transposon mutagenesis 
studies conducted by Welkos et al. (1991) demonstrated that mutations within some pX02 
genes may allow for synthesis of the capsule at levels observed in the wildtype. However, 
a reduction in the LD5o was often observed using a murine subcutaneous model of 
infection. This strongly suggests that other, as yet unidentified genes encoded within 
pX02 may also have a role to play in virulence. Transcription ofthe cap genes occurs as a 
single operon and the individual genes encode the proteins required for synthesis, assembly 
and attachment of the capsule to the cell surface (Makino et al., 1988, 2002). The 
expression of toxin and capsule genes is regulated by a transcriptional activator AtxA, 
encoded within pXOl (Uchida et al., 1993a; Koehler et al., 1994; Dai et al., 1995; 
Bourgogne et al., 2003). Recent work has shown that genetic regulation of the capsule 
genes is more complex than originally proposed (Drysdale et al., 2004, 2005). As well as 
atxA the regulation of capsule gene expression is also governed by two pX02 located 
transcriptional activators; acpA (Vietri et al., 1995) and more recently, a second regulatory 
element, acpB, has been identified (Drysdale et al., 2004). Both AcpA and AcpB are 
homologous to each other (-62% identity) and to AtxA (~50% identity). The atxA gene is 
suggested to control the expression of the capsule genes through the positive regulation of 
acpA and acpB (Drysdale et al., 2004); however, this transcriptional regulation appears to 
be unidirectional as acpA was observed to have no effect on the expression of the toxin 
genes (Bourgogne et al., 2003; Fouet and Mock, 1996; Uchida et al., 1997). AcpA and 
AcpB also appear to have partial functional overlap (Drysdale et al., 2004). Originally 
acpB was thought to have a minor role in the regulation of capsule gene expression 
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(Drysdale et al., 2004). However, evidence from more recent research conducted by the 
same group (Drysdale et al., 2005), found that an acpB but not an acpA mutant showed 
increased LDso values in a murine model. This suggests a more predominant role for this 
regulatory element in the regulation of other genes required for virulence. 
2.4.4 The capsule 
Capsules are observed in many pathogenic bacteria and are required for virulence through 
evasion of the host's immune response (Cunni on et al., 2001; Dale et al., 1996; Domenico 
et al., 1994). Unlike the polysaccharide capsules observed in a range of pathogenic 
bacteria, B. anthracis synthesises a highly negatively charged y-linked D-glutamic acid 
(yPGA) which forms long homopolymers, often observed at greater than 215 kDa, which 
make up the capsule (Record and Wallis, 1955; Zwartou and Smith, 1956). In vitro capsule 
synthesis occurs in bicarbonate rich media, or when the organism is grown under 
conditions of 5 to 20% C02 (Meynell and Meynell, 1964; Green et al., 1985; Thome, 
1993). The capsule has an important role in B. anthracis pathogenesis, as non-
encapsulated mutants are significantly attenuated (Ivins et al., 1986; Drysdale et al., 2005). 
The effect of the presence of the capsule on B. anthracis pathogenesis is two fold. Firstly, 
it decreases the degree of binding to complement components thus inhibiting phagocytosis 
(Mock and Fouet, 2001). Secondly, its simple composition renders it non- or weakly 
immunogenic thus, a significant reduction or elimination of any form of immune response 
is observed (Leppla, 1991; Keppie et al., 1953: Leonard and Thome, 1961; Makino et al., 
1989; Schneerson et al., 2003). There are five different Cap proteins expressed by 
transciption of the capBCADE operon (CapB, CapC, CapA CapE and CapD). CapD is a 51 
kDa enzyme that releases lower molecular weight glutamic acid polymers into the external 
environment through depolymerisation of larger D-glutamic acid polymer chains These 
degraded polyglutamates are predicted to distract or inhibit the host defence mechanisms, 
allowing infection to become established (Uchida et al., 1993b) and appear to be essential 
for vegetative cell outgrowth in vivo (Makino et al., 2002). The CapE protein has been 
identified more recently and is a 47 aa peptide located within the membrane of B. anthracis 
and is also required for polyglutamate synthesis and appears to interact with CapA 
(Candela et al., 2005). A number of groups have recently shown the ability of glutamic 
acid polymers to elicit an immune response when conjugated to a carrier (Rhie et al., 2003; 
Schneerson, et al., 2003; Wang et al., 2004). Thus, there is renewed interest in the 
utilisation of the capsule as a marker for detection and diagnosis and in the development of 
an effective treatment or prophylaxis for anthrax infection (Chabot et al. 2004). 
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2.4.5 Other virulence determinants 
To date much of the research on virulence determinants in B. anthracis has focused on the 
action of the anthrax toxins and to a lesser extent, the capsule; however, more recently 
research has begun on the examination of other B. anthracis virulence factors. Work 
conducted by Xu et al. (2004) identified two adhesins, BA0871 and BA5258, which are 
homologues of a collagen binding protein found within Staphlococcus aureus. Binding of 
the recombinant form B. afllhracis adhesins to collagen was demonstrated by two different 
methods. The first of these was Surface Plasmon Resonance (SPR), where the binding of 
one molecule to another can be monitored due to a change in the angle of incidence at 
which a proportion of light energy can interact with dlocaised electrons (plasmons) formed 
in a metal film, commonly gold. The second method used was the more commonly known 
enzyme linked immunosorbant assay (ELISA). Xu et al. (2004) also observed the 
involvement of these proteins in mediating cell attachment to collagen. Thus, both 
proteins were hypothesised to be involved in establishing anthrax infection, and possibly of 
greatest significance in the cutaneous form of the disease (Xu et al., 2004). More recently, 
the role of rhamnose in B. anthracis pathogenesis was also investigated (Bozue et al., 
2005). There are two isomers of rhamnose, D- and L-rhamnose. The most common isomer 
is L-rhamnose which is found in a variety of Gram positive and Gram negative bacteria 
and functions as a structural component of the cell wall or capsule (Giraud and Naismith, 
2000). The enzymes required for rhamnose biosynthesis are encoded within an rmlABCD 
operon. After examination of mutations within the rlmABCD operon it was reported that 
rhamnose was important for interaction with macrophages in vitro, but did not affect 
virulence in a guinea pig model where the spores were administered intramuscularly 
(Bozue et al., 2005). This mirrors observations conducted on the virulence of other 
exosporia) components in animal models (discussed in section 2.5.2.1), where mutations in 
these genes have no observed affect on virulence; however, the application of an 
inhalational model may be more relevant (Kang et al., 2005). A number of enzymes, in 
particular proteases, have also been put forward as having a role in B. anthracis virulence. 
However, although, B. anthracis contains full structural genes for a number of pathogenic 
factors, such as lysolecithinases, hemolysins or phospholipases it only secretes a small 
proportion of these, believed to be due to a missense mutation in the pieR gene. Pophov et 
al. (2005) examined the potential role of particular proteolytic enzymes in the 
pathogenicity of B. anthracis. In this case, examination of chromosomally encoded genes 
identified a number of putative virulence factors, including collagenases, haemolysins, 
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phospholipases and other toxins. Experimental evaluation was conducted using an Arnes 
derivative cured of both pXOl and pX02, and thus unable to synthesise the toxins or 
capsule. Aronson et al. (2005) demonstrated the regulation of chromosomal proteases, 
implicated with a role in virulence, by pXOI encoded regulatory elements, as has also been 
observed with the regulation of the S-layer proteins Extractable Antigen l (EA I) and the 
Surface array protein (Sap) by at.xA (Mignot et al., 2003). Whether all of the genes 
regulated by atxA have a role in pathogenesis of B. anthracis has yet to be fully elucidated. 
This research demonstrated the complexity of the acquisition of the highly pathogenic and 
virulent phenotype observed in B. anthracis and may suggest that the key to genetic 
discrimination between virulent, attenuated and avirulent strains may lie within regulatory 
regtons. 
2.5 The Bacillus a11tlrracis spore 
As the spore is the infective form of B. allthracis (Dixon et al., 1999b; Liu et al., 2004). 
understanding its structure is essential in the identification of detection targets. The 
knowledge gained from the identification of outer surface targets could also be used in 
preventive therapies and early treatment of an anthrax infection. 
2.5.1 Sporulation 
From extensive work, conducted predominantly usmg B. subtilis, the process of 
sporulation and its genetic control has been extensively characterised and described in a 
number of recent reviews (Henriques and Moran, 2000; Sonenshein, 2000; Kroos and Yu, 
2000; Stephenson and Hoch, 2002; Piggot and Losick, 2002; Errington, 2003; Ryan and 
Shapiro, 2003; Hillbert and Piggot, 2004). The following is a brief overview of this 
process, and covers a number of important genes and their products but does not discuss all 
those involved in the sporulation cycle as this is beyond the scope of this study. 
Spores usually form as the vegetative cells pass out of the exponential growth phase or in 
response to an environmental signal that will limit cell growth, typically nutrient depletion 
(Straiger and Losick, 1996). In B. subti/is, sporulation has been assigned seven phases 
from morphological examination by electron microscopy (Ryter, 1967). Each transitional 
phase of sporulation is completed over a period of approximately one hour and occurs as a 
continuous cycle (Figure 2.2). 
17 
Growth 
~ 
I 
I 
VEGETATIVE 
CELL 
GROWTH 
Stage VI, VII Stage V 
Maturation and Spore coat 
celllysis formation 
SPORULATION 
Stage ll 
Asymmetric 
cell division 
Stage ill 
Engulfment 
Figure 2.2 A diagrammatic representation of seven key stages of 
sporulation, adapted from Errington (2003). 
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Stage 0 is defined as the vegetative cell once committed to sporulation. Stage I is 
characterised by the condensation of two replicated chromosomes, which form an axial 
filament due to alignment along the longitudinal axis of the cell. As the vegetative cell 
enters Stage II, asymmetric cell division, a process similar to medial cell division observed 
in the vegetative cell state, occurs. At tllis stage, a septum forms dividing the cell 
(sporangium) to form the prespore and the mother cell, each containing a single 
chromosome. At stage ID, hydrolysis of the peptidoglycan occurs, followed by the 
engulfment of the prespore by the septal membranes to form the forespore. The free 
protoplast is thus bounded from the cytoplasm of the mother cell by the inner and outer 
forespore membranes. At stage IV, the peptidoglycan of the cortex then forms around the 
forespore, followed by the cortex. These structures are assembled between the membranes 
surrounding the forespore. This is followed by assembly of the spore coat proteins, 
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synthesised by the mother cell, on the outer membrane (Stage V). At Stage VI spore 
maturation occurs and the spore acquires the characteristic properties of resistance, 
dormancy and the ability to germinate. There is no significant observable morphological 
change to the spore during this phase. The final step in sporulation (Stage VII) is lysis of 
the mother cell to release a fully mature spore (Henriques and Moran, 2001; Driks, 1999). 
Under favourable environmental conditions, the spore germinates. The spore interior is 
rehydrated, the spore coat hydrolyses, the cortex is shed, metabolism is activated and 
vegetative cell growth is resumed (Piggot and Coote, 1976; Foster and Johnstone, 1990; 
Setlow, 2003). 
Initiation and regulation of sporulation is controlled by the expression of a number of 
genes in the forespore and the mother cell (Driks, 1999). In the case of B. subtilis, entry of 
the bacterium from the vegetative to the dormant state is directed by a temporally and 
spatially separated cascade ofproteins termed sigma factors (Moran et al., 1981; Strauch et 
al., 1990; Weir et al., 1991; Margolis et al., 1993; Resnekov et al., 1995). The first sigma . 
factor activity to increase is crH, which along with crA effects the expression of a number of 
genes involved in sporulation. Once the septum has formed, crE and crF become active in the 
mother cell and forespore compartment, respectively (Margolis et al., 1991 ). After 
engulfment of the forespore, crE and cr" are replaced by crK and cr0, respectively. crK also 
activates a number of genes involved in late sporulation, most notably synthesis of the 
cortex and the majority of the coat proteins (Margolis et al., 1991). Finally, GerE and crK 
both coordinate the last phase of gene expression within the mother cell (Cutting et al., 
1991; Roe! and Losick, 1995). A more detailed review of the genetic control of spore 
formation in B. subtilis has been described by Driks (1999) and Errington (2003). From 
comparison of the B. subti/is and B. anthracis genome it was observed that important 
structural and regulatory genes involved in sporulation are present and show >50% identity 
(Aronson, 2002). Other well conserved regions in the B. anthracis genome include genes 
encoding SASPs and a number of coat proteins. Examination of the B. anthracis genome 
suggests that many of these genes are similar, if not identical, to those observed in B. 
subtilis (Aronson, 2002). The presence of many of the same genes or gene homologues 
suggests that many of the mechanisms of sporulation are similar (Aronson, 2002). 
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2.5.2 Spore structure 
During the dormant phase, spores are characterised as phase bright and ellipsoidal using 
phase contrast microscopy (Piggot and Coote, 1976; Nicolson and Setlow, 1990). The 
highly refractive nature of a bacterial endospore is dependent on the degree of dehydration, 
which in turn is reliant on correct assembly of the cortex. In the dormant state, spores are 
cryptobiotic and possess a highly ordered structure conferring resistance to extreme 
environmental conditions such as heat, ionising radiation, ultra-violet (UV) radiation, 
pressure and chemicals (Set1ow, 1994; Nicholson et al., 2000; Takamatsu, 2002). The 
basic structure of B. anthracis spores in shown in Figure 2.3. 
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Figure 2.3 The basic structure of Bacillus spores by Transmission Electron 
Microscopy. (a) The inner and outer coat layers of a B. subtilis spore, scale bar 1 OOnm 
(b) A cross section of a B. anthracis spore showing the exosporium, the thinner inner 
coat, cortex, outer coat and the core. (c) The hairy nap and basal layers of the B. 
anthracis exosporium. Scale bar 300 nm (B. anthracis). Adapted from Driks (2002). 
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2.5.2.1 Tile exosporium 
In the case of B. anthracis and other members of the B. cereus group, the surface of the 
outer spore coat has been found to be covered by a loose balloon like structure termed the 
exosporium (Ohye and Murrell, 1973; DesRosier and Lara, 1984; Driks, 1999). This 
surrounds, but is not attached to, the other spore components (Gerhardt, 1967; DesRosier 
and Lara, 1984). The exosporium forms the outermost integument between the spore and 
its external environment (Gerhardt, 1967). The exosporium was thought to be absent in 
some Bacillus species, such as B. subtilis. However, recent research using ruthenium red 
staining has demonstrated the presence of a thin glycoprotein layer surrounding the spores 
of this species and as such this has been proposed to be a previously unidentified thin 
exosporia! outer surface layer (Wailer et al., 2004). Typically, the exosporium consists of 
many layers that surround the spore itself (Gerhardt; 1967; DesRosier and Lara, 1984). 
Analysis of the exosporium revealed that it consisted of a paracrystalline basal layer and a 
"hair like" outer layer, also termed the hairy nap (Roth and Williams, 1963; Hachisuka et 
al., 1966). The crystalline nature of the basa11ayer has also been observed to be conserved 
on both inner and outer sides (Sylvestre et al., 2002). The exosporium also displayed a 
close-packed hexagonal lattice structure (Gerhardt and Ribi, 1964). 
The exosporium itself is composed of a number of proteins, of which a proportion have 
been identified (Steichen et al., 2003; Todd et al., 2003; Lui et al., 2004; Redmond et al., 
2004). However, the function of the majority of these proteins is as yet undetermined. The 
first structural exosporium protein to be identified was the glycoprotein BciA (Sylvestre et 
al., 2002). Since its identification, a number of studies have been conducted to 
characterise this protein. BciA was found to be the primary structural component of the 
hair like filaments and reported to be similar to collagen due to the presence of a number of 
centrally located GXX (usually GPT) repeats. Sylvestre et al. (2002) demonstrated that, 
although the protein has a clear structural role within the exosporium, it is not essential for 
virulence in a subcutaneous model of infection in mice, and does not contribute to the 
resistance of spores to harsh chemical treatment. However, investigation of the role of 
BclA in an inhalational model has not been determined, where BclA may have a specific 
function with regards to this route of infection such as deposition and adhesion to the lung 
cells. Sylvestre et al. (2003) not only demonstrated the presence ofBclA in a wide range of 
B. anthracis isolates but showed considerable size heterogeneity among different Bacillus 
species and strains. The protein has different numbers of GPT repeats and 
[GPT]5GDTGTT repeats and it has been hypothesised that these variations could play a 
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role in the properties of the spores in different environments (Sylvestre et al., 2003). The 
protein consists of three domains; a 19 aa N-terminal domain, a central region containing 
the collagen-like repeats and a C-terminal domain of 134 aa (Sylvestre et al., 2002; 
Steichen et al., 2003). Analysis of the orientation of these filaments by electron 
microscopy suggested that the C-terminal domain is located at the distal end and the N-
terminus is located at the proximal end of each hair like filament, suggesting a role for the 
N-terminal region in binding to the basal layer. BclA was also shown to form a collagen 
like triple helix. However, of note was the observation that these trimers demonstrated a 
significant increase in thermal stability (T m 95°C), compared to mamallian collagen (T m 
37°C). This was also observed in trimers formed only by the C-terminal domain. 
Furthermore, these trimers were also found to be resistant to degradation by a number of 
proteases, high temperatures and concentrations of detergent, and when purified the 
formation of large crystalline sheets was observed (Boydston et al., 2005). These results 
suggest that BclA may form a protective barrier around the spore; however, given the 
resistance of spores devoid of an exosporium to harsh environmental conditions, the 
likelihood is that this protective barrier has a more important function in the interaction of 
the spore with the host (Kang et al., 2005). Daubenspeck et al. (2004) identified novel 
oligosaccharide side chains of BclA; a 715 Da tetrasaccharide, of which multiple copies 
are present within the collagen like region of the protein and a 324 Da disaccharide that 
may be attached outside of this region. The 715 Da tetrasaccharide was found to be 
composed of 3 rhamnose residues and a component termed anthrose. The 324 Da 
disaccharide was composed of a single rhamnose residue (3-0-methyl-rhamnose). 
Daubenspeck et al. (2004) also hypothesised that the anchor points for rhamnose 
oligosaccharides within BetA were the characteristic GPT and [GPT]s repeats. The be/A 
gene is encoded in a cluster composed of 11 ORFs which are also hypothesised to contain 
genes involved in carbohydrate synthesis, more specifically for the spore specific 
carbohydrate 3-0-methyl rhamnose, also associated with BetA, flanked by spoVE 
homologue and enoyl-acyl carrier protein reductase. This was inferred as homologous 
genes were present in the thermophilic bacterium Aneurininibacillus thermoaerophilus in 
which these genes have a role in the synthesis of rhamnose and 3-0-methyl rhamnose 
(Daubenspeck et al., 2004). 
Steichen et al. (2003) demonstrated that BclA was an immunodominant protein of the B. 
anthracis exosporium, during their evaluation of a number of monoclonal antibodies raised 
against y-irradiated spores. Their study also revealed the presence of alanine racemase ( 
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molecular weight. ea. 43 622 Da), iron/manganese superoxide dismutase, SOD (ea m.w. 24 
600 Da) and two other proteins termed BxpA (m.w. ea. 12 842) and BxpB (ExsF/ExsFA) 
(m.w. ea. 17 331 Da). All these proteins have homologues within B. cereus. The nature of 
the association of alanine racemase and SOD with the spore surface is at present unclear. 
They may perform essential roles and/or be tightly adsorbed to the exosporium. Alanine 
racemase is an enzyme which can convert the germinant L-alanine to the germination 
ihbitor D-alanine and so has a role in the regulation of germination. It has been suggested 
that the alanine racemase (along with the inosine hydolase also isolated within the 
exosporium) may suppress germination through degradation of L-alanine or inosine, 
respectively (Gould, 1966; Titball and Manchee, 1987; Steichen et al., 2003; Redmond et 
al., 2004). SOD has been hypothesised to have a number of possible functions within the 
spore, such as involvement in the oxidative cross-linking of exosporium and/or spore coat 
proteins (Henriques and Moran, 2000) or protection from reactive oxygen species (Lynch 
et al., 2000). Spores are highly resistant oxidative stress but it has not been determined if 
this property is due to the ability of the spore to scavenge reactive oxygen species (Inaoka 
et al., 1999). However, the superoxide dismutase SodA of Bacillus subtilis has bee shown 
to be essential for protection against oxidative stress in sporulating cells and ia required for 
maturation of the spore (Henriques et al., 1998; Inaoka et al., 1999). More recently, it has 
been suggested that SOD may regulate the germination of B. anthracis spores on exposure 
to superoxide (Baillie et al., 2005). It was suggested that BxpA and BxpB (ExsF/ExsFA) 
may both have a role in the structure of the B. anthracis exosporium and that BxpB 
(ExsF/ExsF A) was glycosylated or associated with glycosylated material. The latter seems 
the most likely as ExsF forms a complex with BetA (Redmond et al., 2004). Sylvestre et 
al. (2005) indicated that the ExsFA (ExsF/BxpA) and a second protein ExsFB are required 
for the correct localisation of BciA to the spore surface and for the stability of the 
paracrystalline basal layers of the exosporium. (Sylvestre et al., 2005). Later work by 
Steichen et al. (2005) also suggested a role for BxpB, (ExsF/ExsFA) in the suppression of 
germination, although no effects on the spores resistance was observed. 
Fujita et al. (1989) demonstrated that, in the case of B. subtilis, some vegetative cell 
membrane proteins are also present in the spore coat indicating that some of the outer 
forespore membrane is conserved within the dormant spore. Vegetative cell proteins are 
also found within the B. anthracis spore (Steichen et al., 2003; Liu et al., 2004; Redmond 
et al., 2004). This observation has raised uncertainties as to whether some proteins within 
exosporium preparations are true structural components or alternatively strongly adsorbed. 
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Thus, some studies have included salt and detergent washes which have been found to alter 
the protein profile of the exosporium in both B. cereus (Todd et al., 2003) and B. anthracis 
(Redmond et al., 2004). Wailer et al. (2005) identified a second collagen like glycoprotein 
of the exosporium, termed BclB. This protein is homologous to the B. thuringiensis 
glycoprotein ExsH and a 205 kDa glycoprotein within B. cereus. This 205 kDa 
glycoprotein was also found to contain an analogue of the BclA repeat GITGVTGAT; 
however, this motif is not found in B. cereus or B. thuringiensis proteins. Although the 
number of repeats and its relation to the structure of BciB has not been determined as with 
BclA, it was noted that an additional six repeats were present in the Ames strain compared 
to the Steme strain from examination of the genome sequence (Wailer et al., 2005). More 
recently, from related work on the exosporium of B. cereus, ExsA was identified as an 
exosporium component (Todd et al., 2003) and shown to be required for the assembly of 
the coat and exosporium on the surface of the spore (Bailey-Smith et al., 2005). To date 
this protein has not been identified experimentally from B. anthracis spores; however, 
given the abundance of homologous exosporium proteins that have been identified, it is 
likely that, ExsA may have a similar role if present. 
Knowledge of the synthesis and assembly of the exosporium is limited. From early studies 
on B. cereus the exosporium was only observed during the late stages of sporulation 
concurrent with assembly of the spore coat (Ohye and Murrell 1973). The first observation 
of deposition of exosporium components was also detected at Stage IV of sporulation. 
Assembly of the exosporium then continues until the structure is complete at the 
commencement of stage VI of sporulation (Ohye and Murrell, 1973). Following 
immunocytochemical examination of the formation of the exosporium and spore coat it 
was found that exosporium antigens assembled in the cytoplasm of the sporulating cell. In 
contrast, spore coat antigens were observed in the forespore during the early stages of 
septation (Short and Walker, 1975; Short et al., 1977). At maturity the exosporium was 
observed as a complete layer surrounding the spore (Short and Walker, 1975; Short et al., 
1977). 
Recent work conducted by Kang et al. (2005) suggests that the exosporium may have a 
fundamental role in protecting the spore from the host's immune response. It was shown 
that B. anthracis spores devoid of an exosporium were more susceptible to macrophage 
mediated killing than spores that possessed an exopsorium. This work also demonstrated 
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that the target of the macrophage was not the dormant spore (shown by the use of a non-
germinating mutant) but the germinated spore; however, results obtained regarding the fate 
of the spore within the macrophage are not consistent. For example, We1kos et al. (2002) 
suggest that an observed increase in germination within the macrophage may be related to 
increased elimination of the bacteria. In contrast Guidi-Rontani (2001) demonstrated the 
survival of the spore within the macrophage but showed that outgrowth was not possible 
within these cells. 
2.5.2.2 The spore coat 
The structure and complexity of the spore coat varies depending on the species, but 
basically consists of an inner and outer layer (Holt and Leadbetter, 1969; Aronson and 
Fitz-James, 1976). As well as the two coat layers, a third layer has also been observed in 
some Bacillus species that lies between the inner coat and the cortex. It has been suggested 
that this could either be a further coat layer or the outer forespore membrane (Fujita, et al., 
1989; Sakae et al., 1995). The spore coat can occupy up to 50% of the spore volume and 
consists mainly of protein, but also contains complex carbohydrates and lipids (Matz et al., 
1970: Beam an et al., 1971 ). Evidence suggests that removal of the spore coat either by 
chemical methods or genetic mutation is not sporicidal. Spores lacking a spore coat retain 
the property of heat resistance; however, they do become sensitive to hydrogen peroxide, 
lysozyme and organic solvents (Gould and Hitchins, 1963; Gould et al., 1970; Aronson 
and Fitz-James, 1971; Moir, 1981; Zheng et al., 1988; Popham et al., 1995; Jenkinson et 
al., 1981 ). The spore coat also appears to be important for germination, as this structure 
allows the passage of smaller nutrient molecules to germination receptors located beneath 
the spore coat. Furthermore, enzymes that have possible roles in germination have also 
been found within the spore coat (Behravan et al., 2000; Hullo et al., 2001; Bagyan and 
Setlow, 2002). Morphological examination of the B. anthracis spore coat has; however, 
revealed that the coat is thinner than that observed in B. subtilis and although individual 
layers are less distinct, an inner and outer layer can still be observed (Roth and Williams; 
1963; Gerhardt and Ribi, 1964; Hachisuka, et al., 1966; Moberly et al., 1966; Driks, 2002). 
Recent studies by Chada et al. (2003) and Driks (2003) have suggested that the spore may 
also act as a dynamic layer to allow for changes in volume. 
A number of B. subtilis coat proteins have been identified and for many of these their roles 
in resistance and germination are predominantly unclear (Driks, 2002b ). Of the B. subtilis 
spore coat proteins identified a proportion have been implicated in the assembly of the 
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spore coat. However, for many coat proteins inference of function has been difficult, 
particularly as deletion mutants have often shown no observable difference in phenotype 
compared to the wildtype. More recently work conducted by Lai et al. (2003) identified 38 
spore coat proteins of B. subtilis and a further 11 within B. antl~racis. Comparative 
analysis of the B. subtilis and B. antl1racis genomes shows that a number of homologues of 
known B. subti/is coat proteins are present within B. anthracis (Driks, 2002; Lai et al., 
2003). It has been hypothesised that, as many of these proteins are conserved between the 
two species, including the major morphogenetic proteins, a similar function and 
mechanism of coat assembly could be assigned to both species. However, it is notable that 
although proteins involved in correct assembly of the spore coat are present, many of the 
proteins required for the formation of the outer coat appear to be absent in B. anthracis 
(Driks, 2002; Lai et al., 2003). Some of the predicted spore coat proteins (CotJC, CotB 
and CotY/ Z) have been shown to be present experimentally in spore coat extracts (Lai et 
al., 2003). It has also been suggested that B. anthracis specific spore coat proteins are also 
present (Driks et al., 2002a; Lai et al., 2003). However, this may extend to the B. cereus 
group as with the recently identified major spore coat protein Cot-a (Kim et al., 2004). It 
was found that this 13.4 kDa protein was expressed at stage IV of sporulation and appeared 
to be important for the resistance of the spore to toxic chemicals including hypochlorite, 
chloroform and phenol (Kim et al., 2004). In the case of B. subtilis and B. anthracis, 
emerging evidence suggests that many of the functions of spore coat proteins require the 
interaction of a number of components (Boume et al., 1991; Thomas, 1993; Sacco et al., 
1995; Serrano et al., 1999; Seyler et al., 1997, Driks, 1999; Takamatsu et al., 1998; 
Kuwana et al., 2002; Bailey-Smith et al., 2005; Lai et al., 2003; Kim et al., 2006). 
Therefore extensive characterisation of the spore coat is required to elucidate function of 
individual proteins. 
Assembly o[the spore coat 
The primary stages of the assembly of the spore coat commence after septation of the 
vegetative cell and involve the interaction of a number of proteins under the control of crE. 
(Zheng and Losick, 1990; Roe! et al., 1992; Beall et al., 1993; Stevens et al., 1993; Zheng 
et al., 1998). Coat assembly is believed to be predominantly a function of the mother cell 
due to the transcription of a number of different genes whose products may or may not be 
integral parts of the spore coat structure (Boume et al., 1991; Driks et al., 1994; Sacco et 
al., 1995; Driks et al., 1994; Ishikawa et al., 1998; Takamatsu et al., 1998; Serrano et al., 
1999; Bagyan and Setlow, 2002). The majority of the coat proteins are synthesised after 
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activation of crK which occurs after forespore engulfinent (Zheng and Losick, 1990; 
Aronson et al., 1988; Cutting et al., 1991; Zhang et al., 1994; Sacco et al., 1995; Naclerio 
et al., 1996; Henriques et al., 1997; Takamatsu et al., 1998). In stage V of sporulation the 
spore coat and cortex layers fonn, and it is at this time that the spore's gennination and 
resistance properties are observed (Dion and Mandestam, 1980; J enkinson et al., 1980). In 
B. subtilis, evidence suggests that the majority, of the outer and a proportion of the inner 
coat proteins are directed by CotE (Driks and Setlow, 2000; Kim et al., 2006). However, 
other proteins such as SafA (YrbA) and SpoVID also appear to have an important role in 
coat assembly (Beall et al., 1993; Ozin et al., 2000, 2001; Takamatsu et al., 2000; Kim et 
al., 2006). In contrast, little is known about the structure and assembly of the B. anthracis 
spore coat. 
A selected number of spore proteins and strong homologues within B. anthracis sre shown 
in Figure 2.4. 
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Figure 2.4 A model for spore coat assembly on an arc of the spore surface 
showing the possible interactions of proteins for which homologues exist in 
B. anthracis. A number of coat and coat associated proteins are denoted and 
those for which homologues exist within B. anthracis are bold and underlined. 
Known interactions are denoted by arrows with soljd lines. Further possible 
interactions exist between a number of the proteins, determined from 
experimental studies conducted by Kim et al. (2006), denoted by arrows with 
dashed lines (Adapted from Driks, 2000 and Kim et al., 2006) 
The cortex and spore membra11es 
Two spore membranes of opposing structural polarity are formed as a result of forespore 
engulfment during sporulation (Wilkillson et al., 1975), as discussed in section 2.5.1. In 
the mature spore these form the inner and outer spore membranes. The outer spore 
membrane is located below the spore coat, but observation by electron mjcroscopy reveals 
that this structure is not continuous (Aronson and Fitz-James, 1976). Although the outer 
membrane appears to have an important role in spore formation, its role in dormancy is 
unclear. The cortex is a dense inner layer, consisting mainly of peptidoglycan that is 
similar, although not identical, to that found within the vegetative cell. Analysis of the 
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cortex peptidoglycan has revealed a unique structure not observed in the vegetative cell. 
Of note is the decreased amount of cross-linking of muramic acid residues (2.9%) in the 
dormant spore in contrast to 33 to 40% in the vegetative form (Atrih et al., 1996; Popham 
et al., 1996; Atrih and Foster, 1999). Furthermore, it has been observed that approximately 
half of all muramic acid residues are substituted with muramic o-lactam, required for 
hydrolysis of the spore peptidoglycan necessary for spore germination and outgrowth 
(Warth and Strominger, 1969; Sekiguchi et al., 1995; Atrih et al., 1996; Popham et al., 
1996; Meador-Patron and Popham, 2002). Cross-linking has been shown to be important 
for maintaining the dehydrated core allowing for heat resistance (Popham et al., 1995; 
Popham, 2002). However, it has also been revealed that if the spore peptidoglycan is too 
highly cross-linked, degradation is difficult or not attainable; thus, spores are either 
incapable of germinating or the rate of outgrowth is reduced (Meador-Patron and Popham, 
2002). Therefore, evidence suggests that muramic-o-lactam has an important function in 
spore germination and outgrowth and the rate at which this occurs (Meador-Patron and 
Popham, 2002). Differences were also observed in the muramyl and N-acetylmuramic acid 
peptide side chains (Atrih et al., 1996; Popham et al., 1996). 
There is a second layer of peptidoglycan below the cortex that is identical to that found in 
vegetative cells. This layer, also referred to as the germ cell wall, functions as the initial 
cell wall following germination (Moir et al., 2002; Popham, 2002). Below the 
peptidoglycan layer is a second spore membrane, often termed the inner membrane. 
Following germination, this structure becomes the vegetative cell membrane, although its 
lipid composition and the protein to lipid ratio has been found to differ when the spore is in 
the dormant state (Freer and Levinson, 1967; Ellar, 1978). Proteins that have been 
identified in the B. subtilis inner membrane include; (a) GerAA and GerAC, both of which 
are required for germination (Hudson et al., 2001); (b) SleB, a cortex lytic 
transglycosylase, involved in muramic-o-lactam dependent cortex hydrolysis during 
germination (Chirakkal et al., 2002) and (c) YpeB, required for the assembly and/or 
stability of SleB (Chirakkal et al., 2002). Evidence suggests that the inner membrane is 
relatively impermeable to small hydrophobic and hydrophilic molecules and that the 
membrane lipids are immobile (Bertsch et al., 1969; Cowan et al., 2004: Cortezzo and 
Setlow, 2005). 
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2.5.2.4 Tile core 
Located at the centre of the spore is the core, which contains the spore DNA, ribosomes, 
the majority of spore enzymes required for germination, inactive metabolic enzymes 
necessary for outgrowth, and other small molecules. All of these components are 
immobilised in a lattice of salts of divalent cations (principally calcium, although 
magnesium, manganese and low concentrations of other divalent cations are also present), 
chelated in most likely a I :I ratio with pyridine-2,6-dicarboxylic acid ( dipicolinic acid, 
DPA) (Murrell and Warth, 1965; Murrell, 1967; Gould, 1969). DPA accounts for up to 
approximately 20% of the dry core weight and exists predominantly in the spore core. 
DP A is thought to have a role in core dehydration, resistance of spores to wet heat and UV 
radiation, and maintenance of the spore in the dormant state, although the exact mechanism 
by which DP A confers these properties of the spore is unclear (Paidhungat et al., 2000; 
Slieman and Nicholson, 2001; Nicholson et al., 2002). Spore DPA and the associated 
divalent cations are secreted during the initial phase of germination and this has been used 
as a marker for spore detection (discussed further in section 2.6.4). Small acid soluble 
proteins (SASPs) are approximately 60-75 amino acids long and evidence suggests that 
they protect the spore DNA from a wide range of damage caused by UV radiation, 
chemicals, enzymatic attack and free radicals (Setlow, 1993; Setlow and Setlow, 1993, 
1995; Fairhead et al., 1994; Nicholson, 2000). SASPs are thought to bind to spore DNA in 
a manner that decreases the chemical reactivity of the DNA and causes a conformational 
shift from the normal tight handed double helix to an torroidal structure (Setlow, 1988; 
1992a; 1992b; Pogliano et al., 1995). The spore has a significantly lower water content 
( -0.3-1.5g H20 per g dry weight) than that observed in the vegetative state ( -4.0g H20 per 
g dry weight). The dehydrated state of the core is hypothesised to be required for the 
spore's heat resistant properties (Beaman and Gerhardt, 1986; Gerhardt and Marquis, 
1989; Setlow, 1995;) and its ability to remain in a cryptobiotic state (Gerhardt and 
Marquis, 1989), believed to be due to decreased total: nicotinamide adenine dinucleotide 
(NAD); reduced nicotinamide adenine dinucleotide (NADH); nicotinamide adenine 
dinucleotide phophate (NADP); reduced nicotinamide adenine dinucleotide phosphate 
(NADPH); and ATP concentrations in the spore compared to the vegetative cell. 
Furthermore, lower ratios of NADH:NAD and NADPH/NAD compared to the vegetative 
state have also been observed (Setlow and Setlow, 1977; Setlow, 1994). 
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2.6 Isolation and identification of B. a11thracis 
Vegetative cells of B. anthracis can be detected in a wide range of clinical specimens by 
specific staining of the capsule using a polychrome methylene blue stain (M'Fadyean 
stain}, which was first demonstrated in 1903 (M'Fadyean, 1903). Typical colony 
morphology on blood or nutrient agar will be observed as being matt white/grey, flat and 
having a 'crushed glass' appearance and will be tacky. The colonies are often smaller than 
those observed with B. cereus or B. thuringiensis (Parry et al., 1983). These methods are 
ideal with clinical specimens collected from infected individuals for a few hours after 
death. However, in other samples such as environmental samples, the numbers of B. 
alllhracis present may be small and there will also be a natural background of other 
microorganisms. Of particular concern are those that are also within the B. cereus group. 
In this instance selective microbiological techniques are required to distinguish B. 
anthracis from other Bacillus species. B. anthracis can be distinguished from B. cereus and 
B. thuringiensis as it is: (a) non-motile; (b) catalase positive; (c) non-haemolytic or weakly 
haemolytic; and (d) sensitive to penicillin and the gamma phage. Furthermore, the 
organism does not hydrolyse urea, requires thiamine for growth, produces a glutamyl-
polypeptide capsule and does not grow on chloralhydrate agar (Todar, 2004). Identification 
of B. antlwacis using microbiological techniques is effective but time consuming. 
Therefore, a significant proportion of B. anthracis research is being directed at the 
development of specific, sensitive and reliable detection and diagnostic assays. 
2.6.1 Genetic based metbods of detection 
Discrimination of members of the B. cereus group has proven particularly difficult at the 
genetic level due to the high levels of identity between genomes (Andersen et al., 1996; 
Helgason et al., 1990, 2000a, 2000b, 2004; Carlson et al., 1994; 0kstad et al., 1999; Keim 
et al., 200 I; Ticknor et al., 200 I; Radnedge et al., 2003; Priest et al., 2004). Comparisons 
of 16S rRNA sequences and 16S-23S rRNA spacer regions have failed to distinguish 
between the three species (Ash et al., 1991; Daffonchio et al., 2000). Techniques such as 
amplified fragment length polymorphism (AFLP}, variable number tandem repeats 
(VNTR}, pulsed field gel electrophoresis (PFGE}, multi-locus sequence typing (MLST} 
and multi-locus enzyme electrophoresis (MLEE) have also been used to identify different 
members of this group. More recent investigations have adopted the use of single 
nucleotide polymorphisms to identify individual isolates (Zwick et al., 2005). This has 
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also been possible using multi-locus VNTR analysis (MLVA) (Keim et al., 2005). The 
advantage of this type of approach is that identification of individual strains is possible, 
which may allow for identification ofthe original source. 
A range of assays have been developed for the detection of B. anthracis using the 
polymerase chain reaction (PCR) (Beyer et al. 1996; Patra et al. 1996; Sjostedt et al. 1996; 
1997; Bode et al., 2004). However, there are problems with this approach. Most rapid 
real time PCR assays have relied on the use of the virulence determinants encoded within 
pXOl and pX02 (Ramisse et al., 1996; Bell et al., 2002; Ellerbrook et al., 2002). Given 
the identification of a B. cereus strain also carrying pXOl (Hoffinaster et al., 2004), the 
presence of some isolates cured of these plasmids (Tumbull et al., 1992; Ramisse et al., 
1996) and the possibility of transfer, loss or purposeful genetic modification (Baillie, 
2005), complete reliance on the presence of these plasmid encoded genes is not ideal. 
Therefore, identification of other genes to be used in a multiplex format would increase the 
confidence of the results of an assay. However, discrimination of B. anthracis from other 
members of the B. cereus group via chromosomally encoded genes is exceptionally 
difficult, although some genetic differences have been reported (Cherif et al., 2003). A 
number of groups have recently reported the use of real time PCR in the specific detection 
of B. anthracis through the identification of single point mutations in the rpoB and gyrA 
genes (Qi et al., 2001; Drago et al., 2002; Hurtle et al., 2004). However, the specificity of 
such assays is regarded by some groups as being very sensitive to slight alterations in 
assay conditions, resulting in false positive results. Work conducted by Elbrook et al. 
(2005) identified a sequence unique to B. anthracis by subtractive hybridisation to develop 
a real time PCR assay with 100% specificity against a range of Bacillus strains. However, 
further testing to ensure detection of a larger number of B. anthracis strains is required. In 
general, PCR assays are ideal for clinical samples where detection of DNA from the 
vegetative form is possible; however the detection of spores, which would be required for 
environmental monitoring, requires germination and/or outgrowth or disruption of the 
spore itself to release DNA, something that has proven difficult (Ryu et al., 2003). 
Although a low amount of the total DNA is suggested to be associated with the spore 
surface, reliance on this renders the assay unquantitative and relatively insensitive. This 
factor has a second disadvantage in that highly purified spores may not have any DNA 
associated with the outer spore surface, and hence assays that have not been rigorously 
tested may be ineffective, resulting in false negative results. Environmental samples may 
require concentration after collection, due to the small sample volumes required for a PCR 
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assay, and possibly some fonn of sample processing, not only to extract the DNA but to 
eliminate any potential inhibitors of the PCR reaction (Alverez et al., 1995; Kuske et al., 
1998). There is an opinion that these assays require further development to be reliable, 
accurate and sensitive enough for purpose (Webb, 2003). Furthennore, PCR often 
requires the use of trained personnel unless incorporated into a fully automated system, 
and the reagent requirement is relatively high, this increases costs and logistical problems, 
particularly for continuous environmental sampling. The report of the development of a 
universal biosensor for the detection of pathogenic microorganisms, including B. 
anthracis was reported by Baeumer et al. (2004) using an oligonucleotide hybridisation 
assay. However, although showing promise, this assay may be limited to laboratory 
confinnation due to the requirements for incubations at elevated temperature and precise 
buffer requirements for hybridisation. Furthennore, this group also acknowledges that the 
fonnat of the assay requires simplifying. However, advances in microarray technology 
and data processing may enable this type of assay to be fielded in the future. 
The sequencing and annotation of the B. antlzracis Ames genome and comparison with 
related bacteria such as B. cereus (Ariel et al., 2002), has allowed for the identification of 
further putative virulence genes. Microarray analysis conducted by Sergeev et al. (2005), 
identified the presence of putative virulence factor genes within B. alllhracis and other 
members of the B. cereus group which have the potential for use in genetic based detection 
and diagnostic assays. However, the presence of these genes does not indicate that they 
are transcribed, highlighted by the fact that many of these genes were also found to be 
present in the B. subtilis negative control (Sergeev et al., 2005). 
This highlights the fact that gene transcription, and thus detection of the gene products may 
be invaluable in discriminating B. anthracis from other members of the B. cereus group. 
Genetic methods of identification would appear to be invaluable as confinnatory assays, 
and of particular use in specific strain identification (Levy et al., 2005) that could be used 
for forensic analysis within a relatively short time period compared to standard 
microbiological techniques. However, real-time detection of an environmental hazard by 
continuous monitoring is not practical at present (Webb, 2003). 
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2.6.2 Recognition element-analyte recognition based methods of detection 
A recognition element is any molecule capable of binding a target analyte, there are many 
different types of recognition elements, discussed in further detail in 2.8. The most 
common forms of recognition element used for detection of an analyte from a given 
species are antibodies. Immunoassay-based techniques, being quicker than standard 
microbiological techniques, show promise for rapid real time detection. Whilst more 
established assay formats such as ELISA are time consuming, other applications such as 
lateral flow assays or incorporation of the antibodies into other biosensors are more rapid 
(discussed in further detail in section 2.7). However, assays that rely on the use of 
recognition elements have encountered problems in sensitivity and in the generation of an 
antibody or other recognition element that is specific to B. anthracis. In the case of 
antibodies, polyclonal (pAbs) and monoclonal (mAbs) antibodies have been produced with 
a view to reducing the cross-reactivity observed with other Bacillus species. In the case of 
polyclonal antibody, selective adsorption has been utilised with varying degrees of success 
(Lamanna and Eisler, 1960; Fluck et al., 1977; Phillips et al., 1983). In one case the 
complete removal of cross reactivity to closely related species was observed (Phillips and 
Martin, 1988). However, given the variation in antibody specificity that would exist from 
antibodies raised both between animal species and within different animals of the same 
species, this would not be suitable for reproducible specificity and sensitivity of reagents. 
To overcome this, murine mAbs offer a more suitable alternative (as discussed section 
2.10.2.2). There are limited reports of the production of species specific mAbs to B. 
anthracis spores (Phillips et al., 1988; Tumbough and Keamey, 2002), that demonstrated 
low levels of cross reactivity with B. cereus and B. thuringiensis have been reported and 
the epitopes or antigens that they recognise have not been detailed. Early research into the 
production of antibodies against Bacillus spores focused on the inoculation of animals with 
live spores. To eliminate any immune response to vegetative cell antigens, penicillin was 
administered (Lamanna and Eisler, 1960; Norris, 1962). However, the use of live spores 
did incur problems including an tmmune response to vegetative cell antigens if 
prophylaxis was unsuccessful, and death of the immunised animal. This led to the 
immunisation of animals with spores inactivated with heat, formaldehyde or irradiation to 
produce polyclonal (Fluck et al., 1977; Phillips and Martin, 1983; 1988; Phillips et al., 
1983; Phillips et al., 1988; Stopa, 2000) and monoclonal (Phillips et al., 1988; Dang et al., 
2001; Tumbough and Keamey, 2002; Steichen et al., 2003) antibodies. However, this 
approach is not ideal as methods of inactivation can cause differences in the ability of 
resulting antibodies to recognise live spores. Thus, it has been suggested that inactivation 
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methods may alter antigens on the spore surface compared to the live spore, for example 
through denaturation (Phillips et al., 1988; Dang et al., 2001). With the use of both 
inactivated and live spores, resulting antibodies still demonstrate cross reactivity with 
other Bacillus species due to the presence of homologous proteins (Lamanna and Eisler, 
1960; Norris, 1962; Phillips et al., 1983; Fluck et al., 1977; Longchamp and Leighton, 
1999; Stopa, 2000). 
More recent research suggests that the majority of monoclonal antibodies raised against 
whole B. anthracis spores recognise the glycoprotein BciA, a protein which also has a 
homologue within B. cereus (Steichen et al., 2003; Redmond et al., 2004). The 
identification of a unique marker or epitope of a known protein is essential in obtaining 
reagents with the required sensitivity and specificity as well as increasing confidence in 
positive identification. 
In addition to traditional antibodies, other forms of recognition element have been 
produced and utilised for the detection of B. anthracis spores. The advantages of the use 
of such receptors are discussed in sections 2.8-2.11. One such type of recognition element 
that has been employed are peptide recognition elements, usually produced by phage 
display. These recognition elements have had a limited amount of success with regard to 
the detection of B. anthracis spores. Brigati et al. (2004) reported the production of 
peptide recognition elements from a landscape phage display library. Although these 
recognition elements demonstrated increased specificity to B. anthracis spores, cross 
reactivity with B. cereus and B. thuringiensis was still observed. Williams et al. (2003) 
describe the specific identification of B. anthracis through the use of pattern recognition 
with two peptides; one which binds to B. anthracis and a small subset of B. cereus and B. 
thuringiensis strains and the other which did not bind to B. allfhracis. In this case, the 
exact epitope to which the peptides bound has not been determined. 
Lectins have also been used for the discrimination of B. anthracis from other Bacillus 
species (Cole et al., 1984). This research was predominantly focused on vegetative cells 
due to the presence of a galactose containing polysaccharide on the outer surface of B. 
anthracis. However, the observation that spores have lectin binding sites was hypothesised 
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to be due to: (a) retention in an unmodified form, (b) penetration of the receptors through 
the external layers, (c) the synthesis of spore-specific lectin receptors of similar 
composition to those observed in the vegetative state, or (d) vegetative cell contamination. 
From this work, differentiation of spores was possible as B. anthracis spores showed 
strong binding to APA, GSA-1, RCA-1, RCA-11 and SBA1• No binding to these lectins 
was observed in B. subtilis. Only one strain of B. cereus (6464) demonstrated binding to 
APA and only weak binding was observed with APA, RCA-1 and RCA-II (B. mycoides 
6462) and APA, GSA-I, RCA-1, RCA-11 with strong binding to SBA1• This demonstrates 
that although the lectins tested are not completely specific, discrimination of B. anthracis 
is possible through pattern recognition. More recent work conducted by Tarasenko et al. 
(2004) used the interaction of carbohydrates for the detection of B. anthracis spores by 
employing glycoconjugates as the recognition elements. In biological systems, 
glycoconjugates have a range of important roles such as signalling, adhesion and/or 
recognition (Bovin, 1997; Feizi, 2000). More significantly, receptors for microbial 
pathogens on host cells and the structures they recognise are often glycoconjugates (Feizi, 
2000), leading to a hypothesis that interactions are via carbohydrate/carbohydrate binding 
(Misevic and Burger; 1993; Stewart and Boggs, 1993; Misevic and Popescu, 1995; Zhu et 
al., 1995; Koshy and Boggs, 1996;). Furthermore, the binding of carbohydrates to 
glycoconjugates has been established for a number of cell surface proteins, such as those 
involved in adhesion (Bovin, 1997; Rye and Bovin, 1997; Houseman and Mrksich, 2002). 
Various studies have been aimed at mimicking spore recognition (Tarensenko et al., 2002; 
Ji et al., 2003; Williams et al., 2003; Knurr et al., 2003; Kazakov et al., 2004). In the work 
conducted by Tarensenko et al. (2004), the glycoconjugate binding capacities of B. cereus, 
B. thuringiensis, B. pumilus and B. subtilis were observed. Again, differences could be 
discerned through pattern recognition of the spore to different carbohydrates 
(disaccharides). It was hypothesised that binding of the disaccharides was through 
recognition of a monosaccharide on the outer surface; however, this has not been proven. 
Of note was the fact that B. cereus and B. thuringiensis showed stronger binding than B. 
subtilis and B. pumilus, possibly due to the larger exosporium in the B. cereus group. This 
indicates that the exosporium may have an important involvement in carbohydrate binding 
and thus potentially host cell recognition, supporting the observations of the role of the 
exosporium in macrophage uptake shown by Kang et al. (2005). 
1 APA- Abnts precatori11s (specificity for P-D-Gal>a-D-Gal), GSA-I- GrijJo11ia simplicifo/ia (specificity for 
a-D-Gal> a-D-GaiNAc, RCA-I- Ricim1s comm1111is (specificity- P-D-Gal>a-D-Gal), RCA-Il- Ricim1s 
comm1111is (specificity for P-D-Gal>a-D-Gal), SBA- G/yci11e max (specificity- a-D-GalNAc<!P-D-
GalNAc>>a-D-Gal) 
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Other recognition elements that have been used for the detection of B. anthracis spores 
include single chain antibodies, carbohydrates and aptamers (Bruno and Kiel, 1999; Zhou 
et al., 2002; Tarasenko et al., 2004). These are discussed in more detail in sections 2.8 and 
2.11. However, none of these novel recognition elements represent a truly speci fie 
recognition element to B. anthracis, as varying degrees of cross reactivity are observed 
with closely related species. Thus, a truly specific recognition element of this type has not 
been described to date. 
2.6.3 Spore-specific markers for recognition element based detection 
An ideal detection target for a recognition element-based assay would be unique, 
abundant, surface located, expressed under all growth conditions and be essential, such as 
house keeping genes, or required for virulence. As recognition element based detection 
assays are predominantly antibody based, there is an inherent reliance on the identification 
of immunogenic targets. Evidence from early research predicted that antigens located 
within the spore would be useful in the identification of and discrimination of Bacillus 
species (Norris, 1962). However, this has proven to be more complex than originally 
anticipated due to the close genetic relationship between B. anthracis, B. cereus and B. 
thuringiensis. As all of these are environmental organisms, and with B. thuringiensis 
being used widely as an insecticide, the degree of relatedness has implications for the 
production of specific recognition elements for environmental monitoring. To date only 
one B. anthracis specific antigen has been identified, described by Park et al. (2000). 
However, the identity of the antigen was not reported. The advantages of other 
recognition elements, such as peptides or synthetic recognition elements, are that it is 
possible to generate recognition elements against non-immunogenic targets (discussed in 
more detail in section 2.11-2.12). Thus wider range of detection targets can be considered. 
The exosporium is the primary barrier between the spore and the external environment, 
therefore targets located within the exosporium could be useful in the understanding of B. 
anthracis pathogenesis and the development of targets for detection and diagnostic 
purposes. However, only recently have a proportion of exosporium components been 
identified and of these none have been found to be specific to B. anthracis, although some 
37 
are specific to the B. cereus group (Steichen et al., 2003; Todd et al., 2003; Redmond et 
al .. 2004; Lai et al., 2004; Liu et al., 2004). To date only a few of these components have 
been characterised (as discussed in section 2.5.2.1). Further consideration needs to be 
given to the nature of a spore specific marker; for example, the identification of unique 
regions or signatures within a protein and expansion of prospective markers for specific 
identification beyond those located only on the outer surface may be possible. Once a 
specific protein or region has been identified these could be applied to a range of detection 
platforms that have in the past been unsuccessful in specific identification of B. anthracis 
spores, such as immunochromatography (lateral flow assays), flow cytometry (Stopa et al., 
2000; Enserink et al., 2001) or other biological sensors which are discussed in section 2.7. 
Spore-specific carbohydrates could also be utilised for the detection of spores and possibly 
for discrimination at the species level. The first spore specific carbohydrate to be reported 
was rhamnose from the exosporium of B. cereus (Matz et al., 1970). The presence of 
galactosamine and galactose on the spore surface was demonstrated through the use of 
lectins by Cole et al. (1984). Later work has reported 3-0-methyl rhamnose and 
galactosamime isolated for B. anthracis, B. cereus and B. thuringiensis. The latter two 
species can be discriminated from B. anthracis by the presence of fucose and 2-0-methyl 
rhamnose by the use of GC-MS (Fox et al., 1993; Wunscel et al., 1994). Both the spores 
and vegetative cells of these species were found to contain ribose, glucose, galactose, 
glucosamine, mannosamine and muramic acid. Muramic acid and glucosamine are present 
within peptidoglycan and galactose and mannosamine were hypothesised to be present in 
peptidoglycan-polysaccharide in vegetative cells. The presence of these components 
within spores is believed to be due to vegetative cell debris or residual cells within spore 
preparations (Fox et al., 2003). The presence of a spore specific carbohydrate (3-0-
methyl-rhamnose) was also noted within B. subtilis; however, this differed from B. 
anthracis due to the presence of a rhamnose isomer, quinovose (Wunschel et al., 1994). 
Examination of the ultrastructure of B. anthracis spores using a carbohydrate stain showed 
staining of the hairy-nap and basal layers, suggesting these all have a strong carbohydrate 
component. Although much of this work was based on GC-MS profiling, the complexity 
of the analysis would be too problematic for a fieldable system; however, further work 
characterising the glycoproteins of Bacillus species could be valuable for many 
biodetection platforms. 
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2.6.4 Other methods of detection 
Spore specific markers can also be used for non-recognition element based identification 
for example the identification of a particular spore component such as DP A through a 
chemical reaction or spectrometry-based methods may be used. DP A has also been utilised 
as a marker for generic spore detection. As discussed in section 2.5.2.4, in the minutes 
following spore germination DPA is secreted, which can be triggered artificially under 
laboratory conditions. DPA can be detected using a number of methods; one of the most 
promising methods is based on the fluorescence of DPA-lanthaninde metal complexes. 
Terbium has been found to give the most promising resulting in detection limits of -104 
cfu/ml for bacterial spores (Hindle and Hall, 1999). Although this method shows promise 
it is only able to discriminate spores from vegetative cells and thus may not be ideal for 
environmental monitoring specifically for B. anthracis. In addition, the requirement for 
70° C heat shock and subsequent germination with L-alanine cause a delay in the time 
required for positive identification. 
Mass spectrometry based methods have shown promise due to their ability to rapidly 
process and identify proteins of a given organism under laboratory conditions. Dickinson 
et al. (2004) were able to discriminate the spores of different bacterial species using 
matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry (MALDI-TOF 
MS). In the past, one of the predominant challenges in the use of this technique was the 
extraction of the spore proteins prior to mass spectrometry analysis, and have included 
infrared laser irradiation (Ryzhov et al., 2000, Ullom et al., 2001), corona plasma 
discharge (Hathout et al., 1999), sonication, or the use of chemical methods such a 5% 
Trifluoroacetic acid {TFA) (Hathout et al., 2003) or lM HCl. The problems with these 
approaches are the time required for sample processing and the fact that peaks greater than 
10 kDa are often not observed. Therefore, many of the reports of these methods focus on 
the use of SASPs as biomarkers, such as those described by Hathout et al. (2003). In this 
instance, differences were observed in the masses or tryptic peptide maps obtained from 
major and minor alp and y-type SASPs from B. anthracis and B. cereus/B. thuringiensis 
but not between the latter two species. This method would be unsuitable for rapid 
detection as the complexity and length (90 min) of the extraction method would make it 
unsuitable for fieldable use. The method described by Dickinson et al. (2004) used a 
simpler and more rapid solvent extraction, and described sample preparation of a couple of 
minutes, but was unable, as yet to distinguish between members of the B. cereus group. 
Furthermore, this method would require extensive automation for real time environmental 
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monitoring with significant sample clean up and is probably of more use as a confirmatory 
technique. 
2. 7 Biosensors 
In a broad context a biosensor can be considered as any sensor that utilises a biological 
moiety for detection (Piervincenzi et al., 1998), but has often been extended to include the 
detection ofbiological species (Lowe, 1999; Marose et al., 1999). At the most basic level, 
a biosensor typically consists of a detection element (for example an antibody or enzyme), 
a signal transduction event, and a signal processor (Byfield and Abuknesha, 1994). The 
detection event may be direct; for example, the detection of analyte binding to a 
recognition element; or indirect, where detection of a second labelled moiety or the product 
of a secondary reaction is required. The interaction between the detection element and 
analyte is converted into an observed detection event by signal transduction. An example 
of a simple biosensor using direct detection is shown in Figure 2.5. 
Unbound 
analyte 
Detection element 
Sensing interface 
Transducer 
J • ••• 1• • 
:0 
Signal 
processor 
• 
• 
....n.. Signal 
Observed 
detection of target 
analyte 
Figure 2.5 Example of the principal components of a biosensor using direct 
detection. 
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The signal measured is due to a change of a particular parameter, such as capacitance, 
resistance, mass or fluorescence. Examples, but not an exhaustive list, of different types of 
biosensor that have been used for bacterial detection, divided on the basis of the method of 
transduction, are shown in Appendix 2.1. A number of comprehensive reviews of 
biosensor technologies have been conducted (Luppa et al., 2001; lqbal et al., 2000; Ivnitski 
et al., 1999). Biosensors can be utilised for the detection and identification of a range of 
analytes, from low molecular weight species, for example ions, to larger particulates, such 
as viruses and bacteria. Typically, detection utilising biosensors is specific for a target 
analyte, but generic biosensors have also been developed. Dependent on the final 
application, desirable properties for a biosensor may include that the system is essentially 
reagentless, robust, rapid and capable of detection in defined conditions with a sensitivity 
and specificity suitable for the purpose of the assay. One of the largest groups of 
biosensors utilised for the specific detection of target analytes through the incorporation of 
recognition elements are optical biosensors, which often provide an essentially reagentless 
system capable of near real-time detection of a target analyte (Setford, 2000). Commonly, 
these sensors are based on evanescent wave technology such as SPR, the resonant mirror 
or fibre optic waveguides, all of which have been used successfully for the detection of a 
wide range of analytes (Medina et al., 1997; Watts et al., 1994 Anderson et al., 2000). 
More recently, novel methods have been explored such as the use of whispering gallery 
modes in microspheres (Amold et al., 2003). The other most common transduction 
methods which incorporate recognition elements are piezoelectric such as surface acoustic 
wave devices, quartz crystal microbalances, mechanical cantilevers (Wu et al., 1990; Liss 
et al., 2002; Ilic et al., 2004) or electrochemical, including potentiometric and 
amperometric methods (Wang et al., 1997; Uithoven et al., 2000). Although many of 
these biosensor technologies utilise recognition elements, other methodologies exist for 
specific detection without the use of a recognition element. Examples include 
spectroscopic methods, such as Raman spectroscopy (Nelson et al., 1992). However, one 
significant limitation of spectroscopy based techniques has been the analysis of spectra 
often obtained from complex particulates such as bacteria, to allow for identification of the 
desired target (Rossi and Warner, 1985; Jarvis and Goodacre, 2004). A further desirable 
function of a biosensor which uses a recognition element for specific detection is the 
linkage of the binding event to signal transduction (Hellinga and Marvin, 1998). In the 
design of a biosensor, important considerations include the transduction mechanism, the 
nature of the analyte, the specific recognition element (if one is to be used) and the 
interaction between the two, which may include, for example, steric effects and diffusion. 
Many of these parameters are determined by the nature and use of the detection element 
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(the specific recognition element) utilised within the sensor. In order to obtain reliable, 
sensitive and rapid detection of a pathogen any one of these parameters could be evaluated. 
2.8 Recognition elements 
The most common natural molecules used in the specific detection of pathogenic 
microorganisms are antibodies, although other elements include enzymes, peptides, lectins, 
carbohydrate receptors, complementary nucleic acid probes and aptamers (Kiefel and 
ltzstein, 2002; Hone et al., 2003; Williams et al., 2003; Baeurnner et al., 2004; Kirby et al., 
2004). More recently, elements such as whole cells and tissues of plants and animals have 
been utilised, such as genetically engineered pathogen specific B-cell lines which have 
been used to produce the CANARY sensor (Rider et al., 2003). The use of genetically 
engineered bacteria has also been described for detection and used in an array format 
(Kuang et al., 2004). Non-natural recognition elements can also be used in the detection of 
biological species, such as synthetic recognition elements. Examples of these include 
chemical compounds, synthetic peptides or molecularly imprinted polymers (Kodadek et 
al., 2004; Zimmerman and Lemcoff, 2004). Chemical compounds and synthetic peptides 
are usually isolated through the production and screening of large combinatorial libraries 
(Lam et al. 1991). Molecularly imprinted polymers are produced as functional and cross-
linking monomers which are eo-polymerised in the presence of the target of interest, 
creating a molecular imprint that may have the potential to have similar affinity and 
selectivity to antibodies (Vlatakis et al. 1993; Haupt and Mosbach, 1999). Although 
synthetic approaches are often attractive, as the recognition elements are inherently robust 
and relatively easy to produce, one major disadvantage to their use has been obtaining a 
recognition element with the same binding properties (for example affinity) of an antibody 
(Kodadek et al., 2004). A further development within biosensors that has been 
investigated more recently is incorporation of the signal transduction into the recognition 
element (Bark and Hahn, 2000; Jiang et al., 2004). Alternatively, direct signal 
transduction can be achieved through a detectable change (e.g., a visible colour change) in 
the surface after binding of the target analyte to an appropriate recognition element; this 
has been termed a 'smart' or 'self-reporting' surface (Englebienne, 1999; Song et al., 
2002). 
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2.9 The use of antibodies in biosensors 
Antibodies represent a readily available natural source of molecules that have the capacity 
to recognise a wide range of target analytes ranging from defined and characterised 
markers such as specific proteins to complex undefined larger particulates such as bacteria 
(Hellinga and Marvin, 1998). As a result, antibodies have been utilised extensively on a 
wide range of detection platforms, including biosensors (Appendix, Table Al.l). The 
specificity and sensitivity of these immunoassay based technologies are limited by the 
quality of the antibody produced and the selection of the target for recognition. Production 
of poly- and monoclonal antibodies by conventional methods has provided a platform that 
is the basis of many detection and diagnostic technologies. Although antibodies have been 
widely exploited for use in a range of biosensors, use of these natural molecules has often 
required the modification of detection technologies to optimise performance. For example, 
this may involve the use of additional reagents (Fratamico et al., 1998), optimisation of 
assay conditions (Studentsov et al., 2002) or the development or modification of new or 
existing technologies (Perkins and Squirrel, 2000). Furthermore, these natural recognition 
elements can be sensitive to particular assay conditions (Shone et al., 1985) and may not 
provide the sensitivity and specificity required. When used in a biosensor, sensitivity is 
determined not only by the inherent limitations of the antibody to bind to a given target, 
but may also be affected by the number of available binding sites dictated by the density of 
recognition element immobilised and orientation onto a sensor surface (Hock et al., 2002). 
Further consideration also has to be given to parameters such as steric hindrance, diffusion 
of the target analyte and the ability of the surface and recognition element to be effectively 
reused or regenerated (Leidberg and Gopel, 1997). When antibodies are used within 
biosensors it is frequently required that they are immobilised onto a solid support at the 
sensing interface. A number of strategies exist for antibody immobilisation onto a sensor 
surface as shown in Table 2.1. 
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Method Examples Orientation of Ligand Leaching Other 
considerations 
Physical adsorption Use of a suitable surface for protein Random Can be Regeneration of 
retention e.g. nitrocellulose or problematic ligand difficult 
prefabricated surfaces using techniques 
such as corona ionised gas or glow 
e 
Covalent attachment Use of primary amines, thiols and Can be specific if the Regeneration of 
carbohydrate groups on the molecule to be ligand can be modified ligand easier than 
immobilised or engineered when the 
antibody is 
immobilsed by 
other methods, 
dependent on 
stability of 
antibody to 
regeneration 
conditions 
Biospecific (anti-ligand Protein A, Protein L, Protein G, anti- Specific orientation Can be Regeneration of 
to ligand) species antibody through the Fe portion problematic ligand difficult 
of the antibody 
Biospecific (specific tag Biotin/Avidin, His-Tag/Metal Chelate Can be specific if the Can be Regeneration of 
and interaction with ligand can be problematic ligand difficult 
another soecies) modificdlemrinccred 
Entrapment Within a polymer, gel or membrane Non-specific but can Regeneration of 
be coupled with eo- ligand difficult 
valent attachment and there may be 
constraints on 
binding and 
regeneration 
imposed by 
diffusion. 
Entrapment may 
increase stability 
Table 2.1 Antibody immobilisation strategies 
The choice of strategy employed will be dependent on the nature of the sensing interface. 
Techniques such as surface adsorption are time consuming. Often the density of antibody 
loading is relatively low and can be unstable over entended time periods, or in harsh 
buffering conditions, such as those required for regeneration (elution of the bound analyte) 
(Ahluwalia et al., 1992). Approaches most commonly used for antibody immobilisation 
onto a biosensor involve covalent attachment, for which a wide range of sensing interfaces 
have been employed, including self-assembled monolayers, lipid bilayers, silanised glass 
surfaces, gold, functionalised magnetic beads and dextran (Shriver-Lake, 1998; Egodage 
and Wilson, 1998; Fagerstam et al., 1992; Nyquist et al., 2000). A significant advantage 
of covalent methods of immobilisation is that the antibody is also stable in high buffer flow 
rates and after a number of regeneration cycles due to the stability of the bond formed 
between the antibody and a functional group (Catimel et al., 1997; Howell et al., 1998). 
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Covalent attachment also allows the immobilisation of high concentrations of recognition 
element enabling maximum loading of the sensing region with functional binding sites. 
High surface loading must, however, be balanced with steric hindrance of analyte binding 
that may occur if the surface density of the recognition element is too high (Vijayendran 
and Leckband, 2001; Brogan et al., 2003). Furthermore, as with some of the other 
techniques, covalent attachment may not allow for specific orientation of the antibody to 
exposed binding sites; such as immobilisation via amine groups (Kortt et al., 1997). 
Amino groups that can be used for non site-directed covalent attachment are located all 
over the antibody. Therefore, immobilisation occurs in a random orientation so the 
antibody may either be; (a) fully exposed and available for binding; (b) partially exposed 
(but there may be steric problems); or (c) not exposed and not available for binding (Figure 
2.6) (Nisnevitch and Firer, 2001). The advantage of the use of engineered recognition 
elements such as Fab fragments or single chain antibodies (scFv) is that site directed 
attachment to a biosensor surface can be achieved allowing all binding sites to be 
available. Subsequently a significant increase in apparent affinity and assay sensitivity 
may be observed (Kortt et al., 1997). Furthermore, the use of smaller molecules such as 
scFv will increase the density of antibody that can be can be immobilised onto a surface 
compared to that achievable with traditional monoclonal or polyclonal antibodies, also 
allowing for an increase in assay sensitivity (Figure 2.6). 
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a) 
b) 
Figure 2.6 Immobilisation usmg a) a non-directed coupling method onto a 
sensor surface using traditional antibodies and b) a site-directed coupling method 
using scFv. 
2.10 'Traditional' antibodies 
In order to obtain a full understanding of the limitations of traditional antibodies and the 
potential of engineered antibodies, an explanation of antibody structure and production in 
vivo is required. 
Immunoglobulins (Igs) are tetrameric structures consisting of two heavy chains (m.w. ~55 
k:Da, 440-550 aa) and two light chains (m.w. ~25 k:Da, 220 aa). The light and heavy chains 
consist of constant and variable regions and show patterns in the primary structure. The 
constant regions are located at the C-termini of the heavy and light chains (CL or CH 1, CH2 
and CH3), the structure and sequence of these are conserved within an antibody sub-class. 
The Light chain is linked to the heavy chain via a disulphide bridge towards the N-terminus 
of the heavy chain (Figure 2. 7). The two heavy chains are not only linked via a disulphide 
bridge at the hinge region, but also through non-covalent interactions at the C termini 
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(Figure 2. 7). Within the constant region of a defined isotype the amino acid sequence will 
be relatively well conserved. The variable regions of the heavy and light chains show little 
identity within any isotype. Within each variable domain are four conserved framework 
sequences composed of two antiparallel J3-sheets (Poljak et al., 1973). However, the 
greatest variation in amino acid sequence is observed at the antigen binding sites located at 
the N terminus - this is the variable region (Fv). Contained within the variable region of 
both the heavy and light chain are three non contiguous regions which dictate the 
speci ficity of a particular antibody. The specificity is governed by the amino acid sequence 
that forms six polypeptide loops constituting the complementarity determining regions 
(CDRs), three from VH (CDR Hl-3) and three from VL (CDR Ll-3) which together form 
the antigen binding site (Kabat and Wu, 1971; Jones et al., 1986). The regions VH, VL and 
CL can be cleaved to produce the fragment antigen binding (Fab), discussed in more detail 
in section 2.11.1. VH and VL can be linked by a short peptide linker from the C terminus 
of one domain with the N terminus of the other, to form a single chain Fv or scFv 
(Breitling and Dlibel, 2000). 
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Figure 2.7 The basic structure oflgG showing the Fv region 
The immunoglobulin molecule has two identical light and heavy chains; however, the 
molecule adopts an asymmetric conformation. This fact demonstrates the ability of the two 
fragment antigen binding (Fab ), portions to be present in different con formations in 
relation to each other and the Fe domain. The production of Fabs is discussed in further 
detail in section 2.11.1. It has been suggested that the flexibility of the lgG molecule is 
critical for its functionality. 
2.10.1 Antibody specificity and affinity 
Each of the CDRs folds independently and the high level of variability in primary structure 
is responsible for the observed specific (or idiotypic) immune response. The CDR-H3 
region is thought to show the most significant differences in structure and length and 
consequently contributes the most to specificity (Padlan and Kabat, 1988; Wang et al., 
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1991; Hoogenboom and Winter, 1992; Nissim et al., 1994; MacCallum et al., 1996; Morea 
et al., 1997, 1998; Sgirai et al., 1998; 01iva et al., 1998; McCarthy and Hill, 2001). The 
areas within the hypervariable region that are directly in contact with the antigen contain 
the amino acids which demonstrate the most variability and are often referred to as the 
specificity determining residues (SDRs). The amino acid sequence within the CDRs, 
which is not involved in antigen binding or the loops that are formed, is designated the 
framework region (FR) (Padlan et al., 1995). Although these regions are not directly 
involved in antigen recognition (Sheriff et al., 1987; Wedemayer et al., 1997), it is thought 
that they probably play a crucial role in the steric position of the CDR. Therefore, they can 
have an indirect effect on antibody specificity and affinity by providing a scaffold for the 
CDRs (Larnminmak:i et al., 1999; Daugherty et al., 2000; Kusharyoto et al., 2002) or 
effecting tertiary structure (de Haard et al., 1998). For example, decreases in antibody 
affinity due to single aa changes within the FR have been observed (de Haard et al., 1998; 
Caldas et al., 2003). This is supported by the study of humanised murine antibodies which 
demonstrated a reduction in affinity when CDRs were inserted into a human FR (Foote and 
Winter, 1992; Saldanha et al., 1999; Caldas et al., 2003). 
Over the years, conflicting evidence has emerged as to how the CDRs evolve to dictate the 
specificity and affinity of a given antibody (Jerne, 1955; Ehrlich, 1897). However, 
Burnet's theory of clonal selection is widely accepted today (Burnet, 1957). Later work 
showed that V (variable), D (diversity, only found in the heavy chain) and J (joining) gene 
fragments were randomly assembled during the development of the B-lymphocyte 
(Bernard et al., 1978; Brack et al., 1978). More recently it has been suggested that the 
V(D)J recombination can occur after the development phase, in mature cells and this 
occurs in combination with hypersomatic mutation (Rajewsky 1998; Hertz et al., 1998). 
This is how B-lymphocytes are capable of producing high affinity antibodies along with a 
general population effect whereby antigen receptors of B-1ymphocytes acquire mutations 
that enhance antibody affinity and these cells are selected over those that have a lower 
affinity for the antigen (Diaz and Casali, 2002). It has been suggested that during somatic 
mutation changes are made to the SDRs and surrounding amino acids, thought to be 
involved in stabilisation of the SDRs to allow for the optimal conformation for binding to a 
given antigen (Wedemeyer et al., 1997). The exact molecular mechanisms for 
hypermutation within immunoglobulin genes are poorly understood and will not be 
discussed in this review. 
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2.10.2 Traditional methods for antibody production 
The production of poly and monoclonal antibodies is summarised in Figure 2.8. There are 
particular disadvantages to the traditional approach to polyclonal and monoclonal antibody 
production. The production of antibody is reliant on a mammalian immune response, and 
therefore it is difficult to produce antibodies to low molecular weight analytes, non-
immunogenic targets that are similar or identical to 'self -molecules, such sugars, toxic 
substances, unique epitopes, rare epitopes or those that are non-immunodominant that 
could be targets for detection assays (Emanuel et al., 2000). 
TRADITIONAL ANTIDODY 
PRODUCTION 
,, 
,. 
Target 
Analyte/orgaA POLYCLON~ ~MONOCLONAL 
Immunisation of 
host animal 
Range of antibodies to a 
range of epitopes 
Immunisation of 
mouse 
-D-
Spleen cells fused with 
mveloma cells 
-D-
Screening of 
hvbridomas 
~~)-ut 
Cell line that produces 
antibodies to a single epitope 
Figure 2.8 Traditional antibody production. An overview of the production 
of polyclonal and monoclonal antibodies is shown. 
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2.1 0. 2.1 Polyclonal antibodies 
In the case of a polyclonal antibody, the antibody will recognise a range of undefined 
antigens and epitopes, frequently resulting in cross reactivity and, only a small proportion 
of the antibodies may react against the target. Furthermore, the performance and 
characteristics of an antibody produced from animal sera may vary even between the same 
species. As a consequence, the production of reagents in a reproducible manner is often 
difficult. In the case of polyclonal antibodies, it has been suggested that a specific target 
can be identified and antibodies produced, through the use of affinity purification 
(Petrenko and Volyanoy, 2003). However, this requires knowledge of suitable targets and 
expression of the recombinant protein in the correct conformation. Additionally, it is an 
expensive and time consuming procedure, particularly for large scale production. 
2.10.2.2 Monoclonal alltibodies 
In the case of a monoclonal antibody only one epitope, often of an unknown protein, is 
recognised. The use of detection reagents against unidentified and uncharacterised proteins 
could cause significant limitations to a detection assay. In the case of monoclonal 
antibodies, variation should be minimal due to the antibody resulting from the fusion of a 
B lymphocyte with an immortalised cell line. In monoclonal antibody production, 
extensive screening (usually by ELISA) is required to select cell lines with the desired 
properties, usually specificity and sensitivity. These cell lines then have to be propagated 
and maintained (Iqbal et al., 2000). Therefore, antibodies that are produced in a mammal 
may not be the ideal way to produce specific detection reagents. A review of the 
advantages and disadvantages of poly- and monoclonal antibodies within detection 
immuno-assays has been conducted by Andreotti et al. (2003) and are summarised with the 
advantages and disadvantages of the use of engineered antibodies in Table 2.2 
2.11 Engineered Antibodies 
Due to the inherent limitations of natural antibodies, particularly with regards to their use 
within biosensors (as discussed in section 2.9) alternatives to these natural molecules have 
been sought, and one avenue of research has been the production and use of engineered 
antibodies. 
51 
2.11.1 Chemically engineered antibodies 
The use of antibody fragments, rather than the entire antibody molecule can be 
advantageous for a range of applications. Enzymatic digests of IgG molecules can be 
achieved by using papain to yield Fab or by using pepsin to produce a l 00 kDa F(ab')2 
fragment, Fab' fragments can be produced through the reduction of F(ab'h fragments at 
the heavy chain disulphide groups using a reducing agent, commonly 2-
mercaptoethylamine (Figure 2.9). The number of free sulfhydryl groups is dependent on 
both the species from which the antibody was derived and on the immunoglobulin 
subclass. One advantage of the exposure of free sulfhydryl groups is that they can be used 
for site specific attachment to a solid support. Enzymes such as trypsin or ficin can also be 
used as they cleave a range of immunoglobulins in the hinge region of heavy chain pairs 
(Josic and Lim, 2001). 
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Figure 2.9 Digestion of IgG to produce Fah, F(ab')2 and Fab' 
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The use of Fab fragments has distinct advantages over the parent antibody both for in vivo 
and in vitro applications (Subramanian and Velander, 1996; Hudson, 1999). Conjugation 
of different antibody fragments can also be used to produce antibodies that are specific for 
different targets (Martin et al., 1997). In the context of detection assays, the increase in 
sensitivity often observed is thought to be due to the increased density of binding sites and 
the ability for site specific attachment to certain solid supports exposing all antigen binding 
regions (ltoh et al., 1999). Furthermore, the use ofFabs may be more applicable to certain 
biosensor technologies. For example, for ion channel biosensors the use of Fab' fragments 
is required as they can be correctly orientated and have only one recognition site for the 
target antigen, thus ensuring 1:1 binding. They can also be immobilised to a higher density 
again increasing the sensitivity of the assay (Comell et al., 1997). However, disadvantages 
of the use of Fab fragments detailed in Table 2.2 make production expensive (Cheung et 
al., 2003; Jones and Landon, 2003). Loss of binding activity during digestion or 
purification, as well as the inherent constraints imposed by use of the parent antibodies 
produced by traditional methods (Table 2.2) also limit the applicability of these engineered 
antibodies. 
2.11.2 Genetically engineered antibodies 
With the advances in recombinant DNA technology, it may be possible to tailor a new 
class of genetically engineered antibodies to suit the requirements of the detector and 
assay. Recombinant antibody technology combines phage display and cDNA libraries to 
allow for the production of a large number of immunoglobulin (lg) fragment clones. Fab 
fragments can also be produced using recombinant techniques (Better et al., 1988); 
however, smaller recognition elements incorporating the variable domains i.e. the sites 
required for antigen recognition have also been produced. The variable regions can either 
be connected by: (a) non-covalent forces to produce Fv (Skerra and Pli.ickthun, 1988); (b) 
covalently using linkers such as disulphide bridges to create dsFv (Glockshuber et al., 
1990); or (c) a peptide linker used to produce a scFv (Bird et al., 1988; Huston et al., 
1998). The following sections discuss the use of scFv. The first step in the production of 
scFv is the construction of a suitable gene library, which creates a source of recognition 
elements with differing binding specificities. Once a library has been produced, it can be 
screened for scFv that bind the target of interest. Consecutive rounds of selection allow for 
enrichment of the population for those bacteriophage phage expressing scFv that bind to 
the target of interest (Alfthan, 1998). The scFv DNA sequence can be examined and used 
to determine any features that may be important for binding that could be used for further 
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genetic manipulation. One of the distinct advantages of the use of recombinant antibodies 
is that they can be modified for successful incorporation into biosensors. For example, the 
affinity or specificity of a selected scFv can be enhanced using genetic manipulation or 
through experimental design (Griffiths et al., 1994; Krebs et al., 2001). Furthermore, 
protein engineering techniques can also be used to tailor the properties of the antibody for 
the required purpose, including the incorporation of specific immobilisation tags 
(Piervincenzi et al., 1998). Protein engineering has also been investigated as a method of 
changing the signal transduction properties of the binding molecule (Hellinga and Marvin, 
1998). The ability to incorporate signal transduction into a recognition element is highly 
desirable as it allows for simplification of biosensor design and a reduction in the use of 
reagents (Hellinga and Marvin, 1998). A number of approaches can be utilised including 
incorporation of a fluorescent moiety that is sensitive to changes in the environment, such 
as those induced by antigen binding, producing a measurable variance in signal (North, 
1985; Marvin et al., 1997; Marvin and Hellinga, 1998; Renard et al., 2002, 2003; Jespers 
et al., 2004). Alternatively fluorescence resonant energy transfer (FRET) can be used to 
report analyte binding (Forster, 1959; Stryer and Haugland, 1967; de Silva et al., 1997; 
Selvin 2000). However, successful use of this approach is generally limited to recognition 
elements that show a large intrinsic change in conformation on analyte binding such as 
aptamers (Jhaveri et al., 2000) or the use of a more complex engineering strategies, in the 
case of recombinant antibodies (Medintz et al. 2005). This extremely elegant approach 
could not have been achieved through the use of more traditional recognition elements 
such as poly or monoclonal antibodies and represents a very exciting development in the 
use of recombinant antibodies as reagents on biosensor platforms. 
2.11.2.1 Production of genetically engineered antibodies 
Generation ofrecombinant antibodies is commonly undertaken by the use of phage display 
that can either be produced from a monoclonal cell line, naive, synthetic or immunised 
libraries (Willats, 2002). Recombinant forms of monoclonal antibodies with high affinity 
and specificity can be produced; this is particularly advantageous if the cell line is unstable 
or for engineering specific attributes, such as immobilisation tags. This technique can be 
hampered by the presence of aberrant mRNA sequences within the hybridoma resulting in 
the generation of antibody fragments that do not have the same attributes as the parent 
antibody (Duan and Pomerantz, 1994; Ostermeier and Hill, 1996). This can, however, be 
overcome by the use of recombined V L and V H sequences as described by Krebber et al. 
(1997). Synthetic libraries are constructed from V-gene sequences with modifications at 
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particular sites. However, for these libraries to be successfully employed knowledge of the 
CDRs is required and can also be utilised to construct libraries for defined epitopes 
(Hoogenboom and Winter, 1992; Kirkham et al., 1999). In the case of a naive library, the 
antibodies originated in an animal that was not deliberately challenged with a potential 
target. These libraries have been used successfully for the generation of recognition 
elements against a range of target analytes (Winter et al., 1994; Haardt et al., 1999). A 
distinct advantage of the use of naive libraries is that, as with synthetic recognition 
elements, production of recognition elements against toxic or non-immunogenic markers is 
possible (Griffiths et al., 1993; Nissim et al., 1994). However, these libraries may be 
limited by diversity and it has also been observed that the size of the library is directly 
proportional to the affinity of the antibodies isolated (Griffiths et al., 1994). In the case of 
an immlmised library, the animal was exposed to a target of interest and as a result will 
have a large proportion of antibodies directed against the target and a degree of affinity 
maturation will have been conducted in vivo (Clackson et al., 1991 ). Thus, the use of these 
libraries has frequently resulted in the isolation of higher affinity antibodies than those 
selected from a naive source (Clackson et al., 1991). There are also limitations of the 
production of antibodies when using immune libraries. For example these libraries only 
allow for the isolation of scFv against antigenic and/or non-toxic substances and the 
library may be biased towards immunodominant and abundant epitopes (Hoogenboom et 
al., 1998). In the case of immune libraries, antibody sequences are usually obtained from 
the B-cells originating from the spleen of the immunised host (Willats, 2002). Initially, the 
immunoglobulin V domains from the naive or immunised source are amplified by PCR. 
Kirkham and Shroeder (1994) suggested that each of the segments of this domain were 
important in forming the structure of the actual binding site. Furthermore, V genes have 
been implicated as being heavily involved in specific immune responses and it is the V 
genes that are utilised in the production of engineered antibodies. Antibody fragments 
genes have been successfully inserted into a wide range of vectors to facilitate surface 
display; including bacteria, viruses, bacteriophage and yeast (McCafferty et al., 1990; 
Clarkson et al., 1991, Fuch et al., 1991; Marks et al., 1991; Hoogenboom et al., 1991; 
Kieke et al., 1997; Motterhead et al., 2000). One of the most commonly employed 
methods is the use of bacteriophage primarily the filamentous bacteriophage M13. 
Expression of the scFv on the bacteriophage surface is usually achieved by creating a 
fusion protein with the N-terminus of the M13 coat protein, gp3 (Iqbal et al., 2000), 
although other bacteriophage, phagemids and genes have also been employed for phage 
display of engineered antibodies, as reviewed by Benhar (2001). 
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The recombinant antibodies are then expressed on the surface of the phage as the antibody-
encoding DNA is contained within the phage (Figure 2.1 0.). The advantage of the use of 
phage display for antibody engineering is the close link between genoptype and phenotype. 
Either gene libraries or hybridoma cells can be used to produce recombinant antibodies by 
bacteriophage display, although more recent work has applied ribosome display in which 
the scFv are transcribed and translated in a cell free system (I-Ianes et al., 2000). The 
complexes can then be used to bind to a chosen target using a procedure often termed 
biopanning (as discussed in section 2.11.2.2), which continues as with phage display. 
Using this method, and with the incorporation of RT PCR with a low fidelity polymerase, 
Hanes et al. (2000) produced scFv from a na!ve synthetic library that had afflnities within 
the picomolar range. 
Immunisation of host 
___ :D.-
IgG mRNA arranged sequences 
cDNA 
-D. PCR 
Assembly into scFv 
n Fusion of scFv DNA with a phage coat 
~ protein gene 
Population of phage 
expressing a range of 
scFv 
Figure 2.10 A schematic representation of an example of bacteriophage display 
using an immunised library. 
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This method relies on the fusion of millions of antibody encoding genes to the coat protein 
genes of a bacteriophage. Following immunisation, mRNA is isolated, reverse 
transcription of the RNA allows construction of the scFv library. PCR amplification of 
antibody sequences, overlap extension PCR followed by cloning of the assembled scFv 
sequence into a suitable vector allows for expression of the fusion construct on the surface 
of each phage as the coat protein also encoding the scFv gene is incorporated into the 
phage particle. The resultant library contains a large number of phage each displaying 
different scFv. 
2.11.2.2 Biopalflfilfg 
Once a library has been produced, it can be screened for scFv that bind the target of 
interest. Usually antigen is immobilised onto a surface, for example by passive adsorption 
or by biotinylation with subsequent binding onto a streptavidin coated surface (Willats, 
2002). Unbound phage are washed away, leaving only those that bind to the target. 
Finally, the scFv are eluted from the target and propagated using a suitable bacterial host. 
Consecutive rounds of selection allow for enrichment of the population for those phage 
expressing scFv that bind to the target of interest (Figure 2.11 ), a procedure often termed 
'biopanning' (Aifthan, 1998). 
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Figure 2.11 Schematic representation of a possible biopanning procedure for 
scFv against a particular target. ( 1) Production of a scFv library (2) 
Immobilisation of the target of interest onto a solid support and subsequent 
addition of a representative proportion of the scFv (ii) Those phage displaying 
scFv that recognise the target analyte are bound (iii) Unbound phage are removed 
by a series of wash steps (iv) Bound phage are eluted from the target analyte (4) 
The eluted phage that recognise the target analyte are used to re-infect a suitable 
bacterial host to allow for amplification of phage displaying scFv specific to the 
target analyte. At this stage the cycle can be repeated or (5) The phage can be 
evaluated for the desired characteristics, characterised and manipulated further if 
required. 
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2.11.2.3 E11hancing the Specijicity of scFv 
Although scFv can be manipulated to enhance specificity, there are problems associated 
with using surface exposed antigens as targets. As with any other means of recognition 
element production, purified or recombinant antigen may not be available. Furthermore, 
any purification strategy utilised may denature or alter the antigen of interest. If 
recombinant protein is used, the protein structure may differ from the native form or from 
that found when anchored to a cell surface. Consequently, there may be an observed 
decrease in the binding properties of the scFv when the antigen is presented on the surface 
of a whole cell or spore. One method of producing antibodies against a given target is 
through the production of an epitope mimic, also referred to as an anti-idiotypic antibody 
(Hombach et al., 1998). The use of anti-idiotypic antibodies has had varying degrees of 
success. Often, increased binding to the mimic compared to the native target has been 
observed (Goldbaum et al., 1997). Other important techniques for enhancing specificity 
that have been reported are competitive panning and competitive elution. These have 
provided a means to select epitopes that are not shared by two related antigens. Krebs et 
al. (2001) described a method by which pre- and post- adsorption steps could be utilised to 
select out those scFv that bound to possibly cross reactive targets to produce specific scFv. 
As an alternative to this method, Scherer et al. (1998) described a methodology by which 
polyclonal antisera were produced against a specific target and the sera were depleted of 
antibodies that were not specific to the target by purification with the recombinant protein. 
The purified sera that recognised the antigen of interest were then used to construct a scFv 
library. 
2.11.2.4 Enhanci11g the affinity ofscFv 
Genetically engineered antibodies produced from an immune library generally have higher 
affinities than antibodies derived from a nai"ve source (Griffiths et a/, 1994). However, it is 
possible to manipulate the fragments by the use of further techniques to improve these 
affinities. Techniques such as random mutagenesis (Forrer et al., 1999; DeHaard et al., 
1999; Ridgeway et al., 1999; Beiboer et al., 2000) or site-directed mutagenesis (Morrow, 
2000) have been used. However, there are inherent problems associated with both 
approaches. In the case of random mutagenesis; as the mutations are non-specific, they 
often give rise to undesirable properties particularly when using an expression vector 
(Moore and Maranas, 2004). In the case of site-directed mutagenesis, lack of knowledge, 
of the structure-function relationship can present problems with mutated scFv with no 
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ability to bind to the target (Morrow, 2000). Other methods of enhancing affinity include 
ribosomal display and chain shuffiing (Jackson et al., 1992; Kirkham et al., 1994; Alftan, 
1998). The use of in vitro methods to enhance the affinity of a library has achieved 
affinities in the nano to picomolar range (Rader and Barbas, 1997; Alfthan, 1998). Other 
ways of enhancing the affinity of a recognition element to a protein can be drawn from 
techniques developed in other areas. For example, the affinities of synthetic recognition 
elements have been enhanced through the use of lower concentrations of target in a 
specific selection procedure. Mutagenesis, to improve scFv specificity and affinity, is 
based on the determination of hypervariable regions and the analysis of mutations within 
the V genes. Increasing knowledge in this area would lead to a better understanding of 
fundamental mechanisms that could then be applied to phage display or, more likely, to in 
vitro systems such as ribosomal display. 
2.11.2.5 Enhancing stability and engineering for correct orientation 
Protein engineering techniques can also be used to tailor the properties of the antibody for 
the required purpose, such as enhanced stability or use of fusion protein to engineer 
specific tags for correct orientation. Many applications for detection technologies require 
that a recognition element is stable within harsh environmental conditions. However, 
natural antibodies have demonstrated differing stabilities and it has been put forward that 
even single amino acid changes can affect antibody stability (Honegger and Pliickthun, 
2001; Ewert et al., 2003). Ways of increasing antibody stability have included; (a) CDR 
grafting into frameworks of known tolerance to the conditions required, (b) the 
introduction of mutations known to enhance stability, or (c) the use of selective pressure 
(i.e. use of the conditions required) within the selection process (Jung et al., 1999; Ewert et 
al., 2004). To allow for correct orientation of a recognition element on a solid support, 
such as that used on a biosensor, fusion proteins are the common method of choice. 
Commonly histidine tags (His-Tags) are fused into scFv when expressed in its soluble 
form and this is then utilised as a method for purification, detection or sometimes 
immobilisation of the scFv (Lindner et al., 1997). The use of an unpaired cysteine at the 
C-terminus to allow for covalent attachment has also been reported (Kipriyanov and Little, 
1997). Specific modifications at the C-terminus have the advantage of maintaining I: 1 
ratio of recognition element to immobilisation group, ensuring that the binding site is 
exposed (Piervincenzi et al., 1998). Modifications such as this can be used to enhance scFv 
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properties. Once the appropriate clone has been selected or engineered, it ts usually 
required that it is expressed in a soluble fonn. 
2.11.2.6 Expressio11 ofscFv in a soluble form 
The isolation of scFvs from a phage display or ribosomal display library has been well 
documented; however, complications can arise when trying to express the scFv in a soluble 
fonn. When scFvs are cloned into bacterial expression vectors the yield is often poor. This 
can be due to a number of reasons; most commonly the scFv is not contained within the 
periplasm and may aggregate and precipitate. Alternatively, cytoplasmic inclusion bodies 
may fonn containing scFvs with either reduced or no binding activity. The ease with which 
a scFv can be expressed in a soluble fonn and undergo correct folding varies with each 
individual scFv. In general, it has been found that those scFv produced by phage display 
refold and solubilise more readily than those produced from hybridoma cell lines. This is 
likely to result from the method used in phage display, whereby those scFv that possess the 
required binding characteristics and are expressed well are selected and possibly over-
represented within a system. By contrast, those scFv that may bind well, but are toxic to 
the cell, or those which are relatively rare and possess unusual characteristics may not be 
selected. For this reason, it may be necessary to investigate a range of expression vectors 
and refolding and solubilisation strategies. Some that have already been investigated 
include yeast and insect expression systems (Mahiuoz et al., 1998). 
Advances in recombinant DNA technology and computational molecular biology have 
allowed the production of alternatives to traditional antibodies that can be modified to suit 
the requirements of the detector and assay design (Irving et al.; 1996; Lindner et al.; 1997; 
Piervincenzi et al., 1998; Jung et al., 1999). The advantages in the use and production of 
recombinant antibodies compared to traditional approaches are summarised in Table 2.2. 
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0\ 
N 
Chemically engineered 
antibodies 
Polyclonal Monoclonal 
Animal use Yes -required each time Initial - mouse immunised, further As for parent polyclonal or 
production of antibody from cell line monoclonal antibody 
Affinity and Variable within a batch and Reproducible -higher specificity, Specificity can be altered 
specificity from animal to animal single epitope, affmity dependent on using conjugates of 
antibody antibody fragments 
Targets Variable within a batch and Single target, difficult to isolate As for parent polyclonal or 
from animal to animal specific clones that recognise a monoclonal antibody 
unique epitope 
Tailoring of No No Limited 
antibody to suit 
requirements 
Supply Finite supply of an antibody Infmite supply from immortalised As for parent polyclonal or 
from sera cell line monoclonal antibody 
Logistics Use of animals and ongoing Expensive and time consuming to As for parent polyclonal or 
effort to produce quality anti- maintain monoclonal antibody, also 
sera to a wide range of agents requires digestion and 
further purification 
Table 2.2 A comparison of traditional chemically engineered and genetically engineered antibodies. 
Genetically engineered antibodies 
Recombinant DNA technology may 
require initial use, but not always 
necessary 
Reproducible -high specificity and 
affinity 
Can be manipulated to recognise 
unique, rare, sterically shielded or 
non-immunodominant epitopes 
Yes 
Infmite supply from mammalian, or 
more commonly, bacterial cells 
Stable genetic source expression and 
production (bacterial fermentation) 
less expensive and less time 
consuming 
2.12 Summary 
Sensitive and specific detection of BW agents is essential in a military context for the 
protection of armed forces and the maintenance of an effective military response and in a 
bioterrorism scenario for the protection and effective treatment of a susceptible civilian 
population. In both cases, the timely administration of appropriate treatment following 
exposure and effective decontamination of affected areas is critical, making rapid detection 
of these pathogenic microorganisms essential. 
Bacterial endospores of B. anthracis represent the most significant form of the organism in 
a BW scenario due to their resistance to extreme environmental conditions, ability to 
survive for prolonged time periods, ease of production, effective dissemination and their 
ability to infect humans, particularly via the respiratory route. Rapid real time detection of 
B. anthracis is a particular problem and has been stated as 'not yet technologically 
practical' (Webb, 2003). Systems deployed in the US to detect airborne anthrax were 
reported to have problems with false positives and (of more concern) false negatives and 
had a time lag between dissemination and identification of 12-24 h (Webb, 2003). A 
number of methods are available for detection of B. anthracis; however, only a small 
proportion of these could be utilised in the field, and of these, only a minority are capable 
of true real time specific detection. Of these, optical biosensors have shown particular 
promise; however, the detection of larger particulates has been problematic often leading 
to a significant reduction in assay sensitivity. Many detection assays, including those 
employed by optical biosensors, utilise the detection of a binding event, most commonly 
antigen to antibody in the detection of aerosolised BW agents. However, lack of 
sensitivity and specificity is often observed. Therefore, increased knowledge of the 
structural and antigenic components of the B. anthracis spore and the provision of suitable 
recognition elements is essential for the specific detection of this BW agent. This work 
aims to overcome these challenges and to elucidate structural components that may be 
utilised for the production of high affinity specific recognition elements to B. anthracis 
spores. 
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Chapter 3 Materials and methods 
3.1 Bacterial strains and plasmids 
Initial investigations of sonication and surface labelling techniques were undertaken using 
a non-pathogenic organism as a model system. Stock suspensions of Bacillus atrophaeus 
spores were obtained from the Health Protection Agency (HP A) UK. Bacillus atrophaeus 
has been re-classified and was previously B. subtilis var. niger, previously B. globigii (B. 
atrophaeus ). 
For the evaluation of B. anthracis spores a double cured strain (UM23Cl2, pXOr, pX02-) 
was used (kindly provided by Dr. C. Thome). Strain RBA91 (PXOr/PX02-/Sap-) and 
strain SM91 (pXOr/pXOT/Eag-) were kindly provided by the Pasteur Institute. The wild 
type Ames strain (pXOI +/pX02l of B. anthracis acquired from stocks held at Dstl was also 
used for this study. For evaluation of antibodies, y-irradiated wildtype Ames, kindly 
provided by the Health Protection Agency, UK and Steme (pXOl+/pXOT), strain kindly 
provided by Defence Science Technology Organisation (DSTO), Australia, spores were 
used. 
B. cereus (NCTC 11143, NCTC 9946 and NCTC 11145), B. pumilus (NCTC 10337), B. 
brevis (NCTC 2611), B. coagulans (NCTC 10334), B. atrophaeus (NCTC 10073), B 
thuringiensis var. kurstaki and B. thuringiensis var. israelensis were obtained from NCTC 
(Public Health Laboratory National Collection of Typed Cultures). 
3.2 Preparation of Bacillus spores 
A single colony was inoculated into 50 ml of LB Broth (10 g/1 Difco Bacto tryptone, 5 g/1 
Difco Bacto Yeast extract, 10 g/1 NaCI, Difco Bacto agar adjusted to 11 in distilled water) 
in a 250ml conical flask and incubated for approximately 6 h at 37°C. Vent capped 150 
cm2 tissue culture flasks containing 75 ml of new sporulation medium (25 g/1 Difco Bacto 
Agar, 3 g/1 Oxoid Tryptone, 6 g/1 Oxoid Bacteriological peptone, 3 g/1 yeast extract 
(Oxoid), 1.5 g/1 Lab Lemco powder 1 mill of a 0.1% solution MnCh.4H20) for B. 
anthracis spores or isolation agar for all other Bacillus species (6 g/1 Oxoid nutrient broth 
No. 2, CM67, 0.3 g/1 manganese sulphate (MnS04.H20, 0.25 g/1 KH2P04, 12.0 g/1 Oxoid 
technical agar No. 3, Ll3) were inoculated with 2.5 ml to 5 ml of the 6 h culture and 
incubated at 37°C until the culture contained at least 95% phase bright spores, determined 
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by phase contrast microscopy. The spores were recovered by resuspension in 15 ml of ice-
cold sterile distilled water and were harvested by centrifugation at 10000 g for 10 min at 
4°C. The supematant was removed and the pellet resuspended in ice-cold sterile distilled 
water. 
3.3 Washing spores 
Spores were centrifuged at 10000 g for 10 min at 4°C, the supematant was discarded and 
the pellet resuspended in ice-cold sterile distilled water. This was repeated as many times 
as required to achieve > 95% phase bright spores (usually 10). After the final wash the 
spore pellet was resuspended in approximately 40 ml of sterile ice-cold sterile distilled 
water per 200 ml of start volume. A serial 10 fold dilution of washed spores was plated 
onto LB agar plates (10 g/1 Difco Bacto tryptone, 5 gll Difco Bacto Yeast extract, 10 g/1 
NaCI, 1.5% (w/v) Difco Bacto agar to 1 I in distilled water) in triplicate (250 J.ll per plate). 
The remaining diluted samples were incubated at 60°C for 1 h to lyse the vegetative cells, 
these were again plated on onto LB agar plates (in triplicate (250 J.ll per plate). All plates 
were incubated overnight at 37°C. The number of spores and vegetative cells in each 
sample was calculated. The presence of >95% phase bright spores was confirmed using 
phase contrast microscopy. Spore suspensions, at approximately 1 x 109 cfu/ml were 
stored in sterile distilled water at 4°C or -20°C. 
3.4 Urografin purification of B. a11tlrracis spores 
Urografin purification has been used previously to highly purify spores (Williams and 
Tumbough, 2004). B. anthracis UM23CI2 spores that had been washed ten times in ice-
cold sterile distilled water were subsequently Urografin purified and washed a further three 
times in ice-cold sterile distilled water, as described by Williams and Tumbough (2004). 
3.5 Wildtype Ames exosporium preparation 
Unwashed wildtype Ames exosporium was kindly provided by Dr. C. Redmond (Dstl); the 
growth of the strain, preparation of spores and exosporium purification and removal were 
all conducted as described previously (Redmond et al., 2004). 
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3.6 FITC labelling of spores 
Known concentrations, 1 mg/ml, 0.5 mg/ml and 0.2 and 5mg/ml, of FITC (fluorescein 
isothiocyanate isomer I, Sigma) were made in 0.1 M sodium bicarbonate buffer pH 9 
(Sigma) immediately prior to use. Washed B. atrophaeus spores were diluted to 1 x 109 
spores/m] in 0.1 M sodium carbonate bicarbonate buffer pH 9 (Sigma). The FITC was then 
added as detailed in Table 3.1. The FITC spore mix was covered in aluminium foil and left 
to incubate for 2 h at room temperature on a DYNAL windmill to provide continuous 
mixing. The FITC spore mix was then centrifuged at 10000 g and resuspended in PBS (10 
mM sodium phosphate buffer pH 7.4 138 mM KCI, 27 mM NaCI, Sigma), this was 
repeated three times. The FITC labelled spores were then viewed using fluorescence 
microscopy, to determine the optimum labelling protocol. 
Final amount of FITC to Spores @ 1 x 10~ FITC stock Volume of FITC 
be added spores/m! concentration stock to be added 
(mg/ml) (J.!l) 
200 J.lg 1 1 200 
100 J.lg 1 1 100 
50 J.lg 1 1 50 
25 J.lg 1 0.5 50 
12.5 J.lg 1 0.25 50 
Table 3.1. Optimisation of FITC labelling detailing the volumes of FITC required for 
differing amounts to be added to 1ml of 1 x 109 spores/m!. 
The optimal amount of FITC appeared to be 200 J.lg, therefore the spores were labelled as 
described previously. The spores were then sonicated and centrifuged at 10000 g for 10 
min and the supematants removed. The proteins within the supematants were separated by 
SDS PAGE. To visualise the bands on a gel two methods were investigated. One involved 
the transmission of blue light through the gel, the other just utilising the UV light on a Gel 
Documentation system (BioRAD). As a control FITC labelled antibody was also analysed. 
Once any FITC labelled protein bands had been identified the gels were photographed and 
stained using a Colloidal Blue stain (Invitrogen) according to the manufacturer's 
instructions. Supematants were also concentrated using Vivaspin500 filters (5000 MWCO) 
and the analysis by SDS-PAGE (section 3.27). 
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3. 7 Biotinylation of tbe spore surface 
Washed spores were diluted to approximately 1 x 109 cfu/ml and centrifuged (10000 g for 
10 min). The supernatant was removed and replaced with 1 mg/ml sulfo-NHS biotin 
(Perbio) in PBS and incubated for various time periods on ice. The spores were then 
washed twice in PBS and once in 50 mM Tris pH 7.5, 50 mM magnesium chloride 
(MgCh), to quench and remove excess biotin. When the biotinylation was complete the 
spores were centrifuged at 10000 g for 10 min and the supernatant removed and replaced 
with sterile distilled water (Invitrogen), this was repeated three times to ensure all excess 
biotin was removed. The spores were then sonicated (section 3.18.2) or electroporated 
(section 3.15), centrifuged at 10000 g for 10 min and the supernatants removed for 
analysis. To visualise the biotinylated proteins the supernatants from the sonicated spores 
were separated by SDS-PAGE on 4-12% Bis-Tris Novex gels (Invitrogen), as described in 
section 3.27 blotted onto PVDF membranes and probed using a streptavidin HRP 
conjugate (Sigma) 1: 1000 dilution in PBS Tween 20 0.1% for detection of the molecular 
weight marker (MagicMarkTM Western Standard, Invitrogen), as described in section 3.28. 
To ensure the streptavidin peroxidase conjugate did not bind non-specifically to any 
proteins released during sonication, non-biotinylated spores were also sonicated and 
analysed by the same method described above. Once the procedure had been optimised 
various Bacillus species were analysed using this method and differences between the 
profiles examined. 
3.8 Enrichment of biotinylated proteins 
After biotinylation and sonication spores were centrifuged at 10000 g for 10 min and the 
supernatant removed and filtered using a 0.2 Jlm low protein binding filter to remove any 
intact spores. To capture the biotinylated protein 1 m! aliquots of Magnabind streptavidin 
magnetic beads were used (Perbio ). The beads were washed three times in sterile 
phosphate buffered saline PBS (BupH pH 7.4, Perbio ) with the use of a MagnaBind 
Magnet (Perbio ), to separate the magnetic particles from the liquid phase. After the last 
wash the PBS was removed and 1 m! of biotinylated proteins were added and incubated 
overnight at 2-8°C. Once the incubation was complete the beads were washed 5 times with 
sterile PBS and the biotinylated proteins eluted with 1 M KOH for 3 min with mixing. To 
neutralise the high pH from the KOH, 750 Jll fractions were eluted into 250 Jll 1 M citric 
acid (BDH). The elution step was repeated three times and the fractions pooled, and the 
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elution buffer exchanged for PBS and the proteins concentrated using a Vivaspin500 
column (5000 MWCO). Fractions were visualised by SDS PAGE using a 4-12% Bis-Tris 
NuPage gel (Invitrogen), SYPRO stained (Molecular Devices) according to the 
manufacturer's instructions. Samples were then analysed by nano-LC-tandem MS (section 
3.31). 
3.9 Preparation of S-layer proteins 
Bacterial cultures (50 ml) were grown overnight at 37 oc in SPY medium (60 mM 
K2HP04, 45 mM KH2P04, 15 mM ammonium sulphate, 10 mM magnesium sulphate, 2.4 
mM sodium citrate, 0.2% (w/v) glucose 0.2% w/v yeast extract, all Sigma). Cultures were 
centrifuged at 8000 g for 30 min at 4 oc and resuspended in 5 M guanidine hydrochloride 
in 50 mM Tris-HCI, pH 7.2. The resuspended pellets were incubated for 2 hat 20°C with 
shaking, and then centrifuged at 6000 g for 10 min at 4 °C. The supematant was removed 
and dialysed against 4 I of 50 mM Tris-HCl pH 7.5 overnight at 4 °C. S-layer self-
assembly products were sedimented by centrifugation for 30 min at 4 °C. The precipitate 
and supematant were analysed by SDS-PAGE to confirm the presence of S-layer proteins. 
The soluble S-layer protein contained in the supematant was concentrated by ultrafiltration 
and filtered using a 0.45 11m filter. An aliquot of protein before and after concentration 
was retained for analysis. Further purification of S-layer proteins was achieved using a 
HiLoad 1660 Superdex 200 preparatory grade column (Amersham) and an AKTA FPLC 
system (Amersham), monitoring purity by SDS-PAGE (section 3.27). Fractions that 
contained pure S-layer protein were pooled and the concentration determined by BCA 
Assay (Pierce), according to the manufacturer's instructions. 
3.10 Preparation of Escllericllia coli 
E. coli was taken from stock culture maintained at Dstl and streaked out onto LB agar. A 
single colony was inoculated into 50 ml LB Broth and incubated for 6 h at 37°C. Stocks 
were enumerated by viable plate counts. 
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3.11 Preparation of ovalbumin 
A stock solution of Ovalbumin (Sigma, Grade V) was prepared at 10 mg/ml. Stocks were 
diluted down to the desired concentration. 
3.12 Plasmids 
Plasmids pAKlOO (used for phage display) and pAK300 or pAK400 (used for production 
of soluble scFv) were a kind gift from Dr A. Pluckthun (University of Zurich, 
Switzerland), and were used as previously described (Krebber et al., 1997). The pKAPPA 
plasmid was a kind gift prepared by Dr. C. Mayers (Dstl). 
3.13 Antibodies 
For the detection of B. anthracis spores, a polyclonal rabbit anti-B. atrophaeus antibody 
(Dstl) was prepared using whole spores as the immunogen. For detection of B. anthracis 
spores a monoclonal or polyclonal anti- B. anthracis antibody was used (Dstl). Both were 
prepared using whole spore preparations of y-irradiated wildtype Ames strain. For the 
identification of immunogenic proteins of the exosporium, a polyclonal antibody was used 
that had been prepared using washed wildtype Ames exosporium as the immunogen (Dstl). 
For the detection of ovalbumin a polyclonal rabbit anti-ovalbumin antibody was used 
(Dstl) prepared using ovalbumin (Sigma, Grade V) as the immunogen and for bovine 
serum albumin (BSA) detection a monoclonal anti-BSA antibody was obtained from 
Sigma. For the detection of the S-layer protein EAl a monoclonal anti-EAl antibody was 
used. 
3.14 Antibody labelling 
Dimethyl formamide (1 ml) (DMF, Sigma) was added to the biotinylation or fluorescein 
reagent (Molecular Devices) using a l ml syringe. The solution was swirled gently to mix 
and then extracted from the vial. The appropriate amount of biotin or fluorescein, to obtain 
a specific molar coupling ratio (MCR), as detailed in the manufacturer's instructions, was 
then added to 0.5 or l ml of antibody at 1 mg/ml in sterile PBS and left to incubate at room 
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temperature in the dark for 2 h. The antibody was purified using a PD-10 column 
(Amersham), which was first washed with 25 ml of PBS (phosphate buffered saline), to 
allow the column to equilibrate. The antibody solution (0.5 or 1 ml) was loaded onto the 
column and 1.25 or 0.63 m! of PBS added. An additional 3 m! of PBS was loaded onto the 
top of the column and 0.5-1 m! fractions collected. The absorbance was read at 280 nm 
following purification using the PD-10 column, to determine the final antibody 
concentration at 362 nm to determine the amount of biotin present or at 490 nm to 
determine the amount of fluorescein present. The antibody concentration and the molar 
incorporation ratio (MlR) of biotin molecules per lgG was calculated according to the 
manufacturer's instructions. 
3.15 Electroporation of spores 
Based on previous work, (Dr. M. McDonnell, unpublished data) samples were 
electroporated using a BTX 820R electroporator (Harvard Apparatus) using a square wave 
pulse. A I mm gap cuvette was used resulting in an applied voltage of 5 kV/cm between 1 
and 99 0.1 s pulses or 7.5 kV /cm in 12 x 0.000 I s. Deionised water ( 18 Qohm) was used to 
minimise the possibility of arcing, especially at higher voltages. Electrodes in the 
disposable cuvettes were made from aluminium. An aliquot (lOO j.li) of washed B. 
atrophaeus spores at an approximate concentration of 1 x 109 spores/m! was added to an 
electroporation cuvette and exposed to square wave pulses. 
3.16 Sonication using a standard probe sonicator 
Initial evaluation of sonication was carried out using a standard probe sonicator, using a 
Misonix XL2020 (Misonix lnc) ultrasonic liquid processor. This system had a 550 watts 
output, with a 20kHz converter and 1/2" tapped horn. A 3.2 mm microtip probe was used 
to maximise the amplitude of the sonication. The system was tuned according to the 
manufacturer's instructions. 
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3.17 Sonication using a mini sonicator (Cepheid) 
A minisonicator system developed by Cepheid, (CA, USA) was supplied for assessment. 
The system utilised a 20 kHz minisonicator with a 6rnm diameter titanium probe (Figure 
3 .2a). Batch samples of 100 JLl of spore suspension were aliquotted into Smartcycler tubes 
(Eurogentech), shown in Figure 3.2b (Cepheid, CA, US). The samples were exposed to 
cavitation, varying the amplitude and time period of the sonication. Samples were also 
sonicated with the use of acid washed glass beads (Sigma 0.05 mg, <106 J..lm). 
a) b) 
Figure 3.1. The Cepheid minisonicator showing: a) the sonicator with 
sample tube; b) the sample tube (holding 100 Jll of sample). 
3.18 Development and evaluation of a prototype tubular sonicator 
3.18.1 Design 
Using the preliminary results obtained using the standard probe and Cepheid system a 
continuous flow dismption system was developed in collaboration with K. Borthwick and 
T. Coakley, University of Cardiff. The design consisted of a system with a ring transducer 
and a stainless steel tubular coupling layer which allowed for heat dissipation, which was 
found to be a major factor in the degradation of the sensitivity of immunoassay based 
technique. A 26 mm long tubular ceramic transducer (PZT4D, Vemitron, Southampton, 
UK) of outer diameter 63.8 mm and wall thickness 6.52 mm (298 kHz radial resonance of 
the transducer) was fitted with a 50.5 mm outer diameter, 3.8 mm inner diameter steel 
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cylinder (Figure 3.2). The ceramic/steel bond was formed by silver-loaded conductive 
epoxy resin (Circuitworks ®). The epoxy-coated steel was held in a lathe and the 
transducer gently pushed on. A wave generator (Agilent model HP 33 120A) provided an 
input voltage to an amplifier (Model 240L, ENI Rochester, NY) whose output was applied 
to the transducer. 
a) 001 57 69 mm 
63 76 mm 
b) 
,~-11 - ----- ---- ------_J I 11 
D Piezocera:mic 
0 Sta.o.leu steel 
Silver-loaded epoxy resin 
• Waer layer 
Figure 3.2. Schematic diagram of the tubular sonicator (a) vertical plane 
and (b) horizontal plane. Image kindly provided by K. Borthwick, University 
of Cardiff. 
3.18.2 Sample processing 
Initial selection of the optimum frequency for cavitation and other preliminary 
measurements were conducted by K. Borthwick (University of Cardiff). The speed of 
sound, density, elastic stiffness constant and effective acoustic quality factors- for the 
different layers were as detailed by Hawkes et al. (2002). A number of different voltage 
amplitudes were applied to the amplifier input at the selected frequency. This also involved 
determination of the optimal operating frequency for the system found to be 266 kHz, 
identified by a resonance peak. Further design of the system to introduce cooling through 
an increase in the steel heat radiating surface demonstrated a 5°C temperature rise over 60 
s. Initial evaluation of disruption was assessed using Saccharomyces cerevisiae (conducted 
by K. Borthwick, University of Cardiff). After the preliminary evaluation, suspensions of 
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B. atrophaeus and B. anthracis UM23CI2 spores were also subjected to cavitation in this 
system. The transducer was sealed at one end and 600 J.ll of washed B. atrophaeus spores 
at 109 cfu/ml were added, the top end sealed and the sample sonicated for increasing time 
periods. The transducer was washed extensively with sterile distilled water after sonication 
of each sample to avoid any carry over. The transducer was further developed into a flow 
through system. Flow rates were optimised for maximum sensitivity by Resonant Mirror 
immunoassay, as obtained for the batch system. Additional cooling was also integrated into 
the system using heat sinks and small cooling fans. Sample (5 ml) was introduced to the 
system using a pump and the sample sonicated at 267 kHz at a flow rate of 0.3 ml/min. 
Using this system a range of other parameters were tested, including the concentration of 
protein released, the effects of the application of ultrasound in relevant buffers and the 
effects of cavitation on the spore and proteins released. 
3.19 Viable counts 
Serial tenfold dilutions of samples were prepared in sterile distilled water. The samples 
were plated in triplicate onto LB agar plates (1 00 J.ll of sample per plate). Plates were 
incubated overnight at 37°C and colony forming units (cfu) per ml calculated from the 
mean of the dilutions which gave a statistically significant number of colonies per plate (30 
to 300). 
3.20 Total counts 
A Fuchs Rosenthal haemocytometer was prepared, using a cover slip which was applied to 
produce characteristic Newton's rings. Spores were diluted in sterile distilled water and 
loaded into the counting chambers ofthe haemocytometer. 
3.21 Electron microscopy 
All electron microscopy was conducted by J. Parkes or S. Smith, Dstl, with the exception 
of TEM images from immunogold labelling experiments which were undertaken 
personally. 
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3.21.1 Scanning Electron Microscopy (SEM) 
Briefly, 10 111 of sample was placed on a 0.1 J.lm nucleopore analysis membranes, allowed 
to air dry and coated with a conductive layer of gold. Images were obtained using a Hitachi 
S-800 Field Emission SEM operating at 5 kV. 
3.21.2 Transmission Electron Microscopy (TEM) 
Samples were fixed for 18 h in 4% glutaraldehyde buffered in sodium cacodylate (pH 7.2), 
washed 3 times in buffer and post fixed in I% buffered osmium tetroxide. Spores were 
dehydrated through a graded ethanol series and embedded in Spurr's resin. Ultrathin 
sections (50 nm) were stained with uranyl acetate and lead citrate and imaged using a 
Philips CM12 TEM. Photographs were recorded onto Kodak film and digitised at 800dpi 
using an Epson flatbed film scanner. 
3.22 Determination of protein concentration 
Samples were centrifuged at 10000 g for 10 min and the supernatant was recentrifuged at 
6000 g to remove any residual cells or spores. The protein concentration was determined 
using a standard or micro-BCA assay (Perbio) in a 96-well Immunolon 2HB microtitre 
plate (Nunc) according to the manufacturer's instructions. 
3.23 Purification of proteins released 
Samples were centrifuged at 10000 g for 10 m in and the supernatants removed and filtered 
through a 0.2 11m low-protein binding filter (Gelman Sciences). An aliquot was retained 
for analysis. 
3.24 Concentration of proteins released 
Samples were concentrated using a 20 ml Omegacell with 5000 Da molecular weight cut-
off (Sigma). Each sample was sterility checked to confirm the absence of viable spores. 
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The amount of protein in the samples was quantified using a BCA protein assay (Perbio) 
according to the manufacturer's instructions. 
3.25 Immunoassays 
3.25.1 Direct ELISA 
Aliquots (100 Jll) of protein released from sonicated spores, EAI, S-layer extract (10 
Jlg/ml in PBS) or Bacillus spores (1 x 106 spores/m! in water) and appropriate control 
antigens were coated onto Immulon2 HB 96-well microtitre plates (Nunc) and incubated 
overnight at 5 °C. The plates were washed 3 times with sterile phosphate buffered saline 
(PBS) containing 0.05% v/v polyoxyethylene sorbitan monolaurate (Tween 20) (PBST) 
followed by I x PBS (200 Jll per well). Non-specific binding was blocked with I% (w/v) 
milk powder in PBST, {lOO fll per well) and left to incubate for 1 h at room temperature. 
The plates were washed 3 times PBST and 3 times PBS and an antigen specific antibody 
(polylonal anti-B. atrophaeus or a monoclonal or anti-B. anthracis antibody, both prepared 
by Dstl) was added at a fmal concentration of 10 Jlg/ml in 1% (w/v) milk-PBST. A 
species-specific horseradish peroxidase conjugate (goat anti-rabbit HRP conjugate, or a 
goat anti-mouse-HRP conjugate, both Sigma) were added at a I: I 0000 or I: 5000 dilution 
respectively in milk-PBST. Development buffer, composed of 50 ml ABTS buffer (O.IM 
Mn2HP04 Citric acid pH4.3, 1 ABTS tablet {2,2-Azino-bis-3-ethylbenzothiazoline-
6sulphonic acid) and 15J.1l hydrogen peroxide) was added (100 Jll per well) and left to 
incubate until sufficient colour had developed. Bound antibody was quantified by 
measuring the conversion of ABTS substrate to coloured product based on ~14 readings in 
an automated ELISA reader (Anthos 200 I, Anthos Labtec Instruments, Salzburg, Austria). 
Negative controls were incorporate to ascertain background readings. In the case of ELISA 
using scFv, polyethyleneglycol (PEG) -purified phage-displayed scFv were diluted with 
MPBS, and an anti-M13 HRP conjugated antibody (Sigma) used to detect bound phage. 
3.25.2 Capture/sandwich ELISA 
Microtitre plates (Nunc) were coated in aliquots (100 Ill) of antigen specific antibody 
diluted in PBS at a final concentration of 10 Jlg/ml and incubated overnight at 5°C (per 
well). The plates were washed and blocked as described previously (section 3.25.1) and 
antigen added at a known concentration in l% (w/v) milk-PBST (lOO fll per well) and the 
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plates left to incubate for one hour at room temperature, with shaking. The plates were 
washed 3 times in PBST and once in PBS (200 J.ll per well). A secondary antigen specific 
biotinylated antibody (that was prepared using a MCR of IO biotin to I antibody (as 
described in section 3.14) was added at a final concentration oflO J.lg/ml in I% (w/v) milk-
PBST (lOO J.ll per well) and left to incubate for 1 hat room temperature, with shaking. A 
streptavidin HRP conjugate (Sigma) was then added at a final concentration of IO J.lg/ml in 
I% (w/v) milk powder in PBST (100 J.ll per well) and left to incubate for I h at room 
temperature, with shaking. Bound antibody was quantified by measuring the conversion of 
ABTS substrate to coloured product based on ~14 readings in an automated ELISA reader 
(Anthos 200I). Negative controls were incorporated to ascertain background readings. A 
positive was defined as the background plus two standard deviations from the mean. 
3.25.3 Tbresbold® assay 
The Threshold system was developed by Molecular Devices is an antibody based system 
which uses a light addressable potentiometer (LAP) to detect a localised pH change 
produced when antigen binds to antibody. The system works in a sandwich format and is 
shown diagrammatically in Figure 3.3. 
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Figure 3.3 The Threshold® Assay. A complex is formed between the 
streptavidin, biotinylated antibody, the antigen and the fluorescein antibody; the 
reagent mix. This is than allowed to bind to the biotinylated membrane. A second 
anti-urease FITC conjugate is added. The biotinylated membrane (assay stick) is 
then placed into the reader that contains urea. The urea is hydrolysed by urease 
to form ammonia and carbamate. The carbamate then immediately hydrolyses to 
form carbonic acid and two molecules of ammonia. At the physiological pH of 
the reader the ammonia equilibrates with waster and carbonic acid proton 
dissociates finally resulting in two molecules of ammonia and one of carbon 
dioxide. This causes a net increase in pH within a small volume, which is 
measured by the sensor. 
The Threshold® reader was rinsed with water and filled with 28 ml substrate solution (0.6 g 
per 100 ml urea) using a Luer-Lok syringe. Assay buffer (100 ~-tl) composed of 10 mM 
potassium phosphate, 154 mM sodium chloride, 0.005% (w/v) sodium azide, 0.025% (v/v) 
Triton-X lOO, 0.1% (w/v) bovine serum albumin, pH 7.0, was added to all sample and 
positive control wells. Assay buffer (200 ~-tl) was added to all negative control wells and 
lOO ~-tl of sample to the appropriate sample wells. For each Threshold® assay stick 
(Molecular Devices) the reagent mix was prepared as follows: 30 ~-tl polyclonal goat anti-
Ames antibody (prepared using a MCR of 10 biotin to 1 antibody, section 3.14) or 30 ~-tl 
polyclonal rabbit anti-B. atrophaeus antibody (prepared using a MCR of 5 biotin to 1 
antibody, section 3.14) at 100 ~-tg/ml in assay buffer, 30 ~-tl polyclonal goat anti-Arnes 
antibody (prepared using an MCR of 5 fluorescein to 1 antibody, section 3.14) or 
polyclonal rabbit anti-B. atrophaeus (prepared using an MCR of 30 fluorsecein to 1 
antibody, section 3.14) at 100 ~-tg/ml in assay buffer, 100 ~-tl of streptavidin, at 1 mg/ml and 
840 ~-tl of assay buffer. An aliquot of reagent mix was added to all wells, 100 J!l of reagent 
mix was added to all sample wells and 200 J!l of reagent mix was added to all negative 
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control wells. The samples in all wells were mixed and I 00 Jll was transferred to a 
Threshold® assay stick that was placed on the instrument filter block, and left to incubate 
for 1 min. The vacuum was set to low and the reagent allowed to filter through. An anti-
FITC urease conjugate (100 Jll, from a stock prepared by reconstitution of the anti-FITC 
urease conjugate with 30 ml assay buffer per vial Molecular Devices) was added to each 
well and again allowed to filter through. Finally 400 Jll of wash buffer (10 mM potassium 
phosphate, 100 mM sodium chloride, 0.05% (v/v) Tween 20, 0.005% (w/v) sodium azide, 
0.5 mM tetrasodium EDT A, pH 6.5 was added to each well and the vacuum set to high and 
allowed to filter through. The assay stick was released from the filter block and placed in a 
beaker of wash buffer and then read. Each assay was performed in triplicate and negative 
controls were incorporated to ascertain background readings. A positive was defined as the 
background plus two standard deviations from the mean. 
3.25.4 Lateral flow assays 
Lateral flow assays are antibody based and can detect antigen following application of the 
sample into a small well at one end of a membrane strip. The sample then wicks down the 
membrane strip and positive identification is shown as a visible line on the membrane 
strip, produced from the reaction of a specific antigen conjugate (often chromogenic) with 
the antigen. A second line of antibody directed against the conjugate acts as a positive 
control. Samples were diluted as appropriate and three drops of sample placed in the 
sample well of the lateral flow assay, using a disposable Pasteur pipette. The assay was 
incubated at room temperature for a maximum of 20 m in; each assay was performed in 
triplicate. 
3.25.5 Specific near real time detection using the resonant mirror biosensor 
3.25.5.1 Antibody immobilisation 
Antibodies were immobilised onto carboxyrnethylated dextran cuvettes (Affinity Sensors) 
using standard amine coupling methods. Briefly, the surface was washed 3 times with 170 
Jll PBST and was activated using 3 x 170 Jll 0.2 M 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC), 0.05 M N-hydroxysuccinimide 
(NHS) for a defined time period. The activation time was 8 min for the high (T500) and 5 
min for the low molecular weight (T70) carboxyrnethylated dextran cuvettes. These times 
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were found to be optimal for ligand loading and subsequent detection of antigen in 
preliminary experiments. Following activation, the surface was washed 3 times with 170 
J.ll PBST, then 3 times with 170 J.ll 10 mM acetate buffer, pH 4.5. The antibody was then 
added to the acetate buffer at a final concentration of 100 J.lg/ml for 15 min and the surface 
was washed with 3 x 170 J.ll PBST. Finally, unreacted groups were blocked with 1 M 
ethanolamine pH 8.5 and the surface washed 3 x 170 J.ll PBST. 
3.25.5.2 Binding protocol 
The sensor surface was washed with 3 x 170 J.ll PBST and the baseline allowed to 
establish. Antigen (17 J.tl) was added to the surface and left for 10 min. The surface was 
washed 3 x 170 J.ll PBST. The surface was regenerated with 20 mM KOH for 3 min (B. 
atrophaeus spores) or 10 mM KOH for B. anthracis spores. The surface was washed 3 x 
170 J.ll PBST. The protocol was repeated twice so each concentration was performed in 
triplicate. Negative controls were included to assess any non-specific binding including a 
non-specific antibody and a surface that had been activated and blocked. 
3.26 Evaluation of 2,6-pyridinedicarboxylic acid (DPA) release 
The DP A assay was based on that reported by Hindle and Hall ( 1999), optimised for the 
detection of spores and reporting a limit of detection of 2 nM DPA. Stock solutions of 1 
mM DPA (Sigma), 1 mM TbCh (Aldrich) and 0.1 M acetate buffer pH 5.6 (Sigma) were 
prepared. Dilutions of DP A were prepared from 1 nM - 25 J.lM in order to obtain a 
standard curve. All measurements were taken using a Perkin Elmer LS55 Luminescence 
spectrophotometer, using WinLabFL software. The assay was optimised for the 
instrument and the final parameters used were an excitation wavelength of275 nm, a delay 
of 0.1 ms, a gate of 9.9 ms and the detection photo multiplier tube (PMT) set to 775 V. 
Assay reagents were then made up consisting of 3.6 m! 0.1 M acetate buffer and 400 J.ll of 
1 mM TbCb, 2.95 m! was then transferred to a quartz fluorescence cuvette and 50 J.ll of 
DPA standard or sample was added. A total of 10 readings taken for each individual assay, 
each of which was preformed in triplicate. 
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3.27 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) 
The range of proteins released during sonication, was evaluated based on the observed 
differences in molecular weight by SDS-PAGE using Tris-glycine or NuPAGE® Novex 
Bis-Tris precast gels (Invitrogen), according to the manufacturer's instructions. Briefly for 
Tris-glycine gels samples were prepared by adding 15 J.ll of 2 x Laemmli sample buffer 
(Sigma) to I5 J.ll of sample. Sigma wide range molecular weight marker (5 J.ll} was added 
to 5 J.ll 2 x Laemmli sample buffer; ovalbumin (5 J..tg) was added as a control. The samples 
were incubated in a boiling water bath for 4 min and then held briefly on ice, and pulsed in 
a microfuge at 13000 g. Samples (20 J.ll} were loaded into the appropriate wells and the 
gels run according to the manufacturer's instructions. In the case ofBis-Tris Gels, for each 
20 J.ll sample the following reagents were added: 5 J.ll 4x LDS Sample buffer (Invitrogen), 
2 J.ll I Ox reducing agent (lnvitrogen) and I3 J.ll of sample. Samples were incubated at 70°C 
for I 0 min and pulsed in a microfuge at 13000 g. Samples (20 J.ll) were then loaded into 
the appropriate wells and the gels run at the appropriate voltage and time period according 
to the manufacturer's instructions. The gels were removed from the cassettes and fixed and 
stained appropriately using Colloidal Blue or SilverQuest™ Silver staining kit (Invitrogen) 
according to the manufacturer's instructions or used for western Blot analysis. In the case 
of immunopurified proteins from Dynal anti-species beads the bound proteins were eluted 
into Ix LDS reducing sample buffer (Invitrogen) by incubation in a water bath at 70°C for 
10 min. 
3.28 Western blot analysis 
Identification of the proteins recognised by antibody was carried out by western blot 
analysis. Samples separated by SDS-PAGE were transferred onto polyvinyldifluoride 
(PVDF) or 0.2 J.lm nitrocellulose membranes (both Invitrogen) according to the 
manufacturer's instructions. After blocking the membranes overnight in PBST containing 
5% (W N) milk powder PBS O.I% Tween 20 (v/v) blots were rinsed briefly PBS O.I% v/v 
Tween 20 (PBST) and incubated in 5% milk powder PBST, The membranes were then 
probed using an anti-B. atrophaeus antibody (Dstl) at 5 J.lg/ml, or scFv antibody at 2.5 
J..lg/ml in 3% (w/v) MPBST for I h at room temperature with shaking. Blots were washed 
as described previously and incubated in an anti-His HRP conjugate (Sigma) at I: 1000 
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dilution and an anti-rabbit HRP conjugate (Amersham) antibody at l: I 000 dilution in 3% 
(w/v) MPBST for I h at room temperature with shaking. In the identification of 
imrnunogenic proteins of the exosporium the primary antibody was a biotinylated 
polyclonal rabbit anti-Ames antibody at a concentration of 5 J.lg/ml and the secondary 
antibody streptavidin HRP conjugate (Sigma) at I:IOOO or an anti-rabbit HRP conjugate 
(Amersham BioSciences) antibody at l: l 0000 dilution in 3% (w/v) milk powder PBST for 
l h at RT with shaking. To identify biotinylated surface located proteins only a streptavidin 
HRP conjugate (Sigma) at I: I 000 in 3% (w/v) milk powder PBST was used. For 
monoclonal antibody evaluation, all anti-EA l mAbs used as the primary antibody were 
used at a final concentration of 5 J.lg/ml and an anti-mouse HRP conjugate (Amersham) 
was used at l :5000 dilution both in 3% milk powder PBST. For determination of 
molecular mass, MagicMark™ Western protein standard (Invitrogen) was used. Blots were 
washed 1 x I5 min and 4 x 15 min in PBST. Protein bands recognised by the antibody 
were visualised by enhanced chemiluminescence (ECL Detection reagent kit, Amersham) 
and exposed to ECL hyperfilm (Amersham) according to the manufacturer's instructions. 
3.29 Two-dimensional (2D) electrophoresis 
Sample rehydration buffer (8M urea, 2% CHAPS, 0.5% (v/v) carrier ampholytes (pH 3-
10), 0.002% Bromophenol Blue), containing protein sample was loaded into a sample 
loading well of a Zoom IPG cassette (155 J.LI). Initially a wide pH range was chosen, in 
order to determine which narrower pH range would be more appropriate. A pH 3-10 zoom 
strip was placed into the zoom cassette (acidic end first) and the loading wells sealed. The 
samples were incubated for 16 h at room temperature. The sealing tape and loading wells 
were removed, a wick placed at each end of the cassette and 750 J.Ll of deionised water was 
applied to each electrode and the excess blotted off. The IPG cassette was placed into the 
ZOOM® IPG Runner™ Buffer Core and the outer chamber filled with 600 ml of deionised 
water. The samples were run at 500 V for 3-4 h, using a PowerEase®500 Power supply. 
The IEF strips were removed from the cassette for subsequent electrophoresis. LDS sample 
buffer 4x (Invitrogen) was diluted to lx with deionised water (10 ml per strip). 500 J.Ll of 
NuPAGE® Sample Reducing Agent (lOx) was added to 4.5 ml of lx NuPAGE® agent and 
placed in a 15 ml Falcon tube and an IPG strip added and incubated for 15 min at room 
temperature. The IPG strip was removed from the Falcon tube and placed into an 4-20% 
IPG ZOOM® gel well and 400 J.Ll of 0.5% agarose added and allowed to solidify. Wide 
Range molecular weight marker (Sigma) was loaded onto the gel and the gel was run at 
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200 V for 50 min using I x MES running buffer. The gel was removed from the cassette 
and fixed and stained using a SilverQuest stain (lnvitrogen) according to the 
manufacturer's instructions. 
3.30 Identification of the immunogenic proteins of B. antllracis exosporium 
The antibody used for all attachment strategies was a polyclonal rabbit anti-exosporium 
antibody (Dstl). 
3.30.1 Column purification of lmmunogenic B. a11tllracis exosporium proteins 
Antibodies were coupled to the matrix of a I ml HiTrap™ N-hydroxysuccinimide (NHS)-
activated column HP column (Amersham Biosciences) according to the manufacturer's 
instructions. The antibody was dialysed into coupling buffer (0.2 M sodium bicarbonate, 
0.5 M sodium chloride pH 8.3. The column was washed with 6 ml ice-cold HCI and then 
the antibody was loaded onto the column at 5 mglml in coupling buffer and allowed to 
incubate for 1 h at room temperature. The column was washed with 6 ml of buffer A (0.5 
M ethanolamine, 0.5 M NaCI, pH 8.3 and then 6 ml of buffer B (0.1 M acetate, 0.05 M 
NaCI, pH 4.0) and then a further 6 ml of buffer A. After a further incubation at room 
temperature for 30 min the column was washed with 6 ml buffer B, 6 ml buffer A and 
finally 6 ml buffer B. Purification of spore proteins was then undertaken. The column was 
washed with 5 ml PBS and then 1 ml of sample was loaded and the column allowed to 
incubate at room temperature for increasing time periods. The column was washed with 
10 m! PBS and then eluted with 10 mM KOH (shown to be suitable for regeneration using 
the evanescent wave biosensors). To neutralise the elutions 16 Ill of I M HCI. The elution 
of proteins was monitored using the absorbance at 280 nm and samples were also analysed 
by SDS-PAGE. 
3.30.2 Bead-based purification of immunogenic B. a11tllracis exosporium proteins 
3.30.2.1 No11-directed covale11t co11pli11g 
This was carried out with the use of a goat anti-B. anthracis (Ames) antibody to capture 
those proteins that were immunogenic on MagnabindTM carboxylated derivatised beads 
(Perbio). The antibody was immobilised onto the beads by washing the beads 3 times in 
PBS then adding 500 111 of0.2 M EDC/ 0.05 M NHS per 200 111 of beads. The beads were 
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incubated for 30 min at room temperature with mixing and then washed 3 times with PBS. 
Antibody was added (500 J.ll) at a final concentration of 1 mg/ml in sterile PBS and the 
beads incubated overnight at 2-8°C. The efficiency of antibody binding was calculated by 
measuring the absorbance at 280 nm of the antibody solution before immobilisation and of 
the wash fractions after binding. The beads were then washed three times with PBS and 
500 J.ll of 1 M ethanolamine pH 8.5 added and incubated for lO min at room temperature. 
The beads were washed 5 times in PBS. An aliquot (500 J.ll) of sonicated spore supematant 
(from spores sonicated at -1 x 109 cfu/ml) was added and incubated for three hours at 
. room temperature. Any bound proteins were eluted using 500 J.ll of lO mM KOH for five 
min. To neutralise the elutions 8 J.ll of 1 M HCI was added. The sample buffer was 
exchanged for PBS and the samples concentrated using Vivaspin500 columns. The 
samples were analysed by SDS-PAGE and subsequent silver staining (section 3.27). 
3.30.2.2 Site-directed binding 
lmmunopurification using DYNAL anti-species beads was found to yield the most 
successful results for protein purification. The immunopurification method devised for the 
identification ofimmunogenic proteins is represented diagrammatically in Figure 3.3. 
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Magnetic anti-species beads were obtained from DYNAL (sheep anti-rabbit IgG 
Dynabeads™ M-280). To wash the beads, 250 fll of bead stock (1.675 x 108 beads) was 
aliquoted into a tube and placed into a magnetic particle concentrator (MPC) (Dynal) for 2 
min. The supematant was removed and the beads resuspended in 250 fll PBS; 0.1% (v/v) 
Tween 20. This washing step was repeated twice. Rabbit anti-exosporium antibody was 
added to a 250 fll aliquot of beads and left to incubate overnight with rotation at room 
temperature. To remove unbound antibody the beads were washed three times with I ml 
volumes ofPBS; 0.1% (w/v) BSA, using the MPC to separate the beads from the liquid as 
described previously. In order to cross-link the immobilised antibody, the beads were 
resuspended in 10 ml of20 mM dimethyl pimetimidate (Perbio) in 0.2 M ethanolamine pH 
9.5 (Sigma) and incubated for 45 min at room temperature with rotation. The tubes were 
placed into the MPC, the supematant pipetted off and the beads resuspended in 10 ml of 
0.2 M ethanolamine pH 9.5 for 3 h with rotational mixing at room temperature. The beads 
were then washed 3 times using the MPC, once with 10 ml PBS, once with 10 ml PBS, 
0.0 I% (v/v) Triton X-100 to remove non-covalently bound antibody and then finally with 
10 ml PBS. The beads were then incubated with the appropriate antigen or control, in 
sterile PBS, 0.1% (v/v) Tween 20, 0.1% (w/v) BSA. The following controls were 
incorporated: (a) beads with immobilised antibody with no antigen; (b) beads with no 
immobilised antibody incubated with antigen; and (c) beads with no immobilised antibody 
or antigen. Unwashed B. anthracis wild type Ames exosporium was used as the antigen at 
a concentration of approximately 10 J.lg/ml in sterile PBS, 0.1% (v/v) Tween 20, 0.1% 
(w/v) BSA. The beads were left to incubate overnight at room temperature with rotation. 
To remove unbound proteins, the beads were washed 3 times, twice with I ml volumes of 
sterile PBS pH 7.4; 0.1% (v/v) Tween 20 and once with lml PBS only using the MPC. 
The proteins were then eluted directly by incubating the beads in 50 fll LDS reducing 
sample buffer (Invitrogen) for 10 min at 70°C. The samples were centrifuged briefly and 
separated from the beads by placing the tubes into the MPC for 2 min. The samples 
(supematants) were subsequently analysed by SOS-PAGE on a 4-12% pre-cast Bis-Tris 
gel (lnvitrogen) at 125 V for 40 min according to the manufacturers instructions. After 
visualisation with Colloidal Blue Stain (lnvitrogen), each protein band of interest was 
excised and subjected to in situ trypsin digestion using the method of Shevchenko et al. 
(1996). The resulting peptides were separated by nano- reversed phase liquid 
chromatography using a Waters Cl8, 3 f.im, 100A (150 mm x 75 f.im, i.d.) column, and 
electrosprayed into a quadrupole time-of-flight tandem mass spectrometer (section 3.31). 
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3.31 Mass spectrometry (MS) and data processing of immunogenic exosporium 
proteins 
MS was kindly conducted by P. Skipp (University of Southampton). All data were 
acquired using a Q-tofGiobal Ultima (Waters Ltd) fitted with a nanoLockSpray™ source 
to achieve better than I 0 ppm mass accuracy. A survey scan was acquired from m/z 375 to 
1800 with the switching criteria for MS to MS/MS including ion intensity and charge state. 
The collision energy used to perform MS/MS was varied according to the mass and charge 
state of the eluting peptide. 
All MS/MS spectra were automatically processed using MassLynx 4.0 (Waters Ltd) and 
searched against the NCBI non-redundant database (June, 2004 versions), using 
ProteinLynx Global Server 2.05. Proteins were only assigned if, for each peptide ion, 
greater or equal to three experimentally derived y ions could be matched to the predicted 
spectra. 
3.32 Identification of otber B. ant/Jracis spore proteins 
3.32.1 Digestion of tbe supernatant from sonicated spores 
Washed or Urografin purified spores were sonicated and the proteins separated, 
concentrated and quantified as described previously. The protein sample (45 Jll) was 
combined with 2.5 Ill of a 0.25 mg/ml solution of pepsin (Sigma) in water to give a 
substrate to enzyme ratio of24: I. Formic acid was then added to give a final concentration 
of 5% (v/v). Solutions were incubated at 37°C for increasing time periods. Resulting 
mixtures were stored at -20°C until required. 
3.32.2 In-gel digestion of proteins from sonicated spores. 
Proteins released from spores by sonication were separated on 4-12% BJS-TRIS gels 
(Invitrogen) and stained using a Colloidal Blue Stain (Invitrogen). Selected bands were 
excised from the gel and transferred to individual microfuge tubes containing 5% (v/v) 
acetic acid. In gel digestion and subsequent MS analysis was kindly conducted and P. 
Ski pp (University of Southampton), as described previously (3.31 ), or by K. Anderson 
(Dstl). Briefly, the acetic acid was removed from the samples and washed for 2 x 5 min in 
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100 f!l sterile distilled water. The liquid was removed and the samples washed for 2 x 15 
min in 100 f!l water:acetonitrile 1:1 (v/v). The liquid was removed and washed for 5 min 
in acetonitrile. The liquid was removed and the sample rehydrated with 100 f!l 0.1 M 
ammonium bicarbonate for 5 min and then an equal volume of acetonitrile added and 
incubated for 15 min. The liquid was removed and the sample dehydrated for 5 m in in 100 
f!l acetonitrile. After removal of all stain all liquid was removed and the samples vacuum 
dried for 30 min (Concentrator 5301, Eppendorf). The gel sections were then rehydrated in 
1 OOf.ll dithiothreitol in 0.1 M ammonium bicarbonate and incubated for 45 min at 56°C. 
The samples were then cooled to room temperature and the liquid removed, 100 111 of 
55mM iodoacetamide in 0.1 M ammonium bicarbonate was then added and incubated in 
the dark for 30 min. The liquid was removed and the samples washed for 5 min in 0.1 M 
ammonium bicarbonate. An equal volume of acetonitrile was added and incubated for 15 
min and then the liquid removed and the sample dehydrated in 100 f!l acetonitrile for 5 
min. All the liquid was removed from the samples and then they were vacuum dried for 30 
min. The samples were rehydrated in 50 f!l digestion buffer with trypsin (0.1 mM calcium 
chloride, 50 mM ammonium bicarbonate, 12.5 ng/f!l trypsin (sequencing grade, Promega) 
and incubated on ice for 45 min. Digestion buffer (0.1 mM calcium chloride, 50 mM 
ammonium bicarbonate) was added (75 f!l) and incubate overnight at 37°C. Peptides were 
extracted by adding 60 f!l 25 mM ammonium bicarbonate and incubated for 15 min. An 
equal volume of acetonitrile was added and incubated for a further 15 min. The liquid 
containing the peptides was then transferred to a new tube and 100 f!l of 5% (v/v) formic 
acid: acetonitrile, 1: I (v/v) added to the remaining gel samples and incubated for 15 m in 
the liquid was then added to the first extracted peptides and the extraction of the peptides 
in the gel sections repeated and added to the previous fractions. The pooled fractions were 
vacuum dried and stored at -20°C until required for further analysis. Prior to MS analysis 
the digest mixtures were purified using a c18 ZipTip (Millipore), according to the 
manufacturer's instructions. The sample was added to 2 f!l 2.5% (v/v) TFA before binding 
to the Zip Tip to give a final volume of 4 f!l. 
3.32.3 LC-MS/MS of enzymatically digested sonicated spore supernatants 
Spore proteins from washed and Urografin purified spores were prepared and digested as 
described previously. LC-MS/MS analysis was kindly conducted by K. Anderson (Dstl) 
using an LQA DECA ion trap mass spectrometer. Briefly, LC separation utilised a Jupiter 
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(Phenomemex, Macclesfield, UK) C18 column (150 x 1 mm, 5 1-1m, 300A). Solvent 
delivery was provided by an HP1l00 Series LC system (Agilent Techolgies UK Ltd., 
Stockport, UK). A linear gradient elution was conducted at a flow rate of 50 1-1Vmin with a 
mobile phase comprising solvent A (0.05% (v/v) TFA in water) and solvent B (0.05% (v/v) 
TF A in acetonitrile. The gradient used was a hold at 5% B between 0 and 10 min, a linear 
increase to 15% B at 80 min, a linear increase to 65% B at 90 min and finally a linear 
increase to 90% B at 95 min. Subsequently 90% B was held until 97 min and a return to 
5% B at 100 min. The column was then re-equilibrated at 5% B to 145 min. Sample 
volumes used were between 20 and 50 1-11. The ion trap spectrometer was fitted with 
electrospray ionisation interfaces operated in positive ion mode. A spray voltage of 5 kV 
was applied using a capillary temperature of 275°C, sheath gas flow at 20 (arbitary untis) 
and the auxiliary gas set to 0 (arbitary units). Three scan events were conducted, one full 
scan of mass spectra from mlz 400 to 2000, scan two was a data dependent zoom scan 
(scan width ± 5.0 mlz) and the third scan event collected data-dependent MS/MS ion 
spectra. The raw data were converted into DTA file format and individual files from an LC 
separation merged to a single file for submission to the Mascot database. 
3.32.4 Nanospray analysis of in-gel digests 
These were kindly carried out by K. Anderson (Dstl) usmg the Quattro 11 tandem 
quadrupole mass spectrometer fitted with a Z-spray ionisation source. Briefly, 2 1-11 of 
sample was loaded onto a borosilicate glass capillary. Spray was initiated by application of 
gentle back pressure from an air filled syringe using a capillary voltage of 1.25 kV and a 
source block temperature of 80°C. Cone voltage was ramped from 35kV at mlz 300 to 65 
V at mlz 1300. Spectra were scanned from mlz 300 to 1300 over 10 s. Approximately 30 
scans were averaged to give the final spectrum for each sample. Selected ions were subject 
to MS/MS analysis using the average of approximately 30 to 50 scans to produce the 
product ion spectrum for each precursor ion. Two databases were used (Mascot and 
Profound) to search the National Centre of Biotechnnology Information (NCBI) sequence 
database (http://www.ncbi.nih.gov/). Entered search parameters were determined by the 
mass spectrometer utilised for the analysis (e.g. mass tolerance values) and known sample 
treatment. 
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3.33 Construction and use of immune mouse scFv library 
The scFv library was kindly produced and provided by Dr Car! Mayers (Dstl). Briefly six 
12 week old female Balb/c mice were immunised with y-irradiated B. alllhracis Ames 
spores. Each immunisation consisted of I x I 07 spores in Freund's incomplete adjuvant. 
Mice were immunised 4 times at intervals of three weeks, and killed by cervical 
dislocation once they showed a sufficiently high titre (>I: l 00 000) to the spores by 
endpoint ELISA. Spleens were removed from the killed mice and splenic mRNA isolated 
using Trizol regeant (Invitrogen). The total RNA from the immunised mice was used to 
produce the immune scFv library; PCR amplification of antibody sequences, overlap 
extension PCR, cloning of the assembled scFv sequence into pAKIOO and production of 
phage-displayed scFv was carried out by Mayers as described by Krebber et al. ( 1997). 
3.34 Biopanning with EAl 
lmmunotubes (Nunc, UK) were coated with I ml of purified EA I at lO ~-tg/ml in phosphate 
buffered saline (PBS) overnight at 4 oc and blocked with 2 % (w/v) milk powder PBS 
(MPBS). 100 ~-tl of scFv-phage were mixed with 900 ~-tl MPBS, incubated for 1 h at room 
temperature, and added to the coated immunotubes. After a further 2 h room temperature 
incubation, the immunotubes were washed 10 times with PBS 0.1 % (v/v) Tween 20. 
Bound phage were eluted with 100 mM triethylamine and neutralised with 500 J.d I M Tris 
HCI pH 7.5. Eluted phage were infected into log phase XLI-Blue E. coli, and plated on a 
24 cm square 2 x YTGC (6 g/1 peptone from casein; 10 g/1 yeast extract, 5 g/1 NaCI, I% 
(w/v) glucose, 30 J.lg/ml chloramphenicol) agar plate and incubated overnight at 30 °C. 
This procedure was repeated for each round of panning carried out. Competitive panning 
was carried out in an identical fashion, adding S-layer extracts to the scFv-phage MPBS 
solution for l h before panning. The concentrations of antigen used for competitive 
panning were 50 J.lg/ml B. cereus 11145 S-layer protein, and 25 J.lg/ml of B. cereus 11143, 
B. cereus 9946 and B. pumilus S-layer protein. The concentration ofEAl used for panning 
was I or l 0 J.lg/ml. 
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3.35 DNA fingerprinting of scFv clones 
scFv sequences from selected clones were amplified using PCR primers surrounding the 
scFv sequence (scfor and scback; Krebber et al., 1997). Briefly, each 50 J!l PCR reaction 
comprised; 0.5 J!l scfor primer, 0.5 J!l scback primer, 5 J!l lOx PCR buffer (lnvitrogen), l 
J!l I OmM dNTPs, 1.5 J!l 50 mM MgCh, 0.5 J!l Platinum Taq (Invitrogen) and 41 J!l sterile 
H20. The PCR was run for 32 cycles of 94°C for 60 sec, 62°C for 30 sec and 72°C for 60 
s. All products were resolved on 2% E-gels (Invitrogen) using 100 bp markers according to 
the manufacturer's instructions. Those clones containing an 800 bp insert were positive for 
the scFv DNA insert and subjected to BstNl digestion. A lOO ~-tl reaction comprised 10 J!l 
lOx NEB #2 reaction buffer (New England BioLabs), 10 mglml BSA, 35 ~-tl PCR product, 
51 J!l sterile H20; this was then incubated at 60°C for 3 h. Restriction digest products were 
resolved on 4% E-gels (Invitrogen) using 25 bp markers. The PCR and DNA 
fingerprinting were carried out on 10 randomly selected scFv from rounds 1 and 2 and 50 
scFv clones from round three. 
3.36 Obtaining the protein sequences for Round 3 scFv 
Plasmid preparations were completed using the Mini Plasmid Spin Prep Kit (Qiagen), 
according to the manufacturers instructions. The scFv DNA was sequenced to confirm that 
they were unique. These sequences were used for further analysis. The scFv were 
sequenced using forward and reverse primers for the plasmid (Oswell, UK or MWG, 
Sweden). Sequencing data from the DNA of the scFv was translated to a protein sequence 
using the Expasy translation tool (htpp://ca.expasy.orgltools/dna.html). The correct 
reading frame was initially identified through the presence of GGGGS and consecutive 
repeats of this sequence required for the tinker sequence between the VH and VL regions 
that make up the scFv. Heavy and light chain CDRs were identified using the Kabat 
definition, as described by Martin (2001). The heavy and light chain CDR sequences were 
compared for the scFv sequences and similarities identified. 
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3.37 Soluble expression of selected scFvs 
For soluble expression, the scFv backbones from round 3 phage were cut from the pAK I 00 
vector used for biopanning and Iigated into pAK 300 and pAK400 vectors. 
Restriction digestion of the original scFv from the pAk 100 plasmid was undertaken using 
Sfi I (NEB). Each 50 111 reaction consisted of 2.5!11 10x NEB #2 reaction buffer, 0.5 111 
lOOx BSA, l 111 Sfi I, I 11g of DNA to be cut, and sterile distilled H20 to 50 111. The 
restriction digests were incubated overnight at 37°C. Digestion of the pAK300 and 400 
vectors, required for ligation of the scFv plasmid, was completed using 20 11g of vector 
DNA in 200 111 reaction volumes, all reagent volumes were scaled up accordingly. 
3.38 Crystal violet purification of scFv and plasmid DNA 
Loading buffer (5 111) was added to each 25 111 of sample and 30 111 was loaded into each 
lane of a l% Crystal violet gel. The gels were run at 80 V until adequate separation had 
occurred. The cut DNA was observed as clear bands against a purple background and the 
bands excised. The bands were weighed and purified using a SNAPTM gel purification Kit 
(Invitrogen) according to the manufacturer's instructions. 
3.39 Ligation of scFvs into pAKJOO and pAK400 
The cut inserts from the six isolated DNA sequences from the scFv produced by the 
competitive panning procedure were ligated into digested pAK 300 and pAK 400 vectors. 
Ligation reactions were set up consisting of 200 ng of purified Sfi I cut pAK 300 and pAK 
400, 20 ng purified scFv fragment, l 111 (lunit) ofT4 DNA ligase and 4 1115 x Invitrogen 
DNA ligase buffer. Sterile distilled water was added to a final volume of 25 111. The 
ligation reactions were mixed well and incubated overnight at l6°C. 
3.40 Electroporation of competent cells 
Electrocompetent E. coli XLI Blue were prepared by adding 400 111 of sterile dH20 to the 
plasmid containing the scFv insert and centrifuged in a microcon 30 (Sigma) spin column 
at 11000 g for 8 m in at room temperature. This was repeated for a total of 3 washes. The 
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column was inverted and centrifuged at 960 g for 3 min to collect the desalted plasmid. An 
aliquot of plasmid (50 J.ll) was added to the electrocompetent cells, placed into a prechilled 
electroporation cuvette and pulsed at 2500 V, 200 0, 25 J.lF, 2 mm gap using the BioRAD 
electroporation system, noting the time constant (4.5-5 m/s). SOC medium (20 g/1 Bacto-
tryptone, 5 g/1 yeast extract, 0.5 g/1 NaCl, 2.5 ml of 1 M KCl, 20% (w/v) glucouse) (900 
J.ll) was added and incubated at 37°C for one hour with shaking. A ten fold serial dilution 
of transformed cells was plated onto 2xYT 1% glucose, 30 J.lg/ml chloramphenicol and 
incubated overnight at 37°C. 
3.41 Confirming the presence of the scFv insert in selected clones 
3.41.1 Minipreps of transformed cells 
A single colony (5 for each insert and pAK300 and 400 vectors as a control) from the 
transformation was inoculated into 50 ml of LB with 1% glucose, 30 J.lg/ml 
chloramphenicol and incubated overnight at 37°C. Glycerol stocks were also made (50% 
glycerol 2 xYTGC) and the remaining culture used for colony PCR as detailed previously. 
DNA fingerprinting was undertaken using BstNI as described previously. 
3.41.2 Expression and purification of hexa-histidine tagged scFvs 
A single colony was inoculated into 200 ml 2xYTGC for pAK 300 and paK 400 vectors 
containing the scFv inserts and incubated overnight at 37°C with shaking (200 rpm). A 95 
ml volume of 2xYTGC was inoculated with 5 ml of overnight culture incubated until an 
OD600 of -0.8 was obtained. The culture was centrifuged at 2500 g for 10 min at 5°C, and 
the pellet resuspended m 50 ml of expression media. Isopropyl-beta-D-
thiogalactopyranoside (IPTG) was then added to a final concentration of 1 mM and 
incubated at room temperature overnight with shaking. The culture (1 ml) was centrifuged 
and the pellet stored at -20°C, for further analysis. The remaining culture was centrifuged 
at 3500 g for 10 min at 5°C and the pellet resuspended in 5% of the original volume of 
periplasmic extraction buffer (50 mM TrisHCl, 20% w/v sucrose, l mM EDTA). This was 
then incubated on ice with occasional shaking. The suspension was centrifuged at 14000 
rpm for 30 min at 5°C. The supernatant contained the soluble periplasmic extract and the 
pellet contained the insoluble periplasmic material. Both fractions were stored for further 
analysis at -20°C . 
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3.41.3 Initial confirmation of the presence of soluble scFv in the soluble periplasmic 
fraction by ELISA 
Purified EA1 was coated onto ELISA plates at a final concentration of 10 J.lg/ml in PBS 
and incubated overnight at 2-8°C. The ELISA procedure described previously was 
followed (2.25.1) but a mouse anti-His HRP conjugate was used as the secondary antibody 
(1:1000). 
3.42 Purification of hexa-histidine tagged scFv 
The purification of the scFv was achieved using B-PER 6xHis Spin Purification kit 
(Perbio ). An aliquot (1 ml) of 50% nickel chelated agarose slurry was added to each 10 m! 
of periplasmic extract and incubated at room temperature on a rotary mixer for one hour. 
The suspension was centrifuged at 1200 g for 10 min. The supernatant was retained for 
analysis and the pellet resuspended in 500 J.ll of buffer per 1 m! of agarose slurry that was 
initially added. The suspension was transferred to a spin column and centrifuged at 10000 
g for 10 min at room temperature. Wash buffer (500 J.ll) was added and incubated for 5 
m in at room temperature and then centrifuged for 2 m in at 10000 g. This was repeated. 
Finally, the collection tube was changed and the protein eluted by the addition of0.5 ml of 
elution buffer, incubation for 5 min at room temperature and centrifugation for 2 min at 
10000 g. The elution was repeated three times for a total of four elutions. All samples were 
kept for further analysis at -20°C. 
3.43 Analysis of purified samples 
Samples were analysed on 4-12% Bis-Tris NuPage gels (Invitrogen) (section 3.27) and 
blotted onto nitrocellulose membranes (Invitrogen) according to the manufacturer's 
instructions (section 3.28). Gels were stained using a colloidal blue stain (section 3.27) and 
HIS tagged proteins were identified by western blot analysis (section 3.28) with the use of 
a mouse anti-His HRP conjugate (I :2000) using the ECL™ detection system (Amersham). 
Those fractions containing the purified scFv were pooled and the buffer was exchanged for 
sterile PBS using a Vivaspin500 column (Sigma) according to the manufacturer's 
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instructions. The concentration of scFv in the final sample was quantified using a Micro 
BCA Protein Assay (Pierce). 
3.44 Kinetic analysis of scFv binding 
The kinetic data for scFv binding purified EAI was obtained using the BIAcore 3000 
(BIAcore, Sweden) with EAI immobilised onto a CM5 sensor chip, and B. cereus 11145 
S-layer protein as a negative control. Approximately 1500 Response Units (RU) was 
immobilised onto the surface using standard amine coupling and unreacted sites blocked 
with 1M ethanolamine, pH 8.5. ScFv were passed over the immobilised protein at 
concentrations varying from 5-400 nM in HBS EP buffer at a flow rate of 10 f..ll per min. 
To examine cross reactivity, the antibody was immobilised onto the surface, and S-layer 
proteins from B. cereus 11145, B. cereus 11143, B. cereus 9946, B. thuringiensis var. 
isrealensis, thuringiensis var. kurstaki, B. pumilus, B. brevis, B. coagulans and B. 
atrophaeus passed over at final concentration of 400 nM. 
3.45 Detection of whole spores and evaluation of sensitivity using an optical 
biosensor 
The resonant mmor biosensor (Thermo Labsystems, UK.) was used to demonstrate 
detection of whole B. anthracis spores. Antibodies were immobilised onto aRM T70 low 
molecular weight carboxymethylated dextran (CMD) cuvette surface by standard 
EDC/NHS coupling methods as described in. The spores were passed over at various 
concentrations for I 0 m in and the surface regenerated using 20 mM KOH for 3 min. 
3.46 Binding of FITC-Iabelled antibody to spores 
Spores were blocked with 1% BSA (w/v) for 2 h at room temperature, with mixing 
incubated with FITC labelled scFv in PBS 1% BSA (w/v) for 1 h at room temperature, in 
the dark, with mixing. The spores were washed 5 times in PBS and viewed by phase 
contrast and fluorescence microscopy using a. Negative controls were incorporated using 
FITC label and no antibody and a non-specific FITC labelled anti-ovalbumin antibody. 
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3.47 Ligation of scFv into pKappa construct 
Purified pKappa construct was kindly provided by Dr. C. Mayers (Dstl), which contained 
the murine light chain. Restriction digestion of the original scFv from the pAk I 00 plasmid 
and was undertaken using Sfi I (NEB). Each 50 ~I reaction consisted of2.5 ~I I Ox NEB #2 
reaction buffer, 0.5 ~I l OOx BSA, l ~I Sfi I, 1 ~g of DNA to be cut, and sterile dH20 to 
50~1. The restriction digests were incubated overnight at 37°C. Digestion of the pKAPPA, 
required for ligation of the scFv plasmid, was completed using 20 ~g of vector DNA in 
200 ~I reaction volumes, all reagent volumes were scaled up accordingly. Crystal violet 
purification was carried out as described previously (section 3.38). 
3.48 Ligation, expression and purification 
Ligation of the scFv inserts was conducted as described previously (section 3.39) using 
200 ng of sfi cut plasmid and 20 ng of purified scFv DNA. The expression and purification 
procedure was repeated as detailed previously (sections 3.40-3.43). 
3.49 Immunogold labelling 
3.49.1 Preparation of thin sections 
The preparation of thin sections was kindly carried out by S. Smith (Dstl). Briefly, washed 
B. anthracis UM23CI2 spores (lOx) were centrifuged at 2000 g for 5 min and the 
supematant discarded and the spore pellet resuspended in I 00 f.! I 5% ( v/v) gluteraldehyde 
in PIPES buffer and left to incubate for 18 h at room temperature. The spores were 
centrifuged again at 2 000 g for 5 min and the supematant discarded and the pellet 
resuspended in lOO f.1l PIPES buffer (pH 6.8) and incubated for l h at room temperature, 
this wash step was then repeated. The spores were then resuspended in 50 111 l% (w/v) low 
melting point agarose (Sigma) in distilled water. The agarose was allowed to set and cut 
into cubes (~l mm). The samples were dehydrated by incubating twice in 100% ethanol 
for 30 min and then in propylene oxide for 30 min. The samples were then infiltrated with 
a 1: l polypropylene/araldite mixture (from a stock comprising 175 ml Araldite resin 
CY212, 275 ml DDSA hardener, 5 ml dibutyl phthalate warmed to 37°C before mixing 
thoroughly and stored in the dark) to which I% (v/v) BDMA accelerator was added to the 
appropriate volume of resin and mixed for 2 h before use. The samples were then 
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infiltrated with resin alone for 72 h. The samples were transferred to flat embedding 
moulds and polymerised at 70°C for 72 h. The blocks were left at room temperature for at 
least 24 h before cutting. A glass knife was used to cut ribbons of sections and floated onto 
pyroxylin coated nickel grids and allowed to dry. Some sections were stained and 
visualised by TEM prior to labelling (section 3.21.2). 
3.49.2 Immunogold labelling 
The grids were floated on 2% (v/v) Decon 90 in sterile distilled water for 30 min at room 
temperature in a humid chamber. The grids were washed in sterile distilled water and 
dried. The grids were than floated on 50 Jll drops of buffer A (PBS 0.1% (v/v) Tween 20, 
I% BSA, 1% foetal calf serum, filter sterilised using a 0.2 J.lm filter) in a humid chamber 
for 30 min at room temperature. Excess buffer was blotted onto filter paper and the grid 
transferred to a 50 1.11 drop of primary antibody, diluted I: I 0 scFv or l: 100 of monoclonal 
antibody in buffer A, and incubated for 2 h at room temperature in a humid chamber. The 
grids were removed and washed on 430 1.11 buffer A for 5 min and the wash step was 
repeated. Excess buffer was blotted onto filter paper and the grids floated on a 50 J.ll drop 
of goat anti-mouse lgG I 0 nm imunogold conjugate (BB international) diluted I: 50 in 
buffer A and incubated for I hat room temperature in a humid chamber. The grids were 
then washed by floating on 430 J.ll of buffer A, twice, for 5 min then on 430 J.ll of distilled 
water. The grids were dried on filter paper and stained. Each sample was performed in 
duplicate and incorporated two negative controls, one with no antibody and one with a 
non-specific antibody. Sections were viewed under TEM (section 3.21.2). 
3.50 Epitope mapping using linear epitopes 
The EAI sequence was obtained from NCBI (http://www.ncbi.nih.gov/). The sequence 
was split into 14mers with 4 amino acid overlap either side. The sequences were 
synthesised by Alta Bioscience (Birmingham, UK). The scFv were immobilised onto a 
CM5 sensor surface using standard EDCINHS coupling methods as described previously 
(3.25.5.1 ). Peptides were passed over the surface for I 0 m in and the surface regenerated 
using 20 mM KOH as described previously (section 3.25.5.2). 
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Chapter 4 Disruption of bacterial en dos pores 
4.1 Introduction 
There is a requirement for rapid detection of B. anthracis spores in order to administer 
effective treatment to a susceptible population. Therefore, both the specific assay and 
sample processing prior to this must ensure that the pathogen can be rapidly detected 
(Webb, 2003). One detection technology that has demonstrated real time detection of a 
range of smaller molecular weight analytes is the optical evanescent biosensor. This type 
of biosensor is based on the properties of evanescent wave principles and uses small 
changes in optical properties to directly monitor these changes. The use of these biosensors 
is particularly attractive as they provide a means of real time continuous monitoring for the 
presence of pathogenic microorganisms compared to standard techniques (Ghindilis et al., 
1998; Gizeli and Lowe, 1996; Braguglia, 1998; Cruz et al., 2002). However, this 
application has been limited due to the relative insensitivity of the assay for detection of 
bacteria compared to standard methodologies (Watts et al., 1994; Framatico et al., 1998). 
The optical biosensor chosen for this work was the resonant mirror. This instrument detects 
changes in the refractive index that occur near the sensor surface, where the change in the 
refractive index is dependent on the mass of material bound to the surface. As analyte 
binds to surface immobilised ligand, the response is measured directly without any 
requirement for the addition of secondary reagents. The size of the response is dependent 
on Lln, defined as the difference between the refractive index ofthe material bound and that 
of the water displaced (1.33). A large response is observed on protein binding as the 
refractive index is approximately 1.51 thus, ~n = 0.18. Bacterial spores are highly 
refractile due the dehydrated nature of the core and the refractive index of a dormant 
bacterial spore is close to that of a fully dried protein with ~n = 1.52 (Tuminello et 
al., 1997; Katz et al., 2005). However, detection of bacterial spores using optical 
evanescent biosensors has proved particularly difficult (Dstl, Detection Department, 
unpublished data). The reason for the relatively high detection limits of bacterial spores 
despite their higher refractive index is unclear. 
To produce a specific detection system usmg optical evanescent sensors appropriate 
ligands, such as antibodies, must be chemically immobilised onto a sensor surface. Thus, a 
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further consideration is the availability of ligand to bind to analyte. Dextran coated sensor 
surfaces have been widely used for optimum protein detection, since this allows for higher 
density of antibody to be immobilised and for reduced non-specific binding compared to 
other surfaces. The dextran matrix is greater than 100 nm thick, and antibodies 
immobilised within this layer are easily accessible to large protein molecules such as 
toxins. However, intact bacterial cells or spores are not able to penetrate it and only 
antibody on the surface of the gel would be accessible. Thus, on binding a large proportion 
of the spore, typically 0.5-1 J.lm would be outside of the evanescent field which has been 
suggested to reduce assay sensitivity for bacterial cells (Watts et al., 1994; Framtico et 
al., 1998; Horvath et al., 2003). The large size of the bacterial spore in comparison to 
proteins produces further restrictions on detection. In addition, it may not be possible for 
the immobilised ligands to come into contact with epitopes on the spore due to steric 
hindrance, limiting binding events. 
Reduction in the rates of mass transport of larger particles when using optical biosensors is 
another effect that reduces the sensitivity of bacterial detection (Leatherbarrow and 
Edwards, 1999). The reaction of analyte in solution A with the immobilised antibody 8 to 
form the antibody-analyte complex AB is governed by the equilibrium 
A+ B AB (1) 
and the rate is given by the formula: 
d[AB)/dt = ka[A][B]- k.J[AB) (2) 
where ka is the association rate constant and k.J is the dissociation rate constant. The rate of 
response of the detector is therefore proportional to the concentration of the analyte in 
solution. Using the resonant mirror, to obtain a significant response to the binding of a 
protein of molecular weight 60 kDa, in a solution of 50 ng/ml, the concentration would be 
0.8 nM or 4.8 x 1011 molecules/m!. The desired lowest detectable concentration for larger 
particles such as spores would be many orders of magnitude below this (Fox et al., 2002; 
Ivnitski et al., 1999). Although the binding reaction for bacterial spores would be more 
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complex due to the presence of multiple copies of a protein on the surface, theoretically the 
lower concentration of analyte means that the rate of binding would be considerably less 
than soluble protein. The binding of bacterial spores is also likely to be limited by mass 
transport effects, being dependent on the diffusion coefficient, D. Larger particles such as 
bacterial endospores would show reduced mass transport to the sensor surface compared to 
the smaller protein molecules, again reducing the rate of binding. Thus, disruption of cells 
or endospores should enhance assay sensitivity both by increasing the concentration of 
protein available for binding and by reducing mass transport limitations. 
There are a range of methods that can be employed to achieve disruption ofbacterial cells. 
However, bacterial spores are inherently resistant to mechanical, enzymatic and chemical 
methods of disruption, therefore the development of a rapid disruption step is a 
considerable challenge. The addition of enzymes and chemicals and other treatments such 
as high pressure have been reported to achieve physical disruption using milder conditions 
(Hamilton and Sale, 1967; Simpson et al., 1995; Raso et al. 1998; Pol et al., 2000; Luna et 
al., 2003). Once spores have germinated they are less resistant to disruption than those in 
the dormant phase. A range of conditions have been found to induce germination including 
cationic surfactants, the addition of Ca 2+ dipicolinic acid (DPA) complex and exposure of 
the spores to high pressures (Setlow, 2003). However, the induction of germination would 
increase the processing time as a germinant will require time to take effect (Hamilton and 
Sale, 1967). Thus, the use of enzymes and chemicals were not deemed suitable for rapid 
detection methods. 
Kuske et al. (1998) examined the use of hot-detergent treatment, freeze-thaw cycles and 
bead mill homogenisation to break spores to allow for DNA extraction. Bead mill 
homogenisation was reported as being a successful technique for DNA release but was 
discounted for use in the present study because it would be impractical in a rapid detection 
system, due to the requirement for glass beads and multiple passes. Nebulisation was also 
discounted due to the need for multiple treatments. (Jensen et al., 1992; Agranovski et al., 
2002). Although there are conflicting reports of the utility of freeze thawing for the 
disruption ofbacterial spores {Tsai and Olsen, 1991; Car! et al., 1992; Herrick et al., 1993; 
Picard et al., 1992; More et al., 1994; Kuske et al., 1998) this method would obviously not 
be practicable for a rapid in-line disruption system. 
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Sonication is generally achieved by the rapid vibration of the sonicator probe tip producing 
high intensity sound waves, which induces the formation of cavities or gas nuclei in the 
aqueous phase. The bubbles formed may either oscillate, sometimes referred to as stable 
caviation, or implode, often termed transient cavitation (Leighton, 1994; Segebarth and 
Reisse, 2002). The process itself is thought to occur through particulates contained within 
liquid medium acting as bubble nuclei. As a number of bubbles interact with each other, a 
cavitation field is produced (Suslick et al., 1999). In the case of transient cavitation, micro-
streaming can occur creating large shear forces, particularly at a phase boundary, such as 
the gas liquid phase boundary of a bubble. These shear forces may be large enough to 
induce damage on the surface of biological moieties. In the case of transient cavitation, 
bubbles undergo explosive growth followed by rapid collapse, thus, a shock wave is 
generated thought to be sufficient to lyse cell walls (Hughes and Nyborg, 1962; Leighton, 
1994; Huang et al., 2002). When the bubbles implode, the diffuse sound energy is 
concentrated into localised spots as the compression of the gas contained within the bubble 
generates heat. This occurs more rapidly than thermal diffusion, creating short lived 
localised areas of high temperature and pressure, as well as high rates of heating and 
cooling (Suslick et al., 1999). The conditions achieved during this collapse can also drive 
chemical reactions. For example, free radicals can form from sonication of water. In this 
case, ·OH and ·H radicals are produced through the homolysis of water molecules. These 
may then reform as water (H20), hydrogen peroxide (H202) or hydrogen (H2) (vonn 
Sonntag et al., 1999). The majority of work undertaken for biological systems has 
examined the sonication of cells or spores to release internal components, such as DNA. 
Although the breakage of bacterial cells is relatively easy, spores have proven more 
problematic due to their high resistance to mechanical breakage even over prolonged time 
periods of exposure to cavitation (Berger and Marr, 1960). The main disadvantages of the 
technique is the potential for aerosol production within some systems, prolonged treatment 
time and the possible need for ear protection for the operator. Advantages include a 
possible reduction in the clumping and the release of soluble antigen from the spore 
surface improving detection, even without spore breakage. 
Electroporation is another method that has been examined for cellular disruption, although 
the mechanism is still not fully understood. Electroporation occurs when strong electric 
pulses are applied to a membrane, causing a significant increase in conductivity and 
permeability (Lebar et al., 2000). In the electroporation of a bacterial cell the main features 
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of the process are the formation of pores within a lipid membrane on exposure to high 
electric fields (Castro et al., 1993; Vega-Mercado, 1996). If the size and number of the 
pores formed becomes large compared to the surface area of the membrane then 
irreversible damage occurs leading to cell death (Zimmerman, 1986). A model of the 
effects of electric fields on bacterial membranes has been described by Zimmerman ( 1986) 
However, the target of electroporation within the bacterial spore, having a very different 
structure to that of a cell is unclear and reports of the e1ectroporation of bacterial spores are 
scarce, show large variance in results and are inconclusive (Hamilton and Sale, 1967; 
Knorr et al., 1994; Marquez et al., 1994; Simpson et al., 1995). 
The aim of this work was to examine sample processing prior to the detection assay. 
Disruption techniques have been evaluated and characterised to enhance the sensitivity of 
bacterial detection, whilst trying to maintain the speed of the assay and minimise the 
requirement for any additional reagents. Electroporation and sonication were evaluated and 
examined for their potential for rapid disruption of bacterial spores. In preliminary 
experiments B. atrophaeus was used as a model organism for B. anthracis to characterise 
the disruption techniques. B. atrophaeus is used widely as a model for B. anthracis due to 
ease of manipulation and its use within the field to evaluate detection technologies. The 
knowledge gained for the development of an in-line disruption method for improved rapid 
immunological based detection of B. anthracis spores and could be used in further work 
for the identification of suitable detection targets and the rational design of specific 
ligands. 
4.2 Results 
In the following descriptions, 'breakage' is used to define the complete fracturing of cell or 
spores to release internal components. The term 'disruption' is used to define any 
alteration of the exposed surface of the cell or spore. Viable counts represent the number of 
organisms capable of growth following incubation on LB agar overnight at 37°C (section 
3.12) and total counts represent the number of intact organisms, calculated as detailed in 
section 3.20 
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4.2.1 Examination of the effects of electroporation 
In order to determine the effect of electroporation on the spore, a preliminary analysis of 
the extent of spore breakage was undertaken using total and viable counts. The statistical 
significance of the results was determined using the analysis of variance (ANOV A) 
assuming P<0.05. Figure 4.1 shows that increasing the duration of exposure to the electric 
field resulted in a decrease in the total and viable counts (total P = 7.528 x L0-17; viable P = 
8 .803 x 1 o-17) . However, differences were not significant for shorter periods of exposure 
and no significant increase in dismption was observed above 12 pulses. Even after 
electroporation for 99 pulses, the reduction in the cell counts was only approximately 10-
fold. 
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Figure 4.1 Assessment of the disruption of B. atropllaeus spores by 
electroporation for increasing numbers of 0.1 s pulses by total and viable 
counts. Washed B. atrophaeus spores (at 1 x I 09 cfu/ml) were electroporated 
at 5 kV/cm using a square wave pulse ofO.l s width, increasing the number of 
pulses. Error bars show ± 2 standard deviations from the mean. 
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As spore breakage was limited, the effects of the application of an electric field on the 
outer spore surface was examined by scanning electron microscopy (SEM). This showed 
that untreated spores had chamcteristic ridges on the surface. When spores were exposed to 
twelve short square wave pulses of duration of 0.0001 s at a higher field strength (7.5 
kV/cm) no observable debris resulted and the sample looked very similar to the untreated 
control (Figure 4.2a). However, with the application of the lower field strength (5.0 
kV /cm) but longer single pulse duration (0.1 s) some debris was observed. It was also 
noted that although most spores remained intact, some had an abnormal shape, 
characterised by a lack of ridging on the spore coat and/or pustules on the surface. Similar 
results were obtained with B. atrophaeus, B. anthracis UM23CI2 and B. anthracis Steme; 
representative results are shown in Figure 4.2. 
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a) b) 
d) c) 
Figure 4.2 SEMs showing electroporation of B. anthracis UM23Cl2 
spores for increasing numbers of 0.1 s pulses. Washed B. atrophaeus spores 
(at 1 x 109 cfu/ml) were electroporated at 7.5 kV/cm or 5 kV/cm using a 
square wave pulse of O.l s width, increasing the number of pulses. a) 
untreated control b) 7.5 kV/cm 12 x 0.0001 s, c) 5 kV/cm 12 x 0.1 s, d) 5 
kV/cm 24 x 0.1 s. 
4.2.1.1 Evaluation ofproteill release 
The concentration of protein released from 1 x 109 spores/ml B. atrophaeus spores by 
electroporation was analysed by BCA protein assay and SDS PAGE. The concentration of 
protein released by electroporation at 7.5 kV/cm for 12 x 0.0001 s pulses gave a protein 
concentration of - 95 Jlglml by the BCA assay. Results were difficult to interpret due to 
large differences observed in the amount of protein released under the same conditions for 
each replicate, shown and a relationship between the protein released and time period of 
electroporation was difficult to ascertain. Repeated replication of the experiment showed 
that there was a large spread in the results, but that the amount of protein detected 
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decreased with an increasing number of cycles of electroporation (Figure 4.3). These 
results were supported by SDS-PAGE (not shown). 
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Figure 4.3 Protein release from B. atrop/raeus spores electroporated 
for increasing numbers of 0.1 s pulses. Washed B. atrophaeus spores (at 1 x 
l 09 cfu/ml) were electroporated at 5 kV /cm using a square wave pulse of 0.1 s 
width, increasing the number of pulses. The results show three batches of data, 
denoted as replicates, 1, 2 and 3. Error bars show ± 2 standard deviations 
from the mean. 
The reason for this decline was difficult to determine in a complex protein suspension; 
therefore the effects of electroporation on an individual protein was investigated. 
Ovalbumin (500 ~g/ml) was electroporated in the same way as B. atrophaeus spores. 
Electroporation of protein revealed a decrease in concentration over increasing time 
periods (Figure 4.4). To investigate the possibility that the protein was either being 
denatured and precipitating, or was forming deposits on the electrodes a further assay using 
detergents to wash out the cuvette after electroporation was applied. This showed that 
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some proteins were removed from the electrodes (Figure 4.4). However, this did not 
account for all the protein present before electroporation, suggesting that either a 
proportion of the protein may have be removed from the solution within the 
electroporation cuvette and deposited on the electrodes and/or the proteins were 
irreversibly denatured and had precipitated. 
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Recovery of ovalbumin after electroporation for 
increasing numbers of 0.1 s pulses. Ovalbumin (at 500 f.!g/ml) was 
electroporated at 5 kV /cm using a square wave pulse of 0.1 s width, increasing 
the number of pulses. The concentration recovered after electroporation and 
that recovered through extensive washing of the electrodes with PBS Tween 
20 0.05% was assessed. Error bars show ± 2 standard deviations from the 
mean. 
In order to determine if the spores were being broken by electroporation or only disrupted 
and spore proteins released a number of experiments were conducted. The first of these 
was to determine if any DNA was released following electroporation. The polymerase 
chain reaction (PCR) was used to detect any DNA released. However, no positive reults 
were obtained in PCR assays after the electroporation of washed B. atrophaeus spores. To 
assess if electroporation was having an effect on the DNA alone purified B. atrophaeus 
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DNA was also subject to the same conditions as had been used for whole spores. The DNA 
was not detectable by PCR following electroporation, suggesting that the electric field did 
effect the DNA and thus this method was not pursued as a measure of spore breakage. 
Assessment of the release of DP A to determime spore breakahge was therefore conducted 
and compared to sonication and is detailed in section 4.2.2.2. Analysis of the release of 
surface proteins released was conducted by separation of the proteins by SDS-PAGE and 
detection of those recognised by antibody determined by Western blot. This was also 
compared to sonication and is detailed in section 4.2.2.1. The detection of any spore 
antigen released by sonication was completed using the resonant mirror biosensor. In this 
case a polyclonal rabbit anti-B. atrophaeus antibody was immobilised onto a sensor 
surface and electroporated spores introduced. It was not possible to detect untreated or 
electroporated spores using the resonant mirror biosensor, thus this method was unsuitable 
for enhancement of assay sensitivity using the conditions tested and was not pursued 
further. 
4.2.2 Evaluation of a standard probe sonicator 
Initial investigations of the effects of sonication on bacterial spores were undertaken using 
a probe sonicator (Misonix). The statistical significance of the results was determined 
using the analysis of variance (ANOV A) assuming P<0.05 (P = 0.892). There was no 
statistically significant effect of up to 600 s sonication on the viability of B. atrophaeus 
spores (Figure 4.5). 
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Figure 4.5 Viable counts of B. atropltaeus spores after sonication 
with the standard probe sonicator for varying time periods. B. atrophaeus 
spores were washed and sonicated at approximately 1 x 109 cfu/ml using a 
standard probe sonicator (Misonix) at 40% power in 10 s pulses for varying 
time periods. Error bars show ± 2 standard deviations from the mean 
Increasing time periods of sonication up to 120 s had a significant effect on the release of 
protein (Figure 4.6). The maximum amount of protein released was approximately 65 
jlg/ml after 7 min of sonication of 1 x 109 B. atrophaeus spores/m I. However, it was not 
possible to detect treated or untreated spores using the resonant mirror biosensor. 
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Figure 4.6 Protein assay of B. atrophaeus spore proteins sonicated 
for various time periods. B. atrophaeus spores were washed and sonicated at 
1 x 109cfu/ml using a standard probe sonicator (Misonix) at 40% power in 10 
s pulses for varying time periods. The concentration of protein released was 
determined by BCA assay. Error bars show ± 2 standard deviations from the 
mean. 
4.2.2.1 Detectio11 of the release suface protei11s by electroporatio11 a11d so11icatioll by 
western blot a11alysis 
As electroporation and sonication both released protein that was not detectable by 
antibody, the release of surface proteins from the spores was determined. Spores were 
biotinylated using sulfo-NHS-biotin (Pierce), the sulphate group allowing for solubility at 
physiological pH and labelling surface located proteins. Following sonication or 
electroporation of the spores, the supematants containing the proteins released were 
separated by SDS-PAGE on 4- 12% Bis-Tris gels (Invitrogen), blotted onto PVDF 
membranes. 
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Figure 4.7 Western blot analysis of the detection of the release of 
biotinylated suface proteins from B. atrophaeus spores by sonication and 
electroporation. Following sonication using a standard probe sonciator the 
proteins release were separated by SDS-PAGE on 4-12% Bis-Tris precast gels 
(lnvitrogen). The proteins were then transferred to a PVDF membrane and 
probed with a streptavidin peroxidase conjugate (1: 1 000). Biotinylated 
proteins were visualised by ECL™ detection (Amersham). Lane loading was 
as foJiows: a) Sonicated B. atrophaeus spores A) 5 s, B) 30 s, C) 60 s, D) 120 
s, E) 240 s, F) 300 s, G) 420 s, H) 600 s., D tmtreated control (biotinylated no 
sonication) J) Magic Mark™ Western Standard. b) Electroporated B. 
atrophaeus spores. A) 5 kV/cm 1 x 0.1 s, B)5 kV/cm 2 x O. ls, C) 5 kV/cm 3 x 
O.ls, D) 5 kV/cm, 12 x 0.1. E) 24 x O.ls 5 kV/cm, F) 5 kV/cm 48 x O.ls. G) 5 
kV /cm 99 X 0.1s, H) 99 X O.ls wash. n biotinylated no electroporation. J) 
Magic MarkTM Western Standard 
Western blot analysis of biotinylated surface proteins released from sonicated or 
electroporated samples revealed a distinct difference between the two samples. In the case 
of sonication, increasing amounts of proteins were detectable as the time period of the 
sonication increased, reaching a maximum after 7 min (Figure 4.7a). There appeared to be 
two predominant surface proteins released by the sonication process ( 40 and 45 kDa). The 
apparent protein concentration and protein profile changed above 420 s most notably with 
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the apparent loss of the 45 kDa protein. In the case of the electroporated sample, 
biotinylated proteins were only detected after the shortest (l x 0.1 s) electroporation period 
(Figure 4.7b). In both cases, there was no binding of the streptavidin peroxidase conjugate 
to the non-biotinylated and electroporated or sonicated controls completed for each time 
period of each treatment (data not shown). 
4.2.2.2 DPA release from spores 
Following sonication, the concentration of DP A was determined using a method based on 
that described by Hindle and Hall (1999). Increasing periods of electroporation or 
sonication resulted in a similar pattern of DPA release, although the amount released was 
approximately 4.5 times higher using electroporation (Figures 4.8a) compared to 
sonication (Figure 4.8b ). 
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Figure 4.8 DPA release from B. atrophae11s spores a) electroporated 
for increasing numbers of 0.1 s pulses and b) sonicated for increasing 
time periods. Washed B. atrophaeus spores,at 1 x 109 cfu/ml, were sonicated 
at 40% power using a standard probe sonicator (Misonix) or electroporated at 
at 5 kV/cm·' using a square wave pulse of 0.1 s width, increasing the number 
of pulses. Error bars show ± 2 standard deviations from the mean. 
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4.2.3 Evaluation of the extent of disruption and effects of sonication using the 
Cepheid minisonicator system 
The Cepheid minisonicator was the second system evaluated as previous work using PCR 
suggested that using this system spore breakage was achieved after 30 s (Belgrader et al., 
1999). Therefore, this system was evaluated for its utility for the improvement of 
immunoassay sensitivity. Initial investigations of the extent of spore breakage were 
conducted using total and viable counts. The statistical significance of the results was 
determined using the analysis of variance (ANOV A) assuming P<0.05. Figure 4.9 shows 
the there was an effect of increasing periods of sonication on the total and viable counts of 
B. atrophaeus spores (viable, p = 1.845 X 10-17; total, p = 1.905 X w-'\ Viable and total 
counts showed very similar trends. No significant reduction in counts was observed with 
less than 30 S sonication (for 30 S viable p=l.092 X 10-7; total p=1.462 X 10-7) but times 
above 60 s did not result in further loss. 
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Figure 4.9 A comparison of total and viable counts of B. atroplraeus 
spores after sonication for various time periods. The spores were washed 
and sonicated using the Cepheid system at 100% amplitude for defined time 
periods. Error bars show ± 2 standard deviations from the mean. 
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4.1.3.1 Electron Microscopy 
The effects of Cepheid sonication on the structure of B. alrophaeus spores were observed 
by SEM. Untreated samples revealed that the outer spore coat showed ridges running 
parallel to the axis of the spore (Figure 4.1 Oa) There was some evidence of ghost cells and 
some debris, but this was not extensive. After a sonication period of 5 s, there was greater 
evidence of ghost cells (Figure 4.1 Ob). The outer spore coat also appeared rougher than the 
untreated sample. There was some evidence of the appearance of small fragments after 30 
s sonication (Figure 4.1 Oc ). After sonication for 120 s, many spores were broken open and 
large quantities of debris were observed, although some spores did appear to remain intact 
(Figure 4.1 Od). 
Figure 4.11 shows the effect of sonication on the appearance of B. anthracis spores by 
SEM. After 30 s sonication there was some evidence of disruption to the outer layers of the 
spore and fracturing of the spore coat observed as a line or crack running down the axis of 
the spore (Figure 4.11 b). After 120 s sonication a significant amount of disruption and 
breakage was observed (Figure 4.11 c and 4.11 d) which was accompanied by a large 
amount of debris, representing spore fragments and possible aggregates of precipitated 
protein, although the effect was not homogeneous throughout the sample (Figure 4.11 d). 
The extent of disruption of B. anlhracis spores was also observed by transmission electron 
microscopy (TEM). Figure 4.12a shows the untreated control with distinct structures 
clearly visible. Figure 4.12d shows that sonication resulted in removal of the exosporia! 
layers and fracture of the spore coat and all inner structures to release core components. 
However, Figure 4.12b demonstrated that exosporium removal and spore breakage does 
not occur in a uniform manner for a given sample. However, there was apparent 
enlargement and darkening of the core and surrounding cortex. 
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a) b) 
c) d) 
Figure 4.10 SEMs of B. atrophaeus spores a) untreated and b)-d) 
sonicated using the Cepheid system at 100% power b) 5 s, c) 30 s, d) 120 s. 
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Figure 4.11 SEMs of B. anthracis spores ()'-iradiated vaccine strain) 
sonicated using the Cepheid system at 100% power for a) untreated, b) 30 
s c) 120 s, d) 120 s. 
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Figure 4.12 TEMs of B. anthracis UM23Cl2 spores sonicated using the Cepheid system. Washed spores were sonicated for defined 
time periods using the Cepheid system at 100% power a) Untreated B. anthracis y-irrdiated vaccine strain b) sonicated (120 s) B. anthracis '}'-
irradiated vaccine strain, c) Untreated B. anthracis UM23Cl2, d) sonicated (120 s) B. anthracis UM23C12 
4.2.3.2 Assessment of the effects ofsoiJication by EL/SA 
Preliminary investigation of the effects of disruption on an imrnunoasaay based technique 
was conducted by ELISA. For comparative analysis of the results the lowest detectable 
concentration (i.e. that giving a positive result) was defined as any value above the 
backgrmmd + 2 standard deviation of the mean (termed the minimum threshold). By direct 
ELISA it can be seen that there was an approximate 10 fold increase in assay sensitivity 
after sonication of B. atrophaeus spores for 5 s, and an approximate 100 fold increase after 
sonication for 30 s (Figure 4.13). 
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Figure 4.13 Detection of B. atrophaeus spores varying the time period 
of Cepheid sonication (100% amplitude) by direct ELISA. The antibody 
used was a polyclonal rabbit anti-B. atrophaeus antibody (Dstl.). Error bars 
show ± 2 standard deviations from the mean. 
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4.2.3.3 Assessment of the effects of Ceplleid sonication using the resonant mirror 
The resonant mirror was used as a near real-time detection technology to analyse the 
effects of sonication at various amplitudes and for varying time periods on antigen release 
and any deleterious effects of the sonication process. 
The analysis of the detection of an analyte using the resonant mirror biosensor are 
described by Lowe et al. (1997). Prehminary experiments showed that the optimum 
amplitude for sonication was 100%. However, although the magnitude of the response for 
each detectable concentration of spores tested increased with increasing amplitude of 
sonication, there was only a slight improvement in the assay sensitivity (data not shown). 
Figure 4.14 shows that untreated B. atrophaeus spores were not detectable using the 
resonant mirror biosensor. Sonication for 5 or 30 s resulted in a significant increase in 
assay sensitivity, but sonication of B. atrophaeus spores for longer than 30 s demonstrated 
a significant decrease in the sensitivity of the assay. 
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Figure 4.14 
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Time period or sonication (s) 
Degradation in the response of the resonant mirror 
biosensor to the detection oft x 108 cfu/ml B. atropllaeus spores varying 
the time period of Cepheid sonication at 100% amplitude. The antibody 
used was a polyclonal anti-B. atrophaeus antibody (Dstl) which was 
immobilised onto a low molecular weight (T70) carboxyrnethylated dextran 
cuvette. Error bars show ± 2 standard deviations from the mean. 
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For B. anthracis UM23Cl2 spores, untreated spores were detectable using the resonant 
mirror biosensor at l x 108 spores/m I. Preliminary experiments showed that the optimum 
amplitude for sonication appeared to be 50% for 5 s; at amplitudes greater than 50% the 
response, decreased. Figure 4.15 shows the degradation of the response for 5 s sonication 
using increasing amplitudes. 
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Figure 4.15 Degradation in the response of the resonant mirror 
biosensor to the detection of 1 x 108 cfu/ml B. anthracis spores varying 
the amplitude of Cepheid sonication for 5 s. The antibody used was a 
monoclonaJ anti-B. anthracis antibody (Dstl) which was immobilised onto a 
low molecular weight (T70) carboxymethylated dextran cuvette. Error bars 
show ± 2 standard deviations from the mean. 
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4.1.3.4 Evaluatio11 of the effect of/Jeatillg a11d cooli11g 
The results from both immunoassay-based techniques (ELISA and the resonant mirror 
biosensor) suggested that heat could be an important factor in the degradation of the 
response observed in these assays. Therefore a method of sonicating and cooling was 
employed. Samples of B. atrophaeus spores were sonicated in 5 s pulses at 100% 
amplitude and held on ice for one rnin between each pulse until the required time period of 
sonication had been achieved. The samples were then analysed by protein assay, SDS-
PAGE and resonant mirror biosensor analysis. Figure 4.16a shows a higher concentration 
of protein was released from B. atroplzaeus spores after 120 s sonication with pulsing and 
cooling (- 70 J..lg/ml), compared to sonication without (- 55 J..lg/ml). The amount of protein 
released from B. anthracis spores showed a similar trend; however, the maximum amount 
of protein released with pulsing and cooling was higher, - 200 !lg/ml (Figure 4.16b ). The 
samples demonstrating the optimal release of protein for sonication with the incorporation 
of a cooling step using the Cepheid system were evaluated using the resonant mirror 
biosensor. Figure 4.17 shows Cepheid sonication for a total of 120 s in bursts of 5 s with 
intermittent cooling for 1 m in produced a 1 00-fold increase in the detection of B. 
atrophaeus spores. 
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Figure 4.16 Protein release from a) B. atropllaeus spores and b) B. 
a11tllracis spores sonicated using the Cepheid mini-sonicator at 100% 
amplitude for varying time periods with and without cooling. Spores (at 1 
x 109 cfu/ml) weresonicated without pulsing were sonicated continually for a 
defined time period. Samples sonicated with pulsing and cooling were 
sonicated in 5 s pulses with intermittent cooling on ice for 1 min. Protein 
concentrations were determined using a BCA assay. Error bars show ± 2 
standard deviations from the mean. 
122 
200 
180 
160 
-
~ 
'0 140 c 
0 
u 120 41 ~ 
u 
.... 100 ~ 
'-' 
41 
~ 80 c 
0 
c. 60 ~ 41 
~ 
40 
20 
0 
4 5 
I 
I 
I 
I 
I 
I 
- - - - ~- -- - --- -;.; : ~·- - --- - -- --
..... -- I I 
6 7 8 9 
Log10 B. atropllaeus spore concentration (cfu/ml) 
120 s, intermittent cooling - · -ill· - · - 30 s without cooling 
Minimum threshold 
Figure 4.17 Detection of sonicated B. atrophaeus spores using the 
resonant mirror biosensor. Washed spores (1 x 109 cfulml) were Cepheid 
sonicated for 30 s at l 00% amplitude or for 24 x 5 s pulses for a total of 120 s 
sonication, with intermittent cooling on ice for 1 min. The samples were then 
passed over polyclonal anti-B. atrophaeus antibody (Dstl) immobilised onto a 
T70 CMD cuvette. Error bars show± 2 standard deviations from the mean. 
4.2.4 Evaluation of the tubular sonication system using B. atrophaeus spores 
Although evaluation of the Cepheid sonicator showed improvements in immunoassay 
sensitivity, heat appeared to be a major limitation. Therefore in collaboration with Prof. T. 
Coakley and K. Borthwick (University of Cardiff) a novel system was developed to limit 
heating of the bulk solution to minimal levels. The design and development of the tubular 
sonicator is detailed in section 3.18. Following initial development the system was 
characterised using total and viable counts to determine spore breakage. 
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4.2.4.1 AssessmelJt of viability 
There was no statistically significant decrease in the viability of B. atrophaeus spores after 
sonication for any of the time periods tested (Figure 4.18). The statistical significance of 
the results was determined using the analysis of variance (ANOV A) assuming P<0.05 (P = 
0.0785). As no decrease in viability was observed total spore counts were not performed. 
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Figure 4.18 Viable counts of B. atropiJaeus spores after sonication for 
increasing time periods using the tubular sonicator. Spores (at 1 x 109 
cfu/ml) were sonicated in the tubular sonicator in batch mode, at 267 kHz, for 
defined time periods and the viable counts after sonication assessed. Error bars 
show ± 2 standard deviations from the mean. 
4.2.4.2 Electro11 microscopy 
In the case of B. atrophaeus spores, observation of spore morphology after sonication with 
the tubular transducer for 600 s, revealed a reduction in the thickness of the spore coat . A 
significant amount of debris, presumably fragments of the spore coat, was also observed 
but there was no evidence for significant breakage of the spores (Figure 4.19b ). In the case 
of B. anthracis UM23Cl2, many of the spores were devoid of an exosporia! layer seen as 
fragments within the sections. There was also some possible damage to the spore coat. A 
representative section is shown in Figure 4.20. 
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a) 
b) 
Figure 4.19 
Spore coat 
Core 
Fragments of the 
spore coat 
TEM analysis of B. atrophaeus spores before and after 
sonication using the tubular sonicator. a) untreated B. atrophaeus spores, 
b) B. atrophaeus spores sonicated for 300 s. 
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Figure 4.20 
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TEM analysis of B. antllracis UM23CI2 spores before and 
after sonication using the tubular sonicator a) untreated spore b) spores 
sonicated for 300 s. 
4.2.4.3 Protein release 
The amount of protein released after sonication for increasing time periods was evaluated 
through the use of BCA assay and SDS-P AGE. It can be seen that the amount of protein 
released increases with increasing time period of sonication. As observed with the standard 
probe and Cepheid system, there was an initial rapid increase in the amount of protein 
released over increasing time periods. However, it should be noted that the amount of 
protein released was approximately the same as that observed for the Cepheid system 
(Figures 4.21). This was supported by results obtained by SDS PAGE. 
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Figure 4.21 Protein release from B. atrophaeus spores sonicated using 
the tubular sonication system for various time periods. Washed spores (1 x 
I 09 cfu/ml) were sonicated in the tubular sonicator at 267 kHz for increasing 
time periods. Protein concentration was determined using a BCA assay. Error 
bars show ± 2 standard deviations from the mean. 
4.2.4.4 Enhancement of specific detection after sonication 
After sonication of B. atrophaeus spores using the tubular sonicator the sensitivity of the 
resonant mirror biosensor specific immunoassay decreased slightly compared to the 
sensitivity obtained through tl1e sonication of B. atrophaeus spores using the optimised 
Cepheid minisonicator protocol (i.e. with incorporation of cooling) (Figure 4.22). 
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Figure 4.22 Detection of B. atropllaeus spores using the resonant 
mirror biosensor comparing, sonication using the tubular sonicator and 
the Ccpheid mini sonicator with and without cooling. Washed spores were 
sonicated at 1 x I 09 cfu/ml using; (a) the Cepheid system at 100% amplitude 
for 30 s without cooling (the optimised uncooled protocol), (b) with cooling 
for 120 s and, (c) using the tubular sonicator 267 kHz. The samples were then 
passed over polyclonal rabbit anti-B. afrophaeus antibody immobilised onto a 
T70 CMD cuvette. Error bars show ± 2 standard deviations from the mean. 
Tile effects of co!lcentration on protein release 
If a system is to be utilised for the detection of BW agents (in particular spores), it has to 
be used in a range of environments (e.g.an air sample collected into liquid, or a laboratory 
sample) and. Also, particularly in the case of environmental samples, other bacteria, 
proteins or other particulate matter may be present as part of the biological and other 
background. Initial experiments were conducted to examine the efficiency of the release of 
proteins from various concentrations of B. atrophaeus affected the outcome of sonication. 
The effects of concentration on the sonication process were assessed by monitoring protein 
release. There appeared to be an inverse relationship between the concentration of protein 
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released when various concentrations of B. atrophaeus spores were subjected to cavitation 
using the tubular sonicator. After adjustment of the protein concentrations to represent that 
released from 109 spores it was apparent that when the spores were sonicated a tat 
concentrations above this; the higher the initial spore count prior to sonication, the lower 
the concentration of protein released The optimal concentration of B. atrophaeus spores 
was in the order of 1 x 109 spores/ml (Figure 4.23). 
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Figure 4.23 Protein release from B. atropllaeus spores sonicated using 
tbe tubular sonicator sonication system, sonicating for 300s, using varying 
concentrations of B. atropltaeus spores. Spores were sonicated in the tubular 
sonicator at 267 kHz using increasing concentrations of spores ( 1 x 1 09 to 1 x 
1011 cfu/m1). Following sonication the protein concentration was adjusted to 
represent the protein released from 1 x 109 spores/ml and was determined 
using a BCA assay. Error bars show ± 2 standard deviations from the mean. 
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4.2.5 Evaluation of the tubular sonicator operated as a flow through system 
4.2.5.1 Eval11ation of conce11tratioll ofproteill released 
The amount of protein released from the tubular sonicator when operated in a batch mode 
for 300 s was approximately 75 J.l.g/109 spores. However, when the sonicator was operated 
as a continuous flow system the amount of protein released was approximately 50 J.l.g/1 09 
spores, even though the residence time within the sonic zone was 300 s. 
4.2.5.2 Evaluatio11 of the use of differeut buffers and the additio11 of detergents i11 
sonication 
A continuous or batch system may require sonication m a range of different buffers, 
dependent on the method of collection of the sample and the final assay format to be 
utilised. The effect of the addition of different buffers and detergent concentrations on the 
sonication of B. atrophaeus spores was evaluated. Buffers and detergent concentrations 
were selected on the basis of common usage within biosensor systems. The results show 
that, in the absence of detergents, the release of protein decreased as the ionic strength of 
the buffer increased (Figure 4.24). The addition of Tween also significantly increased the 
release of protein from B. anthracis spores (Figure 4.25). 
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HE PES HEPES (l OO mM Tween 20 HE PES (lOO mM 200.05% 800.01% 
IOmM NaCI) 0.05% IOmM NaCI) 
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Buffer 0.01% 
Figure 4.24 Protein release from 109 B. atrophaeus spores by 
sonication in different buffers and with the addition of increasing 
amounts of detergent using the tubular sonicator .. Washed B. atrophaeus 
spores were sonicated (at l x 109 cfu/ml) in water, lOmM HEPES or PBS 
with the addition of various concentrations of Tween 20 using the tubular 
sonciator at a flow rate of 0.3mlfmin at 267 kHz at 800 mY. Protein 
concentration was determined using a BCA assay. Enor bars show ± 2 
standard deviations from the mean. 
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Figure 4.25 
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SDS-PAGE analysis of the effects of various detergents 
on the release of proteins from B. a11tllracis UM23CI2 spores by 
sonication. Washed spores were sonicated (at 1 x 109 cfu/ml) in water with or 
without Tween 20 (0.05% v/v) using the tubular sonicator at a flow rate of 
0.3ml/min at 267kHz at 800 m V. A) B. anthracis UM23Cl2 in H20 untreated 
control, B) B. anthracis UM23Cl2 sonicated in H20, C) B. anthracis 
UM23CI2 sonicated in H20 Tween 20 0.05%, D) reducing sample buffer. E) 
Wide range molecular weight marker (Sigma). 
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4.2.5.3 The effect oft/ae additio11 of protease i11hibitors 
The effect of the addition of a protease inhibitor cocktail (Sigma), or 1, 2.5 5 and 10 mM 
EDT A before sonication was evaluated by SDS-PAGE. There was no significant 
difference in the protein profiles obtained with increasing concentrations of protease 
inhibitor compared to the untreated control (data not shown). Furthermore, there was no 
difference in the profile obtained if the inhibitor was added immediately after sonication. 
4.2.5.4 E11ha11ced specific detection after so11ication 
From analysis using the resonant mirror biosensor, the sensitivity of the detection of B. 
atrophaeus spores showed a 20-fold reduction in assay sensitivity when the tubular 
sonicator was utilized in continuous flow, compared to its operation in a batch format. 
However, it should be noted that the sensitivity of the assay when the tubular sonicator was 
used as a continuous system is the same as that for 30 s sonication using the system in 
batch mode. This supports the results obtained from the evaluation of protein released 
after sonication, which again were similar for the continuous system and the batch system 
after 30 s sonication. Examination of the effect the addition of detergent on assay 
sensitivity reflected the increased amount of protein released, an example of which is 
shown in Figure 4.26. With B. anthracis the improvements in assay sensitivity were similar 
although the lowest detectable concentration was lower as the assay was more sensitive 
than that for B. atrophaeus spores when untreated spores were used. 
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Figure 4.26 Detection of sonicated (continuous flow tubular 
sonicator) B. atrophaeus spores using the resonant mirror biosensor in 
water and phosphate buffered saline (PBS) with two different 
concentrations of Tween 20. The spores were sonicated in the tubular 
sonicator in continuos flow at 267 kHz. Samples were passed over polyclonal 
anti-B. atrophaeus antibody (Dstl) immobilised onto a T70 CMD cuvette. 
Error bars show ± 2 standard deviations from the mean. Sample were 
sonicated in water (H20) or phosphate buffered saline (PBS) or PBS with 0.05 
or 0.1% (v/v) Tween 20 (PBST) 
4.2.5.5 Assessme11t of the effects ojso11ication 011 a specific protein 
An assessment of the effects of ultrasonic cavitation on individual proteins was completed 
through the sonication of three proteins of increasing molecular weight using the tubular 
sonicator for increasing time periods. The three proteins chosen for evaluation were BSA 
(m .w.~ 36 kDa), ovalbumin (m.w. ~ 45 kDa and B. anthracis S-layer protein EAl (m.w.~ 
92 kDa). The samples were analysed by SDS-PAGE to compare differences in the protein 
profiles. The S-layer protein derived from B. anthracis was also evaluated by resonant 
mirror before and after sonication using a single chain anti-EA! antibody (Chapter 5), to 
evaluate antigen denaturation. Evaluation of the protein profiles obtained through SDS-
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PAGE of the three sonicated proteins showed some evidence of smaller and larger 
fragments in the sonicated samples compared to the untreated controls (Figure 4.27). 
Increased 'smearing' down the gel and a greater proportion of material that was unable to 
enter the gel matrix was also noted in the case ofBSA and ovalbumin. 
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Figure 4.27 Effects of ultrasonic cavitation on proteins analysed by 
SDS PAGE. Samples were sonicated using the tubular sonicator in continous 
flow. Following recovery of the sample (diluted 1/20 to give an expected 
concentration of 25 J.t.g/ml) proteins were separated by SDS-PAGE on precast 
4-12% Bis-Tris gels (Invitrogen) and stained with Colloidal Blue stain 
(lnvitrogen). Lane loading was as follows: A) BSA untreated, B) BSA 
sonicated C) Ovalbwnin untreated D) Ovalbumin sonicated E) S-layer protein 
untreated, F) S-layer protein sonicated in water, G) S-layer protein sonicated 
in PBS Tween 20 0.05%, H) S-layer protein sonicated in PBS I) Wide range 
molecular weight marker (SIGMA), J). Reducing sample buffer. 
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4.2.5.6 Assessment of the effects of mixtures 011 specific detectio11 after so1ticati01t 
As the concentration of spores in the sample appeared to have an effect on the efficiency of 
cavitation, the consequence of the presence of other microorganisms and protein within the 
sample was assessed. B. atrophaues spores were sonicated at approximately 1 x 1 os 
spores/ml with the addition of high (1 x 108 cfulml) and low (1 x 106 cfulml) E. coli and 
high (100 ~-tg/ml) and low (10 ~-tg/ml) concentrations of ovalbumin. Using the resonant 
mirror optical biosensor, the results suggest that there was no decrease in the sensitivity of 
the detection of B. atrophaeus when spores were sonicated with a low concentration of 
another micro-organism (E. coli) or protein (ovalbumin), and showed a lowest detectable 
concentration of ~ 10 7 cfulml. When high concentrations of protein were added, there was 
a slight decrease in the sensitivity of the assay for B. atrophaeus spores, although this was 
not statistically significant. However, the addition of E. coli at a high concentration 
appeared to cause a 5 fold decrease in assay sensitivity (Figure 4.28). The final 
concentration of organisms within the sample was 2 x 108 cfu/ml, furthermore a 
background of ~ 1 x 1 os organism may be unrealistically high. This does not support the 
previous observation that no concentration effects were observed with protein release from 
the sonication of B. atrophaeus spores alone. 
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Figure 4.28 Detection of sonicated B. atropltaeus spores using the 
resonant mirror biosensor. Samples were sonicated using the tubular 
sonicator in continuous flow at 267 kHz. The samples used were B. 
atrophaeus at 109 cfu/ml alone and mixed with ovalbumin (OA) at 100 or 
I OJ.!.g/ml) and Escherichia coli (E. coli) at 108 or 106 cfu/ml) The samples 
were then passed over polyclonal anti-B. atrophaeus antibody immobilised 
onto a T70 CMD cuvette. Error bars show ± 2 standard deviations from the 
mean. 
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4.3 Discussion 
Much of the research that has been conducted into characterisation of electroporation 
focuses on the use of artificial lipid bilayer (see Miteva et al., 1999 . However, Troiano et 
al. (1999) suggested that this is an over simplified system. In the context of biological 
systems, an exact explanation and model of the effects of large pulsed electric fields is 
extremely difficult. The reason for this is that there are many ways in which a biological 
system, such as a cell membrane or spore, can be directly or indirectly altered during 
electroporation. The distribution of proteins within a cell membrane or spore coat or 
underlying structures means that the electrical and mechanical properties of the cell or 
spore will not be homogeneous across the surface, so exact models are difficult to apply. 
Furthermore, changes in the external environment due to release of proteins and other 
components during electroporation may also alter the effects on cells or spores (Polk, 
2000). It has been hypothesised if water is used as a suspension medium the electrical 
discharge is transferred to the water giving it bactericidal properties. It has been postulated 
that this is due to the formation of ions, hydrated ions and free radicals and a more 
systemic effect due to the formation of shock waves and UV radiation (Efremov et al., 
2000), although this has never been determined experimentally. In general, the most 
accepted causes of reduction in cell viability from applied electric fields are (a) significant 
damage to cell DNA; (b) severe disruption or changes to the biochemical composition of 
the interior of the cell rendering it incapable of survival; and (c) irreversible mechanical 
disruption to a biological particle or its surface structure (Efremov et al., 2000). 
The bacterial endospore is very different in structure to a vegetative cell, thus the effects of 
applied electric field on the spore are also likely to be different. Pulsed electric fields have, 
in the main, been reported to have no effect on bacterial endospores (Hamilton and Sale, 
1967; Knorr et al., 1994 Simpson et al., 1995). However, results from the work presented 
here suggest that effects can be seen using long pulse widths (0.1 s) and field strengths of 5 
kV /cm. SEM analysis of electroporated B. atrophaeus and B. anthracis spores 
demonstrated that, at 5 kV /cm with increasing number of pulses, a greater amount of debris 
and sometimes 'pustules' were observed on the spore surface. This has also been reported 
for sonication (Chandler et al., 2001). This would suggest that material is being released 
into the surrounding medium and changes are occurring on the spore surface. Whether 
these changes extend to the underlying structures has yet to be determined. The formation 
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of pustules could be due to a number of reasons such as aggregation of protein into 
microspheres and possible precipitation or an effect on the outer integuments caused by a 
large efflux of ions from the highly positively charged core due to the applied electric field 
or a charge effect on the external protein layers may allow for re-orientation of coat or 
exosporium proteins and/or removal from the spore (Carstensen et al., 1971 ). However, at 
present these mechanisms are purely speculative. One other feature of note was the 
reduction in ridging along the longitudinal axis of electroporated spores compared to 
untreated samples. This could be due to a number of factors: (a) disruption of the 
interaction of spore coat proteins required for the formation of a fold (Driks, 2003; (b) an 
increase in spore volume due to the increased permeabilisation of the cortex and/or core 
(Westphal et al., 2003); and (c) induction of germination by the forced efflux of 
components such as DPA from the core (Santa and Doi, 1974). However, to date pulsed 
electric field treatment has not been shown to induce germination (Barsotti and Cheftel, 
1999; Pol et al., 2000). 
Viable and total counts of electroporated spores demonstrated a general trend in a 
reduction in values with increasing numbers of pulses; however, this was only statistically 
significant after 99 0.1 s pulses where a 10 fold reduction was observed. However to attain 
a reduction in the total and viable counts no other pre-treatment was required, at variance 
with results from previous studies (Sale and Hamilton, 1967; Knorr et al. , 1994; Simpson 
et al., 1995). The differences may be a reflection of the longer pulse widths used compared 
to previous experiments as there appeared to be little change in morphology observed with 
spores electroporated with pulses l 000 fold less in duration (0.0001 s) in agreement with 
previous work (Hamilton and Sale, 1967; Knorr et al., 1994). The results from the work 
presented here suggest that the initial effects of an applied pulsed electric field are sub-
lethal and are observed on the outer integuments, although gradual damage to the cortex 
and eventually the inner membrane can not be discounted. Although the membrane is the 
target of electroporation this does not appear to be the case in the case with the spore. 
Evaluation of the release of DP A showed an increase with increasing number of pulses at 
values far greater than would be expected for the number of spores broken. However, the 
amount of DP A released by sonication using a standard probe sonicator was lower, even 
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though both disruption techniques did not show a statistically significant reduction in the 
viable count. This suggests that in the case of electroporation, release of DP A into the 
medium prior to spore breakage may occur. This could be due to a number of reasons, such 
as heating of the bulk solution (McCiain et al. , 2003) or the efflux of DPA from the core 
due to the movement of ions upon application of an electric field. The results of the 
biotinylation of B. atrophaeus spores and subsequent electroporation suggest that with the 
lowest exposure surface proteins were released. However, with increasing numbers of 
pulses the biotinylated protein was not detectable suggesting removal of the protein to the 
electrodes and/or denaturation of protein. 
To determine the effect of electroporation on protein and DNA, ovalbumin and purified B. 
atrophaeus DNA were subject to electroporation. Following the electroporation of protein 
only, the results suggested that at the amount of protein released decreased as the number 
of pulses increased. Washing of the cuvette following electroporation demonstrated that a 
proportion of the protein could be recovered. Complete recovery of the protein may not be 
possible if it was irreversibly denatured and not detected by any of the methods used, or if 
the method of recovery was not 100% efficient. Purified B. atrophaeus DNA was not 
detected following electroporation by PCR, thus it is unclear whether DNA can be released 
from spores using electroporation. A reduction in the optical density of proteins and DNA 
released from vegetative cells exposed to electric fields have been reported previously 
(Efremov et al. , 2000) and were suggested to be due to denaturation and deposition of 
bacterial albumens due to the increase in heavy metal concentration, this could be the 
reason for the effects observed within this system. Following electroporation, there was no 
observed detection of B. atrophaeus spores by immunoassay using any of the conditions 
tested. Thus, although this technjque disrupts bacterial endospores it is unJikely that the 
nature of the electric field required to make tills possible will release detectable antigen 
with the systems currently available. 
Initial evaluation of a standard probe sonicator did not demonstrate any enhancement to the 
sensitivity of the detection of B. atrophaeus spores even though results indicated that 
protein was released, suggesting denaturation of the antibody binding site. The fact that 
there was no statistically significant decrease in the total or viable counts suggested that 
this method did not result in breakage of the spores. This supports previous observations 
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by Berger and Marr (1960) where breakage of bacterial spores was reported to require up 
to one hour of sonication using a standard probe sonicator. Therefore, a minisonicator 
produced by Cepheid that had been reported to break B. atrophaeus spores after 30 s 
(Belgrader et al., 1999) was evaluated. However, a significant propot1ion of B. atrophaeus 
spores were only disrupted after 120 s of sonication. This result was supported by the 
analysis of samples by SEM and TEM where the effect on the outer layers of the B. 
atrophaeus spores were not obvious following shorter periods of sonication (5 and 30 s), 
although there was some possible sloughing of the spore coat which was rougher in 
appearane. Sonication for 120 s had a number of effects on the spores, which were not 
observed to be homogeneous throughout any sample. The spore could be completely 
broken open to leave only debris, the outer layers could be stripped off to reveal a 
smoother inner layer, or the spore could remain intact and morphologically indistinct from 
the untreated sample (Figure 2.15f). The reason for the difference in results could be due to 
the use of PCR by Belgrader et al. (1999) to detect DNA as a marker of spore breakage 
following sonication. Whilst the majority of the spore DNA is located within the core, 
association of DNA with the outer surface of the spore has been reported (Johns et al., 
1994; Kuske et al. , 1998). Therefore, the DNA detected may have been released from the 
outer integuments of the spore. If this is not accounted for then incorrect assumptions of 
the success of a disruption technique could be made. In this study a wide range of 
techniques were used to determine the extent of disruption and breakage of the spores. 
TEM analysis of B. anthracis spores after sonication using the Cepheid system showed an 
observable darkening of the spore core compared to the untreated sample. This may be 
either due to heat activation and/or sub-lethal damage of the interior due to the sonication 
process. Darkened spots have been observed in the protoplasts of spores subject to heat and 
irradiation and have been suggested to be due to aggregation of proteins located within the 
core as has been observed in the case of bacterial cells (Moberly et al., 1966;; Zou et al., 
1998; Woo et al., 2000). The fact that this effect was not observed by TEM of spores 
sonicated using the tubular sonicator, where bulk heating effects were maintained at a 
minimal level, suggests that the darkening of the core is probably attributable to heat rather 
than sub-lethal effects of cavitation within the core. 
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Following preliminary ELISA results, the Cepheid minisonicator demonstrated significant 
improvements in the sensitivity of the detection of B. atrophaeus, from undetectable using 
untreated spores to a lowest detectable concentration of 5 x 107 spores/m! using an optical 
biosensor, the resonant mirror. The optimum sonication period for B. atrophaeus spore 
detection was found to be 30 s without cooling (Figure 4.14), but no reduction in viable or 
total counts were observed (Figure 4.9). This would suggest that protein, recognised by the 
antibody, was being sloughed off the spore coat causing the initial increase in assay 
sensitivity. Although a greater extent of protein release was observed after longer 
sonication periods, this may not cause a further increase in assay sensitivity if heat or other 
degradative effects were denaturing the antigen released. The way in which the samples are 
sonicated using the Cepheid system requires the sample to be enclosed within a sealed 
tube. Therefore, it is likely that the build up of heat during the sonication process using the 
Cepheid system is greater than that observed with other methods of sonication (vonn 
Sonntag et al., 1999). The results for B. anthracis showed a 20 fold increase in assay 
sensitivity by resonant mirror immunoassay after sonication at 50% amplitude for 5 s. 
Furthermore, the effect of denaturation of antigen shown by the observed degradation in 
the sensitivity of the resonant mirror immunoassay was observed above 50% amplitude in 
contrast to B. atrophaeus spores where the sensitivity decreased at I 00% amplitude after 
30 s sonication. This is probably due to the antibody used and in particular the 
characteristics, especially thermal stability, of the antigen recognised (Caldarelli and Los 
Rios, 2001). 
The development of the protocol to incorporate one minute cooling phases after each 5 s 
pulse of sonication, demonstrated further improvements in sensitivity compared to a 
sonication protocol with no cooling. The observation of an apparent increase in released 
protein concentration with cooling suggests that heat caused the severe denaturation of 
proteins, possibly leading to aggregation and/or precipitation. Although a large 
improvement in the sensitivity of the detection of both B. atrophaeus and B. anthracis 
spores after sonication using the Cepheid system was observed the heat generated by the 
process appeared to have a limiting effect. This effect increased with increasing power 
amplitude and with extended time periods of sonication. However, the incorporation of 
cooling into the sonication protocol increased the total time period of sonication to 
unacceptably high levels. 
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To address the issue of heat denaturation of antigen, a novel design of a tubular sonicator 
was developed to limit temperature increases during sonication. This would permit the 
development of rapid assays without delays introduced by cooling requirements and allow 
for characterisation of the effects of cavitation excluding the effects of heating of the bulk 
solution. This system allowed for sensitive detection of B. atrophaeus spores, even though 
the concentration of protein released was not significantly increased, from a maximum of 
approximately 70 f!g/ml using the Cepheid system to a maximum of approximately 80 
f.lg/ml with the tubular sonicator. This again supports the observation that heat is one of the 
major degradative effects observed on proteins. An additional advantage of the tubular 
transducer was that the design was readily applicable to a flow through format. Using the 
system in continuous flow did, however, result in an approximate two-fold reduction in 
assay sensitivity by resonant mirror. The reason for this could be due to a slight decrease in 
the residence time within the sonic zone, in comparison to the previous batch system. 
Because heating of the bulk solution was limited using the tubular sonicator it can be 
concluded that sonication only had an effect on the outer integuments of the spore, 
probably due to cavitation events within the suspension media. In the case of B. atrophaeus 
spores some damage to the spore coat was observed. In the case of B. anthracis spores 
complete removal of the exosporium was observed in many of the spores. However, no 
significant breakage of the spores was observed using the conditions tested, in agreement 
with the viable and total count data. Also of note was possible relaxation of the cortex in 
the case of B. atrophaeus, which has been noted before by Celandroni et al (2004) after 
exposure to heat. Although this system was devoid of bulk temperature increases, hot spots 
generated by cavitation are likely to form during treatment. However, the fact that this was 
not observed in B. anthracis spores where the spore coat remained largely intact, suggests 
this effect may be due to removal of the coat and may serve as increased protection for the 
spore once the coat has been removed or partial degradation of the cortex layer. Further 
experiments would be needed to evaluate these hypotheses. Sonication of B. atrophaeus 
spores and B. anthracis spores within the tubular sonicator also appeared to cause a slight 
reduction in the degree of ridging on the spore surface. Again, it could be speculated that 
this effect was due to the stresses that the spore is subject to on exposure to cavitation, 
143 
although in this case the exact nature of the stresses are difficult to define due to the 
multitude of possible effects of each disruption system. However, localised high 
temperatures, removal of spore coat proteins, in particular those important for ridge 
formation, and possibly other forms of damage such as oxidation may have an effect. No 
significant morphological differences were observed in the core of sonicated spore, 
compared to the untreated controls, again suggesting that cavitation events within the core 
are limited or do not occur, probably due to the dehydrated state of this structure. 
To examine the increase in sensitivity of other immunoassay based techniques the tubular 
sonicator was evaluated with Threshold®, in a flow through format, with the use of 
B. anthracis spores. In this instance a - 100 fold improvement was demonstrated after 
sonication. This improved with the addition of detergent to a further 20 fold improvement 
in the sensitivity of the assay. In the case of the lateral flow assays a significant 
improvement in sensitivity (500-fold) was also observed using B. anthracis. Furthermore, 
it was noted, in the course of the experiments, that the time required for the development of 
the assay at high concentrations was considerably lower than that observed with the 
untreated control. The reason for this was probably due to the fact that the sonication 
procedure released proteins, therefore, wicking of antigen down the membrane to the 
antibody was faster than that observed with a whole spore. Thus, not only was the assay 
sensitivity increased but the assay time was reduced. It should be noted that in all of the 
immunoassay formats tested, no non-specific binding, to antibody, of components released 
during sonication was observed. 
As the tubular sonicator did not generate excessive temperature rises, this was used to 
evaluate the effects of sonication on proteins as this system. From the preliminary analysis 
of sonicated proteins by SOS PAGE and there did appear to be some evidence for 
alteration of proteins during sonication. However, it appears that this is not significant 
enough to reduce the assay sensitivity using the resonant mirror. Furthermore, the addition 
of protease inhibitors and anti-oxidants did not improve assay sensitivity, suggesting either 
that; free radicals and proteases were not released or that they did not have a significant 
effect on the antigen released. Results obtained by SOS PAGE suggested that protein 
aggregation and possible precipitation occurred, as suggested by Strathopulos et al. (2004) 
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as additional bands were observed accompanied by a greater proportion of material that did 
not enter the gel matrix. However, no differences were observed in immunoassay 
sensitivity for sonicated proteins. This suggests the effect of ultrasonic cavitation on the 
protein was negligible in the tubular sonicator using the conditions tested. Alternatively, 
there may have been alterations to the protein, but no denaturation of the antibody binding 
sites. These observations could have been due to a number of effects either singularly or in 
combination: (a) cleavage of higher molecular weight proteins; (b) denaturation of protein; 
or (c) oxidation of the proteins. 
The increase of ionic strength can be advantageous for certain detection platforms such as 
the resonant mirror when dextran is employed, as it has been found to decrease the degree 
of non-specific binding and increase assay sensitivity if the protein to be detected has a low 
pi (Dstl, Detection Dept. unpublished data). Within this system the non-ionic detergent 
Tween was added to decrease the degree of non-specific interactions. However, the 
addition of detergent within the sample may have an advantageous or deleterious effect on 
the outcome of sonication, and consequently the sensitivity of subsequent assays. [n 
general the higher the ionic strength of buffer the lower the amount of soluble protein 
released, resulting in lower assay sensitivity. The reason why this occurred is unclear, and 
requires further investigation. The addition of detergent during sonication did improve the 
yield of protein and the immunoassay sensitivity for B. atrophaeu.s and B. anthracis spores. 
The reason for this observed difference could be that the presence of the detergent in the 
liquid medium may enhance the stability of the bubbles formed during cavitation. Thus at 
the point of collapse the bubble is larger and hence a greater amount of energy released. 
Hence, the effects of microstreaming and resultant erosion of the spore surface, is greater. 
Alternatively there may be an increase in the proportion of bubbles acting as nuclei 
increasing the number of cavitation events. The addition of detergents may also stabilise 
proteins during sonication and limit protein aggregation. This occurs as denaturation of the 
protein may expose hydrophobic regions that are usually shielded within the centre of a 
molecule. If the hydrophobic regions of the proteins are exposed they may interact and 
cause aggregation of the protein, and the presence of detergents may limit this effect 
(Caldarelli and Los Rios, 2001). 
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Initial evaluation of the effects of sonication of mixtures of microorganisms by resonant 
mirror analysis suggests that the presence of additional bacteria can cause a slight decrease 
in the assay sensitivity. It has been suggested that higher concentrations of particles may 
protect other particles from any degradative effects of sonication; however, this would 
appear not to be the case. The results here suggest that when higher concentrations of 
bacterial spores were sonicated the release of protein by ultrasonic cavitation was less 
efficient, and the assay sensitivity decreased. This is most likely due to the increased 
viscosity of the sample reducing cavitation events (Khistmatullin, 2004). 
B. atrophaeus was chosen as a model organism to evaluate the range of disruption 
techniques. Furthermore, as this organism is used to evaluate a wide range of detection 
technologies within the field, characterisation of the effects of disruption was required for 
future work. The most significant effects on the differences between B. anthracis were 
observed within the Cepheid system. In this system the amount of protein released was far 
lower than that observed with B. atrophaeus, furthermore the degradation in the resonant 
mirror immunoassay sensitivity was at lower amplitudes of sonication and lower time 
periods. However, in the tubular sonication no degradation in assay sensitivity was 
observed at the increasing time periods tested for B. atrophaeus. This suggests that the 
consequences of sonication, (such as heat, shown to have the most significant effect) had a 
greater influence on the sensitivity of an immunoassay on B. anthracis than B. atrophaeus. 
However, in the case of the tubular system, the results appear comparable. This does 
however highlight the need for caution in the choice of a 'model organism' when 
characterising systems. The choice of antigen -antibody pair will also have an effect 
dependent on the stability of the antigen to the stresses it is subject to during cavitation. 
This highlights the need for careful selection and characterisation of proteins for sensitive 
detection. Proteins released during the disruption process could be identified and 
characterised for high resistance to ultrasonic denaturation so that appropriate recognition 
elements could be produced. Identification of proteins that were released at high 
concentrations and production of suitable recognition elements against these proteins could 
enhance assay sensitivity further. 
In conclusion, although electroporation was shown to release surface located proteins, 
these proteins were subsequently undetectable by immunoassay due to significant 
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denatumtion and/or deposition on the electrodes. For the use of electric fields to be fully 
explored a range of different pulse shapes lengths and field strengths would have to be 
evaluated and may be significantly different for any given organism or protein. The results 
of this work clearly demonstrate that sonication allowed for the sensitive and rapid 
detection of B. atrophaeus and B. anthracis spores, and this was selected as the method of 
choice for further investigations. 
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Chapter 5 Identification of proteins of the Bacillus anthracis spore 
5.1 Introduction 
In B. anthracis and other members of the B. cereus group, the surface of the outer spore 
coat is covered by a loose balloon like structure, termed the exosporium (Ohye and 
Murrell, 1973; DesRosier and Lara, 1984; Driks, 1999), which surrounds, but is not 
attached to, the other spore components (Gerhardt, 1967; DesRosier and Lara, 1984). The 
exosporium has a close-packed hexagonal lattice structure consisting of a paracrystalline 
basal layer and an outer nap of fme filaments (Roth and Williams, 1963; Gerhard and Ribi, 
1964) and is composed of protein, lipid and carbohydrate (Matz et al., 1970; Beaman et al., 
1971). 
Since the exosporium forms the outermost integument between the spore and its external 
environment, antigens located within the exosporium could be useful as targets for 
detection and diagnostic purposes (Steichen et al., 2003). Some studies have suggested that 
the exosporium and components that may not be structural elementsbut associated with 
this outer layer, may be important for a number of functions within the macrophage due to 
the apparent tight interaction of the exosporium with the phagolysosomal membrane that 
has been observed using transmission electron microscopy (Dixon et al., 1999; Guidi-
Rontani et al., 2001). Therefore, identification of exosporia! antigens may also be 
important for the understanding of B. anthracis pathogenesis and the development of 
improved therapeutics in the treatment or prevention of anthrax infection. 
The first structural exosporium protein to be identified in B. anthracis was BclA, a 
collagen-like glyocoprotein consisting of a number of centrally located GXX (usually 
GPT) repeats (Sylvestre et al., 2002). This protein was found to be the primary structural 
component of the filaments of the hairy nap. The exact function of BclA has yet to be 
elucidated. Sylvestre et al. (2002) demonstrated that, although the protein has a clear 
structural role within the exosporium, it is not essential for virulence in a subcutaneous 
model of infection in mice and does not contribute to the resistance of spores to harsh 
chemical treatment. BclA displays considerable size heterogeneity among the different 
Bacillus species and strains; the protein has different numbers of GPT repeats and 
[GPT]sGDTGTT repeats, and it has been hypothesised that these variations could play a 
role in the properties of the spores in different environments (Sylvestre et al., 2003). 
Steichen et al. (2003) demonstrated that BclA was the immunodominant protein within the 
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exosporium of B. anthracis. As such, it was suggested that this protein may represent a 
potential marker for immunoassay based detection and diagnosis of anthrax infection. 
However, the protein is not unique to B. anthracis, since it has also been shown to be 
present in B. cereus and B. thuringiensis (Castanha et al., 2006; Redmond et al., 
unpublished data). 
A number of studies have been conducted to identify further proteins of the B. anthracis 
exosporium and spore coat utilising a range of techniques. These have predominantly 
involved extraction of the spore coat or exosporium fraction, separation of the proteins by 
one-dimensional (10) gel electrophoresis and identification of the proteins by N-terminal 
sequencing or mass-spectrometry (Lai et al., 2003; Steichen et al., 2003; Todd et al., 2003; 
Liu et al., 2004; Redmond et al., 2004). Many of the proteins identified are as yet 
uncharacterised, and their immunogenicity and suitability as markers for detection and 
diagnostic purposes has not been established. Immunogenic proteins are ideal as markers 
for such assays as they will produce an immune response allowing reagents such as 
antibodies to be developed. The production of an immune response to such markers may 
also suggest a role in the infection process. To date, only BclA and the ExsFA protein 
have been identified as both structural and immunogenic proteins of the B. alllhracis 
exosporium (Sylvestre et al., 2002, 2005; Steichen et al., 2003). More recently, work has 
indicated that the ExsF proteins are required for the proper localisation of BclA to the 
spore surface and for the stability of the paracrystalline basal layers of the exosporium 
(Sylvestre et al., 2005). 
Although the exosporium is the outer integument of the B. anthracis spore its role, 
particularly in B. anthracis pathogenesis is still relatively unclear. Furthermore, many of 
the components of the exosporium identified to date have homologues (sharing up to 100% 
identity), particularly within the B. cereus group. Therefore, extension of the range of 
possible targets for detection and diagnostic purpose to moieties located in underlying 
structures such as the spore coat may yield detection targets that are more likely to meet 
the desired criteria of essential function, and being unique (or having unique regions). The 
aim of the work described here was to firstly examine surface labelling of B. anthracis 
spores and subsequently identify potential detection targets located on the outside of the 
spore, the exosporium. Secondly, an immunopurification strategy was developed using a 
polyclonal antibody raised against exosporium of wild type Ames strain and a simple 
liquid phase based separation method to identify other immunogenic proteins of the B. 
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anthracis exosporium. Finally, the use of sonication, using a novel radial transducer, which 
may extend the range of proteins released from the underlying layers, thus increasing the 
number of targets that could be utilised for recognition element production and subsequent 
incorporation into a detection assay. The implementation of computer modelling to the 
proteins released would allow for the identification of unique regions of a given protein to 
allow for the production of specific recognition elements. 
5.2 Results 
5.2.1 Identification of surface located proteins 
Initial experiments for surface labelling were carried out using B. atrophaeus spores as a 
model system and further investigations conducted using the B. anthracis strain UM23Cl2 
(pXOUpXOT), the wildtype Ames strain exosporium and y-irradiated spores. Other 
closely related Bacillus species were also used for comparison. In this work all spores were 
sonicated using the novel radial transducer as described in Chapter 3 (section 3.18.2). 
5.2.1.1 FJTC /abelli11g of spores 
Analysis of the FITC labelled spores showed that the maximum amount of FITC bound to 
B. atrophaeus spores was achieved using 200 Jlg/ml ofFITC (analysing the absorbance of 
sample at 501 nm). This also produced no background within the sample as observed by 
fluorescence microscopy (data not shown). Following sonication of the spores the proteins 
released were separated from the spores and concentrated. These proteins were then 
separated by SDS-PAGE on a 4-12% Bis-Tris gel (Invitrogen) and the fluorescently 
labelled proteins visualised. A fluorescently labelled polyclonal anti-B. atrophaeus 
antibody was used as the control . No bands were observed in any of the sonicated spore 
samples (Figure 5.1). However, the presence of a band in the antibody control lane 
suggests that the FITC was at a high enough concentration for visualisation using this 
method. 
!50 
ABC DE FGHI J 
Figure 5.1 Visualisation of FITC-labeUed proteins by SDS-PAGE. Samples 
were separated by SDS-PAGE on a 4-12% Bis-Tris gel (lnvitrogen). A) Reducing 
sample buffer, B) Reducing sample buffer, C) B. atrophaeus supernatant 
unconcentrated, D) B. atrophaeus supernatant concentrated xlO, E) B. 
atrophaeus supernatant concentrated x20, F) B. atrophaues supernatant 
concentrated x50, G) No FITC label control H) FITC-labelled antibody, I) 
Reducing sample buffer, J) Reducing sample buffer. 
5.2.1.2 Biotinylation of spores 
The optimum time period for biotinylation of B. atrophaeus spores was 16 h. No proteins 
were observed in the absence of btioinylation (data not shown), suggesting that the 
streptavidin conjugate was not binding non-specifically to any of the proteins released. 
The biotinylation of B. anthracis UM23Cl2 spore proteins and subsequent visualisation 
using SDS-PAGE and Western blotting techniques showed that a range of proteins were 
released (Figure 5.2). The predominant biotinylated proteins within the UM23Cl2 samples 
appeared to migrate at approximately 97 kDa. A fainter band was also observed at 
approximately 85 kDa. The other bands were significantly fainter, with 'smearing' down 
the gel thought to be indicative of either a significant proportion of glycosylated material 
within the surface proteins, an artefact of the sonication process, variability in the degree of 
biotinylation of each protein, or degradation of the proteins. 
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Figure 5.2 Detection of biotinylated spore proteins from B. anthracis 
UM23CI2 spores. Samples were separated by SDS-PAGE on 4-12% Bis-Tris 
gels and blotted onto PVDF membranes. The amount of protein loaded in each 
lane was approximately 5 ~g. Lane loading was as follows A) Biotinylated B. 
anthracis UM23Cl2, B) Unsonicated, biotinylated B. anthracis UM23Cl2 spores, 
C) MagicMark™ Western Standard (Invitrogen). 
Nano-LC mass spectrometry of in-gel digested samples failed to identify the proteins with 
the exception of Extracellular antigen 1 (EA 1 ). The only other protein identification was a 
biotin-avidin complex. 
5.2.2 Identification of immunogenic proteins 
This method made use of available antibodies raised against B. anthracis spores. A range 
of antibody immobilisation strategies was investigated. Non-directed covalent coupling of 
antibody to a column did not yield sufficient protein for identification, probably due to the 
inefficiency of antibody immobilisation to the column, so beads were used to increase the 
available area for binding. These also provided the added advantage of the introduction of 
a concentration step by elution into a reduced volume compared to the original sample 
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volume. Since this method still yielded insufficient concentration of protein, a directed 
attachment approach was adopted. This involved the use of anti-species magnetic beads 
and an anti-exosporium antibody. Exosporium proteins which bound to the beads coated 
with polyclonal rabbit anti-exosporium antibody were eluted and separated by SDS-PAGE 
(Figure 5.3, lane A). The bands at approximately 22 and 45 kDa appeared to correspond to 
the anti-exosporium antibody eluting from the beads, as can be seen from the anti-
exosporium antibody only control (Lane E, Figure 5.3). Four bands at 110, 55, 50 and 20 
kDa and were present in the bead only control sample (Lane D, Figure 5.3). This may have 
been due to the polyclonal anti-species antibody eluting from the beads. A number of the 
eluted proteins, that were not present in the control samples, were selected from Lane A 
(Figure 5.3) and were identified by nano-LC-mass spectrometry and are listed in Table 3.2. 
No bands corresponding to eluted exosporium proteins were observed in the control 
samples, only the presence of antibody (Figure 5.3, lanes B and E). The incorporation of 
BSA and non-ionic detergent into the wash and incubation steps also appeared important in 
the elimination of non-specific binding of protein to the DYNAL beads (data not shown). 
In order to ensure that the individual proteins that were identified were immunogenic and 
not simply eo-eluted with the immunodominant glycoprotein Bc!A, Western blot analysis 
of the original antigen and the exosporium proteins, which bound to the anti-exosporium 
antibody, was conducted using the polyclonal anti-exosporium antibody used to isolate 
(immunopurify) the proteins. Firstly, the polyclonal anti-exosporium antibody was 
biotinylated and this was used to probe a Western blot onto which the proteins eluted from 
the DYNAL beads were transferred, following separation by SDS-PAGE. To probe the 
proteins a biotinylated anti-exosporium antibody was used as the primary antibody and a 
sreptavidin peroxidase conjugate was used as the secondary detection reagent. This would 
reveal proteins recognised by the antibody, but would not show detect any antibody eluted 
during elution from the DYNAL beads .. A number of proteins were observed, in particular 
a high molecular weight protein of approximate! 250 kDa which may correspond to Be lA 
(Figure 5.4a.). To determine if any additional proteins were present a polyclonal rabbit 
anti-exosporium antibody was used to probe the blot and an anti-rabbit HRP conjugate 
used as the secondary antibody. Again, a number of proteins were observed, and in 
contrast to the negative controls a number of lower molecular weight proteins were also 
shown (Figure 5.4b). These proteins can also be observed as faint bands in the exosporium 
positive sample on the gel (lane A, Figure 5.3. This was of relevance as proteins such as 
ExsF, ExsY and CotY have been shown to associate with Bc!A to form large molecular 
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weight complexes (Redmond et al., 2004; Sylvestre et al., 2005). The results shown in 
Figure 5.4 confirmed the imrnunogenic nature of the proteins identified in each band . 
.. 205 kDa 
116 kDa 
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66 kDa 
55 kDa 
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Figure 5.3 The elution of exosporium proteins from DYNAL anti-rabbit 
beads with polyclonal rabbit anti-Ames exosporium antibody bound to the 
anti-rabbit antibody. 20 J.!l of each eluted protein, 1 J..l.g of antibody and 5 J..l.g of 
unwashed wild type Ames exosporium were separated by SDS-PAGE on a 4-12% 
Bis-Tris gel (Invitrogen). Lane loading was as follows: (A) Anti-exosporium 
antibody +ve, exosporium +ve; (B) Anti-exosporium antibody +ve, exosporium -
ve; (C & D) Anti-exosporium antibody -ve, exosporium +ve; (E) Anti-exosporiwn 
antibody only; (F) Unwashed wild type Ames exosporium only; (G) Sigma wide 
range molecular weight marker. The gel was stained with Colloidal Blue Stain 
(Invitrogen). The bands in lane A, indicated by arrows were analysed by nano-LC 
mass spectrometry, 
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Protein Apparent Predicted Predicted Peptide sequences Protein sequence Previously identified 
identification Molecular pi 
Mass 
BA2554 5, 9, 14, 15, 8.16 lTTGSNNY AGTVSSVTCDVVK Band 1, 2, 3, 4, Sand 6 Uu et al., 2004; 
Hypothetical protein 38,250 MGSRYSNSRKKCSCKQCSCKQDDCvrDVFEECKKEHEEQNKACDCCCVQGlltDELRKLVNRSYrUI Rcdmond et al., 2004 
ExsK TQSNNY f>,QTVSSVTCDVVKLANSAGVVTVIISVCKIEAIEALL T 
BA1234 5, 9, 14, 15, 16.1 4.99 AGAPFEAFAPSANLTSCR Band 1, 2, 3, 4, 5, and 6 Liu et al., 2004; 
ExsY 38,250 VESVDDDSCA VLR MSCNENKHHGSSHCVVDVVKFINELQDCSTTTCGSGCEIIPFLGAHNTASVANTRPFILYTKAQAPFE Redmond et al., 2004 
AFAPSANLTSCRSPIFRVESyPDDSCA VLRVLSVVLGDSSPVPPTDDPICTFLA VPNARL VSTSTCITV 
DLSCFCAI CLRDVTI 
BA1238 38, 15, 14, 9, 16.8 4.73 AGAPFEAFAPSANLTSCR Band 2, 3, 4, 5, 6, Uu et a/., 2004; 
CotY 5 VESIDDDDSCA VLR MSCNCNEDHHHHDCDFNCVSNVVRFIHELQECA TTTCGSGCEVPFLGAHNSASV ANTRPFlL YTKf>, Redmond et al., 2004 
GAPFEAFAPSANL TSCRSPIFRVESIDDDDCAVLRVLSVVLGDTSPVPPTDDPICTFLA VPNARLISTN 
TCL TVDLSCFCAIQCLRDVTI 
BA0252 38 43.6 5.68 AGITAPJLVLGPSPPR Band2 Popham et al., 1996; Liu 
Alanine racemase FQGITFNAVR MEEAPFYRDTWVEVDLDA~~FIPSDVEIFAVVKGNAYGHDYVPVAKIALEAGATRLAV et al., 2004; Redmond et 
GDGISYNVTYR AFLDEALVLRRf>,QIT AP!L VLQPSPPRDINV AAENDV AL TVFQKEWVDEAIKL WDGSSTKYHINFDS al., 2004; Steichen et al., 
LQGFEVLVNGK GMGRIGIRERKELKGFLKSLEGAPFLELEGVYTHF A TADEVETSYFDKQYNTFLEQLSWLKEFGVDP 2003; Todd et al., 2003 
KFVHTANSAA TLRFOQITFNA VRIGIAMYGLSPSVEIRPFLPFKLEP ALSLHTKV AHIKQVIKQJ2Q!SY 
.!::!YIYRTKTEEWIA TV AIGY ADG~KRVPIVGRVTMDQFMIHLPCEVPLGTKVTL 
-
IGRQGDEYISA TEV AEYSGTINYEIITTISFRVPRIFlRNGKVVEVINYLNDI 
V. BA0355 CotB IS, 14, 5 19.4 S.4 DUGSFVR Band 3, 4 and 6 Lai et al., 2003; V. 
homologue GTllSVCPDYFVLQNEK MSLFHCDFLKDUQSFVRVNRGGPESQRGTIISVCPDYFVLONEKGELYYYQLSHLKSITKSAKECGS Rcdmond et al., 2004 
CotBl GEL YYYQLSHLK SDCEWEDCACAEDFEALLESFKYCWVKINRGGPEKVEGILQDVSCDFVTLIVKEEilL!AIKHIKSVNY 
NALACGESDESDDSSSKESSNNSGRARAQRQSSRGR 
Second CotB IS 16.8 6.6 VGELVSLGK EX)OOCXLENVLCCDQIKCLVGETVKVNLRGPESRVGELVSLQKQYLTLQLPHQELYYYOLKHVKS Not identified previously 
homolgue' DYLTLQLPHGEL VYYQLK L VKKVKESKCGDCYSSCFCSDEDTFLDILKDLKYKWVKINRGGPECMDGLLSEVHHGCITL VNCDE 
CotB2 VIYVINSHIK.SVSQVVKCKKNEDE 
BA2332 15 and 14 14.4 S.36 NEVPPVETDAR Band 3 and4 Rcdmond et al .. 2004 
Hypothetical protein MFF AKLRGRNEVPPVETDARGEAFFKLSRDELSLKFKLDLFDIEDVV AAHLHIGAKGTNGPVV AFLF 
ExsM GPITNPVSIECA TL TGMITQEDLVGPLAGQTLGTUNEIISGNNINVHTVQHPNGEIRQQLNYC 
BA 1237 BxpB/ 15and 14 17.3 427 FFLSLGTP ANIIPGSGTA VR Band 3 and 4 liu et al., 2004; 
ExsF/ ExsFA MFSSDCEFTKIDCEAKP ASTLPAFGFAFNASAPQF ASLFTPLLLPSVSPNPNITVVPVINDTVSVGDGIR Redmond et al., 2004; 
ILRAGIYQISYTL TISLDNSPV APEAGRfFLSLQTP ANIIPGSQTA VRSNVIGTGEVDVSSGVILINLNPG Steichcn et al., 2003; 
DURIVPVELIGTVDIRAAAL TV AQIS Sylvcstre et al., 2005; 
Todd et al .. 2003 
BA4266 !Sand 14 13.4 6.97 NTFTGILR Band 3 and 4 Kim et al., 2004; Uu et 
HypothetiClll protein MFGSFGCCDNFRDCHHHERERDHREKEREVKPQQPA VCNVLASISVGTELSLLSVKGVGSFNNVIFE al., 2004 
Cot~ha GFCNGV ALFSALARNNNDKDNKDNNKDDKHNQNRNTFTQI!.,RVCPTDIV AlAl 
Table 5.1. lmmunogenic proteins identified from unwashed B. anthracis wild type Ames exosporium using a polyclonal rabbit anti-exosporium 
antibody12 The peptide sequences were used to identify the B. anthracis protein from the B. anthracis Ames genome at NCBI (NC_003997). 
1 The bands of the gel refer to the following molecular weights; Band 1 - 250 kDa, Band 2 - 38 kDa, Band 3 - 15 kDa, Band 4- 14 kDa, Band 5-9 kDa, Band 6- 5kDa. 2 The second CotB homo!gue is degenerate in B. anthracis 
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Figure 5.4 Confirmation of the immunogenic nature of bound proteins. 
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The detection of bound antibody was conducted using; a) biotinylated polyclonal rabbit anti-exosporium detected by streptavidin HRP conjugate 
and b) polyclonal rabbit anti-exosporium detected by goat anti-rabbit HRP conjugate. 10 J..i.l of each eluate was run per lane by SDS-PAGE on a 4-
12% Bis-Tris NuPAGE gels (Invitrogen) and blotted onto a nitrocellulose membrane (Invitrogen). Lane loading was as follows: (A) Anti-
exosporium antibody +ve, exosporium +ve; (B) Anti-exosporium antibody Ab +ve, exosporium -ve; (C) Anti-exosporium antibody -ve, 
exosporium +ve; (D) Anti-exosporium antibodyy only; (E) Sample buffer; (F) MagicMark™ western standard. 
5.2.2.1 lmmunoge11ic proteins of the B. a11tllracis exosporium 
The band at 250 kDa (Fig 5.3 Band 1), contained sequences that correspond to 
previously described exosporium proteins; ExsK and ExsY (Redmond et al., 2004; Liu 
et al., 2004). Sequences derived from these proteins and an additional protein CotY 
were also identified in bands at 40, 15, 14, 9 and 5 kDa (Figure 5.3, bands 2, 3, 4, 5, 6 
respectively). 
Peptides from ExsK, ExsY and CotY were detected in the band at approximately 40 
kDa (Figure 5.3, band 2) may suggest the formation of another multimeric complex, 
which like the complex formed between Bc!A and ExsY and CotY, may be resitant to 
denaturing SDS-PAGE (Redmond et al., 2004). Alanine racemase was also identified 
in Band 2 (Figure 3.5) having an apparent molecular weight of 40 kDa, close to its 
predicted molecular weight (43.6). However, results here may indicate some form of 
interaction of alanine racemase with ExsK, ExsK and CotY. BLAST searches revealed 
ExsY and CotY have homologues with 100% and 97% identity to proteins in B. cereus 
E33L and B. thuringiensis serovar konkukian str. 97-27 respectively. ExsK has 
homologues that have up to 98% identity within B. cereus E33L, Alanine racemase 
has up to 99% identity with other members of the B. cereus group 
ExsF was identified in bands 3 and 4 giving an apparent molecular weight of 14 and 
15, compared to the predicted molecular weight of 17.3 kDa, this disparity could be a 
result of partial degradation, processing or more realistically a discrepancy due to the 
use of a gel electrophoresis to determine the molecular weight of the proteins and has 
been observed previously (Redmond et al., 2004). As with alanine racemase, protein 
homologues sharing 99% identify, are present in the genomes of closely related 
Bacillus species. 
Peptides derived from a CotB homologue (BA0355), were identified in bands 3, 4 and 
6. Furthermore the presence of the peptides VGELVSLGK and 
DYLTLQLPHGELVYYQLK in a band at 15 kDa appear to be derived from a second 
CotB homologue. Using the protein sequences suggested for CotB 1 and CotB2 it was 
found that protein homologues are present in other members of the B. cereus group 
sharing up to 97% identity with both proteins. 
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Bands 3 and 4 (15 and 14 kDa respectively) contained the peptide sequence 
NEVPPVETDAR that correspond to B. anthracis Ames protein BA2332. These bands 
also contained the sequence NTFTGJLR derived from BA4266, a Cot alpha 
homologue (Kim et al., 2004). The genomes of closely related Bacillus species 
possess proteins with up to 100% identity to BA4266. 
5.2.3 Identification of other proteins of the B. at~t!lracis spore 
5.1.3.1 Direct pepsi11 digestio11 a11d ide11tijicatio11 of protei11s of tile B. a11tlrracis 
spore 
Following sonication, and pepsin digestion and analysis of the resultant supematant, a 
range of proteins were identi tied from the B. anthracis spores (Table 5.1 ). The 
majority of the proteins identified have been described previously from experimental 
studies of the B. anthracis spore with the exception of the B. cereus ExsA homologue. 
BLAST searches of sequences revealed that the majority of protein demonstrated high 
percentages of identity (up to 100%) with homologous proteins within the B. cereus 
group. Therefore, these proteins would be unsuitable for examination as potential 
targets for a specific detection assay. However, three proteins BxpA and ExsA and 
EAl were of interest due to the lower degree of identity shared, 91%, and 93% 
respectively with homologous proteins that could be exploited for the production of 
specific recognition elements. 
5.1.3.1 /11-gel digestio11 of samples 
The sonication of spores demonstrated the release of a wide range of proteins from 
Bacillus species spores. Using SDS PAGE, alanine racemase and EAl were the first 
markers to be identified on the basis of the molecular weight and this was confirmed 
by mass spectrometry analysis. Further in gel digestion of proteins, released by 
sonication and subsequently resolved by SDS PAGE identified additional proteins of 
the B. anthracis spore (Table 5.2). As with the direct digestion of the proteins released 
from spores by sonic disruption, some of the proteins have been reported previously in 
specific studies of the B. anthracis exosporium. A small number of proteins have not 
been previously identified in the B. anthracis spore; these are a putative lipoprotein 
(BA2041), hypothetical proteins (BA1021, BA5144), an adhesion lipoprotein 
(BA3189), a menaquinol-cytochrome c reductase, iron-sulfur subunit (BA1544) and 
an alkyl hydroperoxide subunit C (BA0345). 
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\0 
Gene 
Identification 
BA3594 
BA4758 
BA1531 
BA4499 
BA5636 
BA4659 
BA1987 
BA2292 
BA4898 
Protein 
CspB Cold shock 
protein B 
Thioredoxin 
ON A-binding protein 
HU 
Superoxide dismutase 
Phosphate 
acetyltransferase 
Spo YID dependent coat 
assembly factor 
SafA/ExsA 
SASP 
Hypothetical protein 
SASP B sspb 
Peptide sequences 
IEVEGGED 
FKTLEEGQE 
MQNGKVKWFNSEKGFG 
SAIQGEGFKTLEEGQEVTF 
GEKVKVVKVDVDENQETARQ 
FVLKDGKVVDQALGYKPKEAL 
Comments 
CspB BA1629 identified from unwashed exosporium (Redmond et al., 2004). Identified in the 
soluble fraction of B. anthracis spores (Liu et al., 2004) 
Identified in the soluble fraction of B. anthracis spores (Liu et al., 2004) 
IGFGNF V AEASSLSKKDATKA VD Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 
IEIAASKVPAFKPGKALK 2004). B. subtilis homologue Hsb is a coat protein (Lai et al., 2003) 
AKHELPNLPY AY 
EVTSTPNQDSPLTEGKTPVI 
FITVKEKVQGKGIS 
EAGNIGYKIAQRLGNF 
MKIHIVQKGDTL-
DTLKQTNTQLSNPDLIM 
MKIHIVQKGDTL~YG2 
AQEFG 
AALDQM 
SVGGEITKR 
AEQQLGGGYTR 
IL VNGQKVIKNISF 
VQGKKYRIDIVPVGNETPI 
AQEFG 
KLAVPGAE 
SVGGEITKR 
AEQQLGGFQK 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 
2004). Superoxide dismutase BA1489, reported as exopsorium protein (Steichen et al., 2005) 
Present in the soluble and insoluble fraction of B. anthracis spores and induced in the final stage 
of sporulation ("wave 5", Liu et al., 2004) 
ExsA identified in the B. cereus exosporium (Bailey-Smith et al. , 2005) 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores (Liu et al. , 
2004) 
Present in the soluble and exosporium fraction of B. anthracis spores and identified as an 
exosporium protein (Liu et al., 2004) 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores (Liu et al., 
2004). Identified as a spore coat protein (Lai et al. , 2003) 
Table 5.2 1•2Proteins identified from pepsin digests of sonicated spore supernatants. 
'The peptide sequences were used to identify the B. anthracis protein from the B. anthracis Ames genome at NCBI (NC_003997). 2 The peptide sequences identified were not present in B. 
anthracis Ames strain proteins, but were identified from B. anthracis Steme (NC _ 005945) 
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"' 0 
Gene 
Identification 
BA3920 
BA3127 
BA2013 
BA4268 
BA4182 
BA2162 
BA0267 
BA3129 
BA5580 
Protein 
Hypothetical protein 
SASP 
General stress protein 
dpS 
Phosphocarrier protein 
HPrptsH-1 
Pyruvate dehyrogenase 
PdhC 
Hypothetical protein 
GroEL 
Hypothetical protein 
Fructose biphosphate 
aldolase Fba-2 
Table 5.2 continued 
Peptide sequences 
~VADEQEQHT~ 
RLEQAQGKGLDGGAVSDMA 
GERLEQAQGKGLDGGAVSDMA 
EQAQGKGLDGGAVSDMA 
AQEFG 
SVGGEITKR 
AEQQLGGGVTR 
FTLHEKFEEF 
YLATSSVNEGTSKESAEE 
MEKIFKVTSDSGlliARP A TL 
VVE~SPVKGKVLLEVL 
GIGRIAEKPVVKNGEIV A 
~TDKGLLVPVVKDTD 
LVGKGFNPTIAHY 
RALEEPVRQ 
LETGIVDPAKVTRSALQN 
A VVV ADKPEPNAPAMPDMG 
FGQFHMKKAQAGVTL 
~TGDEDLKKFLEGL 
G~SGNPQNEPLHYGEVF 
LRLSKKKGWVVPPPLHVR 
LAAQGAIASHQVF 
KEMLNKALEGKYAVGQF 
IDASHHPFEENVVETTKQVVE 
Comments 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores and induced 
in the final stage of sporulation ("wave 5", Liu et al., 2004 ). 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores (Liu et al., 
2004). Identified in the spore coat but suggested it was unlikely to be a spore coat protein (Lai et al., 
2003) 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores (Liu et al., 
2004). 
Identified in the exosporium and soluble fractions of B. anthracis spores (Liu et al., 2004) 
Isolated from the exosporium and soluble and insoluble fraction of B. anthracis spores and induced 
in the final stage of sporulation ("wave 5" Liu et al., 2004). 
Exosporium protein denoted 'BxpA' (Steichen et al., 2003) 
Identified in unwashed exosporium (Redmond et al., 2004). B. cereus GroEL removed by salt 
washing (Charlton et al., 1999; Todd et al., 2003). Isolated from the exosporium, soluble and 
insoluble fractions of B. anthracis spores (Liu et al., 2004). Isolated from spore coat fractions (Lai et 
al., 2003). Component of the B. anthracis UK anthrax vaccine (Whiting et al., 2004) 
Present in the soluble fraction of B. anthracis spores and induced in the final stage of sporulation 
("wave 5" Liu et al., 2004) 
Identified in the exosporium, soluble and insoluble fractions of B. anthracis spores (Liu et al., 2004 ). 
Fba-1 component of the B. anthracis UK anthrax vaccine (Whiting et al., 2004) 
Gene Protein 
Identification 
BA4539 DnaK 
BA0108 Elongation factor Tu 
BA0887 EAl 
;: Table 5.2 continued 
-
Peptide sequences 
PFISAAGAAGPLHLEL 
IIQLPEGTE 
FRKLLDQAQAGDNlGAL 
ALDADNDGVVNYGSKLSGKD 
NAGDVKLGDVTVSQTSDSAL 
Comments 
Identified in the exosporium, soluble and insoluble fractions of B. anthracis spores (Liu et al., 2004) 
Identified in unwashed exosporium (Redmond et al., 2004). Identified in the exosporium, soluble 
and insoluble fractions of B. anthracis spores and identified as an exosporium protein (Liu et al., 
2004). 
Identified in washed and unwashed exosporium (Redmond et al., 2004). Isolated from the 
exosporium fraction (Liu et al., 2004). Isolated from spore coat fractions (Lai et al., 2003) 
0\ 
N 
Gene 
Identification 
BA2041 
BA3668 
BA5364 
BA0108 
BA2075 
BA3964 
BA5363 
BA1021 
BA3446 
Protein 
Oligopeptide ABC 
transporter, 
oligopeptide-binding 
protein, putative 
Glycosyl hydrolase 
family 18 
Enolase 
Translation 
elongation factor, Tu 
SPFH domain/band 7 
family protein 
Translation 
elongation factor, Ts 
Phosphate 
acetyl transferase 
Hypothetical protein 
Oxidoreductase, 
aldolketo reductase 
famil 
Peptide sequences 
AFVNAMEGL YR 
ETSTGVNLYDSDQADR 
VILSSEFVDK 
G~NDGSLPAYFLVPEK 
ILIGQDAAISPTYQQSTA YLEKPYVK 
Comments 
Not identified by previous proteomics studies. Gene induced in "wave 2" of sporulation (Liu et al., 2004) 
LL VENFTITK SleL ortholgue Isolated from the exosporium and insoluble fraction of B. anthracis spores and identified 
FITNILQT AEK as an exosporium protein (Liu et al., 2004 ). Homologue of the B. subtilis spore coat protein Y aaH (Lai et 
ISQTYNVPLASLAK al., 2003). 
GNNYYVQPGDSL YR 
A VESIA YLQPSTIPIK 
VQLVGDDLFVTNTQK 
AIVPSGASTGEHEAVELR 
LLDQAQAGDNIGALLR 
ALQGEADWEAK 
TTLTAAITTVLAK 
VM(Ox)QPGLNLLIPIVDR 
DV AMlllAA VNPK 
TDADAFGA YLHMGGR 
IGVLTVLEGSTDEAAAK 
GISIVLPEGTDER 
LDALPDAIIK 
FIGHLLDPSER 
LPGQNNFPLLVDHTSR 
VEEGPELVEAIK 
WDLQNGVITIPK 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004). 
Anthrax spore protein reactive with human sera (Kudva et al., 2005). B. subtilis enolase associated with 
wild type spores (Kuwana et al., 2002). Immunoreactive component of the B. anthracis UK anthrax 
vaccine (Whiting et al., 2004 ).Adjacent and near neighbours all found in the exosporium, soluble and 
insoluble fractions BA5365, 5367, 5369, 5376 Liu et al., 2004) 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004). 
Isolated from the soluble and insoluble fraction of B. anthracis spores. Gene located near alanine 
racemase BA2979, 2068 stage Il sporulation protein similar to stomatin-like protein. The gene is induced 
in the final stages of sporulation ("wave 5", Liu et al., 2004). 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004). 
Identified from unwashed exosporium (Redmond et al., 2004) 
Present in the soluble and insoluble fraction of B. anthracis spores and induced in the final stage of 
sporulation ("wave 5", Liu et al., 2004) 
Not identified by proteomics studies, induced in "wave 4" of sporulation (Liu et al., 2004) 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004 ). 
79% identity to B. subtilis YtbE 
Table 5.3. Proteins identified from in-gel digestion of sonicated spore supernatants. 1 
1The peptide sequences were used to identify the B. anthracis protein from the B. anthracis Ames genome at NCBI (NC _ 003997). 2 Two possibilities for protein identification. 
Gene Protein 
Identification 
BA0345 Alkyl hydroperoxide 
reductase subunit C 
BA0106 30S nbosomal protein 
S7 
BA5641 Hypothetical protein 
BA12342 ExsY (Spore coat 
protein Z-1) 
BA12382 CotY (Spore coat 
protein Z-2) 
- BA4266 Hypothetical protein 0\ 
'-' {Spore coat protein 
alpha, cot-alpha) 
BA1531 DNA binding protein 
HU 
BA0251 Putative lipoprotein 
BA3189 Adhesion lipoprotein 
BA5144 Hypothetical 
membrane spanning 
protein 
Table 5.3 continued 
Peptide sequences 
IEYIMIGDPTR 
LANEILDAANNAGASVK 
QATVVMTYER 
GSSLGTQSYTGIIEAAGR 
AGAPFEAFAPSANLTSCR 
AGAPFEAFAPSANLTSCR 
NTFTGILR 
VCPTDIV AIAI 
:MFGSFGCCDNFR 
VQLIGFGNFEVR 
NEEGVFVL TP ALNK 
VSEGVEANLETK 
NADNYVAELQK 
ETNVPIAGTIFTDSLGK 
NCGATDGVLAF~FLNSK 
Comments 
Not identified from proteomics studies (Liu et al., 2004). 79% homology to B. subtilis AhpC 
Identified from the soluble and insoluble fraction of B. anthracis spores 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores and identified as an 
exosporium protein (Liu et al., 2004). 79% identity to B. subtilis spore coat protein YwdL (GerQ) 
Identified in the exosporium, soluble and insoluble fractions of the B. anthracis spore and identified as an 
exosporium protein (Liu et al., 2004). Identified from spore coat fractions (Lai et al., 2003). Isolated 
from washed and unwashed exosporium, denoted 'ExsY' (Redmond et al., 2004) 
Identified in the exosporium, soluble and insoluble fractions of the B. anthracis spore and identified as an 
exosporium protein (Liu et al., 2004). Identified from spore coat fractions (Lai et al., 2003), denoted 
'CotY' (Redmond et al., 2004) 
Identified in the exosporium, soluble and insoluble fractions of the B. anthracis spore identified as an 
exosporium protein (Liu et al., 2004) Spore coat protein (Kim et al., 2004) 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004). B. 
subtilis homologue Hsb is a coat protein (Lai et al., 2003) 
Isolated from the exosporium fraction of B. anthracis spores (Liu et al., 2004). 55% identity to YdcC a 
spore coat protein identified by Kuwana et al., 2002) 
Not identified by previous proteomics studies (Gene induced in "wave 4" of sporulation, Liu et al., 
2004). 
Not identified from proteomics studies gene induced in the final stages of sporulation ("wave 5" Liu et al., 
2004). 
Gene Protein 
Identification 
BA0640 Amino Acid ABC 
transporter 
BA1544 Menaquinol-
cytochrome c 
reductase, iron-
sulphur subunit 
BA5547 A TP synthase subunit 
B 
BA0557 SPFH domain/band 7 
family protein 
BA5548 A TP synthase subunit 
~ c 
BA4154 cytochrome c 
oxidase, subunit 11 
BA0715 phosphate ABC 
BA5547 
Table 5.3 continued. 
Peptide sequences 
NPSTGQVEGFDVDV AK 
EVDFADVVFK 
IFTDEPYGIA VQK 
GTPPLAPLDVYESK 
VEAQELIER 
ADADLSYELQQAK 
AEPLSLLNYK 
IQEW ASIAQGSK 
IVTSSQDL VIPTTGK 
VDNLTVQQVQDIFTGK 
TV AMMSSTDGL VR 
VFNVLDAIDLDGEVP ADVR 
QAPAFEELSTK 
VEILETGIK 
VVDLLAPYIK 
FTQAGSEVSALLGR 
ALSPEIVGEEHYEV AR 
YDDLPEDAFR 
L VGGIEEVIENAK 
Comments 
Isolated from the exosporium fraction of B. anthracis spores (Liu et al., 2004) Homologue of B. subtilis 
spore coat protein Y ckK, Lai et al., 2003 
Not identified from proteomics studies (Liu et al., 2004) 
Isolated from the soluble and insolube fractions of the B. anthracis spore (Liu et al., 2004). 85% identity 
to B. subtilis AtpD 
Identified from the soluble fraction of the B. anthracis spore (Liu et al., 2004). 63% identity to B subtilis 
YuaG 
Isolated from the soluble and insoluble fractions of the B. anthracis spore (liu et al., 2004) 
Identified from the exosporium soluble and insoluble fractions of B. anthracis spores (Liu et al., 2004). 
53% identify to B. subtilis CtaC 
Not identified by previous proteomics studies. Gene induced in "wave 3" of sporulation (Liu et al., 2004). 
44% identity to B subtilis PstS 
Identified from the exosporium, soluble and insoluble fractions of the B. anthracis spore (Liu et al., 2004) 
Gene Protein 
Identification 
BA4229 maltosaccharide ABC 
transponer, 
maltosaccharide-
binding protein, 
BA0887 
BA0267 
~ BA5550 
utative 
EAI 
GroEL 
A TP synthase F I, 
delta subunit 
Table 5.3 continued. 
Peptide sequences 
FTDSSIEAQTYNGK 
GITGESGGPAADGLFNEGK 
GAITGKPDGTYGPTESIDR 
ILNLPVDENAQPSFK 
DF ALNSQNL VVGEK 
VYSDPENLEGYEVESK 
Comments 
Isolated from the exosporium, soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004 ). 50% 
identity to B. subtilis YvfK 
Identified in washed and unwashed exosporium (Redmond et al., 2004) amounts varied. Isolated from the 
exosporium fraction (Liu et al., 2004). Identified from spore coat fraction (Lai et al., 2003). Reponed to 
be a 'persistent' contaminant (Steichen et al., 2004) 
FGSPLITNDGVTIAK Identified in unwashed exosporium (Redmond et al., 2004). B. cereus GroEL removed by salt washing 
FGSPLITNDGVTIAK A VV A VEELK (Charlton et al., 1999; Todd et al., 2003). Isolated from the exosporium, soluble and insoluble fractions of 
VGNDGVITLEESK B. anthracis spores (Liu et al., 2004) 
ENTTVVEGVGSSTEQIEAR 
NVVDEDLLGGIK Isolated from the soluble and insoluble fraction of B. anthracis spores (Liu et al., 2004), 47% identity to 
B. subtilis AtpH 
Two dimensional (20) electrophoresis was conducted on samples in order to identify a 
larger number of proteins; however this was difficult due to the low concentrations of the 
proteins released. Although confident identification of the proteins released and resolved 
by 20-SDS PAGE was not possible, of note is the large number of acidic proteins. 
Furthermore, in comparison to a closely related Bacillus cereus strain NTCC 11143 a 
significant proportion of these proteins were not present suggesting differences in the 
proteins expressed by these two organisms (Figures 5.5-5.6). 
5.2.4 EAI as a detection target 
As shown in Figure 5.7, the sonication of B. anthracis (UM23Cl2 and SM9l, an EA! 
deletion mutant) spores and subsequent visualisation using SOS-PAGE showed that a wide 
range proteins of similar sized proteins were released although a number of lower 
molecular weight species were more predominant within SM91. As a further method of 
identifying proteins exposed on the spore surface, UM23Cl2 and SM91 spores were 
biotinylated and the proteins released after sonication were bound to and eluted from 
streptavidin coated beads. Analysis of biotinylated proteins by western blot revealed the 
presence of an approximately 97 kDa species identified as EAt by nano LC-MS/MS. 
Attempts to identify the low molecular weight proteins in SM91 have been unsuccessful. 
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Increasing pi 
a) 
Increasing pi 
b) 
205 kDa 
116 kDa 
97 kDa 
R4 kDa 
66 kDa 
55 kDa 
45 kDa 
36 kDa 
29kDa 
24kDa 
20kDa 
14.2 kDa 
6.5 kDa 
205 kDa 
116 kDa 
97 kDa 
84 kDa 
66 kDa 
55 kDa 
45kDa 
36 kDa 
29kDa 
24 kDa 
20kDa 
14.2 kDa 
6.5 kDa 
Figure 5.5 Analysis of a) B. a11tllracis UM23Cl2 and b) B. cereus 11143 
spores proteins by 2-dimensional electrophoresis. Spores were sonicated and 
the resultant supematant removed and concentrated. 50 Jlg of sample was loaded 
and separated on an ZOOM IEF strip (pH 3-10, Invitrogen) and then by SDS-
PAGE on 4-12% ZOOM gels. Proteins were visualised using a SilverQuest stain 
(both Invitrogen). 
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120 kDa 
IOOkDa 
80kDa 
60kDa 
50kDa 
40kDa 
30kDa 
20kDa 
Figure 5.6 Detection of biotinylated spore proteins from the surface of 
UM23CI2 (pXOl-/pX021 and SM9l (pXOl-/pX02-/eag} B. a11thracis spores. 
Spores were biotinylated and sonicated, the supernatants from the sonicated 
spores were removed and the released proteins separated by SDS-PAGE on 4-
12% Bis-Tris gels (Invitrogen) and blotted onto a PVDF membrane (Invitrogen) 
Lane loading was as follows; A) B. anthracis UM23Cl2 spores, B) B. anthracis 
SM9l spores, C) Sonicated non-biotinylated UM23C12 spores, D) MagicMark™ 
Western Standard (Invitrogen) 
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5.2.4.1 Evaluation of tile removal of EAJ followillg Urografin purijicatio11 of B. 
anthracis spores 
Williams and Tumbougb. (2004) reported that EAt could be removed from spores 
following Urografin purification and three subsequent wash steps of B. anthracis Steme 
spores, deduced from the absence of a strong band at the expected molecular weight. To 
assess if small amounts of EA1 were still present, this purification procedure was followed 
and western blot analysis using a monoclonal a.-EA L antibody was used to determine the 
presence of EA 1 in purified sonicated spores. The results revealed that although the 
Urografin purification of the spores removed a small proportion of the EAt present, it was 
still detectable by western blot analysis; furthermore, this band was still visible when 
proteins were separated and visualised by SDS PAGE (data not shown). This finding 
prompted the study of the nature of the association of the EA 1 with the spore. Therefore, 
the visualisation of the binding of FITC labelled antibody was undertaken. Surprisingly, in 
this case the results suggest that these antibodies bound to whole spores and this was still 
observed after purification. Representative results are shown in Figure 5.8. As would be 
expected no binding ofFITC to the spore in the absence of antibody was observed. 
To ensure that the observed result was not due to the presence of another protein that 
contained an epitope that was similar to that recognised by the a.-EAl antibody, direct 
pepsin digestion and subsequent LC-MS/MS of the proteins released from purified B. 
anthracis UM23Cl2 by sonication was undertaken. This confirmed the presence of EAl 
within the spores. However, the question as to whether EAI was present in different 
amounts in different strains needed to be assessed, as the Steme strain had been used 
previously (Williams and Tumbough, 2004). Thus, two monoclonal antibodies raised 
against purified EAI were assessed for the ability to detect y-irradiated wildtype type 
Ames, y-irradiated Steme and the avirulent UM23Cl2 B. anthracis strains. Using a direct 
assay format no detection of whole spores was observed with a.-EAI mAb 1 or a.-EA I 
mAb 2 with UM23Cl2 spores. However, in the case of Bacillus anthracis -y-irradiated 
(Wildtype) Ames strain the a.-EA1 mAb 1 showed a 5-fold decrease in assay sensitivity 
compared to anti-EA! mAb 2. In the case ofy-irradiated Steme spores the results showed a 
slight increase in assay sensitivity compared to results obtained using the y-irradiated 
Ames strain. Analysis of sonicated spore supematants and S-layer proteins demonstrated 
the presence of EAI and its homologues in various Bacillus species in spore preparations, 
although the amounts and the molecular weights of the proteins vary in each species 
(Figure 5.9). 
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a) b) 
Figure 5. 7 Evaluation of the binding of a FITC-Iabelled anti-EAl mAb to 
washed and Urografm purified and washed B. a11thracis UM23CI2 spores. A) 
B. anthracis spores washed lOx viewed by fluorescence microscopy (xlOOO), B) 
B. anthracis spores washed 1 Ox viewed by phase contrast microscopy (x 1 000), C) 
B. anthracis spores washed lOx ,Urografin purified and washed 3x viewed by 
fluorescence microscopy (xlOOO), D) B. anthracis spores washed lOx Urografin 
purified and washed 3x, viewed by phase contrast microscopy (xlOOO). 
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AB CD BP 0 H J 
EA1---+ 
120 kDa 
100 kDa 
80 kDa 
60 kDa 
50 kDa 
40 kDa 
30 kDa 
20 kDa 
Figure 5.8 Detection of proteins from sonicated spore supernatants by mAb 
2 (30s exposure). Approximately 20 Jlg of protein was loaded onto a 10% Bis-
Tris (Invitrogen), separated by SDS-P AGE and blotted onto a nitrocellulose 
membrane (Invitrogen). Blots were probed with anti-EA1 rnAb at 10 J.Lg/ml and 
visualised using a rabbit anti-mouse HRP at 1: 10000 dilution. A) B. cereus 9946 , 
B) B. cereus 11145, C) B. cereus 11143, D) B. pumi/us, E) B. anthracis 
UM23Cl2, F) B. anthracis -y-irradiated Ames , F) B. thurigensis var. kuraskai, G) 
B. thurigiensis var. israelensis, H) B.pumilus, Q MagicMark™ Western Standard, 
J) Ovalbumin control 
5.2.5 Modelling of putative detection targets and identification of possible surface 
located unique protein signatures 
5.2.5.1 EAJ 
Modelling was kindly conducted by Dr R. Balhom at the Lawrence Livermore National 
Laboratories (LLNL), Livennore CA, USA. The EA1 protein was shown to exhibit a low 
level (10% - 15%) of sequence identity to a number of proteins whose structures were 
accessible at the Protein Data Bank (PDB). These structures were as follows; 1CWV _A 
(15%), 1FOO_I (14%), 1BU8_A (10%) and 1GOD _A (25%). Even though a low level of 
sequence identity was observed, sequence-structure alignments produced by various 
techniques, yielded hits to these PDB templates. The level of sequence similarity between 
two first templates (lCWV and 1FOO) was ~32% (however, in PDB only the C-terminal 
fragments of these two templates are provided). Both are multi-domain structures 
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composed from a few "All f3" structural domains (middle part of the protein) and one "a + 
f3" domain (the C-tenninal part of the protein). Each one of these domains was 
approximately 100 aa long. 
Using the Structural Classification of Proteins (SCOP), the fold of one domain was 
classified as an immunoglobulin-like f3-sandwich (7 strands in 2 sheets) similar to that 
found in invasin/intimin cell-adhesion fragments. The second fold was observed to be a C-
type lectin-like domain similar to that found in enteropathogenic E. coli intimin. Sufficient 
sequence and structural identity were present for the most, but not all, of the B. anthracis 
EA1 molecule. As a result, LLNL were able to generate a homology model for residues 
302-803. Since the entire protein is 862 amino acids long, the model is missing ~300 
amino acids on the amino terminus and 59 amino acids on the carboxy-terminus of the 
protein. After creation of the initial model this structure was subsequently refined. The 
final model containing four of the structural domains is shown in Figure 5.9 
Figure 5.9 Homology model of B. at~tltracis EAt showing the four 
structural domains Residues 302-803 (Conducted by Dr R. Balhorn, LLNL). 
Following the identification of unique protein signatures for EA1, these were mapped onto 
the final structure to identify those signatures that should be accessible for binding by an 
appropriate recognition element (Figure 5.10). In total, a set of ten unique regions was 
identified (Figure 5.11). Of these eight, were located within the region of the protein that 
was modelled. Regions that could not be mapped onto the protein structure were located in 
the first 300 amino-terminal amino acids. 
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Figure 5.10 Four views of EA1 with the unique peptide signatures mapped 
onto the surface and identified as coloured amino acids. (Conducted by Dr R. 
Balhorn, LLNL). 
GKSFPDVPAGHWAEGSINYLVDKGAITGKPDGTYGPTESIDRASAAVIFTKILNLPVDENA 
QPSFKDAKNIWSSKYIAAVEKAGVVKGDGKENFYPEGKIDRASFASMLVSAYNLKDKVNGE 
LVTTFEDLLDHWGEEKANILINLGISVGTGGKWEPNKSVSRAEAAQFIALTDKKYGKKDNA 
QAYVTDVKVSEPTKLTLTGTGLDKLSADDVTLEGDKAVAIEASTDGTSAVVTLGGKVAPNK 
DLTVKVKNQSFVTKFVYEVKKLAVEKLTFDDDRAGQAIAFKLNDEKGNADVEYLNLANHDV 
KFVANNLDGSPANIFEGGEATSTTGKLAVGIKQGDYKVEVQVTKRGGLTVSNTGIITVKNL 
DTPASAIKNVVFALDADNDGVVNYGSKLSGKDFALNSQNLVVGEKASLNKLVATIAGEDKV 
VDPGSISIKSSNHGIISVVNNYITAEAAGEATLTIKVGDVTKDVKFKVTTDSRKLVSVKAN 
PDKLQVVQNKTLPVTFVTTDQYGDPFGANTAAIKEVLPKTGVVAEGGLDVVTTDSGSIGTK 
TIGVTGNDVGEGT NGATLGSLYVNVTEGNVAFKNFELVSKVGQYGQSPDTKLDLN 
VSTTVEYQLSKYTSDRVYSDPENLEGYEVESKNLAVADAKIVGNKVVVTGKTPGKVDIHLT 
KNGATAGKATVEIVQETIAIKSVNFKPVQTENFVEKKI NIGTVLELEKSNLDDIVKGINLT 
KETQHKVRVVKSGAEQGKLYLDRNGDAVFNAGDVKLGDVTVSQTSDSALPNFKADLYDTLT 
TKYTDKGTLVFKVLKDK 
Figure 5.11 Sequence of B.a11tlrracis EA1 showing the location of the 
signatures with the signal peptide removed. Sequences unique to B. anthracis 
EA l are shown in red. 
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Evaluation of the location of the unique regions predicted that most of the sequences 
identified were surface accessible. Furthermore, a number of these regions were clustered 
towards the C-terminus of the protein (Figure 5.12). 
P ... D LQV524 
P72aVQTEN733 
Figure 5.12 Structure of EAl carboxy-terminal domain showing three 
clustered unique peptide sequences. (Conducted by Dr R Balhorn, LLNL). 
The colours show three unique peptide sequences which together, form a cluster 
on the protein's surface. 
5.2.5.2 Ala11i11e Racemase 
Alanine racemase was also modelled and the location of unique protein regions identified. 
Searches of the PDB revealed nine template molecules that had significant (13-39%) 
sequence identity to B. anthracis alanine racemase: lSFT_A (39%), 116F _A (39%), 
lEPV _A (39%), 1B54 (16%), 1CT5 (16%), 1D7K_A (14%), 1F3T_B (14%), 2TOD_A 
(14%) and 70DC_A (13%). A number of iterations of the homology model were produced 
using 1 SFT as the starting template. A model of the monomeric form of the protein was 
created in Figure 5.13. However, using known facts regarding the protein the final iteration 
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of the model was created as a homodimer. In total eleven unique regions were identified 
within the protein sequence and mapped onto the structure of the homology model (Figure 
5.14). As was observed for EAI, several ofthese unique signatures were also predicted to 
be located within a cluster. However, as sequence data has been added to that available at 
NCBI these regions have been found to no longer be unique. Alanine racemase now has up 
to 99% identity with proteins homologues in closely related Bacillus species, and as such 
was disregarded as a target for the generation of specific recognition elements. 
408 aa 
Figure 5.13 Homology model of the B. a11thracis alanine racemase monomer. 
The location of the unique protein signatures are coloured in green. 
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Figure 5.14 Space flU model of the B. anthracis alanine racemase dimer. 
View l-4 (left to right), dimer rotated to left 90° each view. The location of the 
original unique protein signatures are shown as coloured amino acid side chains, 
however, these regions are no longer unique. (Conducted by Dr. R. Balhorn, 
LLNL). 
5.2.5.3 Adhesion lipoproteill BA3189 
Preliminary analysis of the BA3189 protein enabled the three dimensional structure to be 
modelled for the majority of the protein (highlighted in green, Figure 5.15). Unique regions 
of the protein were identified as mapped onto the structure The regions 'DVMKMT', 
WMNIKN and LKMMKV were predicted to be surface accessible (Figure 5.16). Again 
these surface accessible regions could be exploited for the production of specific 
recognition elements. 
CSSNTNGKBBGSGKLKVVTTYSIIYDMVKQIGGBKVEIHSLVPIGANPHEYDPLPKDVMXMT 
DADMVLYNGLNLBBGGAWFKKLLKTANKSBKDAPVYKVSBGVEAIYLETKGLBKBPDPHAWM 
NIKNGILYABNVKKALIKBDPKNKBFYTKNADNYVABLQKLHDETVNRIHQIPBBKRFLISSE 
GAFKYFGKAYDIKTGYIWBINSBNQGTPDQIRDVVSVIQTNKVPALFVBTSVDRRSMBTVSKE 
TNVPIAGTIFTDSLGKSGBDGDTYLKMMKVNIDTIINGLQK 
Figure 5.15 Unique regions in the BA3189 sequence with the signal pepide 
removed. The modelled portion of the sequence is in green and unique regions 
are shown in red. 
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Red, 77-82: DVMKMT 
Blue, 140-145: PHAWMN 
Green, 143-148 :~ 
Yellow , 295-300: LKMMKW: 
Figure 5.16 Space fill model for BA3189 showing predicted surface located 
unique regions of the protein. (Conducted by Dr. R. Balhorn, LLNL). 
5.2.5.4 ExsA 
BLAST searches and sequence alignment revealed two regions that appeared to be unique 
to B. anthracis (Figure 5 .17). These may represent areas that can be targeted for the 
production of specific recognition elements. However, to date, it has not been possible to 
complete modelling of the proteins and the mapping of these regions onto the protein 
structure. 
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1 MQKGDTLWKIAKKYGVDFDTLKQTNTQLSNPDLIMPGMKIKVP:NGVQVKQIDGAGSAPP 60 B. a 
+QKGDTLWKIAKKYGVDFDTLK+TNTQLSNPDLIMPGMKIKVP V +KQ 1 GAGSAPP 
6 VQKGDTLWKIAKKYGVDFDTLKKTNTQLSNPDLIMPGMKI KVP KSVHMKQQ1GAGSAPP 65 B . c 
121 KEVQVKPQKEMQVKPQKEVQ KLIQIEKPVE PVEKPSVIQKPPVIEKQKPAEKENTKF 180 B . a 
E PVEKPSVIQKPPVI EKQKPAEKENTKF 
126 KEVQVKPQKEMQVKPQKEVQ QPIQ----KE VEKPSVIQKPPVIEKQKPAEKENTKF 181 B . c 
Figure 5.17 Areas of protein sequence showing differences in ExsA by 
comparison of B. anthracis (Ames) (B. a) and B. cereus ATCC 10876 (B. c) 
described by Bailey-Smith et al., 2005. The regions of disparity appear to be 
conserved amongst all other members of the B. cereus group for which protein 
sequence data is available at http://www.ncbi.nih.gov/ (data not shown) (B. 
cereus, B. thuringiensis and B. weilzenstephanis). 
5.2.5.5 BxpA 
BLAST searches and sequence alignment revealed two regions that appeared to be unique 
to B. anthracis (Figure 5.19). These may represent areas that can be targeted for the 
production of specific recognition elements. To date, it has not been possible to complete 
modelling of the proteins and the mapping of these regions onto the protein structure 
40 
AT 
45 AT 
NPYTAPQTQEQQFQQNSYDTRPSYEYPQNPYAAPQNQELQYPQNPYVT 99 B. a 
NPYTAPQTQEQQFQQNSYDTRP+YEYPQNPYAAPQNQELQYPQNPYVT 
NPYTAPQTQEQQFQQNSYDTRPNYEYPQNPYAAPQNQELQYPQNPYVT 104 B. c 
Figure 5.18 Areas of protein sequence showing differences in BxpA by 
comparison of B. a11thracis (Ames) (B. a) and B. cereus G9421 (B. c). The 
regions of disparity appear to be conserved amongst other members of the B. 
cereus group for which protein sequence data ts available at 
http://www.ncbi .nih.gov/ (data not shown) (B. cereus, B. thuringiensis and B. 
weihenstephanis ). 
178 
5.3 Discussion 
The aim of this study was to elucidate structural and surface anti genic components of B. 
anthracis spores. The knowledge gained could be used in a rational design process to 
generate recognition elements for the specific detection of B. anthracis. 
FITC labelling of B. anthracis spores was not successful for the identification of surface 
located proteins. This was probably due to the lowered efficiency of fluorescence observed 
with FITC than would be observed with molecules such as Alexafluor dyes. The 
biotinylation of spores appeared to be a promising technique for the identification of 
surface located proteins. This method has been used by a number of groups for the surface 
labelling of yeast cells (Casamova et al., 1992; Alexandre et al., 2000;), mammalian cells 
(Hurley et al., 1985) and microorganisms (Masouka et al., 2002; Flesch et al., 1995; 
Mendis et al., 2001; Cosma, 1997). However, in the modification and application of this 
method to spores it was found that the low amounts of protein, even following 
concentration, inhibited positive identification of all of the proteins released except EAl. 
Since successful use of this technique would require very large quantities of spores to be 
biotinylated and sonicated, it was not pursued. It is also possible that the proteins released 
were not suitable for mass spectrometry based identification, although as these techniques 
improve this method may prove valuable for the identification of surface located targets 
and provide more important insights into the structure of the B. anthracis spore. 
Steichen et al. (2003) demonstrated that BclA was an immunodominant protein of the B. 
anthracis exosporium by evaluating a number of monoclonal antibodies by western blot 
analysis. In order to establish whether further immunogenic proteins exist within this 
surface layer that may represent markers for a detection or diagnostic assay, an 
immunopurification procedure (Madey et al., 2000; Persaud et al., 2003) was developed. 
The method employed utilised a-species beads and a polyclonal antibody. The use of the 
a-species beads may have aided in the elution of sufficient protein for identification 
compared to other methods which may reduce the number of binding sites available to 
antigen, as correct orientation and increased surface loading of the antibody can be 
achieved (Figure 5.19) (Huang et al., 1996; Nisnevitch and Firer, 2001). Furthermore, the 
increase in the distance between the antigen binding site and the support would have 
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decreased the possibility of steric hindrance, as shown in Figure 5.20 (Huang et al., 1996; 
Nisnevitch and Firer, 1999). 
Non-directed attachment of antibodies to solid 
supports (e.g. amine coupling} 
b) 
Ideally site directed coupling required to expose 
all binding sites 
Figure 5.19 Advantages of site directed antibody immobilisation on a) planar 
and b) spherical supports. 
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Anti-species beads (e.g. goat anti-rabbit) Addition of secondary antibody (t>.g. a rabbit polyclonal 
antibody) allowing for correct orientation of antibody 
Figure 5.20 Decreasing steric hindrance of antigen binding with the use of anti-
species beads 
The choice of a polyclonal antibody allowed for the identification of a greater number of 
targets than would have been identified if a monoclonal antibody had been used. The 
majority of monoclonal antibodies resulting from immunisation with a complex protein 
mixture, such as the exosporium, are likely to react with the most immunodominant protein 
species present, in this case, BclA (Steichen et al., 2003). In contrast, a polyclonal antibody 
will recognise a range of proteins that are capable of eliciting an immune response. 
From the results obtained, a number of immunogenic exosporium proteins were identified 
(BA2332, ExsY, ExsF, CotY, Cot-a, alanine racemase, CotB and a second CotB 
homologue). The detection of multiple proteins within single bands suggested some 
interactions of these proteins that may exist within the exosporium. 
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BA2322 was fust shown to be present experimentally in unwashed exosporium 
preparations by Redmond et al. (2004), although whether this was a true structural 
component of the exosporium or an adsorbed protein was unclear. Steichen et al. (2005) 
cites BA2332 in a list of putative basal layer proteins. From this work BA2332 was 
identified as an inununogenic component of the exosporium and as such has been 
designated ExsM. 
ExsY, ExsK and CotY were also found to be immunogenic and the presence of ExsY and 
CotY in a high molecular weight complex, at 250 kDa was also observed. It has been 
suggested that ExsY and CotY form multimeric complexes with ExsF (ExsFN BxpB) and 
BclA, as well as existing in a monomeric form (Redmond et al., 2004; Sylvestre et al., 
2005). However, in this study no sequences derived from ExsF (ExsFN BxpB) were 
identified. The absence of peptides from BclA is unsurprising as this protein is not 
amenable to mass spectrometry based methods of identification due to its hydrophobic 
nature and relatively few tryptic cleavage sites. 
A second lower molecular weight complex was observed at 40 kDa containing ExsK, 
ExsY and CotY possibly with alanine racemase or an as yet unidentified protein. The 
presence of alanine racemase, an enzyme involved in germination, has been described by a 
number of groups, within the exosporium from both B. anthracis (Liu et al., 2004; 
Redmond et al., 2004) and B. cereus (ATCC 10876) (Todd et al., 2003) spores. It is not 
known whether the presence of this enzyme is due to a close association with the 
exosporium or whether it functions as a structural component as part of the regulatory 
mechanism for spore germination (Steichen et al., 2003; Todd et al., 2003; Redmond et al., 
2004). The presence of alanine racemase within the multimeric ExsK, ExsY and CotY 
complex may suggest a role for these proteins in maintaining this enzyme within the 
exosporium. Recent work conducted by Sylvestre et al. (2005) reported the detection of 
proteins at approximately 37 kDa using antibodies generated from 8BclA exosporium or 
a-ExsF A antibody. These proteins were not detected using the same antibodies when 
t.ExsF A spore extracts were probed. Thus these as yet unidentified proteins were 
hypothesised to require the exsFA gene for assembly within the spore. lt is possible that 
the bands identified at 37 kDa from the Sylvestre study contain the proteins identified in 
the 40 kDa band from this study, accounting for errors in the determination of molecular 
weight. Alternatively ExsFA may be required for the assembly of one or a number of 
exosporium proteins which may include ExsK, ExsY and I or CotY. The others may 
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subsequently form as a complex containing alanine racemase. The alanine racemase could 
then be released upon degradation of the exosporium. Thus, ExsK, ExsY and CotY may 
be present in multimeric complexes and require the ExsFA gene for assembly, although 
this would have to be confirmed experimentally. The requirement for ExsF A for the 
formation of a complex of the exosporium proteins containing alanine racemase rather than 
a reduction in the level of this enzyme may also account for the slower germination rate 
observed for the dExsFA (BxpB) mutant compared to wildtype B. anthracis spores 
(Steichen et al., 2005). 
The presence of CotBl has been reported previously (Redmond et al., 2004; Liu et al., 
2004). The results from this work suggest that it is also immunogenic. However, 
experimental identification of a second CotB homologue within unwashed Ames 
exosporium has not been determined experimentally to date. Thus, this protein has been 
designated CotB2. Sequences for these proteins within the annotated Ames genome 
sequence are either degenerate or absent. However, the entire protein encoding sequence is 
present within the B. anthracis Ames genome sequence and from this work the protein has 
been shown to be present experimentally,thus re-annotation of this area may be necessary. 
The sequences for the two CotB proteins are present within B. anthracis Ames A2012 and 
B. anthracis Steme (BAS0340 and BAS0340). In both strains CotB 1 and CotB2 are 
flanked by a DNA binding domain and a hypothetical protein similar to B. subtilis YrwJ 
and evidence suggests that this is conserved within the Ames genome. The suggested 
sequences of these proteins are denoted below (Figure 5.21) and were derived from 
nucleotide sequence data usmg the Expasy translation tool 
(http://www.expasy.orgltools/dna.htrnl). Figure 5.22 shows the current annotation of this 
region within the Ames genome and the suggested organisation from this work. 
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CotBI 
VSLFHCDFLKDLIGSFVRVNRGGPESQRGTIISVCPDYFVLQNEKGEL YYYQLSHLKSITKS 
AKECGSSDCEWEDCACAEDFEALLESFKYRWVKINRGGPEKVEGILQDVSCDFVTLIVKE 
EIILIAIKHIKSVNYNALACGESDESDDSSSKESSNNSGRARAQRQSSRGR 
CotB2 
LENVLCCDQIKCLVGETVKVNLRGPESRVGELVSLGKDYLTLQLPHGELVYYQLKHVKS 
LVKKVKESKCGDCYSSCFCSDEDTFLDILKDLKYKWVKINRGGPECMDGLLSEVHHGCIT 
L VNCDEVIYVINSHIKSVSQVVKCKKNEDE 
Figure 5.21 Predicted sequence of Cot81 and Cot82 from translation of the 
nucleotide sequence obtained from the B. antllracis Ames complete genome 
NCBI Ref NC 003997.3 (Cot81 365687-366215, CotB2 366228-366678) 
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BA0353 BA0354 
Hypothetical 
protein 
BA0355 CotB 
(degenerate) 
BA0356 
Current annotation B. anthracis. Ames 
BAS338 BAS339 
Hypothetical 
BAS340 BAS341 
cotBI cotBI 
Current annotation B. anthracis. Steme 
BA0353 BA0354 
Hypothetical 
BA0355 
CotBI Cot B2 
BA0357 
ywrJ 
homologue 
BAS342 
ywrJ 
homologue 
BA0357 
ywrJ 
homologue 
BA0358 
BAS343 
BA0358 
Figure 5.21 Suggested re-annotation of the cotB region of the B. anthracis Ames genome 
The B. anthracis CotB homologue has 30% identity to B. subtilis CotB. In B. subtilis 
CotB is located in the outer spore coat (Sacco et al., 1995; Kuwana et al., 2002) and is 
present as a 46 kDa protein (CotB46), which is post-translationally modified to a 66 
kDa form (Cot866), (Zilhao et al., 2005). Examination of the B. subtilis CotB 
sequence reveals few cysteine residues, unlike the relatively cysteine rich CotB l and 
CotB2 proteins within B. anthracis (Zilhao et al., 2004). The cysteine rich nature of 
CotB within B. anthracis would allow for the formation of covalent crosslinks through 
disulphide bonds and/or have a role in binding metals (Steichen et al., 2005). 
Therefore, the interaction of CotB with other proteins between the two species may 
not be the same. Chada et al. (2003) also describe a role for B. subtilis CotB in the 
ridge pattern formation observed in B. subtilis spores and implicated the role of other 
genes cotM, cotX. cotY, cotZ and the cge genes in spore morphogenesis. The proteins 
expressed by these genes have also been hypothesised to glycosylate proteins located 
on the spore surface (Roels and Losick, 1995). This group also demonstrated that 
CotB can form a complex with itself and CotG, a homologue of ExsB, an exosporium 
protein identified in B. cereus by Todd et al. (2003). No peptides derived from B. 
anthracis ExsB in the bands containing the CotB proteins were identified in this study. 
However, preliminary results suggest that interactions may occur between both CotB 
homolgues and ExsF, ExsY, CotY and ExsK due to the presence of peptides derived 
from these proteins in a single band. However, this was difficult to ascertain due to 
their migration close to their predicted molecular weight. AJI of these proteins have 
however been cited as predicted putative basal layer proteins by Steichen et al. (2005) 
which may indicate that interactions between these proteins may occur. 
The cot-a homologue was also identified as an immunogenic component of the 
exosporium. Kim et al. (2004) showed this protein to be localised to the outer spore 
coat and absent from the exosporium by immunogold labelling. However, Liu et al. 
(2004) describes this protein in the exosporium fraction of B. anthracis spores 
suggesting that this protein may also be isolated using exosporium extraction methods. 
A number of other proteins have been described within exosporium preparations but 
were not identified/found as part of this study. The list of proteins identified during 
this study is by no means exhaustive and other proteins in, or associated with, the 
exosporium may be immunogenic. 
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Sonication of bacterial spores was shown to enhance assay sensitivity. Sonication 
may not only release proteins from the exosporium but from underlying layers such as 
the spore coat. Therefore, the number of potential antigens that could be used for 
detection would increase, increasing the probability of finding specific proteins or 
proteins with unique regions. The identification of a number of proteins from a 
complex mixture by direct pepsin digestion following sonic disruption was shown to 
extend the number of putative targets for detection. All of the proteins identi tied using 
this approach had been described previously within the B. anthracis spore, with the 
exception of B. cereus ExsA homologue. This protein has been shown to play an 
important role in the formation and assembly exosporium (Bailey-Smith et al., 2004). 
The use of in-gel digestion of proteins released by sonication identified further 
proteins of the B. anthracis spore. A number of these have been reported in the 
exosporium or coat extracts of spores (Lai et al., 2003; Liu et al., 2004; Redmond et 
al., 2004, Steichen et al., 2004}, supporting the observation that sonication removes 
the outer layers. However, a number of proteins have not been described previously 
including a putative lipoprotein (BA2041}, hypothetical proteins (BAI021, BA5144) 
an adhesion lipoprotein (BA3189), a menaquinol-cytochrome c reductase iron-sulfur 
subunit (8Al544) and an alkyl hydroperoxide subunit C (BA0345). The putative 
lipoprotein BA2041 has some similarity to OppA, which is a predicted cell wall 
protein. However, possibly of note is the fact that this protein in located downstream 
of ExsB (BA2045) and thus may also have a function within the spore. No function of 
the two hypothetical proteins (BAI021 and BA5144) could be inferred by BLAST 
searches, although BA5144 is specific to the B. cereus group and BA l 021 also has 
homologues in Clostridium species which may suggest some function within the 
spore. The BA0345 protein is an alkylhydroperoxide subunit C, a homologue of this 
protein has been described in B. subtilis spores (Casillas-Martinez and Setlow, 1997; 
Kuwana et al., 2002). This enzyme may be speculated to have a role in the protection 
against oxidative stress, however this has been shown not to be the case for B. subtilis 
spores (Casillas-Martinez and Setlow, 1997). However, a possible function in B. 
anthracis as a protection mechanism against the oxidative stress encountered in the 
host macrophage cannot be completely discounted (Kang et al., 2005). 
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The majority of proteins identified would be unsuitable as detection markers as they 
showed high identity with other members of the B. cereus group and surface exposed 
unique regions could not be found. However, on examination of sequence and 
structural predictions Ex sA, BxpA, EA I and BA3189 were potential candidates. The 
BxpA protein (BA2162) was previously identified as a component of the B. anthracis 
exosporium (Steichen et al., 2003). The sequence of the Ex sA protein of B. anthracis 
shares up to 91% identity with other members of the B. cereus group. From 
examination of the protein sequence, two regions were identified that showed 
significant differences between homologous proteins within the B. cereus group 
(Figure 5.17). Other differences observed were in the numbers of proline tandem 
repeats present towards the C-terminal region of the protein, but as these are merely 
repeated short sequences they would not be suitable as linear epitopes. The lower 
degree of sequence identity of this protein compared to other putative targets suggests 
that this could be exploited for the development of specific recognition elements. 
However, computer modelling would be required to ascertain if these unique regions 
are surface exposed. Of particular interest was the identification of an adhesion 
lipoprotein (BA3189). This protein shared only 94% identity to a homologue in B. 
cereus E33L a strain of B. cereus causative of anthrax-like disease in animals. This 
protein shows promise as a B. anthracis-specific marker and more recently has also 
been reported to be a novel choromosomally encoded B. anthracis virulence factor 
termed MntA expressed by vegetative cells (Gat et al., 2005). Further experiments 
would have to be conducted to assign functions to the proteins of interest within the 
spore. 
EAl was investigated as a preliminary target as it was consistently idenitified as a 
component of the spore and has since been reported in a number of studies of the 
exosporium and spore coats of B. anthracis (Lai et al., 2003; Redmond et al., 2004; 
Liu et al., 2004). Furthermore, as none of the proteins identified were unique, it was 
unlikely that traditional methods of antibody production would yield a specific 
detection reagent. Computer modelling predictions suggested the existence of a 
surface exposed unique regions for MntA and alanine racemase. However, in the case 
ofEAl, clusters were identified that could be exploited to develop specific recognition 
elements that could potentially recognise unique three dimensional epitopes containing 
multiple unique protein signatures. Cavities on the protein surface surrounding or 
encompassed by the cluster also provide unique target sites. 
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EAl is a vegetative cell protein; however, results from work confirms earlier reports 
that it is also present in spore preparations (Lai et al., 2003; Liu et al., 2004; Redmond 
et al., 2004) and washed wildtype Ames exosporium (Redmond et al., 2004). At the 
time of conducting this study Williams and Turn bough (2004) suggested that EA 1 was 
a contaminant within spore preparations. However, Western blot analysis using an 
anti-EAt antibody demonstrated the presence of EAt in spores prepared as described 
by Williams and Tumbough (2004), which was confirmed by mass spectrometry. This 
suggested a closer association than previously suggested. However, a decrease in the 
amount of EAt detectable after Urografin purification of B. anthracis spores indicated 
that wash steps do remove a small proportion of this protein target. The detection of 
EAI in all strains tested (UM23CI2, Sterne and wildtype Ames), suggests that this 
observation was not purely due to the original strain utilised, UM23CI2. Evaluation of 
two anti-EA I antibodies by Western blot analysis suggestedEAl is exists in truncated 
forms and/or a range of proteins may be present in the spore which contain the eptiope 
recognised by the anti-EAt antibody as a number of bands below the predicted 
molecular weight were observed. It has been suggested that this also occurs within 
the cell (Ariel et al., 2003},. Artefacts due to sonication seem unlikely, since profiles 
obtained for B. anthracis y-irradiated Ames and UM23CI2 strains using the same 
antibody showed significant differences. This suggests that different forms of the 
protein may exists within different strains, although whether this is significant in the 
spore is unclear. Furthermore, no detection of any 'contaminating material' was 
observed using FITC labelled anti-EAI antibody. In contrast, the results seemed to 
suggest that antibody was binding predominantly to the spore. The reason why EAI 
was observed associated predominantly with the spore may be due to the growth of the 
spores on a solid medium rather than in liquid culture. or variation in the epitope 
recognised by the antibody, the only two differing experimental factors compared to 
that reported previously (Williams and Tumbough, 2004). The purification of spores 
would not occur in vivo so it can not be discounted that selectively bound moieties 
may have as yet unknown functions within the infection process (Charlton et al., 1999; 
Liu et al., 2004). 
The construction of a homology model of EAI (Figure 5.9) suggested that EAI is 
similar to an E. coli intimin (a C-type lectin, a family of Ca2+-dependent lectins that 
show primary structural similarity in their carbohydrate-binding domains.) and a Y. 
pseudotuberculosis invasin. This supports the hypothesis that EA l may have a role in 
the interaction with host cells and may have a role in the aerosolised route of infection 
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which has, to date, not been determined. This role may also suggest a reason for the 
inability to remove all EAl from spore preparations. C-type lectins are found on the 
surfaces of a number of host molecules that have a role in the immune response and 
serve to bind to carbohydrate moieties exposed on the surface. Thus, it could be 
speculated that EA 1 is bound to the carbohydrates moieties within the exosporium, of 
which a number have been described (Sylvestre et al., 2002; Daubenspeck et al., 2004; 
Wailer et al., 2005). Analysis of the surface proteins of an EAI mutant, SM91, 
compared to UM23CI2 suggested that the presence of EAl masked other surface 
exposed moieties. Further experiments would be required to determine if antigen 
masking has any role in the pathogenicity of the B. anthracis spore. 
One-dimensional (ID) and 2-dimensional electrophoresis (2DE) have been widely 
used for proteomic studies. When this is followed by a suitable technique for protein 
identification (commonly mass spectrometry based methods) this has shown promise 
for facilitating the identification of a large number of proteins from complex mixtures 
(Veith et al., 2001; Krah et al., 2003). Differences were seen in the protein profiles of 
B. anthracis compared to closely related species, particularly in the large number of 
lower molecular weight acidic proteins observed in B. anthracis this could account for 
the observed acidity of samples produced using this method and with exosporium 
preparations (C. Redmond personal communication). However in this study, 2DE was 
found to have limitations for the identification of proteins from spore preparations due 
to the high concentrations and volumes of spores that would have to be processed to 
produce sufficient protein for identification. Many of the problems with 2DE such as 
those relating to low abundance of proteins have been reported within other studies, 
prompting the use of alternative approaches (Molloy, 2000; Herbert et al., 200 I; Lilley 
et al., 2002; Shaw and Riederer, 2003). The application of combinations of liquid 
phase based separation methods, in conjunction with mass spectrometry techniques 
have also proved an exceptionally promising alternative to 2DE (Wang and Hanash, 
2003). Therefore, methods such as immunopurification and biotinylation of surface 
located components may prove invaluable in identification of proteins that may have 
important interactions in the infection process. 
ln this study, proteomics based approaches identified a number of novel proteins of the 
B. anthracis spore. Results show that the spore structure is complex and that the 
interactions of many of the individual components are unknown. The utilisation of 
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unique surface :exposed ·regions of;a I protein; could be :iltvaltiable .iii.i tbe pl"Qdtictioil' of 
recognition •elen11::nts for sp~ific identification' where: protein 1homologues are present 
·in closely'relatedl species. lFhis. study ·this has enabled I the identification of'four such 
.targets tliannay 1b"e .utilised for the 'sp:ecific q~tection;oJB, (lfllhrflcls :spore!). 
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Chapter 6 Production of specific single chain antibodies against the B. 
antllracis protein EAt for the detection of whole spores 
6.1 Introduction 
A preliminary step in the development of an immunoassay for the detection of a 
microorganism is the production of a highly specific antibody capable of binding to the live 
pathogen. Traditionally, poly (pAbs) or monoclonal antibodies (mAbs) produced against the 
whole organism have been used. In the case of polyclonal antibodies raised against whole 
cells or spores, the antibody will recognise a range of undefined antigens and epitopes. 
Furthermore, these epitopes may be present on other species, particularly if unique targets are 
rare or non-immunodominant. Monoclonal antibodies, although directed against a single 
epitope, may not be able to discriminate between highly conserved epitopes in related species. 
The use of detection reagents against unidentified and uncharacterised epitopes could cause 
significant limitations to the sensitivity and specificity of a detection assay as well as a 
reduction in the confidence of the results obtained. 
In addition to the problems observed with lack of specificity and the recognition of unsuitable 
target proteins, because the production of antibodies is reliant on a mammalian immune 
response it is difficult to produce antibodies to toxic substances, or to unique, rare or non-
immunodominant epitopes even though such targets could be suitable targets for detection 
assays (Emanuel et al. 2000). In the case of polyclonal antibodies, a specific target can be 
identified and antibodies produced through the use of affinity purified protein (Petrenko and 
Vodyanoy, 2003). However, this requires detailed knowledge of suitable targets and large 
quantities of purified target. Often this is achieved using recombinant protein, but this must 
also be expressed in the correct conformation. Additionally, such procedures are expensive 
and time consuming, particularly for large scale production. 
Despite these limitations, production of natural antibodies has provided a platform that is the 
basis of many detection and diagnostic technologies, but this has often required the 
modification of detection technologies to optimise performance. For example, this may 
involve the use of additional reagents (Fratamico et al., 1998), optimisation of assay 
conditions (Studentsov et al., 2002), the modification of existing technologies or the 
development of new detection systems (Perkins and Squirrel, 2000). 
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Advances in recombinant DNA technology and computational molecular biology have 
allowed the production of alternatives to traditional antibodies that can be modified to suit the 
requirements of the detector and assay design (Irving et al.; 1996; Lindner et al.; 1997; 
Piervincenzi et al.; 1998; Jung et al., 1999). Recombinant antibodies may be used to enhanced 
specificity to a chosen target. One of the distinct advantages of recombinant antibodies is that 
they can be designed or selected to discriminate between very similar proteins. This can be 
done either by experimental methods or by a process of rational design (Giaser et al., 1992.; 
Cai and Garen 1995.; Kirkham et al., 1999; Miyazaki et al.; 1999., McCarthy and Hill, 2001.; 
Skerra, 2000). Single chain antibodies (scFv), contain only the variable region, containing the 
antigen binding sites. The use of these molecules, which can be expressed in a range of 
vectors, such as bacteria, confers significant advantages over polyclonal and monoclonal 
antibodies as discussed in Chapter 2. 
One method of producing antibodies against a given target is through the production of an 
epitope mimic (Hombach et al., 1998). However, increased binding to the mimic compared to 
the native target has been observed (Goldbaum et al., 1997). Other important techniques that 
have been reported are competitive panning and competitive elution. The use of a competitive 
panning procedure (sometimes termed pre-adsorption, subtractive antibody screening or 
negative selection) utilises pre and/or post adsorption steps to select out those scFv that bind to 
potentially cross reactive targets to produce specific scFv (Figure 6.1 ). This strategy is 
particularly significant in the production of antibodies to distinguish between closely related 
targets or to produce antibodies against two distinct epitopes. For example specific anti-
melanoma antibodies have been prepared using a procedure of continuing the selection to the 
final round and then pre-absorbing with melanocytes lO times (Cai and Garen, 1995). As an 
alternative to this method, Scherer et al. (1998) describe a methodology by which polyclonal 
antisera were produced against a specific target on human adipocyte cells. The strategy used 
was to deplete sera of antibodies that were not specific to the target by purification with the 
recombinant protein. The purified sera that recognised the antigen of interest was then used to 
construct a scFv library. 
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5) Analysis of 
isolated phage and 
further 
4) Amplification {'t 
of selected phage ~ 
Figure 6.1 Competitive Biopanning 
iii) Elution 
1) Production of a 
phage based scFv 
library from a 
synthetic, naive of 
immune sou rce 
2) Preadsorption of 
cross reactive scFv 
using an excess of 
potentially cross 
reactive antigen. 
3) Competitive 
selection of specific 
scFv 
l) The scfv library is produced. 2) Potentially cross-reactive scFv are pre-adsorbed using 
target antigen for which cross reactivity is required to be eliminated. Commonly, this is added 
in excess of the antigen for which scFv need to be isolated. 3) During the selection phase 
potentially cross-reactive scFv are not available to bind to the antigen of interest and are ii) 
washed away and iiii) the specific scFv eluted. 4) the phage are then amplified and further 
rounds of panning completed or 5) taken forward for further analysis. 
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An approach that would allow for the production of recognition elements that can discriminate 
between closely related species would be advantageous for sensitive and specific detection of 
B. anthracis spores. Zhou et al (2002) reported an approach to obtain antibodies to B. 
anthracis spores from a naive human library, but cross reactivity with related species was 
observed. Williams et al. (2003) reported the development of peptide recognition elements to 
B. anthracis spores, but the target was unknown. Both of these approaches used whole spores 
where the detection target was not defined - the work described here uses a targeted approach 
to recognition elements production. 
The use of a carefully selected target antigen that contains highly specific, non-conserved 
epitopes allows an increase in the specificity, sensitivity and confidence of a detection assay 
(Labadie and Desnier, 1992). Although a number of proteins were found to be components of 
the B. anthracis spore and released during sonication all of these proteins have homologues 
within the B. cereus group (Chapter 5). Furthermore, previous studies have not been 
successful in identifying a spore protein that is unique to B. anthracis {lvanova., et al., 2003, 
Todd et al., 2003 and Redmond et al., 2004). Therefore, completely unique targets may be 
rare and/or of low abundance, making identification of these proteins and production of 
antibodies by traditional methods difficult. In this study, examination of the protein sequence 
and the use of computer modelling allowed for the identification of four targets that contained 
unique regions, predicted to be exposed on the surface of the protein. Thus, these targets could 
potentially be used for the production of speci fie recognition elements. 
The work described here addresses a targeted approach to the production of recognition 
elementsrecognition elements. This was achieved through the production of single chain 
antibodies that specifically detected B. anthracis spores through recognition of an individual 
protein target namely the surface layer protein EA l. EA I is a vegetative cell protein; 
however, this protein was consistently identified using a range of techniques described in 
Chapter 5 and is supported by previous studies (Lai et al.,2003; Liu et al., 2004; Redmond et 
al., 2004; Williams and Turnbough 2004). Although Williams and Turnbough (2004), suggest 
that this protein is a contaminant of B. anthracis spores and can be removed by Urografin 
purification and subsequent wash steps, this is in variance to the finding of this study (Chapter 
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S). EA I is known not to be unique to B. anthracis, but also has homologues within other 
Bacillus species and the monoclonal antibodies tested were shown to cross-react with other 
Bacillus species. The aim of this work was to develop specific scFv to EA I. Once a specific 
recognition elements to a characterised protein has been produced demonstration of the 
detection of B. anthracis spores would be required. If the method was successful it could be 
applied to the other targets identified in ChapterS. 
6.2 Results 
EAI was prepared and purified (section 3.9). Confirmation that the purified protein was EAl 
was undertaken by SOS PAGE, western blot using a monoclonal anti-EA I antibody and mass 
spectrometry based methods (3.23.1.3-3.32.1.4). 
6.2.1 Single chain antibodies produced by non-competitive panning 
An immune library was constructed as detailed in 3.33 used the M 13 bacteriophage as an 
expression vector as described by Krebber et al. (1997). The non-competitive panning strategy 
used here required three rounds of biopanning against the immobilised target antigen, purified 
EA I. The observed binding to EAI in ELISA by the polyclonal population of scFv present 
after each round of selection showed an increasing signal after round 2 and 3 of selection 
(Figure 6.2). The immune library used was expected to contain antibodies to EA I as the mice 
had been immunised with B. anthracis spores. This library would be expected to contain scFv 
to a range of spore and exosporium antigens, and has been used to produce antibodies to 
several other spore surface proteins in addition to EA I (data not shown). The large increase in 
signal observed after round 3 is likely to be linked to the increased stringency of washing in 
this round (20 washes) compared with the lower stringency of the earlier rounds (10 washes). 
After round 3 of non-competitive biopanning, SO scFv clones were selected and their ability to 
bind EA! assessed by direct ELISA. A sample result from ten of these clones is shown in 
Figure 6.3. Of the SO scFv clones analysed 43 were found to bind to EA I. Only 2 of these 43 
scFv clones demonstrated any cross-reactivity to purified B. atrophaeus S-layer protein. 
BstNI fingerprinting of all the scFv clones that bound to EAl, demonstrated that there were 
196 
13 unique clones. These clones were all confirmed to be different by DNA sequencing and 
are referred to here as scFv l to scFv 13. 
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RO RI R2 R3 -ve contro l 
Polyclonal single chain 
B. a11thracis UM23CI2 spores 
D B. cereus 11143 spores 
~ B. mrthracis S-layer protein EA I 
Figure 6.2 ELISA results showing binding of polyclonal anti-EAt scFv to EAt 
from each round of the non-competitive biopanning procedure. Polyclonal phage-
displayed scFv from each round of the biopanning procedure (unpanned library 
designated round 0; RO-R3 represents the results of each panning round) were diluted 
50% (v/v) in MPBS for detection of EA l . An anti-ovalbumin scFv was used as a 
negative control (labelled - ve control). Bound phage were detected using an anti-
M 13 HRP conjugated antibody. Assays were performed in triplicate; error bars show 
two standard deviations from the mean. A positive result was defined as being higher 
than the average of the background signal plus three standard deviations of the mean 
background sample. 
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Figure 6.3 ELISA results demonstrating binding of ten monoclonal scFv to B. 
a11tllracis EAl and to B. atropllaeus S-layer protein. Monoclonal phage-displayed 
scFv isolated from the third round of EAt panning were prepared from 2 ml of 
supematant by PEG precipitation and resuspended in 0.4 ml 2% (w/v) MPBS. An 
anti-ovalbumin scFv was used as a negative control (labelled - ve control), and a 
polyclonal scFv known to bind to B. anthracis spores were used as a positive control 
(labelled +ve control). Bound phage were detected using an anti-M 13 HRP 
conjugated antibody. Assays were performed in triplicate, error bars show ± two 
standard deviations from the mean. A positive result was defined as being higher 
than the average of the background signal plus three standard deviations of the mean 
background sample. 
6.2.2 Sequencing data from scFv 
The complementarity detennining regions (CDRs) were defined using the Kabat definition as 
described by Martin (200 1 ). Although a range of schemes have been described, the Kabat 
definition is used as a standard for the numbering of protein residues within the antibody 
sequence. Using these numerical data, the light and heavy chains CDRs of the antibody can be 
defined (Martin, 2001). Some sequences obtained from the DNA could not be analysed as, on 
translation, the sequence appeared to contain a large number of stop codons and are not 
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shown. In some instances the CDRs could not be determined as those sequences did not obey 
the Kabat definition (Martin, 200 I). 
The sequencing data revealed varying degrees of similarity between the CDRs for all the scFv 
analysed. In summary: 
(I) The light chain CDRs for scFv I were similar to scFv 2 except scFv I had 4 linker 
sequences and scFv 2 had I. 
(2) The heavy and light chains of scFv 9 were similar to scFv 8, with only small deletions in 
CDR-Ll and CDR-L3. 
(3) The only sequence that was very different in all CDRs was scFv 6, which was found to 
cross react with a range of S-layer proteins. 
(4) In CDR-HI a prominent consensus sequence was S Y GID MS, which was also found to 
be a predominant consensus sequence from single chain antibodies produced against whole 
spores (C. Mayers personal communication.). 
(5) The highest degree of variability was observed within the protein sequences that form 
CDR-H3. 
The CDR sequences are shown in tables 6.1 and 6.2. 
The cross-reactivity of l3 unique scFv was determined by direct ELISA against S-layer 
proteins isolated from other Bacillus species. All of the 13 unique scFv tested showed cross 
reactivity with S-layer proteins from the other Bacillus species tested (for brevity, these 
ELISA results are summarised in Table 6.3). The highest degree of cross-reactivity was 
observed with B. cereus NCTC 11145 and B. pumilus S-layer proteins. 
199 
Antibody Light chain CDRs 
I .... 2 L3 
scFv I K A s Q N V G T N V A s A s y R y s Q Q y N s y p L M 
scFv 2 K A s Q N V G T N V A s A s y R y T Q Q y s s y p w T 
scFv 7 H A lo N I N V w L s K A p N L H T Q Q G Q s H p R T 
scFv I! R s s lo s L V H s N G N T y L H K V S N F R s s Q T T H V p y T 
scFv 3 R A s E s V D N y G I s F M N A A S N IQ G s Q Q s K E V p w T 
scFv6 s A s s s V s s s y L y S T s N L A s Q QR R s s p p T 
scFv 8 s A s s s V s y M H S T s N L ~ s Q Q R s s IY p L T 
scFv 10 s A s s s V s y M H D T s K L A s Q Q w A ~ ~ N p p I T 
scFv 12 s A s s s V s y M H D T s K L A s F Q G s G IY P L T 
scFv 13 s A s s s V s y M H D T s K L A s lo Q w s s N lP p I T 
scFv 9 s A s s s V s y M H s T s N A s 1R s R y P L T 
scFv 5 s c I Q p R I Q H s R ioL p w T 
. . . . 
N Table 6.1. The complementarity deterrmmng regions (CDRs) of the hght cham of scFv produced by a non-competitive 
0 
0 
panning strategy 
Antibody Heavy chain CDRs 
HI ~ ~3 
scFv I 
scFv2 s y G M s TI SA s G T y T y yp D s V c y y G lv 
scFv 7 H s G D R G L R S M E G V lo G Q IR T M V T V 
scFv !I 
scFv 3 
scFv6 A D y y M s F I R N K A K G YT T D YS AS V D R N y GS H w YF D w 
scFv 8 s y D M s T I s s G G s y T y yp D s V S I L T T G A E G y H s X Q A X R p 
scFv 10 s y D M s TI ss G G s y T y yp D s V lv s X ~ L G p R X p X X T T V s s A s G 
scFv 12 s y G M s TI SG G G s y T y yp D s V ~ R y D y F D y 
scFv 13 s y D M s TI ss G G s y T y YP D s V IV s X L L G p R c p c c T V s s A s G V 
scFv9 
scFv 5 s y G M s T I ST s G T y T y yp D s V c y y G V R J.. L c y E L L G s R IN L s H 
.. Table 6.2. The complementarity determinig regions (CDRs) of the heavy chain of scFv produced by a non-competitive 
panning strategy 
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Table 6.3.Summary of ELISA results demonstrating the binding of unique 
monoclonal scFv to EAl and the cross-reactivity to other purified S-layer 
proteins, determined by ELISA. Soluble scFv were produced, purified by 
immobilised metal affinity chromatography (IMAC) and used at 5 J.tg/ml in ELISA. 
Bound phage were detected using an anti-His tag HRP conjugated antibody (Sigma). 
Each assay was performed in triplicate. A summary of these ELISA assays is 
presented here; results are expressed in terms of the percentage of the maximum 
signal seen in the assay ( +++ indicates 60-100% of the maximum, ++ indicates 20-
59%, + indicates a signal greater than detection threshold, defined as the background 
signal plus 3 standard deviations from the mean of the background signal, and -
indicates a signal below the detection threshold.) 
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6.2.3 Single chain antibodies produced by competitive panning 
After failing to isolate B. anthracis specific anti-EA I scFv, a competitive panning strategy 
was employed. This involved negative selection of cross-reacting scFv by binding them to S-
layer proteins from species that cross-reacted with the original anti-EA1 scFvs. The S-layer 
proteins were extracted from each Bacillus species and purified by gel-filtration 
chromatography (section 3.9). The panning procedure was repeated as detailed for the non-
competitive strategy, but this time a mixture of competitive S-layer extracts (50 J.lg/ml B. 
cereus 11145 S-layer protein, and 25 J.lg/ml of B. cereus 11143, B. cereus 9946 and B. pumilus 
S-layer protein) were added to the solution of panning phage at the first panning round. The 
amount of EA 1 used to coat the immunotube was also varied ( 1 or 10 J.lg/ml). Binding to EA 1 
in ELISA by the polyclonal population of scFv present after each round of panning showed a 
large increase in signal after the first round of panning. This could be due to the stringent 
negative selection in the first round that would have decreased the number of scFv that may 
bind to EAl. There was no significant difference in signal observed between the polyclonal 
scFvs selected using 1 or lO J.lg/ml of EA1 (Figure 6.4). After round 3 there was still some 
cross-reactivity with B. cereus 11145 S-layer protein, however this was much lower than that 
observed in round 3 scFv phage using the non-competitive approach (Figure 6.4). 
After round 3 of competitive panning, 50 scFv (25 from each of the 1 J.lg/ml and 10 J.lg/ml 
selections) clones were selected and analysed by ELISA. Ten of these are shown as an 
example in Figure 6.5. In total, 18 scFv cross-reacted with B. cereus 11145 S-layer protein (6 
from the 1 J.lg/ml strategy and 12 from the lO J.lg/ml strategy). Three of the selected scFv did 
not bind EA 1, all of which were taken from the 1 J.lg/ml EA 1 panning. 29 of the 50 scFv 
analysed were found to be specific for B. ant/,.acis EA I; 16 of these were selected using 1 
J.lg/ml EA I and 13 were selected using EA 1 at a concentration of I 0 J.lg/ml. This result 
demonstrates the utility of the competitive panning method. It was not possible to obtain scFv 
antibodies specific to B. anthracis EA 1 by conventional non-competitive panning, while the 
competitive method rapidly isolated non cross-reactive scFv antibodies that did not recognise 
B. cereus 11145 S-layer protein. 
202 
3.0 
2.5 
2.0 
E 
" 
" 
1.5 ~
< 
1.0 
0.5 
0.0 
R3 IOug!ml R3 lug!ml R3 non-comp -ve control 
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• B. cereus 11145 S-layer protein 
D B. anthracis UM23CI2 
~ B. a/1/hracis S-layer protein EA I 
Figure 6.4 ELISA results showing binding of polyclonal anti-EAI from round 
3 of competitive and non-competitive biopanning procedures. Polyclonal phage-
displayed scFv from round 3 of the biopanning procedure were diluted 50% (v/v) in 
MPBS for detection of B. anthracis EA1 , B. cereus 11145 S-layer protein and B. 
anthracis UM23CI2 spores. Three biopanning procedures were used; competitive 
panning with B. anthracis EAl at 10 f.!g/ml (labelled R3 10 f.!g/ml) or 1 f.!g/ml 
(labelled R3 1 f.!g/ml), or non-competitive panning with B. anthracis EA1 at 10flg/ml 
(labelled R3 non-comp ). An anti-ovalbumin scFv was used as a negative control 
(labelled - ve control). Bound phage were detected using an anti-M13 HRP 
conjugated antibody. Assays were performed in triplicate, error bars show ± two 
standard deviations from the mean. A positive result was defined as being higher 
than the average of the background signal plus three standard deviations of the mean 
background sample. 
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Figure 6.5 An example of ELISA results showing binding of anti-EAl 
monoclonal scFvs selected by competitive biopanning procedures that show no 
cross reactivity with B. cereus 11145 S-layer protein. Monoclonal phage-displayed 
scFv isolated from the third round of EA 1 competitive panning were prepared from 2 
ml of supematant by PEG precipitation and resuspended in 0.4 ml 2% (w/v) MPBS. 
An anti-ovalbumin scFv was used as a negative control (labelled - ve control), and a 
polyclonal scFv known to bind to B. anthracis spores were used as a positive control 
(labelled +ve control). Bound phage were detected using an anti-M13 HRP 
conjugated antibody. Assays were performed in triplicate, error bars show ± two 
standard deviations from the mean. A positive result was defined as being higher 
than the average of the background signal plus tlu·ee standard deviations of the mean 
background sample. 
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ScFv antibodies from rounds 1 and 3 of the competitive panning were examined by BstN 1 
fingerprinting to identify unique clones. As expected there was greater diversity of scFv after 
round l than after round 3 of panning. However, the diversity of scFv was much lower using 
the competitive strategy when compared with the scFv isolated by the non-competitive 
strategy. Only six unique scFv were identified in total from both the I J.lg/ml and 10 J.lg/ml 
competitive panning strategies by BstNl fingerprinting, and were confirmed unique by DNA 
sequence analysis (EAl.l, EA1.23, EAl.IO, EA1.20, EAlO.l, EAI0.4). To distinguish the 
scFv from those using the non-competitive strategy the concentration of EAl used and the 
clone number were used to identify the scFv. For example EAl.l describes clone 1 from the 
l J.lg/ml strategy. The CDR sequences are shown in Tables 6.4 and 6.5. The light and heavy 
chain CDRs for all scFv were similar except for EA10.1 which was dramatically different in 
all CDRs. EAl.l was only different in one amino acid in CDR-Ll where arginine was 
substituted for alanine. EA1.23 also only differed in CDR-H3 where the sequence was 
extended by 9 amino acids. EAl.lO and EA10.4 were all exactly the same in all CDRs. When 
the entire antibody sequence was analysed there were minor differences in the surrounding 
scaffold sequence. EAI.20 differed to EAl.lO and EA1.10.4 by one threonine deletion in 
CDR-Ll. 
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Antibody Light chain CDRs 
Ll L2 L3 
EAl.l A A s K s V T T s G y s y M H L A s N L E s Q H s R D L p w T 
EAI.IO R A s K s V T T s G y s y M H L A s N L E s Q H s R D L p w T 
EAI.23 R A s K s V T T s G y s y M H L A s N L E s Q H s R D L p w T 
EA10.4 R A s K s V T T s G y s y M H L A s N L E s Q H s R D L p w T 
EAI.20 R A S K s V T s G y s y M H L A S N L E s Q H s R D L p w T 
EAIO.l H A s Q N N I N V w L s K A S N L H T Q Q G Q s y p w T 
Table 6.4. The complementarity determining regions (CDRs) of the light chain of scFv produced by competitive panning 
N 
o strategy 
0'1 
Antibody Heavy chain CDRs 
HI H2 H3 
EA I.I S F G M H y] ss D G S T I y y A D T V w L G G y A M D y 
EAl.JO s F G M H YI ss D G S T I y y A D T V w L G G y A M D y 
EA 1.23 s F G M H y J ss D G S T I y y A D T V w L G G y A M D y G V K E p Q s p s 
EA10.4 s F G M H y I ss D G S T I y y A D T V w L G G y A M D y 
EA1.20 s F G M H y I s s D G S T I y y A D T V w L G G y A M D y 
EAIO.J s H w I E E I LP G S G S T N y N E K F K D R D y G N N s F D y 
Table 6.5. The complementarity determining regions (CDRs) of the heavy chain of scFv produced by acompetitive panning 
strategy 
In CDR-Hl the consensus sequence was SF GM H whereas in the non-competitive scFv the 
predominant consensus sequence was S Y G/D M S. In a comparison of CDR-H2 for both the 
competitive and non-competitve scFv some differences are observed, as shown below 
T I S A/T/0/S G T/S Y T Y Y P D S V (non-competitive). 
Y IS S D G STIYYADTV (competitive) 
In CDR-L3 the predominant sequence of the scFv from the competitive panning strategy was 
also found within scFv 5 from the scFv generated by the non-competitive method. 
The only CDR that showed no similarities between the two methods used to produce a-EA I 
scFv was CDR-H3. In comparing the scaffold sequences for the scFv for both methods, 
similarities in the sequences were observed in the regions flanking the CDRs. 
The similarities of whole sequences produced by both the competitive and non-competitive 
panning methods were ascertained using the CLUSTALW algorithm. This allowed the 
construction of a phylogenetic tree (Figure 6.6). Comparison of the sequences for the scFv 
obtained by the competitive and non-competitive panning strategies suggests that all those in 
the competitive group are very similar, with the exception of EA I 0.1 which shares higher 
identity with scFv 7 produced by the non-competitive method. 
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Figure 6.6 Rooted tree diagram of the anti-EAt scFv sequences obtained from 
non-competitive and competitive panning strategies. The tree was obtained using 
CLUSTALW. 
The cross-reactivity of the six unique scFv isolated by competitive panning was determined by 
direct ELISA against S-layer proteins isolated from other Bacillus species. None of these 
scFv showed any cross-reactivity with S-layer proteins from the other Bacillus tested (Table 
6.3). This indicated that all six scFv recognised epitopes are unique to B. anthracis EA I. To 
verify this result, the scFvs were used to probe purified Bacillus S-layer extracts on western 
blots. Detection of purified B. anthracis EA I was demonstrated with all six scFv generated 
(two shown as examples in Figure 6.7). EAI.l, EAI.23, EAI.IO and EAIO.I showed no cross 
reactivity with any other Bacillus S-layer proteins tested, even in overexposed blots. EA1.20 
and EA I 0.4 did show low levels of cross-reactivity with B. pumilus S-layer protein (only 
visible after a 30 minute exposure; example shown in Figure 6.7b). This cross-reactivity with 
B. pumilus S-layer protein was never observed by ELISA, Resonant Mirror or BIAcore 
analysis (data not shown). 
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Figure 6. 7 Cross-reactivity of monoclonal scFv selected by competitive 
biopaooing to Bacillus S-layer proteins by Western blot. The cross reactivity of 
two different anLibodies is shown here; scFv EAl. l (blot a) and scFv EA10.4 (blot 
b). Each S-layer protein extract was separated by SDS-PAGE(5 J.Lg per lane) on a 
10% Bis-Tris NuPAGE gels (lnvitrogen) and blotted onto nitrocelluose membranes 
(lnvitrogen). Lane loading was as follows: A) B. pumilus S-layer protein, B) B. 
brevis S-layer protein, C) B. coagu/ans S-layer protein, D) B. anthracis S-layer 
protein EAl , E) B. cereus 11145 S-layer protein, F) B. cereus 11143 S-layer 
protein, G) B. cereus 9946 S-layer protein H) B. atrophaeus S- layer protein l) 
MagicMarkTM Western standard, J) ovalbumin negative control. After probing, 
bound scFv was visualised using an anti-His tag HRP conjugated antibody (Sigma) 
fo llowed by enhanced chemiluminescent detection. 
6.2.4 Use of specific EAt antibodies on bioseosors 
The S-layer protein EA l was immobilised onto the surface of a BIAcore carboxymethylated 
dextran sensor surface (section 3.44). The scFv were passed over at concentrations of 5-400 
nM (section 3.44). Analysis of the affinity constants of the six B. anthracis EAt-specific scFv 
on the BIAcore biosensor demonstrated that the highest affinity constants were seen in the 
scFv selected using l)lg/ml of EAl compared to those isolated using 10 )lg/ml EA1 (Table 
6.4). No binding was observed on the BlAcore with any of these six specific scFv for any S-
layers evaluated (B. pumilus, B. cereus 11145, B. cereus 1 I 143, B. cereus 9946, B. coagu/ans, 
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B. brevis, B. atrophaeus, B. thuringiensis var. israelensis and B. thuringiensis var. kurstaki; 
(data not shown). 
Single chain kA (1/M) kD(M) 
EAI.l 5.85E+IO 1.71E-11 
EA1.23 4.48E+IO 2.23E-ll 
EAI.lO 1.72E+08 5.81E-09 
EA1.20 1.89E+10 5.28E-ll 
EAIO.l 1.01E+09 9.91E-10 
EA10.4 3.55E+08 2.81E-09 
Table 6.6. Equilibrium association (kA) and dissociation (kD) constants for scFv 
antibody clones produced using competitive panning strategies. Equilibrium 
constants were derived using the BIAevaluation software (BIAcore) using a simple 
Langmuir l: l binding model and the association (k.) and dissociation (k,.) rate 
constants calculated for each set of data. The equilibrium constant kA was 
calculated from the ratio k. I k.t and kD from k.t I k •. 
Demonstration of the detection of intact B. anthracis spores was carried out usmg the 
Resonant Mirror biosensor. Three of the specific scFvs (EAl.l, EA1.23 and EAl.lO) were 
taken forward for evaluation of the sensitivity to whole B. anthracis UM23Cl2 spores on this 
real-time biosensor. For comparison, an anti-EA! monoclonal antibody (mAb) was also 
evaluated. All scFv demonstrated detection of untreated B. anthracis spores (Figure 6.8), 
although the sensitivity of the assay improved significantly when the spores were sonicated. 
In comparison, the mAb could not detect intact B. anthracis UM23CI2 spores at any of the 
concentrations tested, and only a small amount of binding was observed after sonication 
(Figure 6.8). The scFv showed no cross-reactivity to any other Bacillus species spores tested 
(both untreated or sonicated) while the mAb showed detection of sonicated B. cereus 11145 
spores using this method. 
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Figure 6.8 Detection of B. anthracis UM23CI2 spores on a real-time biosensor 
using a competitively selected scFv {EAl.l) and a monoclonal anti-EAt 
antibody. Antibodies were immobilised using standard EDC/NHS coupling onto a 
T70 CMD surface (Labsystems, Affinity sensors). Intact or sonicated spores were 
passed over immobilised scFv EAI.I (scFv intact or sonicated spores) or anti-EAt 
monoclonal (mAb intact or sonicated spores) antibody in PBS 0.05% (v/v) Tween 
20. Spores were sonicated as described previously, using the tubular sonicator 
(Chapter 5). Error bars show± two standard deviations from the mean. 
6.2.5 Recognition of Urografin purified spores using FITC-Iabelled scFv. 
As was reported previously with the anti-EA I antibody (Chapter 3), the results suggest that 
the scFv bound to whole spores that had been subsequently Urografin purified and washed 
according to the method described by Wlliams and Turnbough (2004). Representative samples 
are shown in Figure 6.9. No binding of FITC to the spore in the absence of antibody was 
observed, or binding of a non-specific FITC -labelled antibody was observed. 
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a) b) 
Figure 6.9 Evaluation of the binding of a FITC labelled anti-EAt scFv (EAl.l) 
to Urografin purified B. a11thracis UM23CI2 spores. a) B. anthracis spores washed 
1 Ox urografin purified and washed 3x viewed by fluorescence microscopy (x 1 000), b) 
B. anthracis spores washed 1 Ox, urografin purified, and washed 3x, viewed by phase 
contrast microscopy (xlOOO). 
6.2.6 Immunogold labelling 
In order to complete the immunogold labelling experiments using the smallest number of 
conjugates the scFv DNA sequence has to be cut from the original plasmid and ligated into a 
pKAPPA plasmid, kindly provided by C. Mayers (Dstl) (section 3.47-3.48). This plasmid had 
the advantage of containing a mrnine kappa chain, so only a gold-labelled anti-murine 
antibody was required for immunogold labelling experiments (section 3.49). Immunogold 
labelling of thin sections of washed UM23Cl2 spores showed using the anti EA1 scFv, EAl.l 
showed that most of the antibody was observed as being bound to the exosporium, more 
specifically the hair like projections within the nap of the exosporium. Some antibody was 
observed around the spore and not associated with the exosporium using this method. 
However, this was often observed withjn darker areas of the section, possibly indicating 
exosporium fragments. No binding of the gold label was observed in the absence of antibody. 
Representative sections are shown in Figure 6.10. 
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c) 
Figure 6.10 Representative TEMs of immunogold labeled B. anthracis 
UM23CI2 spores using scFv EA1.1 (a and b). A representative section from the 
negative control is shown in 6.10c. 
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6.2.7 Peptide mapping of linear epitopes 
Linear peptides of the derived from the EAl protein sequence (section 3.50) were synthesised 
using 14mers with a 4 aa overlap. Using the BIAcore all anti-EAl scFv produced by the 
competitive pannjng strategy were immobilised onto a sensor surface and peptides passed over 
the surface at a concentration of to determine if they bound to the peptides (section 3.50). The 
results suggested that all of the antibodies bound in the same region, with the exception of 
EA 1 0.4, to which no binding was observed to any linear epitope. Mapping of the linear 
epitopes to which a response was observed suggested that the epitope was contained within the 
region LNLPVDENAQPSFKDAKNIWI of the EAl protein. An example of the results 
obtained is shown in Figure 6.11. 
Figure 6.11 Binding of linear peptides to immobilised scFv EAl.l. Antibodies 
were immobilised using standard EDC/NHS coupling onto a T70 CMD surface 
(Labsystems, Affinity sensors). Peptides were passed over for 10 min. Error bars 
show ± two standard deviations from the mean. 
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6.3 Discussion 
The aim of producing the scFv was for use in an optical biosensor, in order to demonstrate the 
near real-time detection B. anthracis with the exclusion of all other Bacillus species. 
Therefore, demonstration that the anti-EA! scFvs would not react with S-layer proteins from 
other Bacillus species was required. It is often argued that any antibody can cross react with 
another unrelated target, leading to the observation that "an antibody is only truly specific in 
the background in which it is tested" (Holt et al., 2000). In a biodetection context, the relevant 
background is the background that the sample would have been isolated from, usually an 
environmental air sample. For this reason only a selection of Bacillus species was tested for 
cross reactivity. An organism of particular concern was B. thuringiensis, used (and sprayed) 
widely as an insecticide. BLAST searches demonstrate a very high degree of similarity 
between the EAI protein sequence of B. thuringiensis and B. anthracis. The other organism 
of concern was B. cereus, another closely related species found widely in soil (Helgason et al., 
2000). The high cross-reactivity of the scFv produced by non-competitive biopanning suggests 
that the S-layer proteins of these species may contain proteins that are homologous to the B. 
anthracis EA I S-layer protein. The higher degree of cross-reactivity observed with spores of 
B. pumilus, B. atrophaeus and B. cereus 11145 suggests that these proteins demonstrate the 
greatest degree of similarity to EA1, or that a highly conserved or immunodominant epitope 
exists within these species (Holt et al., 2000). Irrespective of the reason why these scFv were 
cross-reactive, none where of any use for specific detection of B. anthracis. 
The ELISA results from the competitive biopanning strategy indicate that some scFvs that 
cross-react with B. cereus 11145 S-layer protein were still selected, even though a competitive 
selection procedure was used. This may be because the cross-reactive antigens from closely 
related species were not sufficiently in excess (although 10-fold excess was used) leaving 
cross-reactive scFv to bind to the target. Furthermore, the cross reactive epitope within the S-
layer protein that binds to the scFv may be immunodominant, ensuring that a large proportion 
of the scFvs bind to this site (Holt et al., 2001). It may also be due to selective pressures 
imposed by growth or expression, or a combination of these factors. Despite the cross 
reactivity of the round 3 polyclonal scFv population it was hoped that some scFv clones with 
reduced cross-reactivity would have been selected. 
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Results of the sequence analysis after competitive panning suggests that this process rapidly 
led to the elimination of a large proportion of the population of scFv clones by negative 
selection. This could suggest that some binders were lost through further rounds of selection, 
either due to low affinity or selection pressures of bacterial growth or expression. The scFvs 
produced by the competitive approach showed less diversity in the CDRs than those produced 
by competitive selection. As expected, variations in CDR-H3 gave the main source of 
diversity between the different antibodies, as CDR-H3 is mainly responsible for specificity 
(McCarthy and Hill, 2001) 
The results for the determination of affinity constants (KA and KD) revealed that these B. 
anthracis specific scFvs had apparent nanomolar affinities for EA I, suggesting sufficient 
affinity for them to be used for sensitive detection. As absolute specificity was used as the 
original criterion for success, other stronger binders (albeit cross-reactive) may have been 
eliminated through the competitive panning process. It is likely that the affinities of these 
antibodies could be improved by further maturation techniques if desired (for example, 
Jermatus et al., 2001; Mossner and Pluckthun, 2001). 
The results of the epitope mapping suggest that all the scFv, with the exception of EAI0.4 
bind the same epitope, this supports sequence data for the scFv. This is perhaps unsurprising 
as EAI0.4 showed the least similarity in sequence compared to the other scFv. The epitope to 
which EAI0.4 bound could not be determined using this approach so it is likely that this 
antibody binds to a discontinuous three dimensional epitope. Interestingly, the areas to which 
the scFv bound correlate in part to the unique sequences identified as being surface located 
(Chapter 5) by BLAST, as shown in Figure 6.12. In comparison to the predicted unique 
regions highlighted in Chapter 5 (Figure 5.10-5.11), one of these regions DAKNIWS, was also 
predicted to be located on the surface of the protein. However, the other area to which the 
antibody bound, PVDENA, only showed one amino acid substitution compared to closely 
related species such as B. cereus E33L. This region was also not predicted to be surface 
located. These amino acids (PVDENA) may have no role in determining the specificity of a 
recognition elements, alternatively it may be an important residue for the structure of the 
surface located region, or the modelled structure by be incorrect and this region may also be 
surface located. These results suggests that a assumption of binding to linear exposed regions, 
whilst possible, may be over simplified; however, this approach is at least suitable for 
identifying the potential to produce specific recognition elements. In future work smaller 
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peptide sequences could be used to define the epitope to which the antibody bound more 
clearly and amino acid substitution could be used to determine those residues which are 
essential for antibody binding. 
B. anthracis 24 
B. cereus E33L 106 
Figure 6.12 Areas of difference in the EAI sequence in the regions bound 
by selected scFv. Difference between B. anthracis and B. cereus E33L S-layer 
protein within the region are highlighted in red. 
Usually, scFv libraries that are produced from immunised mice are used to obtain scFvs that 
show high affinities for the desired targets. While naive libraries have been used successfully, 
it has been documented that higher affinities and a wider diversity of antibodies can be 
obtained from an immune library. Competitive panning is extremely useful in this case to 
reduce the complexity of these immune libraries by eliminating cross-reactive antibodies. 
Immune libraries have the advantage of having undergone significant affinity maturation in 
the mouse; the antibodies evolve in vivo in the B cell by hypersomatic mutation within the 
hypervariable regions to enhance specificity and affinity (Borrebaeck and Ohlin, 2002). 
The immune library used here was created from mice immunised with a complex antigen 
(whole B. anthracis spores) not specifically against EA I, so this library would have contained 
a selection of antibodies that bound to a range of target antigens. The diversity of this library 
may be limited with respect to those that recognise a range of EA I epitopes. If an a-EA I 
library had been utilised, this may have enhanced the probability of isolating an EA I specific 
scFv by non-competitive selection, although in practice it is preferable to producing a single 
library for each complex target, allowing a range of antibodies to be isolated whilst 
minimising animal use. It is possible that this method may only be applicable to highly 
immunogenic antigens such as EA!. Western blot analysis of a polyclonal goat antiserum 
raised against whole B. anthracis spores also showed binding to EA I, demonstrating that it is 
present and immunogenic in spore preparations (data not shown). It is important to remember 
that the specific EA I antibodies must have been lost during non-competitive panning, perhaps 
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due to competition from non-specific antibodies with higher affinities for the target or other 
selection pressures such as slow growth. 
Unlike previous applications of competitive panning (for example, Cai and Garen, 1995; 
Scherer et al., t998; Krebs et al., 2001), the much simpler procedure of one step negative 
selection demonstrated here shows that a complex mixture of competitors can be used in the 
first round of selection to remove the majority of non-speci fie binders and isolate a number of 
scFvs specific for the original target. 
As previously discussed (Chapter 5) it has been suggested that EAt is a contaminant within 
spore preparations and could be removed through the use of Urografin purification (Williams 
and Tumbough, 2004). However, this does not agree with the observations made in this work. 
After labelling the scFv created with FITC and allowing the antibodies to bind to Urografin 
purified and washed spores the antibodies were found to bind to whole spores and not any 
contaminating material within the sample. This confirms previous observations using an u-
EA t mAb (Chapter 5). 
The insertion of the scFv sequence into the pKAPPA construct was advantageous for 
immunogold labelling as this construct had been designed to incorporate a His-tag for 
purification but also murine kappa chain. Therefore, the gold particle would be kept as close to 
the site of binding as possible as only an anti-mouse gold conjugate was used. If the scFv had 
been used in the previous constructs, containing only a His-tag, a series of antibodies would 
have to have been used to incorporate an anti-species gold conjugate. lmmnogold labelling of 
whole spores revealed that most of the antibody was bound to the hairy nap of the exosporium. 
Although selective binding of EAt to the exosporium may be fortuitous, a function for EAI 
within the spore (in particular in vivo) can not be discounted until further experiments are 
conducted (Charlton et al., 1999; Liu et al., 2004). The fact that the antibody bound to the 
hairy nap suggests that EAt, or the EAt epitope recognised by the antibody, is present within 
this layer. A small proportion of antibody was visualised surrounding the spore; on closer 
examination this was observed associated with darker material within the section, possibly 
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fragments of the exosporium. However, these hypotheses would have to be assessed in future 
work. The results to date do however, suggest that EA I, either whole or in a truncated form, 
has a stronger association with the exosporium than previously suggested by Williams and 
Tumbough (2004). 
The generation of specific recognition elements for EA 1 and consequently B. anthracis spores 
in this case, was only possible using the competitive strategy. The resultant recombinant 
antibodies should be useful across a wide range of detection techniques, from the conventional 
laboratory analysis methods such as ELISA and Western blotting to detection technologies 
capable of near real time detection such as evanescent wave based biosensors. The use of 
these specific recognition elements on the Resonant Mirror biosensor enabled the detection of 
anthrax spores in near real time, with no false positives even when exposed to very high 
backgrounds of closely related Bacillus species that commonly cross-react with anti-anthrax 
polyclonal and monoclonal antibodies. This is the first demonstration of antibodies that are 
able to perform to this high specification have been described. 
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Chapter 7 General Discussion and Conclusions 
In this study, three main areas were addressed in order to achieve the near real time 
detection of B. anthracis spores. The first issue was to address the theoretical limitations 
associated with the detection of larger particulates using optical biosensors (Watts et al., 
1994; Framatico et al., 1998), by disrupting the spore prior to the assay. Secondly, it was 
necessary to characterise the antigenic and other components of the spore that were surface 
accessible and/or released by the disruption step. Finally a specific ligand was developed 
for detection. 
A preliminary survey of disruption techniques, and the requirement for a rapid flow 
through system that could disrupt the spores prior to the detection assay, suggested that 
electroporation and sonication were the two most promising approaches. Although these 
two techniques have been utilised for many years for various purposes, they still remain 
relatively uncharacterised, particularly in the case of bacterial spores. Furthermore, the use 
of such techniques for enhancement of immunoassay-based techniques has not been 
described. 
It was found that electroporation did have an effect on bacterial spores, observed as sub-
lethal alterations of the outer integuments and the release of components into the 
surrounding medium; this is an observation that has previously been widely dismissed with 
the exception of one study by Marquez et al. ( 1997). However, the mechanisms by which 
this occurred could still only be speculated upon. Further experiments are required to 
determine any alteration to the underlying structures of the spore and to fully understand 
the mechanisms by which this occurs. Using the conditions tested, the electroporation of 
spores did not confer an increase in assay sensitivity probably due to the denaturation of 
protein and/or migration and deposition of proteins and DNA on the electrodes. 
In the case of sonication, preliminary work suggested that heat was a limiting factor, as a 
number of cooling steps were required to allow for recognition of the proteins released. 
The development of a radial transducer allowed for in line disruption of the spores whilst 
limiting heating of the bulk solution. Using this system, significant improvements in the 
sensitivity of the detection of B. anthracis spores (up to 500 fold) was demonstrated, using 
an optical biosensor and other immunoassay based techniques. Therefore, the application 
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of disruption to enhance the sensitivity of the near real time detection has been shown 
experimentally for the first time and could have significant implications for a range of 
immunoassay based technique for detection and diagnosis. 
As in previous studies, defining the effect of ultrasonic cavitation was difficult. The 
reasons for this are probably two-fold, firstly due to the complexity of the numerous 
possible outcomes of sonication such as high local heating, shear forces, and the 
production of free radicals and secondly due to the difficulty in characterising and 
predicting of the outcomes of these effects on a complex moiety such as a spore. The use 
of the tubular sonicator, where bulk heating was maintained at definable levels, confirmed 
that the predominant effect of sonication on the bacterial endospore was to remove the 
outer integuments of the spore, probably due to cavitation events and microstreaming 
within the surrounding media. Previous observations of internal damage were probably 
largely attributable to heat, as they were not observed using this system. Although 
preliminary results suggest that ultrasonic cavitation may have an effect on the proteins 
released, as has been suggested by Strathopulos et a/ (2004), this appeared to be negligible 
for antibody based detection using the conditions tested. The increase in assay sensitivity 
was probably due to the release of proteins from the surface resulting in an apparent 
increase in analyte concentration, increased mass transport to the sensor surface and a 
reduction in steric hindrance. Therefore the choice of antibody antigen pair would be 
essential in achieving the optimal assay sensitivity. For antibody based detection the 
immunogenicity of a target would also be advantageous. To this aim, the structural and 
surface located antigenic components of the B. anthracis spore were determined. 
The exosporium of Bacillus anthracis represents the primary barrier between the spore and 
the external environment and as such represents a source of putative detection targets. The 
identification of the immunodominant exosporium protein BclA has already been reported; 
however, this glycoprotein shares high identity with homologues of closely related species 
which have been identified experimentally in B. cereus and B. tlwringiensis spores and as 
such is not suitable for specific detection (Sylvestre et al., 2002; Steichen et al., 2003). [n 
this study, the identification of other immunogenic proteins of the B. ant/Jracis exosporium 
was achieved through the development of an immunopurification procedure. Using this 
technique, 9 proteins were identified, 8 of which have been described previously in 
exosporium preparations (Steichen et al., 2003; Todd et al., 2003; Liu et al., 2004; 
Redmond et al., 2004). A second CotB homologue was also identified experimentally as a 
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component of unwashed B. alllhracis exosporium, which has not been reported previously. 
The nature of the association of alanine racemase with the exosporium is still unclear, 
although preliminary results suggest this enzyme may interact with other immunogenic 
proteins, ExsY, ExsK and CotY. ExsFA (ExsF/ BxpB) was also identified as an 
immunogenic protein and has also been widely cited as a component of the exosporium 
from both B. anthracis and B. cereus spores (Steichen et al., 2003; Todd et al., 2003; Liu 
et al., 2004; Redmond et al., 2004; Sylvestre et al., 2005) and has been reported to be 
associated with BclA (Steichen et al., 2003, 2005; Redmond et al; 2004; Sylvestre et al., 
2005). This is the main structural component of the fine filaments of the exosporium hairy 
nap. Along with ExsFA, a second ExsF protein, ExsFB appears to have an important 
structural role within the exosporium. Together, these ExsF proteins may be required for 
the proper locaJjsation of BclA to the spore surface and for the stability of the exosporium 
crystalline basal layers (Sylvestre et al., 2005). The ExsF proteins are probably organised 
in multimeric complexes with other exosporium proteins (Redmond et al., 2004; Sylvestre 
et al., 2005). The immunogenicity of ExsF (ExsFA) was also shown in a recent study by 
Sylvestre et al. (2005). 
The identification of immunogenic proteins of B. afllhracis may suggest a more primary 
role in anthrax infection as well as being important in the development of immunoassays 
for detection and diagnostic purposes. The exact function of the majority of the proteins 
identified in this study and their location within the outer spore surface layers has yet to be 
elucidated. However, these results and other work suggest that complex interactions exist 
between identified exosporium proteins in the formation and assembly of the spore coat 
and exosporium (Bailey-Smith et al., 2005; Sylvestre et al., 2005). Future experiments will 
seek not only to answer these questions, but the methodology developed using polyclonal 
antibodies from different species and antibodies raised against different micro-organisms 
could be utilised to identify immunogenic proteins. This technique could possibly provide 
an important step in the identification of antigenic markers for the development of 
detection and diagnostic assays and medical countermeasures including vaccines, as well 
as enhancing the understanding of markers that may be important in pathogenesis. 
A number of proteins were identified following sonication of B. anthracis spores using the 
tubular sonicator, some of which have not been described previously as spore proteins 
from experimental observations. The results suggested that this system could be used to 
increase the number of putative detection targets to beyond those located in the 
exosporium. In the absence of proteins specific to B. anthracis, computer modelling 
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techniques were used to evaluate the location of unique regions within the protein that 
were predicted to be surface accessible. This allowed for rational selection criteria to be 
implemented to select targets for which specific ligands could theoretically be produced. 
To date EA!, BA3189 (MntA), BxpA and ExsA may function as such targets. BxpA has 
been described as a component of the B. anthracis exosporium (Steichen et al., 2003). 
However, MntA and ExsA represent novel B. anthracis spore proteins. 
MntA (BA3189) has been found to be a chromosomally encoded virulence factor of B. 
anthracis (Gat et al., 2005). Although reported previously as being present predominantly 
in the cell (Gat et al., 2005), in this study it was also isolated from spore preparations. In 
the work reported by Gat et al. (2005) a mntA deletion mutant was found to demonstrate 
retarded growth in rich media, delayed release from cultured macrophages and increased 
sensitivity to oxidative stress. A role in increased oxidative stress is of interest, as work 
conducted by Kang et al. (2005) suggests that a role of the exosporium may have a 
protective role within the host macrophage. Thus, proteins such as such as superoxide 
dismutases, alkyl hydroperoxide reductases (such as BA0345 identified in this study) and 
other identified components of the outer spore layers (Lai et al., 2003; Liu et al.,2004; 
Redmond et al., 2004; Steichen et al., 2005) may also have a role in this function Future 
experiments will seek to address this, for example by the use spores in which of the genes 
which encode these proteins have been deleted and subsequent evaluation of survival 
within the macrophage. 
The ExsA protein has not been reported previously within the B. alllhracis spore. Work 
conducted by Bailey-Smith et al. (2005) showed that the ExsA protein of B. cereus (ATCC 
10876) has a functional role in the formation of the spore coat and exosporia! layer. The 
ExsA proteins are homologues of Sa fA of B. subtilis. The SafA protein has been found to 
be associated and directly interact with SpoVID during the preliminary stages of the 
assembly of the spore coat and is located at the interface between this layer and the spore 
coat in mature spores (Ozin et al., 2000, 2001). Localisation of SafA within the spore is 
also dependent on SpoVIA (Ozin et al., 2001). As with B. cereus (Bailey-Smith et al., 
2005), SpoVID and SpoVIA also have homologues within the B. anthracis genome and 
thus may be required for the assembly of ExsA (Bailey-Smith et al., 2005). The 
requirement for ExsA for the assembly of the coat and exosporium suggests that this 
protein may have an essential function and thus would make a suitable target for detection 
and diagnostics assays. In this study, the sonication of B. anthracis spores only appeared to 
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disrupt the exosporium and to a lesser extent the underlying spore coat. Thus, since ExsA 
is required for formation of the exosporium taken in combination with the known location 
of SafA, it could be speculated that ExsA may also be located at the interface between the 
spore coat and exosporium. Further experimentation using ligands, such as scFv, generated 
against the ExsA proteins and subsequent immunogold could be used to determine if this 
hypothesis is correct. 
The direct identification of proteins specific to the B. cereus group through direct analysis 
of pepsin digests obtained from sonicated spores may have significant implications for 
mass spectrometry based identification. In previous work, Small acid soluble proteins 
(SASPs) have been extracted following exposure to acid and identified by matrix assisted 
laser desorption ionisation mass spectrometry (MALDI-MS) (Elhanny et al., 2001; 
Hathout et al., 2003; Warscheid et al., 2003; Warscheid and Fenselau, 2003; Horneffer et 
al., 2004; Whiteaker et al., 2004; Pribil et al., 2005). Generic identification of the presence 
of spores is certainly possible using these methods; however, discrimination at the species 
level is more problematic as this is often attributable to a single tryptic digest. More 
recently presented work has questioned the reproducibility of the identification of the key 
peptides required for discrimination at the species level (Jue et al., 2005). Thus, although 
SASPs may be useful for mass spectrometric identification they may not always provide a 
reliable method of distinguishing different species. The results obtained here using a 
physical disruption step and subsequent MS/ MS identification may provide more reliable 
markers for species specific identification. However, the statistically significant 
reproducible identification by MS would need to be assessed. 
In variance with previous studies (Williams and Turnbough, 2004), EAI was identified in 
Urografin purified spores and was consistently identified using a range of techniques. This 
protein has been previously identified in spore coat extracts and exosporium (Lai et al., 
2003; Liu et al., 2004; Redmond et al., 2004). Preliminary evaluation of monoclonal 
antibodies and scFv that recognised EAI were found to bind to the spore and not to any 
contaminating material within the spore preparation. Immunogold labelling confirmed 
these observations and determined that a significant proportion of antibody was bound to 
exosporium, more specifically to the hair-like projections of the nap. This observation, 
combined with data obtained from homology models suggested that EAI was located 
within the hairy nap, possibly bound to the carbohydrate component of BciA and/or BciB. 
One potential problem with the use of numerous washing and purification steps is that the 
fragility of the exosporium to these conditions has not been determined. Therefore, the 
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release of exosporal fragments during such processes can not be discounted (Pembrey et 
al., 1999). Although not proven, this could be considered a possible reason for the decrease 
in the amount of EA I. Ideally, quantification of known structural components before and 
after treatment would be needed to assess the effect of the purification procedures. Further 
work would be then be required to determine if the purification process had any effect on 
pathogenicity due to the possible loss of exosporium components. Although EAl may be a 
contaminant of these preparations, the selective adsorption to the exosporium, as with other 
non-structural components, may have an as yet undescribed function and as such EA I was 
not disregarded as a target for specific detection. As the role of EAI within the spore is 
unclear, but since it had been consistently identified from spore preparations and was not 
unique to B. anthracis this target was taken forward for the production of specific ligands. 
Monoclonal anti-EAl antibodies were not specific to B. anthracis and were found to cross-
react with closely related species. The generation of specific recognition elements for EAl, 
and consequently B. antlzracis spores, was possible through use of a competitive 
biopanning strategy. The use of the resultant a-EAl scFv demonstrated real-time detection 
of B. anthracis spores. Research to date using pre-adsorption has not demonstrated the 
elimination of cross-reactivity to such a broad range of cross-reactive targets in one single 
step. Therefore, although EAl may not represent the 'ideal' detection target, the 
methodology used could be implemented for other proteins of the B. anthracis spore. In 
conclusion, the method of competitive panning described here provides a significant 
advantage over conventional monoclonal and polyclonal approaches, particularly for 
critical diagnostic and detection applications. 
Proteomics is a rapidly expanding area and as more sequence data from various organisms 
becomes available, the ability to select detection targets for the production of detection 
ligands is increasing. The approaches described within this study could be useful in the 
identification of novel proteins to which specific ligand could be generated. Conversely, as 
sequence data is added the number of unique regions may decrease, as was found during 
this work, thus creating an impetus to define the biological background from which the 
sample may be derived, as well as knowledge of the presence and abundance of proteins 
within closely related bacteria. 
The use of BLAST searches and computer modelling were useful in the selection of 
potential targets for the production of specific ligands; however, the presence of a gene 
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does not indicate whether it is transcribed. Furthennore, examination of the genomes of 
closely related species suggests that the evolution of a pathogenic species can occur 
through the expression and regulation of genes as well as the acquisition of additional 
genes. Thus, one important consideration would be the detennination of the presence of 
proteins within closely related species. This in itself presents a problem because although 
large scale analysis of the proteins present in closely related species could be achieved by 
microarray analysis, this technique has inherent problems and would be limited to genes 
induced in sporulation as described by Liu et al. (2002) and the number of organisms 
required to be analysed by this method would take considerable time. The alternatives are 
the use of techniques such as Isotope Coded Affinity Tag (ICAT) and the Absolute 
Quantification of proteins and post translational modification (AQUA) that can 
quantitatively detennine the concentration of a protein of interest, without the need for an 
antibody (Gerber et al., 2003). Again, this procedure would be relatively time consuming 
for the number of organisms to be evaluated and is limited to proteins suitable for such 
analyses. Computer modelling techniques are confined by ability to obtain accurate 
sequence and structural infonnation for the proteins of interest. 
The identification of a target that fulfils all the criteria of surface location, specificity, 
abundance, required for virulence and expression under all possible conditions seems 
unlikely considering this and other research. For example, using mass spectrometry based 
techniques, CotY and ExsY have been shown to be two of the most abundant proteins 
within exosporium preparations (Liu et al., 2004). Examination of genomic data (Todd et 
al., 2003) has shown that in B. cereus and B. anthracis the exsF, exsY, and cotY genes are 
located in a gene cluster close to other genes thought to be required for fonnation of the 
exosporium. Results from this study also indicate that these proteins are irnmunogenic. 
However, these proteins show high degrees of identity with closely related species as such 
it is unlikely that specific ligands could be produced. The most promising approach may be 
the use of an array of ligands each of which may fulfil these criteria. Pattern recognition 
could specifically identify the organism, as has been described for lectin, glycoconjugate 
and peptide based ligands (Cole et al., 1984; Williams et al., 2003; Tarensenko et al., 
2004). The disadvantages ofthe approaches used previously are that the target to which the 
ligand binds has not been reported or characterised, thus it may not be ideal for detection 
purposes. This study has detennined a number of targets for which some of the desirable 
properties of a detection target may be met and will be fully evaluated in future work. 
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A number of studies have been conducted into the elucidation of the proteins of B. 
anthracis spores (Sylvestre et al., 2002, 2005; Steichen et al., 2003; 2005; Lai et al., 2003; 
Liu et al., 2004; Redmond et al., 2004). However, large numbers of putative spore proteins 
still remain undetected (Lai et al., 2003; Liu et al., 2004). This study has contributed to the 
knowledge of components of the B. allthracis spore and identified a number of 
immunogenic proteins although the location, function and potential interactions of such 
proteins remains unclear. The identification of a unique antigen of the B. anthracis spore 
has proven particularly challenging and to date no such antigen has been described in the 
literature. All previous research has focused on the use of whole spores to identify specific 
ligands that may or may not be suitable for detection. 
In conclusion, the use of a rational design process for the production of specific ligands has 
been shown for the first time and used for the elimination of cross reactivity to a known 
protein target. Combined with the use of continuous flow sonication, a highly sensitive 
method for the near real time specific detection of B. anthracis spores has been 
demonstrated. 
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Appendix 1 Supplementary tables 
Type of biosensor and Principle Detection elements 
examples 
OPTICAL (Evanescent wave based) 
Surface Plasmon SPR occurs when monochromatic plane-polarized light hits a metal Recognition element 
Resonance (SPR). film, commonly gold, under conditions of total internal reflection. most commonly 
When this takes place free electrons of the metal oscillate and absorb antibodies. 
energy at a certain angle of incident light. The angle at which this 
happens is called the SPR angle and will change due to alterations in 
the evanescent field i.e. binding of target to ligand. 
Light Scattering SPR. SPR coupled to light scattering signals observed from bound Recognition element 
particles. most commonly 
antibodies. 
Surface Plasmon Based on SPR but a surface is generated with functional (binding) Recognition element 
Diffraction. and reference areas to create a surface grating structure. The most commonly 
amplitude of the dielectric grating is changed by binding of the target antibodies. 
analyte to the functional areas. Binding is monitored as a change in 
the diffraction intensity. Any bulk effects often observed with 
evanescent wave techniques which take place over both the reference 
and functional areas are not observed as they will not alter the 
grating amplitude and hence not change the diffraction intensity. 
Surface Plasmon Field- Based on SPR but the evanescent wave is utilised to excite Recognition element 
enhanced fluorescence fluorophores near a metal/dielectric surface. most commonly 
spectroscopy. antibodies. 
Table Al.l. Examples of biosensor technologies described on the basis of the method of transduction. 
Examples of applications (key 
references) 
Proteins, bacteria, viruses, DNA 
hybridization. (Medina et al., 
1997.) 
Bacteria, viruses, protein. 
Example Escherichia coli. 
(Perkins and Squirrel, 2000) 
Proteins, bacteria, viruses. 
Example Human gonadotropin. 
(Yu and Knoll, 2004). 
Proteins, bacteria, viruses, DNA 
hybridization. (Ekgasit et al., 
2004). 
Example Principle Detection elements Examples of 
applications (key 
references) 
Resonant Mirror. Through the use of a high and low index dielectric material, at a certain angle of Recognition element most Proteins, bacteria, 
incidence light is coupled into the high refractive index layer and undergoes total commonly antibodies. viruses, DNA 
internal reflection allowing an evanescent wave to propagate to the sample layer. hybridization. (Watts 
Reflection of the light incurs a phase change which can be monitored. The phase et al., 1994 ). 
change is dependent on alterations in the evanescent field i.e. an analyte binding to a 
ligand. 
Bidiffractive Binding of target analyte is detected through a change in the refractive index within Recognition element most Staphyloccocal 
grating sensor. the evanescent field and a change in the refractive index of each propagating light commonly antibodies. Enterotoxin B, Ricin. 
mode (TMo and TEo). The difference between the two decoupled beam angles can (O'Brien et al., 2000). 
be used to measure the response. 
Interferometer. Based on an optical system of a Young~ interferometer. Mass coverage (binding) Recognition element. Bacteria (Svenson, 
causes a local change in the phase velocity of light in the wave-guide and is detected 1993.) 
by an interferometric set-up. 
Ellipsometry. Measurement of a change in the polarisation state of an elliptically polarised beam Recognition element. Salmonella 
from thin films Typhimurium. 
(Schneider et al., 
1997.) 
Imaging Based on ellipsometry but an image of the film can be obtained making it useful for Recognition element. Yersinia 
Ellipsometry. micro array. enterocolitica. (Bae et 
al., 2004). 
Table Al.l. continued 
N 
w 
0 
Example 
Whispering gallery modes 
in microspheres. 
Fibre Optic. 
FLUORESCENCE BASED 
Flow Cytometry. 
Capillary electrophoresis. 
Real-time PCR. 
FISH. 
Intrinsic fluorescence of 
biological particles. 
Vertical Cavity Surface 
Emitting Lasers 
Table Al.l. continued 
Principle 
Light is coupled from an optical fibre to stimulate modes in a dielectric sphere. 
On binding to the sphere there is an interaction with the evanescent field of the 
whispering gallery mode shifting the frequency of the mode. 
Evanescent wave fibre optic based e.g. RAPTOR. 
Cells are labelled using a fluorescent dye or labelled antibody. As cells pass 
through the illuminated sensing region of the flow cell, a fluorescent pulse is 
emitted for labelled species. Scattered light from cells can also give size, shape 
and structure information. 
Electrophoresis within a narrow bore capillary, detection is based on the output 
of an electropherograrn which will measure UV absorbance or fluorescence. 
Detection of fluorescence emitted by dyes released during DNA amplification. 
DNA hybridisation to a target probe labelled with a flurophore. 
Detection of the intrinsic fluorescence emitted by Biological particles. 
Detection of near infrared dyes. 
Detection elements Examples of 
applications (key 
references. 
Recognition elements Bovine serum albumin 
could be used. (BSA). Arnold et al., 
2003 
Recognition element Ricin, Bacillus globigii 
most commonly (Bacillus subtilis var. 
antibodies. niger spores, F. 
tularensis .. Anderson et 
al., 2000. 
Recognition element E. coli and 
most commonly Staphylococcus aureus. 
antibodies. Gunasekera et al., 2000. 
Recogntion element Range of target analytes 
DNA or annbody. e.g. toxins. Bassi et al., 
2000. 
None. DNA. Ke et al., 2000. 
DNA. DNA. Amann and Kuhl, 
1998. 
None. Intrinsically fluorescent 
species. Reyes et al., 
1999. 
None. Thrush et al., ??) 
N 
VJ 
-
Example 
Bioluminescence. 
Adenosine triphosphate 
(A1P)/ Adenylate kinase 
(AK) detection, 
Luciferase based 
Chemiluminescence. 
Examples luminol, 
lophine, lucigenin or 
oxalate derivative 
Electrogenerated 
chemiluminescence 
CHROMOGENIC 
Enzyme Linked 
Irnmunofiltration Assay* 
Flow through capillary 
enzyme immunoassay* 
Liquid crystals 
Stabilised Colloidal 
systems e.g. gold 
hydrosols 
Table Al.l continued. 
Principle 
Uses the A1P dependent luciferase-luciferin reaction to produce light. AK can 
be used to enhance assay sensitivity. Bacteriophage can be used for specific 
lysis of target organisms. 
These can undergo oxidation in the presence of hydrogen peroxide (H20 2) to 
produce light. 
Using a positively biased electrode luminol is oxidised in the presence ofH20 2 
light emission occurs. 
A biosensor based on a solid phase Enzyme Linked Irnmunosorbent Assay 
(ELISA). 
A biosensor based on a solid phase ELISA. 
Changes in the orientation of liquid crystals on binding of analyte can be 
amplified and transduced into a optical signal visible to the naked eye. 
The absorption band of gold nano-particles is typically around 520 nm on 
aggregation and coupling reactions that occur using a ligand and an analyte. On 
binding there is a shift in the surface plasmon absorption resulting in a 
observable colour change. 
Detection elements Examples of 
applications (key 
references. 
Bacteriophage. Bacteria e.g. S. aureus. 
Prosser, 1994 and 
Blasco et a/1998 
Recognition element Range of analytes e.g. 
most commonly E. coli 0157:H7. Liu et 
antibodies. al., 2003 
Recognition element B. anthracis spores, S. 
commonly a labelled typhimurium, E. coli 
antibody. 0157:H7. Yu and Stopa, 
1996. 
Recognition element E. coli Paffard et al., 
most commonly 1996; Aubert et al., 
antibodies/ON A 1997. 
hybridization. 
Recognition element SEB, bacteriophage 
most commonly M13, E. coli. Koch et 
antibodies al., 2000. 
Recognition element Biotin/avidin. Gupta et 
al., 1998 
Recognition Lectin. Hone et al., 
elements. 2003. 
Example Principle Detection elements Examples of 
applications (key 
references.) 
Holographic. Metabolite Change in pH due to a specific enzyme/substrate reaction using None. Metabolite detection. 
holographic biosensor. hydrogels eo-polymerised with monomers incorporated with ionisable Marshall et al., 2004. 
groups and cross-linkers. A change of pH produces a visible colour 
change. 
ELECTROCHEMICAL 
Light Addressable Measures local changes in an alternating photocurrent generated using a Recognition element Nesseria meningtidis, 
Potentiometric. rapid pulsing light source (often a light emitting diode). most commonly Yersinia pestis. Libby 
antibodies/ON A and Wada, 1998/ 
hybridization. Hafernan et al., 1998 
Potentiometric. Electrodes detect changes in potential at constant current (usually zero). Recognition element Cryptosporidium. 
Wangetal., 1997. 
Amperometric. Uses enzyme catalysed electro-oxidation or reduction. Recognition element Bacillus subtilis spores. 
most commonly Uithoven et al., 2000. 
antibodies. 
PIEZOELECTRIC (GRAVIMETRIC) 
Quartz Crystal Microbalance. The surface of the crystal is coated with a specific binding molecule, Antibody/ Aptamers. E. coli, Y. pestis and 
binding of target analyte causes an increase in the mass and hence Salmonella dysenteriae. 
increase the resonant frequency of oscillation decreases. Koening and Gratzel, 
1993; Liss et al., 2002. 
Table Al.l continued 
Example Principle Detection elements Examples of 
applications (key 
references.) 
Surface Acoustic Wave Based on surface acoustic wave mode of propagation. These waves Recognition element DNA 
(SAW). possess a longitudinal and a vertical shear component that can couple hybridization. Wu 
with medium at the device interface which alters the amplitude and et al., 1990. 
velocity of the wave. Therefore SAW sensors are sensitive to changes in 
mass. 
Mechanical cantilever. Binding of target analyte to ligand immobilised onto the cantilever is Recognition element. DNA. Zhang and 
detected as adsorption. Stress bends the cantilever either away from or Xu., 2004 
towards the analyte this can be measured using the optical beam 
deflection technique. 
Resonating mechanical Binding of target analyte alters the natural resonant frequency of the Recognition element. Baculovirus. llic et 
cantilever. mechanical oscillator due to a change its total mass on binding. al., 2004. 
Magnetoelectronic 
Magnetoresistive-based Based on the giant magnetoresisti ve effect. Two magnetic layers are used Recognition element DNA. Graham et 
sensor. and a magnetic field applied. When the two layers are aligned the most antibodies/DNA al., 2004). 
resistance is low and when they are anti-parallel in alignment the hybridization. 
resistance is high. Either the target analyte or secondary ligand to the 
target can be magnetically labelled. Recognition elements are 
immobilised onto magnetic field sensors which detect the presence of the 
magnetic label. 
Table Al.l continued 
Example Principle Detection elements Examples of applications 
(key references.) 
Magnetoelastic. Detection of changes in the resonant frequency of the Recognition element. E. coli 0157:H7. (Ruan et 
vibration of the sensor due to an externally applied magnetic al., 2003). 
field. As the mass or elasticity changes on binding of a target 
analyte the resonant frequency changes. These changes can 
be detected using a number of methods (e.g. optically or 
acoustically). 
Electrical A gated ion channel is used for signal transduction, the Recognition Cholera toxin. (Cornell et 
Impedence/Capacitan conductance of the ion channels switches on analyte binding, elements. al., 1997; Song and 
ce/Conductance. this has also be coupled to a change in optical fluorescence on Swanson, 1999). 
Ion channel. anlyte binding. 
SPECTROSCOPY 
Raman. Vibrational spectroscopy. None. (Nelson et al., 1992) 
Surface-enhanced As Raman but using modified surface to enhance the Raman None. E. coli. (Jarvis and 
Raman Spectroscopy. signal. Goodacre, 2004) 
Infrared Absorbance spectra can be obtained from bacteria, however, None. Rossi and Warner, 1985 
spectroscopy. this is difficult to interpret. 
Transmission Surface Measurement of change in surface plasmon absorbance of Recognition element. Biotin/avidin. Lahav et 
Plasmon Resonance discontinuous gold films. al., 2004 
Spectroscopy. 
Table Al.l continued 
Appendix 2 Names and Addresses of suppliers 
Agilent Tecbolgies UK Ltd, Lakeside, Cheadle Royal Business Park., Stockport, 
Cheshire, UK 
Alta Bioscience The University of Birmingham, Edgbaston, Birmingham, UK 
Antbos Labtec Instruments, GmbH, Lagerhausstr. 507,5071, Salzburg, Austria 
Amersbam BioSciences, Chalfont St. Giles, Bucks, UK 
BIAcore, Rapsgatan 7, Uppsala, Sweden 
BioRad, BioRad House, Maylands Avenue, Hemel Hampstead, Herts, UK 
Cepheid 
Eurogentec Ltd. P.C. House, 2 South street, Hythe, Southampton, Hampshire, UK 
ENI Rochester, NY 
Invitrogen, Fountain Road, Inchinnan Business Park, Paisley, UK. 
Harvard Apparatus (a division ofHarvard Bioscience), 84 October Hill Road, Holliston, 
MA, USA. 
Misonix, 1938 New Highway, Farmingdale, NY 11735. 
Molecular Devices Ltd, 660-665 Eskdale Road, Winnersh Triangle, Wokingham, Berks, 
UK 
MWG Biotech, 90 Long Acre, Covent Garden, London, UK 
New England BioLabs (UK) Ltd. 75/77, Know! Piece, Wilbury Way, Hitchin, Herts, UK 
Nunc, BRL, Life Technologies Ltd., Trident House, Washington Road, Paisley, UK 
Oxoid Ltd, Wade Road, Basingstoke, Hampshire, UK 
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'0swell1!0sewiLDNl'X sequencing Ser:v,ices, Soutllampton {lJniversity~ !SouthaptonlhlK 
Perbio. (previouslyEierce ), Century House, High,Street,TattenhaU, .Cheshire, 1l:JK 
PHLS, 6li1 :coHndale Avenue,;Lmidon, 
iSigma; 1FancyRoad Poole, Borset, UK. 
!fhermo l.absystems, Saxon Way ,Bar Hill 1, Ciunbri~ge; UI<, 
Vernitron, ·tlionihill,;southampton,.·ul( 
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